<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>ES2672205T3 - 
  Liver Stem Cells Isolated
 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/ES2672205T3/en">
    <meta name="description" content="
   
    Progenitor cell or human liver stem cell for use in the treatment of a liver disease, wherein said progenitor cell or human liver stem cell is: (i) an isolated human progenitor cell or stem cell originating from human adult liver that it has growth in monolayers, flattened form, wide cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle -actin (ASMA), or (ii) as defined in (i), and is a cell line, or (iii) as defined in (i), and is comprised in A cell population.
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Liver Stem Cells Isolated
 
     ">
    <meta name="DC.date" content="2006-12-14" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    Progenitor cell or human liver stem cell for use in the treatment of a liver disease, wherein said progenitor cell or human liver stem cell is: (i) an isolated human progenitor cell or stem cell originating from human adult liver that it has growth in monolayers, flattened form, wide cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle -actin (ASMA), or (ii) as defined in (i), and is a cell line, or (iii) as defined in (i), and is comprised in A cell population.
   
 
   ">
    <meta name="citation_patent_application_number" content="ES:10192665.7T">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/00/c2/df/7f2744464bbdcd/ES2672205T3.pdf">
    <meta name="citation_patent_number" content="ES:2672205:T3">
    <meta name="DC.date" content="2018-06-13" scheme="issue">
    <meta name="DC.contributor" content="Etienne Sokal" scheme="inventor">
    <meta name="DC.contributor" content="Mustapha Najimi" scheme="inventor">
    <meta name="DC.contributor" content="Universite Catholique de Louvain UCL" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Liver Stem Cells Isolated
 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Spanish</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA338316330" lang="EN" source="national office" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso en el tratamiento de una enfermedad heptica, en la que dicha clula progenitora o clula madre heptica humana es: (i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y -actina de msculo liso (ASMA), o (ii) tal como se define en (i), y es una lnea celular, o (iii) tal como se define en (i), y est comprendida en una poblacin celular.</span>Progenitor cell or human liver stem cell for use in the treatment of a liver disease, wherein said progenitor cell or human liver stem cell is: (i) an isolated human progenitor cell or stem cell originating from human adult liver that it has growth in monolayers, flattened form, wide cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle -actin (ASMA), or (ii) as defined in (i), and is a cell line, or (iii) as defined in (i), and is comprised in A cell population.</span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K35/00"><a id="link" href="#" class="style-scope state-modifier">A61K35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing materials or reaction products thereof with undetermined constitution</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K35/12"><a id="link" href="#" class="style-scope state-modifier">A61K35/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="A61K35/28"><a id="link" href="#" class="style-scope state-modifier">A61K35/28</a></state-modifier>
                  <span class="description style-scope classification-tree">Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K35/00"><a id="link" href="#" class="style-scope state-modifier">A61K35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing materials or reaction products thereof with undetermined constitution</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K35/12"><a id="link" href="#" class="style-scope state-modifier">A61K35/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K35/37"><a id="link" href="#" class="style-scope state-modifier">A61K35/37</a></state-modifier>
                  <span class="description style-scope classification-tree">Digestive system</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K35/407"><a id="link" href="#" class="style-scope state-modifier">A61K35/407</a></state-modifier>
                  <span class="description style-scope classification-tree">Liver; Hepatocytes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P1/00"><a id="link" href="#" class="style-scope state-modifier">A61P1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the alimentary tract or the digestive system</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P1/16"><a id="link" href="#" class="style-scope state-modifier">A61P1/16</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P29/00"><a id="link" href="#" class="style-scope state-modifier">A61P29/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/00"><a id="link" href="#" class="style-scope state-modifier">A61P3/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/00"><a id="link" href="#" class="style-scope state-modifier">A61P3/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/06"><a id="link" href="#" class="style-scope state-modifier">A61P3/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Antihyperlipidemics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/00"><a id="link" href="#" class="style-scope state-modifier">A61P3/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/08"><a id="link" href="#" class="style-scope state-modifier">A61P3/08</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism for glucose homeostasis</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/00"><a id="link" href="#" class="style-scope state-modifier">A61P3/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/08"><a id="link" href="#" class="style-scope state-modifier">A61P3/08</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism for glucose homeostasis</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P3/10"><a id="link" href="#" class="style-scope state-modifier">A61P3/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/08"><a id="link" href="#" class="style-scope state-modifier">A61P31/08</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents for leprosy</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/12"><a id="link" href="#" class="style-scope state-modifier">A61P31/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Antivirals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/12"><a id="link" href="#" class="style-scope state-modifier">A61P31/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Antivirals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/14"><a id="link" href="#" class="style-scope state-modifier">A61P31/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Antivirals for RNA viruses</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/12"><a id="link" href="#" class="style-scope state-modifier">A61P31/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Antivirals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/20"><a id="link" href="#" class="style-scope state-modifier">A61P31/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Antivirals for DNA viruses</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P37/00"><a id="link" href="#" class="style-scope state-modifier">A61P37/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for immunological or allergic disorders</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P37/02"><a id="link" href="#" class="style-scope state-modifier">A61P37/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunomodulators</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P37/06"><a id="link" href="#" class="style-scope state-modifier">A61P37/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunosuppressants, e.g. drugs for graft rejection</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P43/00"><a id="link" href="#" class="style-scope state-modifier">A61P43/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P7/00"><a id="link" href="#" class="style-scope state-modifier">A61P7/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for disorders of the blood or the extracellular fluid</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P7/04"><a id="link" href="#" class="style-scope state-modifier">A61P7/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N5/00"><a id="link" href="#" class="style-scope state-modifier">C12N5/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N5/06"><a id="link" href="#" class="style-scope state-modifier">C12N5/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Animal cells or tissues; Human cells or tissues</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N5/0602"><a id="link" href="#" class="style-scope state-modifier">C12N5/0602</a></state-modifier>
                  <span class="description style-scope classification-tree">Vertebrate cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N5/067"><a id="link" href="#" class="style-scope state-modifier">C12N5/067</a></state-modifier>
                  <span class="description style-scope classification-tree">Hepatocytes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N5/0672"><a id="link" href="#" class="style-scope state-modifier">C12N5/0672</a></state-modifier>
                  <span class="description style-scope classification-tree">Stem cells; Progenitor cells; Precursor cells; Oval cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5005"><a id="link" href="#" class="style-scope state-modifier">G01N33/5005</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5008"><a id="link" href="#" class="style-scope state-modifier">G01N33/5008</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5044"><a id="link" href="#" class="style-scope state-modifier">G01N33/5044</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5067"><a id="link" href="#" class="style-scope state-modifier">G01N33/5067</a></state-modifier>
                  <span class="description style-scope classification-tree">Liver cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 17 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">ES2672205T3</h2>
                  <p class="tagline style-scope patent-result">Spain</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Translation of granted European patent ( former B3)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/00/c2/df/7f2744464bbdcd/ES2672205T3.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;cell&quot;,&quot;cells&quot;,&quot;liver&quot;,&quot;human&quot;,&quot;progenitor&quot;]" data-before="20051221"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/ES2672205T3"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2672205T3/es"><a id="link" href="#" class="style-scope state-modifier">Spanish</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Etienne Sokal"><a id="link" href="#" class="style-scope state-modifier">Etienne Sokal</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Mustapha Najimi"><a id="link" href="#" class="style-scope state-modifier">Mustapha Najimi</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Universite Catholique de Louvain UCL
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2006</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2672205T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES10192665.7T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2006328988B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2006328988A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE602006020071D1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE602006020071T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PL1969118T5/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PL06819033T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ATE498005T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AT06819033T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US8673635B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US12/097,743</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2007071339A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP2006/012046</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN103989710B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201410143665.8A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK1969118T4/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK06819033.9T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2634510C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA2634510A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK2281875T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK10192665.7T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PT2281875T/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PT101926657T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP5250423B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2008546208A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2281875B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP10192665.7A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PL2281875T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PL10192665T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1969118B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP06819033.9A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-14</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2014</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US8778607B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/152,673</div>
                <div class="style-scope application-timeline">Filing date: 2014-01-10</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US9107910B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/294,886</div>
                <div class="style-scope application-timeline">Filing date: 2014-06-03</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2015</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US9775863B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/795,195</div>
                <div class="style-scope application-timeline">Filing date: 2015-07-09</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2017</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US9931360B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US15/686,729</div>
                <div class="style-scope application-timeline">Filing date: 2017-08-25</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application ES10192665.7T events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="litigation style-scope application-timeline"></div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><a target="_blank" class="style-scope application-timeline" href="https://patents.darts-ip.com/?family=37775557&amp;utm_source=google_patent&amp;utm_medium=platform_link&amp;utm_campaign=public_patent_search&amp;patent=ES2672205(T3)"><span class="title-text style-scope application-timeline">First worldwide family litigation filed</span></a><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">"Global patent litigation dataset by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2006-12-14</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Universite Catholique de Louvain UCL"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Universite Catholique de Louvain UCL</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2018-06-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2018-06-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2672205T3/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of ES2672205T3</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Active</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2026-12-14</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (16)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (49)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=ES&amp;NR=2672205T3&amp;KC=T3&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/ES/2672205/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/ES2672205T3">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Spanish</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES138288259" lang="EN" load-source="google" class="style-scope patent-text">
  <p id="p00001" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00002" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00003" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00004" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00005" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00006" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00007" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00008" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00009" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00010" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00011" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00012" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">DESCRIPCION</span>DESCRIPTION</span>
  </p>
  <p id="p00013" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clulas madre hepticas aisladas Campo de la invencin</span>Isolated liver stem cells Field of the invention</span>
  </p>
  <p id="p00014" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente invencin se refiere a clulas progenitoras o clulas madre hepticas aisladas, originadas a partir de hgado adulto, para su uso en medicina, hepatologa, errores congnitos del metabolismo heptico, trasplante, enfermedades infecciosas, insuficiencia heptica. La presente invencin se refiere tambin al uso de estas clulas para toxicologa y farmacologa.</span>The present invention relates to progenitor cells or isolated liver stem cells, originating from adult liver, for use in medicine, hepatology, congenital errors of liver metabolism, transplantation, infectious diseases, liver failure. The present invention also relates to the use of these cells for toxicology and pharmacology.</span>
  </p>
  <p id="p00015" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Antecedentes de la invencin</span>Background of the invention</span>
  </p>
  <p id="p00016" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El hgado es un rgano clave que efecta muchas funciones vitales tales como homeostasis de glucosa, detoxificacin de xenobiticos o sntesis de macromolculas. Por tanto, el deterioro de una de las mltiples funciones hepticas podra tener un impacto drstico sobre la salud. La incidencia mundial de enfermedades hepticas agudas o crnicas establece a estas patologas entre la 5a y 9a causa de muerte, segn la Organizacin Mundial de la Salud. Hasta ahora, el nico tratamiento curativo para enfermedades hepticas terminales sigue siendo el trasplante de hgado. El desenlace para pacientes que se sometieron a sustitucin heptica quirrgica es bastante bueno, con ms de un 95% de recuperacin. Sin embargo, a pesar de las nuevas tcnicas quirrgicas que incluyen trasplante parcial de hgado y de pariente vivo, la creciente escasez de rganos conduce a una mayor mortalidad en la lista de espera. Por lo tanto, es un objetivo importante en la investigacin de la medicina de trasplantes la demostracin del uso potencial de clulas hepticas en regeneracin heptica y el tratamiento de enfermedades hepticas.</span>The liver is a key organ that performs many vital functions such as glucose homeostasis, xenobiotic detoxification or macromolecule synthesis. Therefore, the deterioration of one of the multiple liver functions could have a drastic impact on health. The global incidence of acute or chronic liver diseases establishes these pathologies between the 5th and 9th cause of death, according to the World Health Organization. Until now, the only curative treatment for terminal liver diseases is still liver transplantation. The outcome for patients who underwent surgical liver replacement is quite good, with more than 95% recovery. However, despite new surgical techniques that include partial liver and living relative transplantation, the growing shortage of organs leads to higher waiting list mortality. Therefore, the demonstration of the potential use of liver cells in liver regeneration and the treatment of liver diseases is an important objective in transplant medicine research.</span>
  </p>
  <p id="p00017" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trasplante de clulas hepticas (TCH) es un procedimiento emergente que implica la infusin de una suspensin de clulas hepticas en el sistema portal del receptor. Est orientado a la recuperacin de la funcin heptica del receptor como consecuencia del injerto y repoblacin del parnquima enfermo. El TCH se valid por primera vez en modelos animales en los que se haba demostrado que los hepatocitos singnicos podan sobrevivir indefinidamente y ser capaces de corregir diversos defectos enzimticos (para revisin, vase Najimi y Sokal. 2005. Minerva Pediatr. 57 (5): 243-57).</span>Liver cell transplantation (TCH) is an emerging procedure that involves the infusion of a liver cell suspension into the recipient's portal system. It is oriented to the recovery of the hepatic function of the recipient as a result of grafting and repopulation of the diseased parenchyma. TCH was validated for the first time in animal models in which it had been shown that syngeneic hepatocytes could survive indefinitely and be able to correct various enzyme defects (for review, see Najimi and Sokal. 2005. Minerva Pediatr. 57 (5): 243-57).</span>
  </p>
  <p id="p00018" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En seres humanos, los estudios anteriores se haban diseado para el tratamiento de insuficiencia heptica aguda. Estos estudios alentaron a los facultativos a extender el TCH a indicaciones adicionales y hasta ahora se han notificado al menos 30 casos en todo el mundo para diversos defectos (Strom y col. 1997. Transplant Proc. 29 (4): 2103-6). En el campo especfico de las enfermedades metablicas, 13 casos notificaron el uso de hepatocitos para el tratamiento, entre otros, del sndrome de Crigler-Najjar de tipo I, defectos del ciclo de la urea o enfermedades raras tales como, por ejemplo, enfermedad de Refsum infantil. Estos estudios demostraron el injerto de los hepatocitos en el parnquima y en consecuencia una mejora del estado del paciente hasta 18 meses despus del trasplante.</span>In humans, previous studies had been designed for the treatment of acute liver failure. These studies encouraged physicians to extend TCH to additional indications and so far at least 30 cases have been reported worldwide for various defects (Strom et al. 1997. Transplant Proc. 29 (4): 2103-6). In the specific field of metabolic diseases, 13 cases reported the use of hepatocytes for the treatment, among others, of Crigler-Najjar syndrome type I, urea cycle defects or rare diseases such as, for example, disease of Children's Refsum These studies demonstrated the graft of hepatocytes in the parenchyma and consequently an improvement in the patient's condition up to 18 months after transplantation.</span>
  </p>
  <p id="p00019" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sin embargo, debido a que el suministro de hepatocitos humanos maduros para trasplantes es an limitado, de hecho ms o menos tan limitado como la disponibilidad del hgado completo, la investigacin est tambin orientada a obtener clulas trasplantables de otras fuentes, tales como clulas progenitoras y clulas madre, por ejemplo de origen embrinico o adulto, que podran ser multiplicables, por ejemplo in vitro, y ser capaces de diferenciarse en hepatocitos maduros funcionales, especialmente in vivo despus del trasplante. En consecuencia, hay una gran necesidad de desarrollar nuevos medios que sean tiles en el tratamiento de diversas enfermedades o afecciones asociadas a enfermedades asociadas al hgado, particularmente dados los tratamientos inadecuados disponibles actualmente para la mayora de estos trastornos.</span>However, because the supply of mature human hepatocytes for transplants is still limited, in fact more or less as limited as the availability of the whole liver, research is also aimed at obtaining transplantable cells from other sources, such as progenitor cells and stem cells, for example of embryonic or adult origin, which could be multiplied, for example in vitro, and be able to differentiate into functional mature hepatocytes, especially in vivo after transplantation. Consequently, there is a great need to develop new means that are useful in the treatment of various diseases or conditions associated with liver associated diseases, particularly given the inadequate treatments currently available for most of these disorders.</span>
  </p>
  <p id="p00020" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Histricamente, se crea que los clulas madre embrionarias (CME) estaban implicados solo en la organognesis, debido a su divisin clonal ilimitada observada y a la diferenciacin pluripotente en clulas derivadas de tejidos completos. Por otro lado, los procesos de regeneracin en rganos adultos estaban tpicamente adscritos a las clulas progenitoras adultas. No obstante, se ha revisado esta teora a la vista del descubrimiento de clulas madre en rganos adultos que expresan marcadores embrionarios conocidos. Por tanto, las caracterizaciones de clulas madre y clulas progenitoras estn basadas ahora no solo en el proceso de desarrollo (embrionario frente a adulto), sino tambin en la presencia de marcadores celulares especficos en los mismos. Es ms, la expresin de marcadores celulares, tales como protenas de membrana o factores de transcripcin, puede variar a lo largo de las rutas de diferenciacin y reflejar diversos estmulos (por ejemplo, estmulos ambientales) y necesidades celulares. A menudo, se observa que, en el transcurso de un proceso de diferenciacin, una clula madredejar gradualmente de exhibir marcadores indicativos de su pluripotencia, por ejemplo Oct-4, y ser capaz de expresar marcadores atribuibles a etapas posteriores, por ejemplo, marcadores de un linaje especfico. Como ejemplo no limitante, puede perderse progresivamente Oct-4 durante la maduracin y, por otro lado, las clulas que entran en el linaje endodrmico pueden empezar a expresar a-fetoprotena.</span>Historically, it was believed that embryonic stem cells (CME) were involved only in organogenesis, due to their observed unlimited clonal division and pluripotent differentiation in cells derived from whole tissues. On the other hand, regeneration processes in adult organs were typically ascribed to adult progenitor cells. However, this theory has been reviewed in view of the discovery of stem cells in adult organs that express known embryonic markers. Therefore, the characterizations of stem cells and progenitor cells are now based not only on the development process (embryonic versus adult), but also on the presence of specific cell markers in them. Moreover, the expression of cell markers, such as membrane proteins or transcription factors, can vary along differentiation pathways and reflect various stimuli (eg, environmental stimuli) and cellular needs. It is often observed that, in the course of a differentiation process, a stem cell will gradually stop displaying markers indicative of its pluripotency, for example Oct-4, and will be able to express markers attributable to later stages, for example, markers of A specific lineage. As a non-limiting example, Oct-4 may be progressively lost during maturation and, on the other hand, cells entering the endodermal lineage may begin to express a-fetoprotein.</span>
  </p>
  <p id="p00021" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Con respecto a la regeneracin heptica mediante trasplante de clulas, pueden considerarse varios tipos de clula fuente posibles. Por ejemplo, se esperara que los CE fueran capaces de regenerar cualquier rgano debido a su pluripotencia. Es ms, este camino est extensamente explorado en la tcnica. Sin embargo, los CE tienden a</span>With regard to liver regeneration by cell transplantation, several possible source cell types can be considered. For example, the EC would be expected to be able to regenerate any organ due to its pluripotence. Moreover, this path is extensively explored in the art. However, the EC tend to</span>
  </p>
  <p id="p00022" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00023" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00024" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00025" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00026" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00027" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00028" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00029" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00030" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00031" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00032" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00033" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">generar crecimiento tumoral cuando se introducen en cualquier tejido distinto de tero. Por lo tanto, su uso in vivo contina limitado por el riesgo de desviacin carcinognica. Incluso una diferenciacin exitosa in vitro anterior de los CE podra no ser suficientemente segura para considerar la inoculacin humana.</span>generate tumor growth when introduced into any tissue other than the uterus. Therefore, its use in vivo remains limited by the risk of carcinogenic deviation. Even a previous successful in vitro differentiation of the EC may not be safe enough to consider human inoculation.</span>
  </p>
  <p id="p00034" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sera una alternativa ms segura el uso de clulas progenitoras adultas que, al contrario que los CE, tienden a presentar una capacidad limitada de divisin clonal y su diferenciacin da lugar a clulas derivadas con destinos ms limitados. En el hgado, se han descrito progenitoras adultas tales como clulas ovales (precursoras de colangiocitos y hepatocitos) o clulas de tipo hepatocito pequeas. Sin embargo, su uso mdico se hace difcil por su escasez en rganos adultos normales.</span>It would be a safer alternative to use adult progenitor cells that, unlike the EC, tend to have a limited capacity for clonal division and their differentiation results in derived cells with more limited destinations. In the liver, adult progenitors such as oval cells (cholangiocyte and hepatocyte precursors) or small hepatocyte-like cells have been described. However, its medical use is difficult due to its shortage in normal adult organs.</span>
  </p>
  <p id="p00035" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por consiguiente, representaran una gran mejora en las fuentes de trasplante de clulas madre adultas que mostraran capacidad de divisin clonal con riesgo reducido o ausente de desviacin carcinognica. Se estn evaluando actualmente varios tipos de clulas madre adultas en estudios de trasplante de clulas hepticas. Por ejemplo, se estn estudiando clulas madre mesenquimales (CM) de sangre perifrica o de cordn umbilical debido a su capacidad de transdiferenciarse en clulas maduras adicionales de otro linaje. Adems, las clulas madre hematopoyticas de mdula se han estudiado tambin en trminos de potencias de regeneracin heptica.</span>Therefore, they would represent a great improvement in adult stem cell transplant sources that show clonal division capacity with reduced or absent risk of carcinogenic deviation. Several types of adult stem cells are currently being evaluated in liver cell transplant studies. For example, mesenchymal stem cells (CM) of peripheral blood or umbilical cord are being studied because of their ability to transdifferentiate into additional mature cells of another lineage. In addition, hematopoietic marrow stem cells have also been studied in terms of liver regeneration powers.</span>
  </p>
  <p id="p00036" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Aunque la caracterizacin in vitro de clulas madre adultas sigue presentando dificultades, se acepta actualmente en el campo que dicha caracterizacin puede implicar ventajosamente detectar (i) marcadores de su origen o linaje embrinico (especialmente mesodrmico, endodrmico, ectodrmico o hematopoytico), (ii) la expresin de marcadores que reflejen el nivel de diferenciacin y por tanto en cierta medida predictivos de las diferentes progenies posibles, y (iii) el destino in vitro o in vivo despus de la diferenciacin. Por consiguiente, la caracterizacin y distincin de clulas madre adultas obtenibles a partir de hgado normal puede implicar ventajosamente la evaluacin de la presencia o ausencia de (i) marcadores que reflejen el origen embrinico complejo de este rgano, (ii) marcadores de diferenciacin (por ejemplo, de la presencia de albmina) y (iii) al menos un marcador indicativo del destino de la clula madre.</span>Although in vitro characterization of adult stem cells continues to present difficulties, it is currently accepted in the field that such characterization may advantageously involve detecting (i) markers of their origin or embryonic lineage (especially mesodermal, endodermal, ectodermal or hematopoietic), (ii) the expression of markers that reflect the level of differentiation and therefore to some extent predictive of the different possible progenies, and (iii) the destination in vitro or in vivo after differentiation. Therefore, the characterization and distinction of adult stem cells obtainable from normal liver may advantageously imply the evaluation of the presence or absence of (i) markers that reflect the complex embryonic origin of this organ, (ii) differentiation markers (by example, of the presence of albumin) and (iii) at least one marker indicative of the destination of the stem cell.</span>
  </p>
  <p id="p00037" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Segn el conocimiento actual, el hgado se origina principalmente a partir del endodermo y los hepatocitos son parte del linaje endodrmico. Sin embargo, la formacin de clulas hepticas implica tambin la interaccin entre el epitelio endodrmico y el mesodermo cardiognico. Adems, en el desarrollo fetal, la hematopoyesis tiene lugar tambin en el hgado. Dada esta interaccin durante el desarrollo, no hay que tener prejuicios cuando se contemplan los marcadores presentes en clulas madre hepticas, puesto que podran esperarse linajes endodrmico, mesodrmico y/o hematopoytico.</span>According to current knowledge, the liver originates mainly from the endoderm and hepatocytes are part of the endodermal lineage. However, the formation of liver cells also involves the interaction between the endodermal epithelium and the cardiogenic mesoderm. In addition, in fetal development, hematopoiesis also occurs in the liver. Given this interaction during development, it is not necessary to have prejudices when considering the markers present in liver stem cells, since endodermal, mesodermal and / or hematopoietic lineages could be expected.</span>
  </p>
  <p id="p00038" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cuando se valora el nivel de diferenciacin y asignacin de tipo celular, pueden evaluarse diferentes marcadores celulares, como se lleva a cabo adicionalmente en esta divulgacin. Por ejemplo, durante el proceso de diferenciacin de clulas pueden reducirse o desaparecer algunos marcadores, otros pueden aumentar u obtenerse y an otros pueden recorrer todo el camino hasta una clula especializada y funcional. A modo de ejemplo no limitante, durante la organognesis, concretamente durante la vida fetal, se considera que los hepatoblastos son los progenitores comunes de las clulas que forman el parnquima (especialmente hepatocitos y clulas biliares) y que expresan entre otros citoqueratina 7 (CK-7) as como CK-19, albmina y a-fetoprotena. En el hgado adulto, un progenitor comn conocido para hepatocitos y clulas biliares es la clula oval, que expresa CK-19, albmina y a- fetoprotena. Despus de la diferenciacin en clulas biliares, se mantiene la expresin de CK-19 y a-fetoprotena, mientras que la expresin de CK-7 (considerada un rasgo de clulas ms inmaduras) tiende a cesar. Por otro lado, los hepatocitos mantienen la expresin de a-fetoprotena y albmina, pero no muestran expresin de las CK anteriores. Tambin a partir de este ejemplo, se deduce que la caracterizacin de las clulas madre puede ser compleja, pero que puede usarse ventajosamente la valoracin de los marcadores para indicar el tipo o propiedades de las clulas.</span>When the level of differentiation and assignment of cell type is assessed, different cell markers can be evaluated, as further carried out in this disclosure. For example, during the cell differentiation process some markers may be reduced or disappear, others may increase or be obtained and still others may go all the way to a specialized and functional cell. As a non-limiting example, during organogenesis, specifically during fetal life, hepatoblasts are considered to be the common progenitors of the cells that form the parenchyma (especially hepatocytes and bile cells) and that express among other cytokeratin 7 (CK- 7) as well as CK-19, albumin and a-fetoprotein. In the adult liver, a common progenitor known for hepatocytes and bile cells is the oval cell, which expresses CK-19, albumin and a-fetoprotein. After differentiation into bile cells, the expression of CK-19 and a-fetoprotein is maintained, while the expression of CK-7 (considered a more immature cell trait) tends to cease. On the other hand, hepatocytes maintain the expression of a-fetoprotein and albumin, but do not show expression of the above CK. Also from this example, it follows that the characterization of the stem cells can be complex, but that the evaluation of the markers can be advantageously used to indicate the type or properties of the cells.</span>
  </p>
  <p id="p00039" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El documento WO 03/000848 da a conocer el aislamiento de un determinado tipo de clulas progenitoras hepticas humanas a partir de hgado adulto humano. Chagraoui et al. (Blood, 2003, vol. 101, n. 8, 2973-2982) y Zhang et al. (Cell Biology International, 2005, vol. 29, n. 3, 213-219) estudian determinadas poblaciones celulares de hgado fetal.</span>WO 03/000848 discloses the isolation of a certain type of human liver progenitor cells from human adult liver. Chagraoui et al. (Blood, 2003, vol. 101, No. 8, 2973-2982) and Zhang et al. (Cell Biology International, 2005, vol. 29, no. 3, 213-219) study certain fetal liver cell populations.</span>
  </p>
  <p id="p00040" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Al entender de los inventores, los estudios previos describan el aislamiento de clulas progenitoras a partir de hgado adulto normal, mostrando dichas clulas ms de un destino celular. No se ha descrito una lnea de clulas madre hepticas adultas capaz de amplificacin in vitro y diferenciacin in vivo en hepatocitos, y preferiblemente con solo el destino celular de hepatocito. Adems, los estudios previos usaban tcnicas complicadas, tales como FACS, medios suplementados con calcio o gradientes de densidad especfica para aislar sus clulas madre hepticas.</span>In understanding the inventors, previous studies described the isolation of progenitor cells from normal adult liver, said cells showing more than one cell destination. An adult liver stem cell line capable of in vitro amplification and differentiation in vivo in hepatocytes, and preferably with only hepatocyte cell fate, has not been described. In addition, previous studies used complicated techniques, such as FACS, calcium supplemented media or specific density gradients to isolate their liver stem cells.</span>
  </p>
  <p id="p00041" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En consecuencia, es un objeto de la invencin proporcionar clulas progenitoras o clulas madre derivadas de hgado adulto novedosos con propiedades mejoradas y particularmente tiles, por ejemplo, en trasplante de clulas hepticas. La memoria descriptiva tambin pretende proporcionar un procedimiento sencillo para aislar dichas clulas.</span>Accordingly, it is an object of the invention to provide novel adult liver-derived progenitor cells or stem cells with improved and particularly useful properties, for example, in liver cell transplantation. The specification also aims to provide a simple procedure for isolating said cells.</span>
  </p>
  <p id="p00042" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sumario de la invencin</span>Summary of the invention</span>
  </p>
  <p id="p00043" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00044" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00045" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00046" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00047" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00048" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00049" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00050" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00051" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00052" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00053" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe clulas progenitoras o clulas madre derivadas de hgado adulto, lneas celulares de los mismos o poblaciones celulares que comprenden los mismos, obtenidos a partir de un tejido heptico normal. Se describen tambin en la presente memoria descriptiva procedimientos de aislamiento de estas clulas, su cultivo, caracterizacin antes y despus de la diferenciacin y su uso para trasplante, modelos animales de enfermedad humana, toxicologa y farmacologa.</span>The present specification describes progenitor cells or stem cells derived from adult liver, cell lines thereof or cell populations comprising the same, obtained from normal liver tissue. Methods of isolation of these cells, their culture, characterization before and after differentiation and their use for transplantation, animal models of human disease, toxicology and pharmacology are also described herein.</span>
  </p>
  <p id="p00054" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente invencin proporciona la materia en cuestin como se expone en todos y cada uno de los puntos (i) a (xxxiv) a continuacin:</span>The present invention provides the subject matter as set forth in each and every one of items (i) to (xxxiv) below:</span>
  </p>
  <p id="p00055" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre heptica humana para su uso en el tratamiento de una enfermedad heptica, en la que dicha clula progenitora o clula madre heptica humana es:</span>(i) a progenitor cell or human liver stem cell for use in the treatment of a liver disease, wherein said progenitor cell or human liver stem cell is:</span>
  </p>
  <p id="p00056" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i ') an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
  </p>
  <p id="p00057" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') tal como se define en (i'), y es una lnea celular, o</span>(ii ') as defined in (i'), and is a cell line, or</span>
  </p>
  <p id="p00058" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii') tal como se define en (i'), y est comprendida en una poblacin celular.</span>(iii ') as defined in (i'), and is comprised in a cell population.</span>
  </p>
  <p id="p00059" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en (i) anteriormente, en la que dicha clula progenitora o clula madre humana aislada es tambin negativa para citoqueratina-19 (CK-19) y CD133.</span>(ii) The progenitor cell or human liver stem cell for use as set forth in (i) above, wherein said progenitor cell or isolated human stem cell is also negative for cytokeratin-19 (CK-19) and CD133.</span>
  </p>
  <p id="p00060" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en (i) o (ii) anteriormente, en la que dicha clula progenitora o clula madre humana aislada expresa adems una, ms de una o todas de las siguientes molculas: CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>(iii) The progenitor cell or human liver stem cell for use as set forth in (i) or (ii) above, wherein said progenitor cell or isolated human stem cell further expresses one, more than one or all of the following molecules: CD49e, CD13, CD54 and major histocompatibility complex (MHC) class I (HLA-ABC).</span>
  </p>
  <p id="p00061" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iv) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en cualquiera de (i) a (iii) anteriormente, en la que la enfermedad heptica es fenilcetonuria y otras aminoacidopatas, hemofilia y otras deficiencias de factor de coagulacin, hipercolesterolemia familiar y otros trastornos del metabolismo lipdico, trastornos del ciclo de la urea, glucogenosis, galactosemia, fructosemia, tirosinemia, deficiencias del metabolismo de protenas e hidratos de carbono, aciduria orgnica, enfermedades mitocondriales, trastornos peroxismicos y lisosmicos, anomalas de la sntesis de protenas, defectos de transportadores de clulas hepticas, defecto de glucosilacin, hepatitis, cirrosis, errores congnitos del metabolismo, insuficiencia heptica aguda, infecciones hepticas agudas, toxicidad qumica aguda, insuficiencia heptica crnica, colangitis, cirrosis biliar, sndrome de Alagille, deficiencia de a-1-antitripsina, hepatitis autoinmune, atresia biliar, cncer de hgado, enfermedad qustica del hgado, esteatosis heptica, galactosemia, clculos biliares, sndrome de Gilbert, hemocromatosis, hepatitis A, hepatitis B, hepatitis C y otras infecciones vricas de hepatitis, porfiria, colangitis esclerosante primaria, sndrome de Reye, sarcoidosis, tirosinemia, enfermedad de almacenamiento de glucgeno de tipo 1 o enfermedad de Wilson.</span>(iv) The progenitor cell or human liver stem cell for use as set forth in any of (i) to (iii) above, in which the liver disease is phenylketonuria and other aminoacidopathies, hemophilia and other coagulation factor deficiencies , familial hypercholesterolemia and other disorders of lipid metabolism, urea cycle disorders, glycogenosis, galactosemia, fructosemia, tyrosinemia, deficiencies of carbohydrate and protein metabolism, organic aciduria, mitochondrial diseases, peroxisomal and lysosomal disorders, synthesis abnormalities of proteins, liver cell transporter defects, glycosylation defect, hepatitis, cirrhosis, congenital metabolism errors, acute liver failure, acute liver infections, acute chemical toxicity, chronic liver failure, cholangitis, biliary cirrhosis, Alagille syndrome, deficiency of a-1-antitrypsin, autoimmune hepatitis, biliary atresia, liver cancer, cystic liver disease, liver steatosis, galactosemia, gallstones, Gilbert's syndrome, hemochromatosis, hepatitis A, hepatitis B, hepatitis C and other viral infections of hepatitis, porphyria, primary sclerosing cholangitis, Reye's syndrome , sarcoidosis, tyrosinemia, type 1 glycogen storage disease or Wilson's disease.</span>
  </p>
  <p id="p00062" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(v) Un procedimiento de realizacin de pruebas de toxicidad in vitro que comprende exponer a un agente de prueba una clula progenitora o clula madre heptica humana y observar al menos un efecto sobre la viabilidad celular, funcin celular o ambas, en el que dicha clula progenitora o clula madre heptica humana es:</span>(v) A method of conducting in vitro toxicity tests comprising exposing a progenitor cell or human liver stem cell to a test agent and observing at least one effect on cell viability, cell function or both, in which said cell Progenitor or human liver stem cell is:</span>
  </p>
  <p id="p00063" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') un clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i ') an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
  </p>
  <p id="p00064" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') tal como se define en (i'), y es una lnea celular, o</span>(ii ') as defined in (i'), and is a cell line, or</span>
  </p>
  <p id="p00065" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii') tal como se define en (i'), y est comprendida en una poblacin celular.</span>(iii ') as defined in (i'), and is comprised in a cell population.</span>
  </p>
  <p id="p00066" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(vi) Un procedimiento de realizacin de estudios de metabolismo de frmacos in vitro, que comprende exponer a un agente de prueba una clula progenitora o clula madre heptica humana y observar un cambio en la estructura, concentracin o ambas del agente de prueba, en el que dicha clula progenitora o clula madre heptica humana es:</span>(vi) A method of conducting in vitro drug metabolism studies, which comprises exposing a progenitor cell or human liver stem cell to a test agent and observing a change in the structure, concentration or both of the test agent, in the that said progenitor cell or human liver stem cell is:</span>
  </p>
  <p id="p00067" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de</span>(i ') an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of</span>
  </p>
  <p id="p00068" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00069" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00070" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00071" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00072" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00073" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00074" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00075" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00076" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00077" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
  </p>
  <p id="p00078" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') tal como se define en (i'), y es una lnea celular, o</span>(ii ') as defined in (i'), and is a cell line, or</span>
  </p>
  <p id="p00079" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(Ni') tal como se define en (i'), y est comprendida en una poblacin celular.</span>(Ni ') as defined in (i'), and is comprised in a cell population.</span>
  </p>
  <p id="p00080" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(vii) Un procedimiento de realizacin de pruebas para detectar agentes para tratar infecciones hepticas, que comprende infectar con un agente infeccioso vrico de inters una clula progenitora o clula madre heptica humana y proporcionar una poblacin infectada, exponer la poblacin infectada a una cantidad predeterminada de agente de prueba, y observar los efectos, si los hay, de la exposicin de dicha cantidad predeterminada de agente de prueba sobre la replicacin vrica del agente infeccioso vrico en la poblacin infectada, y en el que dicha clula progenitora o clula madre heptica humana es:</span>(vii) A test procedure for detecting agents for treating liver infections, which comprises infecting a progenitor cell or human liver stem cell with a viral infectious agent of interest and providing an infected population, exposing the infected population to a predetermined amount of test agent, and observe the effects, if any, of the exposure of said predetermined amount of test agent on viral replication of the viral infectious agent in the infected population, and in which said progenitor cell or human liver stem cell is :</span>
  </p>
  <p id="p00081" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i ') an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
  </p>
  <p id="p00082" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') tal como se define en (i'), y es una lnea celular, o</span>(ii ') as defined in (i'), and is a cell line, or</span>
  </p>
  <p id="p00083" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii') tal como se define en (i'), y est comprendida en una poblacin celular.</span>(iii ') as defined in (i'), and is comprised in a cell population.</span>
  </p>
  <p id="p00084" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(viii) El procedimiento tal como se expuso en (vii) anteriormente, en el que el agente infeccioso incluye un virus de la hepatitis.</span>(viii) The procedure as set forth in (vii) above, in which the infectious agent includes a hepatitis virus.</span>
  </p>
  <p id="p00085" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ix) Un procedimiento de produccin de una protena de inters que comprende introducir en una clula progenitora o clula madre heptica humana un gen funcional que codifica una protena de inters, incubar la poblacin de las clulas progenitoras o clulas madre hepticas en condiciones eficaces para la transcripcin y traduccin, y recoger la protena de inters, y en el que dicha clula progenitora o clula madre heptica humana es</span>(ix) A method of producing a protein of interest comprising introducing into a progenitor cell or human liver stem cell a functional gene encoding a protein of interest, incubating the population of the progenitor cells or liver stem cells under conditions effective for the transcription and translation, and collect the protein of interest, and wherein said progenitor cell or human liver stem cell is</span>
  </p>
  <p id="p00086" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i ') an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
  </p>
  <p id="p00087" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') tal como se define en (i'), y es una lnea celular, o</span>(ii ') as defined in (i'), and is a cell line, or</span>
  </p>
  <p id="p00088" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii') tal como se define en (i'), y est comprendida en una poblacin celular.</span>(iii ') as defined in (i'), and is comprised in a cell population.</span>
  </p>
  <p id="p00089" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(x) El procedimiento tal como se expuso en (ix) anteriormente en el que la protena de inters comprende un antgeno de vacuna.</span>(x) The method as set forth in (ix) above in which the protein of interest comprises a vaccine antigen.</span>
  </p>
  <p id="p00090" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xi) El procedimiento tal como se expuso en cualquiera de (v) a (x) anteriormente en el que dicha clula progenitora o clula madre humana aislada es tambin negativa para citoqueratina-19 (CK-19) y CD133.</span>(xi) The procedure as set forth in any of (v) to (x) above wherein said isolated progenitor cell or human stem cell is also negative for cytokeratin-19 (CK-19) and CD133.</span>
  </p>
  <p id="p00091" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xii) El procedimiento tal como se expuso en cualquiera de (v) a (xi) anteriormente en el que dicha clula progenitora o clula madre humana aislada expresa adems una, ms de una o todas de las siguientes molculas: CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLAABC).</span>(xii) The procedure as set forth in any of (v) to (xi) above in which said isolated progenitor cell or human stem cell further expresses one, more than one or all of the following molecules: CD49e, CD13, CD54 and major class I histocompatibility complex (MHC) (HLAABC).</span>
  </p>
  <p id="p00092" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xiii) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en cualquiera de (i) a (iv) anteriormente, o el procedimiento tal como se expuso en cualquiera de (v) a (xii) anteriormente, en el que dicha clula progenitora o clula madre heptica humana aislada es:</span>(xiii) The progenitor cell or human liver stem cell for use as set forth in any of (i) to (iv) above, or the procedure as set forth in any of (v) to (xii) above, in which said progenitor cell or isolated human liver stem cell is:</span>
  </p>
  <p id="p00093" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') negativa para CD45, CD34, CD117, CD133 y CK-19; y</span>(i ') negative for CD45, CD34, CD117, CD133 and CK-19; Y</span>
  </p>
  <p id="p00094" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') positiva para CD90, CD29 CD44, vimentina, ASMA y ALB.</span>(ii ') positive for CD90, CD29 CD44, vimentin, ASMA and ALB.</span>
  </p>
  <p id="p00095" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xiv) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en cualquiera de (i) a (iv) anteriormente, o el procedimiento tal como se expuso en cualquiera de (v) a (xii) anteriormente, en el que dicha clula progenitora o clula madre heptica humana aislada es:</span>(xiv) The progenitor cell or human liver stem cell for use as set forth in any of (i) to (iv) above, or the procedure as set forth in any of (v) to (xii) above, in which said progenitor cell or isolated human liver stem cell is:</span>
  </p>
  <p id="p00096" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') negativa para CD45, CD34, CD117, CD133 y CK-19;</span>(i ') negative for CD45, CD34, CD117, CD133 and CK-19;</span>
  </p>
  <p id="p00097" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') positiva para CD90, CD29 CD44, vimentina, ASMA y ALB; y</span>(ii ') positive for CD90, CD29 CD44, vimentin, ASMA and ALB; Y</span>
  </p>
  <p id="p00098" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00099" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00100" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00101" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00102" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00103" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00104" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00105" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00106" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00107" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00108" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii') expresa adems CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA- ABC).</span>(iii ') also expresses CD49e, CD13, CD54 and major class I histocompatibility complex (MHC) (HLA-ABC).</span>
  </p>
  <p id="p00109" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xv) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en cualquiera de (i) a (iv) anteriormente, o el procedimiento tal como se expuso en cualquiera de (v) a (xii) anteriormente, en el que la clula progenitora o clula madre heptica humana puede diferenciarse en hepatocitos y no se diferencia en osteocitos o adipocitos.</span>(xv) The progenitor cell or human liver stem cell for use as set forth in any of (i) to (iv) above, or the procedure as set forth in any of (v) to (xii) above, in that the progenitor cell or human liver stem cell can differentiate into hepatocytes and does not differ into osteocytes or adipocytes.</span>
  </p>
  <p id="p00110" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xvi) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en cualquiera de (i) a</span>(xvi) The progenitor cell or human liver stem cell for use as set forth in any of (i) a</span>
  </p>
  <p id="p00111" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iv) anteriormente, o el procedimiento tal como se expuso en cualquiera de (v) a (xii) anteriormente, en el que la clula progenitora o clula madre heptica humana se modifica adems genticamente.</span>(iv) above, or the procedure as set forth in any of (v) to (xii) above, in which the progenitor cell or human liver stem cell is also genetically modified.</span>
  </p>
  <p id="p00112" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xvii) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en (xvi) anteriormente o el procedimiento tal como se expuso en (xvi) anteriormente, en el que dicha clula se modifica genticamente para aumentar su capacidad replicativa.</span>(xvii) The progenitor cell or human liver stem cell for use as set forth in (xvi) above or the procedure as set forth in (xvi) above, in which said cell is genetically modified to increase its replicative capacity.</span>
  </p>
  <p id="p00113" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xviii) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en (xvi) anteriormente o el procedimiento tal como se expuso en (xvi) anteriormente, en el que dicha clula se transfecta o se transforma de manera estable o transitoria con un cido nucleico que codifica un producto gnico que potencia el crecimiento, la diferenciacin y/o el funcionamiento de dicha clula.</span>(xviii) The progenitor cell or human liver stem cell for use as set forth in (xvi) above or the procedure as set forth in (xvi) above, in which said cell is transfected or stably transformed or transient with a nucleic acid that encodes a gene product that enhances the growth, differentiation and / or functioning of said cell.</span>
  </p>
  <p id="p00114" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xix) La clula progenitora o clula madre heptica humana para su uso tal como se expuso en (xvi) anteriormente o el procedimiento tal como se expuso en (xvi) anteriormente, en el que dicha clula se modifica genticamente para sobreexpresar de manera constitutiva o inducible un polipptido normalmente expresado por hepatocitos.</span>(xix) The progenitor cell or human liver stem cell for use as set forth in (xvi) above or the procedure as set forth in (xvi) above, in which said cell is genetically modified to constitutively overexpress inducible a polypeptide normally expressed by hepatocytes.</span>
  </p>
  <p id="p00115" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xx) La clula progenitora o clula madre heptica humana modificada genticamente para su uso tal como se expuso en (xix) anteriormente o el procedimiento tal como se expuso en (xix) anteriormente, en el que dicha clula se modifica genticamente para sobreexpresar de manera constitutiva o inducible un polipptido seleccionado del grupo que consiste en ornitina transcarbamilasa, argininosuccinato sintetasa, argininosuccinato liasa, arginasa, fosfato de carbamilo sintasa, glutamato de N-acetilo sintasa, glutamina sintetasa, glucgeno sintetasa, glucosa-6- fosfatasa, succinato deshidrogenasa, glucocinasa, piruvato cinasa, acetil CoA carboxilasa, cido graso sintetasa, alanina aminotransferasa, glutamato deshidrogenasa, ferritina, receptor de lipoprotena de baja densidad (LDL), enzimas P450, alcohol deshidrogenasa, albmina, transferrina, componente C3 del complemento, a2- macroglobulina, fibringeno, factor XIII, factor IX y a1-antitripsina.</span>(xx) The progenitor cell or genetically modified human liver stem cell for use as set forth in (xix) above or the procedure as set forth in (xix) above, in which said cell is genetically modified to overexpress in a manner constitutive or inducible a polypeptide selected from the group consisting of ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, arginase, carbamyl synthase phosphate, N-acetyl synthetase, glutamine synthetase, glycogen synthetase, glucose-6- phosphatasease, succinate-glucose , pyruvate kinase, acetyl CoA carboxylase, fatty acid synthetase, alanine aminotransferase, glutamate dehydrogenase, ferritin, low density lipoprotein receptor (LDL), P450 enzymes, alcohol dehydrogenase, albumin, transferrin, component C3, a2-macroglobulin, fibrinogen, fibrinogen , factor XIII, factor IX and a1-antitrypsin.</span>
  </p>
  <p id="p00116" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxi) La clula progenitora o clula madre heptica humana modificada genticamente para su uso tal como se expuso en (xvi) anteriormente, en la que dicha clula se modifica genticamente para expresar una hormona o un anticuerpo, y en la que dicha hormona o anticuerpo se secreta en la circulacin.</span>(xxi) The genetically modified human liver stem cell or progenitor cell for use as set forth in (xvi) above, wherein said cell is genetically modified to express a hormone or an antibody, and wherein said hormone or antibody It is secreted in the circulation.</span>
  </p>
  <p id="p00117" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxii) Una composicin farmacutica para su uso en el tratamiento de una enfermedad heptica que comprende:</span>(xxii) A pharmaceutical composition for use in the treatment of a liver disease comprising:</span>
  </p>
  <p id="p00118" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- una clula progenitora o clula madre heptica humana, en la que dicha clula progenitora o clula madre heptica humana es:</span>- a progenitor cell or human liver stem cell, wherein said progenitor cell or human liver stem cell is:</span>
  </p>
  <p id="p00119" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i') una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i ') an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one lymphohematopoietic lineage marker selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
  </p>
  <p id="p00120" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii') tal como se define en (i'), y es una lnea celular, o</span>(ii ') as defined in (i'), and is a cell line, or</span>
  </p>
  <p id="p00121" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii') tal como se define en (i'), y est comprendida en una poblacin celular; y</span>(iii ') as defined in (i'), and is comprised in a cell population; Y</span>
  </p>
  <p id="p00122" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- un portador farmacuticamente aceptable.</span>- a pharmaceutically acceptable carrier.</span>
  </p>
  <p id="p00123" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxiii) La composicin farmacutica para su uso tal como se expuso en (xxii) anteriormente, en la que dicha clula progenitora o clula madre humana aislada es tambin negativa para citoqueratina-19 (CK-19) y CD133.</span>(xxiii) The pharmaceutical composition for use as set forth in (xxii) above, wherein said progenitor cell or isolated human stem cell is also negative for cytokeratin-19 (CK-19) and CD133.</span>
  </p>
  <p id="p00124" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxiv) La composicin farmacutica para su uso tal como se expuso en (xxii) o (xxiii) anteriormente, en la que dicha clula progenitora o clula madre humana aislada expresa adems una, ms de una o todas de las siguientes molculas: CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>(xxiv) The pharmaceutical composition for use as set forth in (xxii) or (xxiii) above, wherein said isolated progenitor cell or human stem cell further expresses one, more than one or all of the following molecules: CD49e, CD13, CD54 and major class I histocompatibility complex (MHC) (HLA-ABC).</span>
  </p>
  <p id="p00125" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxv) La composicin farmacutica para su uso tal como se expuso en cualquiera de (xxii) a (xxiv) anteriormente, en la que dicha clula progenitora o clula madre heptica humana se modifica adems genticamente.</span>(xxv) The pharmaceutical composition for use as set forth in any of (xxii) to (xxiv) above, wherein said progenitor cell or human liver stem cell is further genetically modified.</span>
  </p>
  <p id="p00126" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxvi) La composicin farmacutica para su uso tal como se expuso en cualquiera de (xxii) a (xxv) anteriormente, en la que dicha composicin farmacutica se formula en una forma de dosificacin unitaria inyectable.</span>(xxvi) The pharmaceutical composition for use as set forth in any of (xxii) to (xxv) above, wherein said pharmaceutical composition is formulated in an injectable unit dosage form.</span>
  </p>
  <p id="p00127" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00128" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00129" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00130" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00131" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00132" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00133" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00134" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00135" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00136" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00137" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00138" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La materia en cuestin proporcionada por la invencin pertenece por tanto especficamente a la divulgacin, descripcin y enseanzas de la presente memoria descriptiva.</span>The subject matter provided by the invention therefore pertains specifically to the disclosure, description and teachings of the present specification.</span>
  </p>
  <p id="p00139" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una clula progenitora o clula madre aislada novedosa (una clula de vertebrado, preferiblemente de mamfero, an ms preferiblemente humana), originada a partir de hgado adulto, caracterizada porque expresa simultneamente (concretamente es positivo para) al menos un marcador mesenquimal, especialmente uno, ms de uno, por ejemplo 2, 3 o 4, o todos los marcadores CD90, CD44, CD73, vimentina y a-actina de msculo liso (ASMA), con el marcador de hepatocito albmina (ALB) y posiblemente con uno o ms de otros marcadores hepticos o de hepatocitos, preferiblemente uno, ms de uno o todos de CD29, a- fetoprotena (AFP), a-1-antitripsina y/o transportador MRP2. Dicha clula progenitora o clula madre heptica adulta puede expresar adicionalmente una, ms de una o todas las siguientes molculas indicativas de propiedades o funciones de tipo hepatocito: G6P, CYP1B1, CYP3A4, HNF-4, TDO, TAT, GS, GGT, CK8, EAAT2. Dicha clula progenitora o clula madre heptica adulta puede caracterizarse adicionalmente por uno, ms de uno o todos los siguientes: negativo para al menos los marcadores hematopoyticos CD45 y CD34 y posiblemente tambin de uno o ms de otros marcadores hematopoyticos tales como, por ejemplo, CD105, HLA-DR, negativo del marcador epitelial colangioctico citoqueratina 19 (CK-19) y posiblemente de ms marcadores epiteliales; negativo para al menos los marcadores de clulas madre indiferenciadas CD117 y Oct-4 y posiblemente tambin de uno o ms de un marcador de clulas madre embrionarias; y bajo nivel de expresin de AFP. Preferiblemente, dicha clula progenitora o clula madre heptica adulta puede tener una morfologa de tipo mesenquimtica, en particular que implica uno o ms de uno o todos de crecimiento en monocapas, forma aplanada, citoplasma amplio y/o ncleos ovoides con uno o dos nucleolos.</span>The present specification also describes a novel progenitor cell or isolated stem cell (a vertebrate, preferably mammalian, even more preferably human) cell, originated from adult liver, characterized in that it simultaneously expresses (specifically is positive for) at least one mesenchymal marker, especially one, more than one, for example 2, 3 or 4, or all CD90, CD44, CD73, vimentin and smooth muscle a-actin (ASMA) markers, with the albumin hepatocyte (ALB) marker and possibly with one or more other hepatic or hepatocyte markers, preferably one, more than one or all of CD29, a-fetoprotein (AFP), a-1-antitrypsin and / or MRP2 transporter. Said progenitor cell or adult liver stem cell may additionally express one, more than one or all of the following molecules indicative of hepatocyte-like properties or functions: G6P, CYP1B1, CYP3A4, HNF-4, TDO, TAT, GS, GGT, CK8, EAAT2. Said progenitor cell or adult liver stem cell can be further characterized by one, more than one or all of the following: negative for at least the hematopoietic markers CD45 and CD34 and possibly also one or more other hematopoietic markers such as, for example, CD105 , HLA-DR, negative of the cytokeratin cholangiocytic epithelial marker 19 (CK-19) and possibly more epithelial markers; negative for at least the undifferentiated CD117 and Oct-4 stem cell markers and possibly also one or more of an embryonic stem cell marker; and low level of AFP expression. Preferably, said progenitor cell or adult liver stem cell may have a mesenchymal type morphology, in particular that involves one or more of one or all of growth in monolayers, flattened form, wide cytoplasm and / or ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00140" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una clula madre aislada originada a partir de hgado humano que es positiva para CD90, CD29 y CD44, que es positiva para albmina, positiva para vimentina y positiva para a- actina de msculo liso. La memoria descriptiva describe que los clulas madre aisladas son tambin negativos de CK-19, negativos de CD45, negativos de CD34 y negativos de CD117. La presente memoria descriptiva describe tambin una poblacin celular que comprende clulas madre mesenquimales progenitores que tienen al menos tres de las siguientes caractersticas: expresin de albmina detectable por anticuerpo; expresin de vimentina detectable por anticuerpo; expresin de a-actina de msculo liso detectable por anticuerpo; ausencia de CK-19; ausencia de CD45, ausencia de marcador CD45, ausencia de marcador CD34, ausencia de marcador CD117, evidencia de marcador CD90, evidencia de marcador CD29 o evidencia de marcador CD44. Preferiblemente, las clulas tienen todas las caractersticas anteriormente enumeradas. La memoria descriptiva describe que las clulas madre son clulas madre hepticas humanas.</span>The present specification also describes an isolated stem cell originating from human liver that is positive for CD90, CD29 and CD44, which is positive for albumin, positive for vimentin and positive for smooth muscle a-actin. The description describes that the isolated stem cells are also CK-19 negative, CD45 negative, CD34 negative and CD117 negative. The present specification also describes a cell population comprising progenitor mesenchymal stem cells having at least three of the following characteristics: albumin expression detectable by antibody; vimentin expression detectable by antibody; smooth muscle a-actin expression detectable by antibody; absence of CK-19; absence of CD45, absence of CD45 marker, absence of CD34 marker, absence of CD117 marker, evidence of CD90 marker, evidence of CD29 marker or evidence of CD44 marker. Preferably, the cells have all the characteristics listed above. The description describes that the stem cells are human liver stem cells.</span>
  </p>
  <p id="p00141" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe que la clula madre aislada originada a partir de hgado adulto es positiva para CD90, CD73, CD29 y CD44 y positiva para albmina, positiva para vimentina y positiva para a-actina de msculo liso.</span>The present specification describes that the isolated stem cell originated from adult liver is positive for CD90, CD73, CD29 and CD44 and positive for albumin, positive for vimentin and positive for a-actin smooth muscle.</span>
  </p>
  <p id="p00142" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento para obtener una clula progenitora o clula madre aislada o una poblacin celular que comprende dicha clula progenitora o clula madre, comprendiendo el procedimiento: (a) disociar hgado adulto o una parte del mismo formando una poblacin de clulas primarias a partir de dicho hgado adulto o parte del mismo, (b) sembrar la poblacin de clulas primarias sobre un sustrato que permita la adherencia de clulas sobre el mismo y (c) cultivar las clulas de la poblacin de clulas primarias, que se han adherido a dicho sustrato, durante al menos 7 das, preferiblemente al menos 10, al menos 13 o al menos 15 das.</span>The present specification also describes a method for obtaining an isolated progenitor cell or stem cell or a cell population comprising said progenitor cell or stem cell, the method comprising: (a) dissociating adult liver or a part thereof forming a population of cells primary from said adult liver or part thereof, (b) sow the population of primary cells on a substrate that allows the adhesion of cells on it and (c) cultivate the cells of the population of primary cells, which have been adhered to said substrate, for at least 7 days, preferably at least 10, at least 13 or at least 15 days.</span>
  </p>
  <p id="p00143" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento para obtener la clula madre heptica aislada, o la poblacin del mismo como se describe en la presente memoria, que comprende las etapas de cultivar clulas hepticas adultas, aislar hepatocitos de las mismas, sembrar los hepatocitos y cultivar dichos hepatocitos durante al menos 7 das, preferiblemente al menos 10, al menos 13 y al menos 15 das.</span>The present specification also describes a procedure for obtaining the isolated liver stem cell, or the population thereof as described herein, which comprises the steps of culturing adult liver cells, isolating hepatocytes thereof, sowing hepatocytes and culturing said hepatocytes for at least 7 days, preferably at least 10, at least 13 and at least 15 days.</span>
  </p>
  <p id="p00144" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una clula progenitora o clula madre heptica adulta humana aislada, una lnea celular del mismo y/o poblacin celular que comprende la misma, obtenible u obtenida directamente usando los procedimientos descritos en la presente memoria.</span>The present specification also describes a progenitor cell or isolated adult human liver stem cell, a cell line thereof and / or cell population comprising the same, obtainable or obtained directly using the procedures described herein.</span>
  </p>
  <p id="p00145" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe el establecimiento de una poblacin celular particular (lnea celular) de clulas progenitoras o clulas madre hepticas humanas adultas tal como se describe en la presente memoria y el depsito de dicha lnea celular aislada el 20 de febrero de 2006 segn el Tratado de Budapest en la Coleccin Coordinada de Microorganismos Belga (BCCM/LMBP) con el nmero de registro LMBP 6452CB (dado por la autoridad depositaria internacional, referencia de identificacin dada por el depositante: ADHLSC). En consecuencia, la presente invencin se refiere a una clula aislada, lnea celular y poblacin celular depositada en la BCCM con el nmero de registro LMBP 6452CB (en la presente memoria, la lnea celular LMBP 6452CB), a las sublneas de la misma, incluyendo sublneas clonales, y a la progenie de la misma, incluyendo progenie diferenciada de la misma, y a derivados modificados genticamente o de otro modo de la misma.</span>The present specification also describes the establishment of a particular cell population (cell line) of progenitor cells or adult human liver stem cells as described herein and the deposition of said isolated cell line on February 20, 2006 according to the Budapest Treaty in the Belgian Coordinated Collection of Microorganisms (BCCM / LMBP) with the registration number LMBP 6452CB (given by the international depositary authority, identification reference given by the depositor: ADHLSC). Accordingly, the present invention relates to an isolated cell, cell line and cell population deposited in the BCCM with the registration number LMBP 6452CB (herein, the cell line "LMBP 6452CB"), to the sublines thereof , including clonal sublines, and the progeny thereof, including differentiated progeny thereof, already genetically modified derivatives or otherwise thereof.</span>
  </p>
  <p id="p00146" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una composicin que comprende la clula progenitora o clula madre heptica aislada o la poblacin de la misma segn la invencin. Preferiblemente, las clulas hepticas son</span>The present specification also describes a composition comprising the progenitor cell or isolated liver stem cell or the population thereof according to the invention. Preferably, the liver cells are</span>
  </p>
  <p id="p00147" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00148" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00149" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00150" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00151" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00152" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00153" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00154" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00155" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00156" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00157" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00158" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">clulas hepticas humanas, o clulas hepticas de mamfero.</span>human liver cells, or mammalian liver cells.</span>
  </p>
  <p id="p00159" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las clulas progenitoras o clulas madre tal como se describen en la presente memoria (mencionando especficamente, aunque por supuesto sin limitacin, la lnea LMBP 6452CB) suponen varias ventajas considerables. Por ejemplo, al contrario que las clulas de origen embrionario, las presentes clulas progenitoras o clulas madre son de origen adulto y pueden presentar un menor riesgo de crecimiento incontrolado (tumoral) o transformacin maligna cuando se usan en terapia.</span>Progenitor cells or stem cells as described herein (specifically mentioning, although of course without limitation, the LMBP 6452CB line) have several considerable advantages. For example, unlike embryonic origin cells, the present progenitor cells or stem cells are of adult origin and may present a lower risk of uncontrolled (tumor) growth or malignant transformation when used in therapy.</span>
  </p>
  <p id="p00160" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adems, los inventores advirtieron que las clulas progenitoras o clulas madre como se describen en la presente memoria no presentan sustancialmente capacidad de diferenciarse en los tipos celulares mesodrmicos (por ejemplo, osteocitos o condrocitos, clulas de tejido conectivo), lo que reduce la formacin ectpica de dichos tejidos cuando las clulas se administran e implantan en tejido heptico.</span>In addition, the inventors warned that progenitor cells or stem cells as described herein do not substantially exhibit the ability to differentiate into mesodermal cell types (e.g., osteocytes or chondrocytes, connective tissue cells), which reduces ectopic formation. of said tissues when the cells are administered and implanted in liver tissue.</span>
  </p>
  <p id="p00161" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores advirtieron tambin que las clulas progenitoras o clulas madre de la invencin pueden tener preferencia particular por diferenciacin en hepatocitos o clulas de tipo hepatocito, lo que las hace particularmente adecuadas para la reconstitucin de funciones hepatocticas en el hgado.</span>The present inventors also warned that the progenitor cells or stem cells of the invention may have particular preference for differentiation into hepatocytes or hepatocyte-like cells, which makes them particularly suitable for the reconstitution of hepatocytic functions in the liver.</span>
  </p>
  <p id="p00162" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las presentes clulas progenitoras o clulas madre son claramente diferentes de los clulas madre derivadas de hgado descritos anteriormente, tales como clulas ovales, por ejemplo en sus caractersticas morfolgicas y de expresin de marcador.</span>The present progenitor cells or stem cells are clearly different from the liver-derived stem cells described above, such as oval cells, for example in their morphological and marker expression characteristics.</span>
  </p>
  <p id="p00163" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las clulas progenitoras o clulas madre hepticas adultas descritas en la presente memoria son particularmente tiles en medicina, hepatologa, errores congnitos del metabolismo heptico, trasplante, enfermedades infecciosas e insuficiencia heptica. Las clulas progenitoras o clulas madre hepticas tal como se describen en la presente memoria son particularmente tiles para el trasplante de clulas hepticas (humanas), la preparacin de modelos animales de trasplante de clulas hepticas humanas, hgados bioartificiales, lneas celulares hepticas in vitro y modelos animales de enfermedades hepticas humanas adquiridas, pruebas de cribado del metabolismo heptico (farmacocintica, citotoxicidad, genotoxicidad) y terapia gnica dirigida a clulas hepticas. Las clulas progenitoras o clulas madre hepticas como se describen en la presente memoria pueden diferenciarse adicionalmente en hepatocitos.</span>The progenitor cells or adult liver stem cells described herein are particularly useful in medicine, hepatology, congenital errors of liver metabolism, transplantation, infectious diseases and liver failure. Progenitor cells or liver stem cells as described herein are particularly useful for liver (human) cell transplantation, the preparation of animal models of human liver cell transplantation, bioartificial livers, in vitro liver cell lines and models Acquired human liver disease animals, liver metabolism screening tests (pharmacokinetics, cytotoxicity, genotoxicity) and gene therapy targeting liver cells. Progenitor cells or liver stem cells as described herein can be further differentiated into hepatocytes.</span>
  </p>
  <p id="p00164" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una composicin farmacutica que comprende una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin celular de la misma, o una progenie de la misma incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria, y un portador farmacuticamente aceptable. Preferiblemente, las clulas hepticas son clulas hepticas humanas o clulas hepticas de mamfero.</span>The present specification also describes a pharmaceutical composition comprising a progenitor cell or liver stem cell, a cell line thereof or cell population thereof, or a progeny thereof including differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein, and a pharmaceutically acceptable carrier. Preferably, the liver cells are human liver cells or mammalian liver cells.</span>
  </p>
  <p id="p00165" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento de tratamiento de enfermedad heptica que comprende administrar una cantidad eficaz de una clula progenitora o clula madre heptica, una lnea celular de la misma o una poblacin celular de la misma, o progenie de la misma incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria. La presente memoria descriptiva describe tambin que la enfermedad heptica incluye, pero sin limitacin, fenilcetonuria y otras aminoacidopatas, hemofilia y otras deficiencias de factor de coagulacin, hipercolesterolemia familiar y otros trastornos del metabolismo lipdico, trastornos del ciclo de la urea, glucogenosis, galactosemia, fructosemia, tirosinemia, deficiencias del metabolismo de protenas e hidratos de carbono, aciduria orgnica, enfermedades mitocondriales, trastornos peroxismicos y lisosmicos, anomalas de la sntesis de protenas, defectos de transportadores de clulas hepticas, defecto de glucosilacin, hepatitis, cirrosis, errores congnitos del metabolismo, insuficiencia heptica aguda, infecciones hepticas agudas, toxicidad qumica aguda, insuficiencia heptica crnica, colangitis, cirrosis biliar, sndrome de Alagille, deficiencia de a-1-antitripsina, hepatitis autoinmune, atresia biliar, cncer de hgado, enfermedad qustica del hgado, esteatosis heptica, galactosemia, clculo biliar, sndrome de Gilbert, hemocromatosis, hepatitis A, hepatitis B, hepatitis C y otras infecciones vricas de hepatitis, porfiria, colangitis esclerosante primaria, sndrome de Reye, sarcoidosis, tirosinemia, enfermedad de almacenamiento de glucgeno de tipo 1 o enfermedad de Wilson.</span>The present specification also describes a method of treating liver disease comprising administering an effective amount of a progenitor cell or liver stem cell, a cell line thereof or a cell population thereof, or progeny thereof including differential progeny , especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein. The present specification also describes that liver disease includes, but is not limited to, phenylketonuria and other aminoacidopathies, hemophilia and other deficiencies of coagulation factor, familial hypercholesterolemia and other disorders of lipid metabolism, urea cycle disorders, glycogenosis, galactosemia, fructosemia, tyrosinemia, protein and carbohydrate metabolism deficiencies, organic aciduria, mitochondrial diseases, peroxisomal and lysosomal disorders, protein synthesis abnormalities, liver cell transporter defects, glycosylation defect, hepatitis, cirrhosis, congenital errors of the metabolism, acute liver failure, acute liver infections, acute chemical toxicity, chronic liver failure, cholangitis, biliary cirrhosis, Alagille syndrome, a-1-antitrypsin deficiency, autoimmune hepatitis, biliary atresia, liver cancer, cystic liver disease gado, hepatic steatosis, galactosemia, gallstone, Gilbert's syndrome, hemochromatosis, hepatitis A, hepatitis B, hepatitis C and other viral infections of hepatitis, porphyria, primary sclerosing cholangitis, Reye's syndrome, sarcoidosis, tyrosinemia, glycogen storage disease Type 1 or Wilson's disease.</span>
  </p>
  <p id="p00166" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento para tratar errores de la expresin gnica que comprende: (i) introducir en una clula progenitora o clula madre heptica, lnea celular de la misma o poblacin celular de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito como se describe en la presente memoria, una copia funcional de un gen, proporcionando una poblacin transformada; y (ii) introducir en el hgado de un paciente, estando dicho paciente necesitado de la copia funcional del gen, al menos una porcin de la poblacin transformada. Como alternativa, la poblacin transformada puede introducirse en el hgado de un mamfero no humano produciendo un nuevo modelo animal de patologa heptica.</span>The present specification also describes a method for treating gene expression errors comprising: (i) introducing into a progenitor cell or liver stem cell, cell line thereof or cell population thereof or progeny thereof, including progeny differentiated, especially hepatocytes or hepatocyte-like cells as described herein, a functional copy of a gene, providing a transformed population; and (ii) introducing into the liver of a patient, said patient in need of the functional copy of the gene, at least a portion of the transformed population. As an alternative, the transformed population can be introduced into the liver of a non-human mammal producing a new animal model of liver pathology.</span>
  </p>
  <p id="p00167" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una composicin para tratar errores de la expresin gnica que comprende una clula progenitora o clula madre heptica transformada, una lnea celular de la misma o poblacin celular de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas</span>The present specification also describes a composition for treating gene expression errors comprising a progenitor cell or transformed liver stem cell, a cell line thereof or cell population thereof or progeny thereof, including differentiated progeny, especially hepatocytes. or cells</span>
  </p>
  <p id="p00168" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00169" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00170" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00171" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00172" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00173" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00174" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00175" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00176" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00177" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00178" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00179" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">similares de hepatocitos, opcionalmente modificada genticamente, como se describe en la presente memoria, en los que se ha introducido una copia funcional de un gen.</span>hepatocyte-like, optionally genetically modified, as described herein, in which a functional copy of a gene has been introduced.</span>
  </p>
  <p id="p00180" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin una composicin farmacutica para tratar errores de la expresin gnica que comprende una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin celular de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, como se describe en la presente memoria, en los que se ha introducido una copia funcional de un gen, y un portador farmacuticamente aceptable.</span>The present specification also describes a pharmaceutical composition for treating gene expression errors comprising a progenitor cell or liver stem cell, a cell line thereof or cell population thereof or progeny thereof, including differentiated progeny, especially hepatocytes. or hepatocyte-like cells, as described herein, in which a functional copy of a gene has been introduced, and a pharmaceutically acceptable carrier.</span>
  </p>
  <p id="p00181" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento para potenciar la regeneracin de un hgado lesionado o enfermo que comprende administrar al hgado una cantidad eficaz de una clula progenitora o clula madre heptica, de una lnea celular de la misma o poblacin celular de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria.</span>The present specification also describes a procedure to enhance the regeneration of an injured or diseased liver which comprises administering to the liver an effective amount of a progenitor cell or liver stem cell, of a cell line thereof or cell population thereof or progeny. thereof, including differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein.</span>
  </p>
  <p id="p00182" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un dispositivo auxiliar heptico que comprende una carcasa que alberga una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria.</span>The present specification also describes a liver auxiliary device comprising a housing that houses a progenitor cell or liver stem cell, a cell line thereof or population thereof or progeny thereof, including differentiated progeny, especially hepatocytes or cells of hepatocyte type, optionally genetically modified, as described herein.</span>
  </p>
  <p id="p00183" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento de realizacin de un ensayo de toxicidad in vitro que comprende: exponer una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria, a un agente de ensayo y observar al menos un efecto, si lo hubiera, del agente de ensayo sobre la poblacin de clulas hepticas. Preferiblemente, el al menos un efecto incluye un efecto sobre la viabilidad celular, la funcin celular o ambas.</span>The present specification also describes a method of conducting an in vitro toxicity test comprising: exposing a progenitor cell or liver stem cell, a cell line thereof or population thereof or progeny thereof, including differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein, to a test agent and to observe at least one effect, if any, of the test agent on the liver cell population. Preferably, the at least one effect includes an effect on cell viability, cell function or both.</span>
  </p>
  <p id="p00184" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento de realizacin de estudios de metabolismo de frmacos in vitro que comprende: (i) exponer una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria, a un agente de ensayo, y (ii) observar al menos un cambio, si lo hubiera, que implique al agente de ensayo despus de un periodo de ensayo predeterminado. Preferiblemente, el al menos un cambio incluye un cambio de estructura, concentracin o ambos del agente de ensayo.</span>The present specification also describes a method of conducting in vitro drug metabolism studies comprising: (i) exposing a progenitor cell or liver stem cell, a cell line thereof or population thereof or progeny thereof, including differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein, to a test agent, and (ii) observe at least one change, if any, that involves the test agent after a predetermined trial period. Preferably, the at least one change includes a change in structure, concentration or both of the test agent.</span>
  </p>
  <p id="p00185" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento de realizacin de ensayos de agentes eficaces para tratar infecciones vricas que comprende (i) infectar con un agente infeccioso de inters una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria, proporcionando una poblacin infectada, (ii) exponer la poblacin infectada a una cantidad predeterminada de agente de ensayo y (iii) observar los efectos, si los hubiera, de la exposicin sobre la poblacin infectada. En una realizacin, el agente infeccioso incluye un microorganismo. En otra realizacin, el agente infeccioso incluye uno o ms virus, bacterias, hongos o combinaciones de los mismos. En una realizacin particular, los efectos observados incluyen efectos sobre la replicacin vrica de un agente infeccioso vrico. Preferiblemente, el agente infeccioso vrico incluye un virus de la hepatitis.</span>The present specification also describes a method of carrying out tests of effective agents to treat viral infections comprising (i) infecting with a infectious agent of interest a progenitor cell or liver stem cell, a cell line thereof or population thereof. or progeny thereof, including differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein, providing an infected population, (ii) exposing the infected population to a predetermined amount of test agent and (iii) observe the effects, if any, of exposure on the infected population. In one embodiment, the infectious agent includes a microorganism. In another embodiment, the infectious agent includes one or more viruses, bacteria, fungi or combinations thereof. In a particular embodiment, the observed effects include effects on viral replication of a viral infectious agent. Preferably, the viral infectious agent includes a hepatitis virus.</span>
  </p>
  <p id="p00186" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento de produccin de una protena de inters que comprende (i) introducir en una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria, un gen funcional que codifica una protena de inters, (ii) incubar dicha poblacin celular en condiciones eficaces para que tenga lugar la transcripcin, traduccin y opcionalmente modificacin postraduccional y (iii) recoger la protena de inters. Preferiblemente, las clulas hepticas son clulas hepticas humanas. En una realizacin, la protena de inters comprende un antgeno de vacuna.</span>The present specification also describes a method of producing a protein of interest comprising (i) introducing into a progenitor cell or liver stem cell, a cell line thereof or population thereof or progeny thereof, including differentiated progeny , especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein, a functional gene encoding a protein of interest, (ii) incubating said cell population under effective conditions for transcription, translation and optionally post-translational modification and (iii) collect the protein of interest. Preferably, the liver cells are human liver cells. In one embodiment, the protein of interest comprises a vaccine antigen.</span>
  </p>
  <p id="p00187" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un procedimiento de realizacin de estudios in vitro o in vivo sobre el desarrollo heptico y la diferenciacin de hepatocitos que comprende: exponer una clula progenitora o clula madre heptica, una lnea celular de la misma o poblacin de la misma o progenie de la misma, incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificada genticamente, como se describe en la presente memoria, in vitro o in vivo a condiciones que afecten a las condiciones de diferenciacin y observando al menos un efecto sobre la poblacin de las clulas.</span>The present specification also describes a procedure for conducting in vitro or in vivo studies on liver development and hepatocyte differentiation comprising: exposing a progenitor cell or liver stem cell, a cell line thereof or population thereof or progeny thereof, including differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, as described herein, in vitro or in vivo at conditions affecting the differentiation conditions and observing at least one effect on The population of the cells.</span>
  </p>
  <p id="p00188" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin las clulas, la preparacin de las mismas, la caracterizacin de las mismas, el procedimiento de cultivo de las mismas y la produccin de las mismas.</span>The present specification also describes the cells, the preparation thereof, the characterization thereof, the culture method thereof and the production thereof.</span>
  </p>
  <p id="p00189" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin la conservacin de estas clulas mediante crioconservacin y el cultivo de las clulas.</span>The present specification also describes the conservation of these cells by cryopreservation and cell culture.</span>
  </p>
  <p id="p00190" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00191" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00192" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00193" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00194" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00195" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00196" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00197" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00198" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00199" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00200" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin la tcnica de trasplante de clulas en animales y seres humanos.</span>The present specification also describes the technique of cell transplantation in animals and humans.</span>
  </p>
  <p id="p00201" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin el uso de la clula madre heptica tal como se describe en la presente memoria para la preparacin de un medicamento para el tratamiento de las enfermedades anteriormente mencionadas. La presente memoria descriptiva describe tambin el uso de la clula madre heptica como se describe en la presente memoria en un kit o kit en piezas.</span>The present specification also describes the use of the liver stem cell as described herein for the preparation of a medicament for the treatment of the aforementioned diseases. The present specification also describes the use of the liver stem cell as described herein in a kit or piece kit.</span>
  </p>
  <p id="p00202" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En particular, la presente memoria descriptiva tambin describe la materia en cuestin como se expone en todos y cada uno de los puntos (i) a (xxvii) a continuacin:</span>In particular, the present specification also describes the subject matter as set forth in each and every one of items (i) to (xxvii) below:</span>
  </p>
  <p id="p00203" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano caracterizada porque coexpresa al menos un marcador mesenquimal, preferiblemente uno, ms de uno o todos de los marcadores CD90, CD73, CD44, vimentina y a-actina de msculo liso (ASMA), con el marcador de hepatocito albmina (ALB).</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver characterized in that it coexpresses at least one mesenchymal marker, preferably one, more than one or all of the markers CD90, CD73, CD44, vimentin and a-actin of smooth muscle (ASMA), with the albumin hepatocyte marker (ALB).</span>
  </p>
  <p id="p00204" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) La clula progenitora o clula madre humana aislada tal como se expuso en (i) anteriormente, en la que la clula coexpresa aSmA y ALB.</span>(ii) The progenitor cell or isolated human stem cell as set forth in (i) above, in which the cell co-expresses aSmA and ALB.</span>
  </p>
  <p id="p00205" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (i) o (ii) anteriormente, en la que dicha clula expresa adems CYP3A4.</span>(iii) The isolated progenitor cell or human stem cell as set forth in any one of (i) or (ii) above, wherein said cell further expresses CYP3A4.</span>
  </p>
  <p id="p00206" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iv) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (i), (ii) o (iii) anteriormente, en la que dicha clula es negativa para citoqueratina-19 (CK-19).</span>(iv) The isolated progenitor cell or human stem cell as set forth in any one of (i), (ii) or (iii) above, wherein said cell is negative for cytokeratin-19 (CK-19).</span>
  </p>
  <p id="p00207" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(v) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (i) a (iv) anteriormente, en la que la clula coexpresa CD90, CD73, CD44, vimentina, ASMA y ALB.</span>(v) The progenitor cell or isolated human stem cell as set forth in any one of (i) to (iv) above, in which the cell coexpresses CD90, CD73, CD44, vimentin, ASMA and ALB.</span>
  </p>
  <p id="p00208" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(vi) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (i) a (v) anteriormente, que expresa adems uno o ms marcadores hepticos distintos o de hepatocitos elegidos de CD29, alfa-fetoprotena (AFP), alfa-1 antitripsina, HNF-4 y transportador MRP2.</span>(vi) The isolated progenitor cell or human stem cell as set forth in any one of (i) to (v) above, which also expresses one or more different hepatic markers or hepatocytes chosen from CD29, alpha-fetoprotein (AFP) , alpha-1 antitrypsin, HNF-4 and MRP2 transporter.</span>
  </p>
  <p id="p00209" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(vii) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (i) a (vi) anteriormente, en la que dicha clula es negativa para CD45, CD34 y CD117.</span>(vii) The isolated progenitor cell or human stem cell as set forth in any one of (i) to (vi) above, wherein said cell is negative for CD45, CD34 and CD117.</span>
  </p>
  <p id="p00210" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(viii) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (i) a (vii) anteriormente, en la que dicha clula tiene morfologa de tipo mesenquimal, preferiblemente que implica cualquiera o todos de crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos.</span>(viii) The isolated progenitor cell or human stem cell as set forth in any one of (i) to (vii) above, wherein said cell has mesenchymal type morphology, preferably involving any or all of the growth in monolayers, flattened shape, wide cytoplasm and ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00211" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ix) La clula progenitora o clula madre humana aislada tal como se expuso en una cualquiera de las reivindicaciones (i) a (viii) anteriormente, en la que dicha clula puede diferenciarse en hepatocitos o clulas de tipo hepatocito y preferiblemente no se diferencia en tipos celulares mesodrmicos.</span>(ix) The isolated progenitor cell or human stem cell as set forth in any one of claims (i) to (viii) above, wherein said cell can be differentiated into hepatocytes or hepatocyte-like cells and preferably does not differ in mesodermal cell types.</span>
  </p>
  <p id="p00212" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(x) Una clula progenitora o clula madre humana aislada tal como se expuso en (i) anteriormente, en la que dicha clula expresa CD90, CD73, CD29, CD44, CD13, vimentina, ASMA, ALB, AfP, CyP3a4 y alfa-anti-tripsina.</span>(x) An isolated progenitor cell or human stem cell as set forth in (i) above, wherein said cell expresses CD90, CD73, CD29, CD44, CD13, vimentin, ASMA, ALB, AfP, CyP3a4 and alpha-anti -tripsin.</span>
  </p>
  <p id="p00213" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xi) La clula progenitora o clula madre humana aislada tal como se expuso en (x) anteriormente, en la que dicha clula es negativa para CK-19 y CK-7.</span>(xi) The progenitor cell or isolated human stem cell as set forth in (x) above, wherein said cell is negative for CK-19 and CK-7.</span>
  </p>
  <p id="p00214" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xii) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (x) o (xi), en la que dicha clula es negativa para CD133, CD117, CD45, CD34 y HLADR.</span>(xii) The isolated progenitor cell or human stem cell as set forth in any one of (x) or (xi), wherein said cell is negative for CD133, CD117, CD45, CD34 and HLADR.</span>
  </p>
  <p id="p00215" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xiii) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (x), (xi) o (xii), en la que dicha clula tiene morfologa de tipo mesenquimal, preferiblemente que implica cualquiera o todos de crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos.</span>(xiii) The isolated progenitor cell or human stem cell as set forth in any one of (x), (xi) or (xii), wherein said cell has mesenchymal type morphology, preferably involving any or all of growth in monolayers, flattened shape, wide cytoplasm and ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00216" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xiv) La clula progenitora o clula madre humana aislada tal como se expuso en uno cualquiera de (x), (xi), (xii) o (xiii) anteriormente, en la que dicha clula puede diferenciarse en hepatocitos o clulas de tipo hepatocito y preferiblemente no se diferencia en tipos celulares mesodrmicos.</span>(xiv) The isolated progenitor cell or human stem cell as set forth in any one of (x), (xi), (xii) or (xiii) above, in which said cell can be differentiated into hepatocytes or hepatocyte-like cells and preferably it does not differ in mesodermal cell types.</span>
  </p>
  <p id="p00217" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xv) Una lnea celular de o una poblacin celular que comprende la clula progenitora o clula madre heptica humana aislada tal como se expuso en uno cualquiera de (i) a (xiv) anteriormente, y progenie de la misma, preferiblemente en la que la poblacin celular comprende al menos el 70%, preferiblemente al menos el 80% y ms preferiblemente al menos el 90% de las clulas progenitoras o clulas madre hepticas humanas aisladas o progenie de las mismas.</span>(xv) A cell line of or a cell population comprising the progenitor cell or isolated human liver stem cell as set forth in any one of (i) to (xiv) above, and progeny thereof, preferably in which the Cellular population comprises at least 70%, preferably at least 80% and more preferably at least 90% of the progenitor cells or human liver stem cells isolated or progeny thereof.</span>
  </p>
  <p id="p00218" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xvi) Un procedimiento para obtener una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano o una poblacin celular que comprende dicha clula progenitora o clula madre, comprendiendo el procedimiento: (a) disociar hgado adulto o una parte del mismo para obtener una poblacin de clulas primarias a partir de dicho hgado adulto o parte del mismo, (b) sembrar la poblacin de clulas primarias sobre un sustrato que permite la adherencia de las clulas al mismo, y (c) cultivar clulas de la poblacin de clulas</span>(xvi) A method for obtaining an isolated progenitor cell or human stem cell originating from a human adult liver or a cell population comprising said progenitor cell or stem cell, the method comprising: (a) decoupling adult liver or a part thereof to obtain a population of primary cells from said adult liver or part thereof, (b) sow the population of primary cells on a substrate that allows the adhesion of the cells thereto, and (c) cultivate cells of the population of cells</span>
  </p>
  <p id="p00219" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00220" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00221" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00222" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00223" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00224" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00225" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00226" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00227" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00228" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00229" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00230" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">primarias, que se han adherido a dicho sustrato, durante al menos 7 das, preferiblemente al menos 10, al menos 13 o al menos 15 das hasta que la poblacin de clulas cultivadas se ha vuelto al menos el 40% y preferiblemente al menos el 70% confluente, permitiendo de ese modo la aparicin y proliferacin de las clulas progenitoras o clulas madre en la poblacin celular; y (d) aumentar la proporcin de las clulas progenitoras o clulas madre en la poblacin celular sometiendo a pases la poblacin celular al menos una vez y preferiblemente al menos dos veces, obteniendo de ese modo preferiblemente una poblacin sustancialmente homognea de las clulas progenitoras o clulas madre.</span>primary, which have adhered to said substrate, for at least 7 days, preferably at least 10, at least 13 or at least 15 days until the population of cultured cells has become at least 40% and preferably at least 70 % confluent, thereby allowing the appearance and proliferation of progenitor cells or stem cells in the cell population; and (d) increasing the proportion of the progenitor cells or stem cells in the cell population by passing the cell population at least once and preferably at least twice, thereby preferably obtaining a substantially homogeneous population of the progenitor cells or cells. mother.</span>
  </p>
  <p id="p00231" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xvii) El procedimiento tal como se expuso en (xvi) anteriormente, en el que la poblacin celular se somete a pases entre 2 y 8 veces en la etapa (d).</span>(xvii) The procedure as set forth in (xvi) above, in which the cell population is subjected to passes 2 to 8 times in step (d).</span>
  </p>
  <p id="p00232" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xviii) El procedimiento tal como se expuso en (xvi) o (xvii) anteriormente, que comprende adems la crioconservacin de las clulas progenitoras o clulas madre humanas aisladas o la poblacin celular que comprende dichas clulas.</span>(xviii) The method as set forth in (xvi) or (xvii) above, which further comprises cryopreservation of isolated human progenitor cells or stem cells or the cell population comprising said cells.</span>
  </p>
  <p id="p00233" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xix) Una clula progenitora o clula madre de hgado adulto humano aislada tal como se expuso en uno cualquiera de (i) a (xiv) anteriormente, lnea celular de la misma y/o una poblacin celular que comprende tales, que puede obtenerse mediante u obtenerse directamente usando el procedimiento tal como se expuso en uno cualquiera de (xvi) a (xviii) anteriormente.</span>(xix) A progenitor cell or isolated human adult liver stem cell as set forth in any one of (i) to (xiv) above, cell line thereof and / or a cell population comprising such, which can be obtained by or obtained directly using the procedure as set forth in any one of (xvi) to (xviii) above.</span>
  </p>
  <p id="p00234" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xx) Una composicin que comprende la clula progenitora o clula madre heptica humana tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente, o la lnea celular o poblacin celular tal como se expuso en uno cualquiera de (xv) o (xix) anteriormente, opcionalmente en la que dicha composicin es una composicin farmacutica que comprende adems un portador farmacuticamente aceptable.</span>(xx) A composition comprising the progenitor cell or human liver stem cell as set forth in any one of (i) to (xiv) or (xix) above, or the cell line or cell population as set forth in any one of (xv) or (xix) above, optionally wherein said composition is a pharmaceutical composition further comprising a pharmaceutically acceptable carrier.</span>
  </p>
  <p id="p00235" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxi) Uso de las clulas progenitoras o clulas madre hepticas humanas tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente o la lnea celular o poblacin celular tal como se expuso en uno cualquiera de (xv) o (xix) anteriormente para la diferenciacin in vitro o ex vivo de dichas clulas en clulas de linaje de hepatocito, particularmente en hepatocitos o clulas de tipo hepatocito.</span>(xxi) Use of the progenitor cells or human liver stem cells as set forth in any one of (i) to (xiv) or (xix) above or the cell line or cell population as set forth in any one of (xv ) or (xix) above for in vitro or ex vivo differentiation of said cells into hepatocyte lineage cells, particularly hepatocytes or hepatocyte-like cells.</span>
  </p>
  <p id="p00236" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxii) Un procedimiento para la diferenciacin de las clulas progenitoras o clulas madre hepticas humanas tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente o la lnea celular o poblacin celular tal como se expuso en cualquiera de las reivindicaciones (xv) o (xix) anteriormente en clulas del linaje de hepatocito, particularmente en hepatocitos o clulas de tipo hepatocito, que comprende exponer las clulas progenitoras o clulas madre, lnea celular o poblacin celular a medio de induccin de diferenciacin heptica.</span>(xxii) A procedure for the differentiation of progenitor cells or human liver stem cells as set forth in any one of (i) to (xiv) or (xix) above or the cell line or cell population as set forth in any of claims (xv) or (xix) above in hepatocyte lineage cells, particularly hepatocytes or hepatocyte-like cells, comprising exposing the progenitor cells or stem cells, cell line or cell population to liver differentiation induction medium.</span>
  </p>
  <p id="p00237" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxiii) Las clulas progenitoras o clulas madre hepticas humanas tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente o la lnea celular o poblacin celular tal como se expuso en uno cualquiera de (xv) o (xix) anteriormente, o progenie de las mismas, o la composicin tal como se expuso en (xx) anteriormente, para su uso en terapia, preferiblemente para su uso en el tratamiento de enfermedad heptica o para potenciar la regeneracin de un hgado lesionado o enfermo, ms preferiblemente para su uso en el tratamiento de enfermedad heptica incluyendo fenilcetonuria y otras aminoacidopatas, hemofilia y otras deficiencias de factor de coagulacin, hipercolesterolemia familiar y otros trastornos del metabolismo lipdico, trastornos del ciclo de la urea, glucogenosis, galactosemia, fructosemia, tirosinemia, deficiencias del metabolismo de protenas e hidratos de carbono, aciduria orgnica, enfermedades mitocondriales, trastornos peroxismicos y lisosmicos, anomalas de la sntesis de protenas, defectos de transportadores de clulas hepticas, defecto de glucosilacin, hepatitis, cirrosis, errores congnitos del metabolismo, insuficiencia heptica aguda, infecciones hepticas agudas, toxicidad qumica aguda, insuficiencia heptica crnica, colangitis, cirrosis biliar, sndrome de Alagille, deficiencia de a-1-antitripsina, hepatitis autoinmune, atresia biliar, cncer de hgado, enfermedad qustica del hgado, esteatosis heptica, galactosemia, clculo biliar, sndrome de Gilbert, hemocromatosis, hepatitis A, hepatitis B, hepatitis C y otras infecciones vricas de hepatitis, porfiria, colangitis esclerosante primaria, sndrome de Reye, sarcoidosis, tirosinemia, enfermedad de almacenamiento de glucgeno de tipo 1 o enfermedad de Wilson.</span>(xxiii) Progenitor cells or human liver stem cells as set forth in any one of (i) to (xiv) or (xix) above or the cell line or cell population as set forth in any one of (xv) or (xix) above, or progeny thereof, or the composition as set forth in (xx) above, for use in therapy, preferably for use in the treatment of liver disease or to enhance the regeneration of an injured liver or patient, more preferably for use in the treatment of liver disease including phenylketonuria and other amino acids, hemophilia and other coagulation factor deficiencies, familial hypercholesterolemia and other disorders of lipid metabolism, urea cycle disorders, glycogenosis, galactosemia, fructosemia, tyrosinemia, deficiencies of protein and carbohydrate metabolism, organic aciduria, mitochondrial diseases, peroxisomal disorders and lysoso Mycoses, protein synthesis abnormalities, liver cell transporter defects, glycosylation defect, hepatitis, cirrhosis, congenital metabolism errors, acute liver failure, acute liver infections, acute chemical toxicity, chronic liver failure, cholangitis, biliary cirrhosis, Alagille syndrome, a-1-antitrypsin deficiency, autoimmune hepatitis, biliary atresia, liver cancer, cystic liver disease, liver steatosis, galactosemia, gallstone, Gilbert's syndrome, hemochromatosis, hepatitis A, hepatitis B, hepatitis C and other viral infections of hepatitis, porphyria, primary sclerosing cholangitis, Reye's syndrome, sarcoidosis, tyrosinemia, type 1 glycogen storage disease or Wilson's disease.</span>
  </p>
  <p id="p00238" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxiv) Las clulas progenitoras o clulas madre hepticas humanas, lnea celular poblacin celular o composicin para su uso tal como se expuso en (xxiii) anteriormente, en la que entre 107 y 109 clulas van a administrarse a un sujeto humano.</span>(xxiv) Progenitor cells or human liver stem cells, cell population cell line or composition for use as set forth in (xxiii) above, in which between 107 and 109 cells are to be administered to a human subject.</span>
  </p>
  <p id="p00239" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxv) Uso de las clulas progenitoras o clulas madre hepticas humanas tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente, la lnea celular o poblacin celular tal como se expuso en uno cualquiera de (xv) o (xix) anteriormente, o progenie de las mismas, o la composicin tal como se expuso en (xx) anteriormente, para realizar pruebas de toxicidad in vitro; o para realizar estudios de metabolismo de frmacos in vitro; o para realizar pruebas para detectar agentes eficaces para tratar infecciones hepticas, preferiblemente en el que el agente infeccioso incluye un microorganismo, ms preferiblemente uno o ms virus, bacterias, hongos o combinaciones de los mismos, incluso ms preferiblemente virus de la hepatitis; o para producir una protena de inters a partir de un gen funcional que codifica la protena de inters introducido en las clulas progenitoras o clulas madre, lnea celular o poblacin celular, preferiblemente en el que la protena de inters comprende un antgeno de vacuna.</span>(xxv) Use of progenitor cells or human liver stem cells as set forth in any one of (i) to (xiv) or (xix) above, the cell line or cell population as set forth in any one of (xv ) or (xix) above, or progeny thereof, or the composition as set forth in (xx) above, to perform in vitro toxicity tests; or to perform in vitro drug metabolism studies; or to perform tests to detect agents effective to treat liver infections, preferably wherein the infectious agent includes a microorganism, more preferably one or more viruses, bacteria, fungi or combinations thereof, even more preferably hepatitis viruses; or to produce a protein of interest from a functional gene that encodes the protein of interest introduced into the progenitor cells or stem cells, cell line or cell population, preferably in which the protein of interest comprises a vaccine antigen.</span>
  </p>
  <p id="p00240" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxvi) Un dispositivo auxiliar heptico que comprende una carcasa que alberga la clula progenitora o clula madre</span>(xxvi) A hepatic auxiliary device comprising a housing that houses the progenitor cell or stem cell</span>
  </p>
  <p id="p00241" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00242" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00243" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00244" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00245" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00246" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00247" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00248" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00249" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00250" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00251" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">heptica humana tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente o la lnea celular o poblacin celular tal como se expuso en uno cualquiera de (xv) o (xix) anteriormente, o progenie de la misma.</span>human liver as set forth in any one of (i) to (xiv) or (xix) above or the cell line or cell population as set forth in any one of (xv) or (xix) above, or progeny of the same.</span>
  </p>
  <p id="p00252" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(xxvii) Las clulas progenitoras o clulas madre hepticas humanas tal como se expuso en uno cualquiera de (i) a (xiv) o (xix) anteriormente o la lnea celular o poblacin celular tal como se expuso en uno cualquiera de (xv) o (xix) anteriormente, o progenie de las mismas, o la composicin tal como se expuso en (xx) anteriormente, en las que se ha introducido una copia funcional de un gen, para tratar errores de expresin gnica.</span>(xxvii) Progenitor cells or human liver stem cells as set forth in any one of (i) to (xiv) or (xix) above or the cell line or cell population as set forth in any one of (xv) or (xix) above, or progeny thereof, or the composition as set forth in (xx) above, in which a functional copy of a gene has been introduced, to treat gene expression errors.</span>
  </p>
  <p id="p00253" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Breve descripcin de las figuras:</span>Brief description of the figures:</span>
  </p>
  <p id="p00254" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La figura 1 muestra la apariencia morfolgica de clulas progenitoras o clulas madre derivadas de hgado adulto humano de la invencin (ADHLSC), preparados como en el ejemplo 1, despus de un mes de cultivo, usando microscopa ptica (contraste de fases). A, a menor confluencia; B, a mayor confluencia. Aumentos: 100 x</span>Figure 1 shows the morphological appearance of progenitor cells or stem cells derived from human adult liver of the invention (ADHLSC), prepared as in example 1, after one month of culture, using optical microscopy (phase contrast). A, at a lower confluence; B, at greater confluence. Magnifications: 100 x</span>
  </p>
  <p id="p00255" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Figura 2A: Presencia de tincin inmunofluorescente de clulas progenitoras o clulas madre derivadas de hgado adulto humano de la invencin (ADHLSC), preparados como en el ejemplo 1, despus de 1 mes de cultivo, para a- actina de msculo liso (A1), vimentina (A2) y albmina (A3, policlonal; A4, monoclonal), B: perfiles de expresin gnica segn PCR-TI en dicha lnea celular (ADHLSC, hilera 1), en comparacin con hepatocitos humanos (hHep, hileras 2), clulas estrelladas humanas (hSC, hileras 3) y hepatoblastoma humano (HepG2, hileras 4).</span>Figure 2A: Presence of immunofluorescent staining of progenitor cells or stem cells derived from human adult liver of the invention (ADHLSC), prepared as in Example 1, after 1 month of culture, for smooth muscle a-actin (A1), vimentin (A2) and albumin (A3, polyclonal; A4, monoclonal), B: gene expression profiles according to PCR-TI in said cell line (ADHLSC, row 1), compared to human hepatocytes (hHep, rows 2), cells Human stars (hSC, rows 3) and human hepatoblastoma (HepG2, rows 4).</span>
  </p>
  <p id="p00256" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La figura 3 muestra la diferenciacin de clulas progenitoras o clulas madre derivadas de hgado adulto humano de la invencin (ADHLSC) en el linaje de tipo hepatocito in vitro. Se diferenciaron las clulas como en el ejemplo 1, se tomaron fotografas el da 2 (J2), da 14 (J14) y da 30 (J30) del proceso.</span>Figure 3 shows the differentiation of progenitor cells or stem cells derived from human adult liver of the invention (ADHLSC) in the hepatocyte lineage in vitro. The cells were differentiated as in example 1, photographs were taken on day 2 (J2), day 14 (J14) and day 30 (J30) of the process.</span>
  </p>
  <p id="p00257" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La figura 4 muestra varias imgenes de tincin con hematoxilina y eosina en hgado quimrico de ratones uPA/SCID trasplantados con clulas ADHLSC indiferenciadas, como se detalla en el ejemplo 1, demostrando que estas clulas se vuelven hepatocitos diferenciados.</span>Figure 4 shows several images of staining with hematoxylin and eosin in chimeric liver of uPA / SCID mice transplanted with undifferentiated ADHLSC cells, as detailed in example 1, demonstrating that these cells become differentiated hepatocytes.</span>
  </p>
  <p id="p00258" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La figura 5 muestra varias imgenes de tincin de albmina humana que desvelan el origen humano de la poblacin de tipo hepatocito observada 10 semanas despus del trasplante como en el ejemplo 1 con ADHLSC indiferenciadas.</span>Figure 5 shows several human albumin staining images that reveal the human origin of the hepatocyte-type population observed 10 weeks after transplantation as in example 1 with undifferentiated ADHLSC.</span>
  </p>
  <p id="p00259" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Descripcin detallada</span>Detailed description</span>
  </p>
  <p id="p00260" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se usa en la presente memoria, las formas singulares un, una y el/la incluyen tanto los referentes singulares como plurales a menos que el contexto dicte claramente otra cosa. A modo de ejemplo, una clula designa una o ms de una clula.</span>As used herein, the singular forms "a", "a" and "the" include both the singular and plural referents unless the context clearly dictates otherwise. As an example, "a cell" designates one or more than one cell.</span>
  </p>
  <p id="p00261" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los trminos comprendiendo, comprende y comprendido por como se usan en la presente memoria son sinnimos de incluyendo, incluye o conteniendo y contiene, son inclusivos o de extremos abiertos y no excluyen miembros, elementos o etapas de procedimiento adicionales no enumerados.</span>The terms "comprising", "comprises" and "comprised of" as used herein are synonymous with "including", "includes" or "containing" and "contains", are inclusive or open-ended and do not exclude members , additional elements or procedural steps not listed.</span>
  </p>
  <p id="p00262" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Obtencin de las clulas de la invencin</span>Obtaining the cells of the invention</span>
  </p>
  <p id="p00263" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe un procedimiento para obtener una clula progenitora o clula madre aislada, o una poblacin celular que comprende dicha clula progenitora o clula madre, comprendiendo el procedimiento: (a) disociar hgado adulto o una parte del mismo, formando una poblacin de clulas primarias a partir de dicho hgado adulto o parte del mismo, (b) plantar la poblacin de clulas primarias sobre un sustrato que permita la adherencia de las clulas al mismo y (c) cultivar clulas de la poblacin celular primaria que se hayan adherido a dicho sustrato durante al menos 7 das, preferiblemente al menos 10, al menos 13 o al menos 15 das.</span>The present specification describes a procedure for obtaining an isolated progenitor cell or stem cell, or a cell population comprising said progenitor cell or stem cell, the method comprising: (a) dissociating adult liver or a part thereof, forming a population of primary cells from said adult liver or part thereof, (b) planting the population of primary cells on a substrate that allows the adhesion of the cells thereto and (c) culturing cells of the primary cell population that have adhered to said substrate for at least 7 days, preferably at least 10, at least 13 or at least 15 days.</span>
  </p>
  <p id="p00264" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se usa en la presente memoria, el trmino clula aislada designa en general una clula que no est asociada a una o ms clulas o uno o ms componentes celulares con los que la clula est asociada in vivo. Por ejemplo, una clula aislada puede haberse retirado de su entorno nativo, o puede resultar de la propagacin, por ejemplo propagacin ex vivo, de una clula que se ha retirado de su entorno nativo.</span>As used herein, the term "isolated cell" generally designates a cell that is not associated with one or more cells or one or more cellular components with which the cell is associated in vivo. For example, an isolated cell may have been removed from its native environment, or it may result from the propagation, for example ex vivo propagation, of a cell that has been removed from its native environment.</span>
  </p>
  <p id="p00265" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino in vitro como se usa en la presente memoria denota exterior o externo al cuerpo animal o humano. El trmino in vitro como se usa en la presente memoria debera entenderse que incluye ex vivo". El trmino ex vivo" designa tpicamente tejidos o clulas retirados de un cuerpo animal o humano y mantenidos o propagados fuera del cuerpo, por ejemplo en un recipiente de cultivo.</span>The term "in vitro" as used herein denotes external or external to the animal or human body. The term "in vitro" as used herein should be understood to include "ex vivo." The term "ex vivo" typically designates tissues or cells removed from an animal or human body and maintained or propagated outside the body, by example in a culture vessel.</span>
  </p>
  <p id="p00266" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino poblacin celular designa en general un agrupamiento de clulas. A menos que se indique otra cosa, el trmino designa un agrupamiento celular que consiste en o que comprende clulas aisladas como se definen en la presente memoria.</span>The term "cell population" generally designates a cluster of cells. Unless otherwise indicated, the term designates a cell grouping consisting of or comprising isolated cells as defined herein.</span>
  </p>
  <p id="p00267" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Una poblacin celular puede consistir en clulas que tienen un fenotipo comn o puede comprender al menos una fraccin de clulas que tienen un fenotipo comn. Se dice que las clulas tienen un fenotipo comn cuando son sustancialmente similares o idnticas en una o ms caractersticas demostrables incluyendo, pero sin limitacin, apariencia morfolgica, la presencia, ausencia o nivel de expresin de componentes celulares o productos</span>A cell population may consist of cells that have a common phenotype or may comprise at least a fraction of cells that have a common phenotype. Cells are said to have a common phenotype when they are substantially similar or identical in one or more demonstrable characteristics including, but not limited to, morphological appearance, the presence, absence or level of expression of cellular components or products.</span>
  </p>
  <p id="p00268" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00269" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00270" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00271" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00272" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00273" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00274" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00275" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00276" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00277" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00278" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00279" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">particulares, por ejemplo, ARN, protenas u otras sustancias, actividad de ciertas rutas bioqumicas, capacidad y/o cintica de proliferacin, potencial de diferenciacin y/o respuesta a las seales de diferenciacin o comportamiento durante el cultivo in vitro (por ejemplo, adherencia, no adherencia, crecimiento en monocapa, cintica de proliferacin o similares). Dichas caractersticas demostrables pueden definir por lo tanto una poblacin celular o una fraccin de la misma.</span>particular, for example, RNA, proteins or other substances, activity of certain biochemical pathways, proliferation capacity and / or kinetics, differentiation potential and / or response to differentiation or behavior signals during in vitro culture (for example, adhesion , non-adhesion, monolayer growth, proliferation kinetics or the like). Said demonstrable characteristics can therefore define a cell population or a fraction thereof.</span>
  </p>
  <p id="p00280" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cuando se dice en la presente memoria que una poblacin celular es heterognea, esto denota en general una poblacin celular que comprende dos o ms clulas o fracciones de clulas que no tienen un fenotipo comn, por ejemplo, una poblacin celular que comprende clulas de dos o ms tipos celulares diferentes. A modo de ejemplo y no de limitacin, puede aislarse una poblacin celular heterognea a partir del hgado, y puede comprender diversos tipos de clulas hepticas incluyendo, pero sin limitacin, hepatocitos (por ejemplo, hepatocitos grandes y pequeos), colangiocitos, clulas de Kupffer, clulas estrelladas hepticas (clulas de Ito) y clulas endoteliales hepticas.</span>When it is said herein that a cell population is "heterogeneous," this generally denotes a cell population that comprises two or more cells or cell fractions that do not have a common phenotype, for example, a cell population that comprises cells of two or more different cell types. By way of example and not limitation, a heterogeneous cell population can be isolated from the liver, and can comprise various types of liver cells including, but not limited to, hepatocytes (e.g., large and small hepatocytes), cholangiocytes, Kupffer cells , hepatic star cells (Ito cells) and liver endothelial cells.</span>
  </p>
  <p id="p00281" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cuando se dice en la presente memoria que una poblacin celular es homognea, consiste en clulas que tienen un fenotipo comn. Una poblacin celular que se dice en la presente memoria que es sustancialmente homognea comprende una mayora sustancial de clulas que tienen un fenotipo comn. Una poblacin celular sustancialmente homognea puede comprender al menos un 70%, por ejemplo al menos un 80%, preferiblemente al menos un 90%, por ejemplo al menos un 95% o incluso al menos un 99% de clulas que tienen un fenotipo comn, tal como el fenotipo designado especficamente (por ejemplo, el fenotipo de la clula progenitora o clula madre). Como se usa en la presente memoria, el trmino sustancialmente homogneo como se usa en la presente memoria puede englobar tambin por tanto una poblacin homognea.</span>When it is said herein that a cell population is "homogeneous," it consists of cells that have a common phenotype. A cell population that is said herein to be "substantially homogeneous" comprises a substantial majority of cells that have a common phenotype. A "substantially homogeneous" cell population may comprise at least 70%, for example at least 80%, preferably at least 90%, for example at least 95% or even at least 99% of cells having a phenotype common, such as the specifically designated phenotype (for example, the progenitor cell or stem cell phenotype). As used herein, the term "substantially homogeneous" as used herein may also encompass a homogeneous population.</span>
  </p>
  <p id="p00282" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino poblacin celular que comprende una clula progenitora o clula madre designa una poblacin celular como se define en la presente memoria que comprende al menos una clula progenitora o clula madre y tpicamente una fraccin de clulas progenitoras o clulas madre como se definen en la presente memoria. Habitualmente, las clulas progenitoras o clulas madre de dicha fraccin pueden tener un fenotipo comn.</span>The term "cell population comprising a progenitor cell or stem cell" designates a cell population as defined herein that comprises at least one progenitor cell or stem cell and typically a fraction of progenitor cells or stem cells as defined herein. present memory Usually, the progenitor cells or stem cells of said fraction may have a common phenotype.</span>
  </p>
  <p id="p00283" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino clula progenitora designa en general una clula no especializada o relativamente menos especializada y competente de proliferacin, o su progenie, que puede dar lugar a al menos un tipo celular relativamente ms especializado. A modo de ejemplo y no de limitacin, una clula progenitora puede dar lugar a descendientes que pueden diferenciarse en uno o ms linajes, produciendo clulas relativamente ms especializadas cada vez, en el que dichos descendientes y/o clulas relativamente ms especializadas cada vez pueden ser ellas mismas clulas progenitoras, o incluso producir clulas diferenciadas terminalmente, concretamente, clulas totalmente especializadas que pueden ser postmitticas. El trmino engloba tambin clulas madre como se definen en la presente memoria.</span>The term "progenitor cell" generally designates a non-specialized or relatively less specialized and competent proliferation cell, or its progeny, which can give rise to at least one relatively more specialized cell type. By way of example and not limitation, a progenitor cell can give rise to offspring that can differentiate into one or more lineages, producing relatively more specialized cells each time, in which said offspring and / or relatively more specialized cells can increasingly be they themselves progenitor cells, or even produce terminal differentiated cells, specifically, fully specialized cells that can be postmitotic. The term also encompasses stem cells as defined herein.</span>
  </p>
  <p id="p00284" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se dice que una clula progenitora da lugar a otra clula relativamente ms especializada cuando, a modo de ejemplo y no de limitacin, la clula progenitora se diferencia volvindose la otra clula sin experimentar primero divisin celular, o la otra clula se produce despus de una o ms rondas de divisin y/o diferenciacin celular de la clula progenitora o progenie de la misma.</span>It is said that a progenitor cell "gives rise to" another relatively more specialized cell when, by way of example and not limitation, the progenitor cell differs by becoming the other cell without first experiencing cell division, or the other cell is produced after one or more rounds of cell division and / or differentiation of the progenitor cell or progeny thereof.</span>
  </p>
  <p id="p00285" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino clula madre designa una clula progenitora capaz de autorrenovacin, concretamente, que puede proliferar sin diferenciacin, con lo que la progenie de una clula madre o al menos una parte de la misma retiene sustancialmente el fenotipo no especializado o relativamente menos especializado, el potencial de diferenciacin y la competencia de proliferacin de la clula madre progenitora. El trmino engloba clulas madre capaces de una autorrenovacin sustancialmente ilimitada, concretamente, en los que la capacidad de la progenie o parte de la misma de proliferacin adicional no est sustancialmente reducida en comparacin con la clula progenitora, as como clulas madre que presentan una autorrenovacin limitada, concretamente en los que la capacidad de la progenie o parte de la misma de proliferacin adicional est demostrablemente reducida en comparacin con la clula progenitora.</span>The term "stem cell" designates a progenitor cell capable of self-renewal, namely, that can proliferate without differentiation, whereby the progeny of a stem cell or at least a portion thereof substantially retains the non-specialized or relatively less specialized phenotype, the potential for differentiation and proliferation competence of the progenitor stem cell. The term encompasses stem cells capable of substantially unlimited self-renewal, namely, in which the capacity of the progeny or part thereof for additional proliferation is not substantially reduced compared to the progenitor cell, as well as stem cells that have limited self-renewal , specifically in which the capacity of the progeny or part thereof for additional proliferation is demonstrably reduced compared to the progenitor cell.</span>
  </p>
  <p id="p00286" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto sabe que las propiedades anteriores designan en general el comportamiento in vivo de clulas progenitoras y clulas madre, y pueden duplicarse en condiciones apropiadas completamente o al menos en parte in vitro y/o ex vivo.</span>An expert knows that the above properties generally designate the in vivo behavior of progenitor cells and stem cells, and can be duplicated under appropriate conditions completely or at least partly in vitro and / or ex vivo.</span>
  </p>
  <p id="p00287" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Basndose en la capacidad de dar lugar a diversos tipos celulares, una clula progenitora o clula madre puede describirse habitualmente como totipotente, pluripotente, multipotente o unipotente. Se define una clula nica totipotente por ser capaz de crecer, concretamente, desarrollarse, hasta un organismo completo. Una clula pluripotente no es capaz de crecer hasta un organismo completo, pero es capaz de dar lugar a tipos celulares originarios de las tres capas germinales, concretamente mesodermo, endodermo y ectodermo, y puede ser capaz de dar lugar a todos los tipos celulares de un organismo. Una clula multipotente es capaz de dar lugar al menos a un tipo celular de cada uno de dos o ms rganos o tejidos diferentes de un organismo, en la que dichos tipos celulares pueden originarse a partir de la misma o diferente capa germinal, pero no es capaz de dar lugar a todos los tipos celulares de un organismo. Una clula unipotente es capaz de diferenciarse en clulas de solo un linaje celular.</span>Based on the ability to give rise to various cell types, a progenitor cell or stem cell can usually be described as totipotent, pluripotent, multipotent or unipotent. A single totipotent cell is defined by being able to grow, specifically, develop, to a complete organism. A "pluripotent" cell is not able to grow to a complete organism, but it is capable of giving rise to cellular types originating from the three germ layers, specifically mesoderm, endoderm and ectoderm, and may be able to give rise to all cell types. of an organism. A "multipotent" cell is capable of giving rise to at least one cell type of each of two or more different organs or tissues of an organism, in which said cell types can originate from the same or different germ layer, but It is not capable of giving rise to all cell types of an organism. An "unipotent" cell is able to differentiate into cells of only one cell lineage.</span>
  </p>
  <p id="p00288" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los trminos diferenciacin, diferenciar o derivados de los mismos como se usan en la presente memoria</span>The terms "differentiation", "differentiate" or derivatives thereof as used herein</span>
  </p>
  <p id="p00289" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00290" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00291" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00292" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00293" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00294" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00295" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00296" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00297" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00298" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00299" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00300" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">denotan el proceso mediante el cual una clula no especializada o relativamente menos especializada se vuelve relativamente ms especializada. En el contexto de la ontogenia celular, el adjetivo especializado es un trmino relativo. Por tanto, una clula diferenciada es una clula que ha progresado ms all en una cierta ruta de desarrollo que la clula con la que se est comparando. Una clula diferenciada puede ser, por ejemplo, una clula diferenciada terminalmente, concretamente una clula totalmente especializada que asume funciones especializadas en diversos tejidos y rganos de un organismo, y que puede ser, pero no es necesario, postmittica. En otro ejemplo, una clula diferenciada puede ser tambin una clula progenitora en un linaje de diferenciacin, que puede proliferar y/o diferenciarse adicionalmente. De forma similar, una clula est relativamente ms especializada si ha progresado ms all en una cierta ruta de desarrollo que la clula con la que se est comparando, considerndose por lo tanto la ltima no especializada o relativamente menos especializada. Una clula relativamente ms especializada puede diferir de la clula no especializada o relativamente menos especializada en una o ms caractersticas fenotpicas demostrables tales como, por ejemplo, la presencia, ausencia o nivel de expresin de componentes celulares o productos particulares, por ejemplo, ARN, protenas u otras sustancias, la actividad de ciertas rutas bioqumicas, la apariencia morfolgica, la capacidad y/o cintica de proliferacin, el potencial de diferenciacin y/o la respuesta ante seales de diferenciacin, etc., en la que dichas caractersticas significan la progresin de la clula relativamente ms especializada ms all en dicha ruta de desarrollo.</span>they denote the process by which a non-specialized or relatively less specialized cell becomes relatively more specialized. In the context of cellular ontogeny, the adjective "specialized" is a relative term. Therefore, a "differentiated cell" is a cell that has progressed further along a certain developmental path than the cell with which it is being compared. A differentiated cell can be, for example, a terminal differentiated cell, specifically a fully specialized cell that assumes specialized functions in various tissues and organs of an organism, and which may be, but is not necessary, postmitotic. In another example, a differentiated cell can also be a progenitor cell in a differentiation lineage, which can proliferate and / or further differentiate. Similarly, a cell is "relatively more specialized" if it has progressed further along a certain developmental path than the cell with which it is being compared, therefore being considered the last "non-specialized" or "relatively less specialized". A relatively more specialized cell may differ from the non-specialized or relatively less specialized cell in one or more demonstrable phenotypic characteristics such as, for example, the presence, absence or level of expression of cellular components or particular products, for example, RNA, proteins. or other substances, the activity of certain biochemical pathways, morphological appearance, proliferation capacity and / or kinetics, the potential for differentiation and / or response to differentiation signals, etc., in which said characteristics mean the progression of the relatively more specialized cell beyond that development path.</span>
  </p>
  <p id="p00301" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los ejemplos no limitantes de diferenciacin pueden incluir, por ejemplo, el cambio de una clula madre pluripotente a un tipo dado de clula progenitora o clula madre multipotente, el cambio de una clula progenitora o clula madre multipotente a un tipo dado de clula progenitora o clula madre unipotente o el cambo de una clula progenitora o clula madre unipotente a tipos celulares ms especializados o a clulas especializadas terminalmente en un linaje celular dado. La diferenciacin de una clula no especializada o menos especializada en una clula ms especializada puede proceder mediante la aparicin de clulas con un grado intermedio de especializacin.</span>Non-limiting examples of differentiation may include, for example, the change from a pluripotent stem cell to a given type of progenitor cell or multipotent stem cell, the change from a progenitor cell or multipotent stem cell to a given type of progenitor cell or cell. Unipotent stem or the change of a progenitor cell or unipotent stem cell to more specialized cell types or terminal specialized cells in a given cell lineage. The differentiation of a non-specialized or less specialized cell into a more specialized cell can proceed through the appearance of cells with an intermediate degree of specialization.</span>
  </p>
  <p id="p00302" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Disociacin del tejido heptico</span>Dissociation of liver tissue</span>
  </p>
  <p id="p00303" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se ha mencionado, el procedimiento tal como se describe en la presente memoria comprende la etapa de disociar hgado adulto o una parte del mismo, formando una poblacin de clulas primarias a partir de dicho hgado adulto o parte del mismo.</span>As mentioned, the method as described herein comprises the step of dissociating adult liver or a part thereof, forming a population of primary cells from said adult liver or part thereof.</span>
  </p>
  <p id="p00304" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino hgado designa el rgano denominado hgado. El trmino parte del hgado designa en general cualquier parte del rgano hgado, sin ninguna limitacin en cuanto a la cantidad de dicha parte o de la regin del rgano hgado donde se origina. Preferiblemente, todos los tipos celulares presentes en el rgano hgado pueden estar tambin representados en dicha parte del hgado. La cantidad de la parte del hgado puede deducirse al menos en parte de consideraciones prcticas, por ejemplo, la necesidad de obtener suficientes clulas hepticas primarias para practicar razonablemente el procedimiento tal como se describe en la presente memoria. Dichas consideraciones resultarn evidentes para un experto a la vista de las presentes enseanzas. Por tanto, a modo de ejemplo y no de limitacin, una parte del hgado puede representar (tpicamente en p/p) al menos un 0,1% del hgado, o al menos un 1%, o al menos un 10%, o al menos un 20%, o al menos un 30%, o al menos un 40%, o al menos un 50%, o al menos un 60%, o al menos un 70%, o al menos un 80%, o al menos un 90% o ms del rgano hgado. En otros ejemplos no limitantes, una parte del hgado puede ser de al menos 1 g, o de al menos 10 g, o de al menos 100 g, o de al menos 200 g, o de al menos 300 g, o de al menos 400 g, o de al menos 500 g, o de al menos 600 g, o de al menos 700 g, o de al menos 800 g, o de al menos 900 g, o de al menos 1000 g, o de al menos 1100 g, o de al menos 1200 g, o de al menos 1300 g o de al menos 1400 g o ms. Por ejemplo, una parte del hgado puede ser un lbulo heptico, por ejemplo, el lbulo derecho o el lbulo izquierdo, o el segmento IV extirpado durante la operacin de divisin del hgado.</span>The term "liver" refers to the organ called the liver. The term "part of the liver" generally refers to any part of the liver organ, without any limitation as to the amount of said part or the region of the liver organ where it originates. Preferably, all cell types present in the liver organ may also be represented in said part of the liver. The amount of the part of the liver can be deduced at least in part from practical considerations, for example, the need to obtain sufficient primary liver cells to reasonably practice the procedure as described herein. Such considerations will be apparent to an expert in view of the present teachings. Thus, by way of example and not limitation, a part of the liver may represent (typically in w / w) at least 0.1% of the liver, or at least 1%, or at least 10%, or at least 20%, or at least 30%, or at least 40%, or at least 50%, or at least 60%, or at least 70%, or at least 80%, or at minus 90% or more of the liver organ. In other non-limiting examples, a part of the liver may be at least 1 g, or at least 10 g, or at least 100 g, or at least 200 g, or at least 300 g, or at least 400 g, or at least 500 g, or at least 600 g, or at least 700 g, or at least 800 g, or at least 900 g, or at least 1000 g, or at least 1100 g, or at least 1200 g, or at least 1300 g or at least 1400 g or more. For example, a part of the liver may be a hepatic lobe, for example, the right lobe or the left lobe, or segment IV removed during the liver division operation.</span>
  </p>
  <p id="p00305" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino hgado adulto como se usa en la presente memoria designa el hgado que ha alcanzado una madurez de desarrollo sustancial en la organizacin de tejido y composicin celular.</span>The term "adult liver" as used herein designates the liver that has reached a maturity of substantial development in the organization of tissue and cellular composition.</span>
  </p>
  <p id="p00306" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En particular, es sabido por un experto que el hgado puede experimentar cambios de desarrollo durante un periodo de tipo inmediatamente despus del nacimiento, despus del cual alcanza una organizacin sustancialmente madura. Por ejemplo, en sujetos humanos, el hgado en el nacimiento contiene una poblacin considerable de clulas hematopoyticas, que desaparecen sustancialmente del hgado al cabo de 1-2 semanas despus del nacimiento. Adems, el hgado de sujetos humanos en el nacimiento contiene una poblacin de clulas progenitoras hepticas, que se reemplazan sustancialmente por hepatocitos maduros y clulas biliares al cabo de varios meses despus del nacimiento.</span>In particular, it is known by an expert that the liver may undergo developmental changes during a type period immediately after birth, after which it reaches a substantially mature organization. For example, in human subjects, the liver at birth contains a considerable population of hematopoietic cells, which substantially disappear from the liver after 1-2 weeks after birth. In addition, the liver of human subjects at birth contains a population of hepatic progenitor cells, which are substantially replaced by mature hepatocytes and biliary cells after several months after birth.</span>
  </p>
  <p id="p00307" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En consecuencia, en sujetos humanos, hgado adulto designa el hgado de sujetos en cualquier momento despus del nacimiento, preferiblemente a trmino, y pueden ser, por ejemplo, de al menos un mes de edad despus del nacimiento, por ejemplo, de al menos 2 meses, al menos 3 meses, por ejemplo, al menos 4 meses, al menos 5 meses, por ejemplo, al menos 6 meses despus del nacimiento tal como, por ejemplo, 1 ao o ms, 5 aos o ms, al menos 10 aos o ms, 15 aos o ms, 20 aos o ms o 25 aos o ms despus del nacimiento. Por tanto, un hgado adulto, o hgado maduro, puede encontrarse en sujetos humanos que por lo dems se describiran en trminos convencionales de lactante, nio, joven, adolescente o adulto.</span>Consequently, in human subjects, "adult liver" designates the liver of subjects at any time after birth, preferably at term, and may be, for example, at least one month of age after birth, for example, at at least 2 months, at least 3 months, for example, at least 4 months, at least 5 months, for example, at least 6 months after birth such as, for example, 1 year or more, 5 years or more, at least 10 years or more, 15 years or more, 20 years or more or 25 years or more after birth. Therefore, an "adult liver," or mature liver, can be found in human subjects that would otherwise be described in conventional terms of "infant," "child," "young," "adolescent," or "adult."</span>
  </p>
  <p id="p00308" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00309" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00310" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00311" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00312" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00313" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00314" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00315" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00316" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00317" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00318" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00319" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto apreciar que el hgado puede alcanzar una madurez de desarrollo sustancial en diferentes intervalos postnatales de tiempo en diferentes especies animales, y puede interpretar apropiadamente el trmino hgado adulto con referencia a cada especie.</span>An expert will appreciate that the liver can reach substantial developmental maturity at different postnatal time intervals in different animal species, and can properly interpret the term "adult liver" with reference to each species.</span>
  </p>
  <p id="p00320" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El hgado o parte del mismo se obtiene a partir de un sujeto, sujeto donante o donante, que designan intercambiablemente un animal vertebrado, preferiblemente un mamfero, ms preferiblemente un ser humano.</span>The liver or part thereof is obtained from a "subject", "donor subject" or "donor", which interchangeably designates a vertebrate animal, preferably a mammal, more preferably a human being.</span>
  </p>
  <p id="p00321" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino mamfero incluye cualquier animal clasificado como tal incluyendo, pero sin limitacin, seres humanos, animales domsticos y de granja, animales de zoolgico, animales de deportes, mascotas, animales de compaa y animales experimentales tales como, por ejemplo, ratones, ratas, conejos, perros, gatos, vacas, caballos, cerdos y primates, por ejemplo, monos y simios.</span>The term "mammal" includes any animal classified as such including, but not limited to, humans, domestic and farm animals, zoo animals, sports animals, pets, pets and experimental animals such as, for example, mice, rats, rabbits, dogs, cats, cows, horses, pigs and primates, for example, monkeys and apes.</span>
  </p>
  <p id="p00322" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Segn la invencin, el hgado adulto o parte del mismo es de un sujeto humano. Como se detalla en otro lugar de la memoria descriptiva, las clulas progenitoras o clulas madre o lneas celulares o progenie de las mismas derivadas tal como se describe en la presente memoria de hgados de sujetos humanos, pueden usarse ventajosamente, por ejemplo, en la investigacin y terapia de pacientes, especialmente pacientes humanos, que padecen enfermedad heptica.</span>According to the invention, the adult liver or part thereof is from a human subject. As detailed elsewhere in the specification, progenitor cells or stem cells or cell lines or progeny thereof derived as described herein in human subjects livers, can advantageously be used, for example, in research. and therapy of patients, especially human patients, suffering from liver disease.</span>
  </p>
  <p id="p00323" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin que el hgado adulto o parte del mismo puede proceder de un sujeto animal no humano, preferiblemente un sujeto mamfero no humano. Las clulas progenitoras o clulas madre o lneas celulares o progenie de las mismos, derivadas como se describe en la presente memoria de hgados de sujetos animales no humanos o mamferos no humanos, pueden usarse ventajosamente, por ejemplo, en la investigacin y terapia de enfermedad heptica en miembros de la misma especie, relacionada u otra especie animal no humana o de mamfero no humano, o incluso en la terapia de pacientes humanos que padecen enfermedad heptica (por ejemplo, xenotrasplante, dispositivos hepticos bioartificiales que comprenden clulas de animal no humano o mamfero no humano). A modo de ejemplo y no de limitacin, pueden originarse clulas de mamfero no humano particularmente adecuadas para uso en terapia humana a partir de cerdos.</span>The present specification also describes that the adult liver or part thereof can come from a non-human animal subject, preferably a non-human mammalian subject. Progenitor cells or stem cells or cell lines or progeny thereof, derived as described herein from livers of non-human animal or non-human mammalian subjects, can be advantageously used, for example, in liver disease research and therapy. in members of the same species, related or other non-human or non-human mammalian species, or even in the therapy of human patients suffering from liver disease (for example, xenotransplantation, bioartificial liver devices comprising non-human or mammalian animal cells non-human). By way of example and not limitation, non-human mammalian cells particularly suitable for use in human therapy can be originated from pigs.</span>
  </p>
  <p id="p00324" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un sujeto donante puede estar vivo o muerto, segn se determina por criterios aceptados en la tcnica tales como, por ejemplo, el criterio cardiopulmonar (que implica habitualmente un cese irreversible de las funciones circulatoria y respiratoria) o el criterio de muerte cerebral (que implica habitualmente un cese irreversible de todas las funciones del cerebro completo, incluyendo el tronco enceflico). La recogida puede implicar procedimientos conocidos en la tcnica tales como, por ejemplo, biopsia, extirpacin o escisin.</span>A donor subject may be alive or dead, as determined by criteria accepted in the art such as, for example, the "cardiopulmonary" criterion (which usually implies an irreversible cessation of circulatory and respiratory functions) or the "brain death" criterion. (Which usually implies an irreversible cessation of all functions of the entire brain, including the brainstem). Collection may involve procedures known in the art such as, for example, biopsy, excision or excision.</span>
  </p>
  <p id="p00325" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto apreciar que al menos algunos aspectos de recoger el hgado o parte del mismo de sujetos donantes pueden estar sometidos a las normas legales y ticas correspondientes. A modo de ejemplo y no de limitacin, la recogida de tejido heptico de un donante humano vivo puede tener que ser compatible con la sustentacin de la vida posterior del donante. En consecuencia, puede retirarse tpicamente solo una parte del hgado de un donante humano vivo, por ejemplo usando biopsia o extirpacin, de tal modo que se mantenga un nivel adecuado de funciones hepticas fisiolgicas en el donante. Por otro lado, la recogida del hgado o parte del mismo de un animal no humano puede ser, pero no es necesario, compatible con la supervivencia posterior del animal no humano. Por ejemplo, el animal no humano puede sacrificarse humanitariamente despus de la recogida del tejido. Estas y otras consideraciones anlogas resultarn evidentes para un experto en la tcnica y reflejan los estndares legales y ticos.</span>An expert will appreciate that at least some aspects of collecting the liver or part thereof from donor subjects may be subject to the corresponding legal and ethical standards. By way of example and not limitation, the collection of liver tissue from a living human donor may have to be compatible with the subsequent life support of the donor. Consequently, only a part of the liver of a living human donor can be typically removed, for example using biopsy or excision, such that an adequate level of physiological liver functions is maintained in the donor. On the other hand, the collection of the liver or part thereof from a non-human animal may be, but is not necessary, compatible with the subsequent survival of the non-human animal. For example, the non-human animal can be humanely sacrificed after tissue collection. These and other similar considerations will be apparent to a person skilled in the art and reflect legal and ethical standards.</span>
  </p>
  <p id="p00326" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se describe en la presente memoria, el hgado o parte del mismo puede obtenerse a partir de un donante, especialmente un donante humano, que tenga una circulacin sostenida, por ejemplo el corazn latiendo, y funciones respiratorias sostenidas, por ejemplo los pulmones respirando o ventilacin artificial. Segn las normas ticas y legales, el donante puede tener que estar en muerte cerebral o no (por ejemplo, la retirada del hgado completo o una porcin del mismo, que no sera compatible con la supervivencia posterior de un donante humano, puede permitirse en seres humanos con muerte cerebral). La recogida del hgado o parte del mismo de dichos donantes es ventajosa, puesto que el tejido no sufre la anoxia sustancial (falta de oxigenacin) que resulta habitualmente de la isquemia (cese de la circulacin).</span>As described herein, the liver or part thereof can be obtained from a donor, especially a human donor, having a sustained circulation, for example the heart beating, and sustained respiratory functions, for example the lungs breathing or artificial ventilation According to ethical and legal norms, the donor may have to be in brain death or not (for example, the withdrawal of the whole liver or a portion thereof, which would not be compatible with the subsequent survival of a human donor, may be allowed in beings humans with brain death). The collection of the liver or part thereof from said donors is advantageous, since the tissue does not suffer the substantial anoxia (lack of oxygenation) that usually results from ischemia (cessation of circulation).</span>
  </p>
  <p id="p00327" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se describe tambin en la presente memoria, y como advirtieron sorprendentemente los presentes inventores, el hgado o parte del mismo puede obtenerse a partir de un donante, especialmente un donante humano, en que en el momento de recogida del tejido haya cesado la circulacin, por ejemplo, no lata su corazn, y/o hayan cesado las funciones respiratorias, por ejemplo, no respiren los pulmones y no tenga ventilacin artificial. Aunque el hgado o parte del mismo de estos donantes puede haber sufrido al menos cierto grado de anoxia, los presentes inventores advirtieron que pueden obtenerse tambin clulas progenitoras o clulas madre viables tal como se describe en la presente memoria a partir de dichos tejidos. El hgado o parte del mismo puede obtenerse al cabo de aproximadamente 24 horas despus del cese de la circulacin del donante (por ejemplo del latido cardiaco), por ejemplo, al cabo de aproximadamente 20 h, por ejemplo al cabo de aproximadamente 16 h, ms preferiblemente al cabo de aproximadamente 12 h, por ejemplo al cabo de aproximadamente 8 h, an ms preferiblemente al cabo de aproximadamente 6 h, por ejemplo al cabo de aproximadamente 5 h, al cabo de aproximadamente 4 h o al cabo de aproximadamente 3 h, todava ms preferiblemente al cabo de aproximadamente 2 h, y lo ms preferiblemente al cabo de aproximadamente 1 h, tal como al cabo de aproximadamente 45, 30 o 15 minutos despus del cese de la</span>As also described herein, and as the present inventors surprisingly warned, the liver or part thereof can be obtained from a donor, especially a human donor, in which at the time of tissue collection the circulation has ceased, for example, your heart does not beat, and / or respiratory functions have ceased, for example, do not breathe your lungs and do not have artificial ventilation. Although the liver or part thereof of these donors may have suffered at least some degree of anoxia, the present inventors cautioned that progenitor cells or viable stem cells can also be obtained as described herein from such tissues. The liver or part thereof can be obtained after approximately 24 hours after cessation of donor circulation (for example, heartbeat), for example, after approximately 20 h, for example after approximately 16 h, more preferably after about 12 h, for example after about 8 h, even more preferably after about 6 h, for example after about 5 h, after about 4 h after about 3 h, still more preferably after about 2 h, and most preferably after about 1 h, such as after about 45, 30 or 15 minutes after cessation of the</span>
  </p>
  <p id="p00328" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00329" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00330" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00331" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00332" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00333" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00334" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00335" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00336" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00337" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00338" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00339" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">circulacin del donante (por ejemplo del latido cardiaco).</span>donor circulation (for example, heartbeat).</span>
  </p>
  <p id="p00340" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los tejidos recogidos como anteriormente pueden enfriarse aproximadamente a temperatura ambiente o a una temperatura menor que la temperatura ambiente, pero habitualmente se evita la congelacin del tejido o partes del mismo, especialmente cuando dicha congelacin dara como resultado la nucleacin o el crecimiento de cristales de hielo. Por ejemplo, el tejido puede mantenerse a cualquier temperatura entre aproximadamente 1C y temperatura ambiente, entre aproximadamente 2C y temperatura ambiente, entre aproximadamente 3C y temperatura ambiente, entre aproximadamente 4C y temperatura ambiente, y puede mantenerse ventajosamente a aproximadamente 4C. El tejido puede mantenerse tambin en hielo como es conocido en la tcnica. El tejido puede enfriarse durante todo o parte del periodo isqumico, concretamente, el tiempo despus del cese de la circulacin en el donante. Es decir, el tejido puede someterse a isquemia en caliente, isquemia en fro o una combinacin de isquemia en caliente y en fro. El tejido recogido puede mantenerse as durante, por ejemplo, hasta 48 h antes del procesamiento, preferiblemente durante menos de 24 h, por ejemplo menos de 16 h, ms preferiblemente durante menos de 12 h, por ejemplo menos de 10 h, menos de 6 h, menos de 3 h, menos de 2 h o menos de 1 h.</span>Tissues collected as above can be cooled to approximately room temperature or at a temperature lower than room temperature, but freezing of tissue or parts thereof is usually avoided, especially when such freezing would result in nucleation or growth of ice crystals. For example, the fabric can be maintained at any temperature between about 1  C and room temperature, between about 2  C and room temperature, between about 3  C and room temperature, between about 4  C and room temperature, and can be advantageously maintained at about 4  C. The tissue can also be kept "on ice" as is known in the art. The tissue can be cooled during all or part of the ischemic period, specifically, the time after cessation of circulation in the donor. That is, the tissue can undergo hot ischemia, cold ischemia or a combination of hot and cold ischemia. The collected tissue can thus be maintained for, for example, up to 48 h before processing, preferably for less than 24 h, for example less than 16 h, more preferably for less than 12 h, for example less than 10 h, less than 6 h, less than 3 h, less than 2 h or less than 1 h.</span>
  </p>
  <p id="p00341" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El tejido recogido puede mantenerse ventajosamente, pero no necesariamente, sumergido, por ejemplo completa o al menos parcialmente, en un medio adecuado y/o puede perfundirse, aunque no necesariamente, con un medio adecuado antes del procesamiento posterior del tejido. Un experto es capaz de seleccionar el medio adecuado que puede apoyar la supervivencia de las clulas del tejido durante el periodo antes del procesamiento.</span>The collected tissue can be advantageously maintained, but not necessarily, submerged, for example completely or at least partially, in a suitable medium and / or can be perfused, although not necessarily, with a suitable medium before further processing of the tissue. An expert is able to select the appropriate medium that can support tissue cell survival during the period before processing.</span>
  </p>
  <p id="p00342" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El procedimiento tal como se describe en la presente memoria comprende disociar tejido de hgado adulto como se describe anteriormente formando una poblacin de clulas primarias.</span>The method as described herein comprises dissociating adult liver tissue as described above forming a population of primary cells.</span>
  </p>
  <p id="p00343" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino disociar como se usa en general en la presente memoria designa desestabilizar parcial o completamente la organizacin celular de un tejido u rgano, concretamente, desestabilizar parcial o completamente la asociacin entre las clulas y los componentes celulares de un tejido u rgano. Como puede entenderse por un experto, el objetivo de disociar un tejido u rgano es obtener una suspensin de clulas (una poblacin celular) a partir de dicho tejido u rgano. La suspensin puede comprender clulas solitarias o individuales, as como clulas unidas fsicamente formando conglomerados o grupos de dos o ms clulas. La disociacin preferiblemente no causa, o causa lo menos posible, una reduccin de la viabilidad celular.</span>The term "dissociate" as generally used herein refers to partially or completely destabilizing the cellular organization of a tissue or organ, namely, partially or completely destabilizing the association between cells and cellular components of a tissue or organ. As can be understood by an expert, the objective of dissociating a tissue or organ is to obtain a suspension of cells (a cell population) from said tissue or organ. The suspension may comprise solitary or individual cells, as well as physically linked cells forming clusters or groups of two or more cells. Dissociation preferably does not cause, or causes as little as possible, a reduction in cell viability.</span>
  </p>
  <p id="p00344" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un procedimiento adecuado para disociar hgado o parte del mismo para obtener una poblacin (suspensin) de clulas primarias a partir del mismo puede ser cualquier procedimiento conocido en la tcnica incluyendo, pero sin limitacin, digestin enzimtica, separacin mecnica, filtracin, centrifugacin y combinaciones de los mismos. En una realizacin, el procedimiento para disociar hgado o parte del mismo puede comprender la digestin enzimtica del tejido heptico para liberar clulas hepticas. En una realizacin, el procedimiento para disociar hgado o parte del mismo puede comprender la desestabilizacin o separacin mecnica del tejido heptico para liberar clulas hepticas. En una realizacin, el procedimiento para disociar hgado o parte del mismo puede comprender una combinacin de digestin enzimtica y desestabilizacin o separacin mecnica del tejido heptico para liberar clulas hepticas.</span>A suitable method for dissociating liver or part thereof to obtain a population (suspension) of primary cells therefrom can be any procedure known in the art including, but not limited to, enzymatic digestion, mechanical separation, filtration, centrifugation and combinations of the same. In one embodiment, the method for dissociating liver or part thereof can comprise enzymatic digestion of liver tissue to release liver cells. In one embodiment, the method for dissociating liver or part thereof may comprise destabilization or mechanical separation of liver tissue to release liver cells. In one embodiment, the method for dissociating liver or part thereof can comprise a combination of enzymatic digestion and destabilization or mechanical separation of liver tissue to release liver cells.</span>
  </p>
  <p id="p00345" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los procedimientos para disociar hgado o parte del mismo como anteriormente estn documentados en la tcnica. Por ejemplo, el aislamiento de clulas hepticas a partir de tejido heptico es bien con conocido desde mediados de los 60 (Howard y col. 1967. J. Cell. Biol. 35: 675-84). Se aislaron hepatocitos de rata usando una tcnica de digestin mecnica y enzimtica combinada modificada posteriormente por Berry y Friend (J. Cell. Biol. 43: 506-20, 1969). Esta tcnica se desarroll adicionalmente por Seglen convirtindose en la tcnica de perfusin con colagenasa en dos etapas usada ampliamente (Methods Cell. Biol. 13: 29-83, 1976).</span>The procedures for dissociating liver or part thereof as previously documented in the art. For example, the isolation of liver cells from liver tissue is well known since the mid-1960s (Howard et al. 1967. J. Cell. Biol. 35: 675-84). Rat hepatocytes were isolated using a combined mechanical and enzymatic digestion technique subsequently modified by Berry and Friend (J. Cell. Biol. 43: 506-20, 1969). This technique was further developed by Seglen becoming the widely used two-stage collagenase perfusion technique (Methods Cell. Biol. 13: 29-83, 1976).</span>
  </p>
  <p id="p00346" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En consecuencia, en una realizacin, el procedimiento para disociar hgado o parte del mismo para obtener una poblacin (suspensin) de clulas primarias a partir del mismo es o comprende la tcnica de perfusin con colagenasa en dos etapas. Un experto ser consciente de que, desde la publicacin anterior de dicha tcnica, se han descrito y/o son concebibles diversas modificaciones de la misma, y se incluyen en la presente memoria descriptiva.</span>Accordingly, in one embodiment, the method for dissociating liver or part thereof to obtain a population (suspension) of primary cells therefrom is or comprises the two-stage collagenase perfusion technique. An expert will be aware that, since the previous publication of said technique, various modifications of the same have been described and / or conceivable, and are included herein.</span>
  </p>
  <p id="p00347" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A modo de ilustracin y no de limitacin, sigue una breve descripcin de una tcnica con colagenasa en dos etapas comn. Para hgados completos, las cnulas pueden disponerse en los vasos sanguneos mayores del hgado, y fijarse mediante suturas. Para partes o segmentos del hgado, las cnulas pueden disponerse en aberturas de los vasos sanguneos abiertas sobre la superficie cortada y fijarse mediante suturas. En este caso, habitualmente tienen que sellarse las aberturas de vasos sanguneos pequeos para evitar escapes de las disoluciones de perfusin por la superficie cortada. Se perfunde el tejido heptico con una disolucin tampn exenta de cationes divalentes precalentada a 37C que contiene un agente quelante de cationes tal como, por ejemplo, cido etilendiaminotetraactico (EDTA) o cido etilenglicoltetraactico (EGTA). Las disoluciones tampn pueden comprender disoluciones salinas tales como, por ejemplo, cido W-2-hidroxietilpiperazin-N-etanosulfnico (HEPES), medio E de Williams, disolucin salina equilibrada de Hank o disolucin salina equilibrada de Earl, y pueden incluir tambin sales tales como NaCl y KCl, entre otras. Esto conduce a la desestabilizacin de las estructuras desmosmicas que mantienen juntas las clulas. Se perfunde entonces el tejido con una disolucin tampn que</span>By way of illustration and not limitation, a brief description of a common two-stage collagenase technique follows. For complete livers, the cannulas can be placed in the major blood vessels of the liver, and fixed using sutures. For parts or segments of the liver, the cannulas can be placed in openings of open blood vessels on the cut surface and fixed by sutures. In this case, the openings of small blood vessels usually have to be sealed to prevent leakage of perfusion solutions from the cut surface. The liver tissue is perfused with a buffer solution free of preheated divalent cations at 37  C containing a cation chelating agent such as, for example, ethylenediaminetetraacetic acid (EDTA) or ethylene glycol tetraacetic acid (EGTA). Buffer solutions may comprise saline solutions such as, for example, W-2-hydroxyethylpiperazin-N'-ethanesulfonic acid (HEPES), Williams medium E, Hank's balanced salt solution or Earl's balanced salt solution, and may also include salts such as NaCl and KCl, among others. This leads to the destabilization of the desmosomic structures that hold the cells together. The tissue is then perfused with a buffer solution that</span>
  </p>
  <p id="p00348" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00349" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00350" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00351" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00352" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00353" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00354" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00355" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00356" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00357" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00358" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00359" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00360" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">contiene cationes divalentes tales como Ca2+ y Mg2+ y enzimas degradantes de la matriz que actan digiriendo el tejido. Las clulas hepticas primarias, especialmente hepatocitos, se liberan habitualmente mediante desestabilizacin mecnica suave, por ejemplo, rascando con un peine, agitando y comprimiendo a travs de filtros, por ejemplo filtros de acero inoxidable, estopilla o tela de nailon, para completar mecnicamente el proceso de disociacin celular. Dichos filtros pueden tener tamaos de tamiz que permitan el paso de hepatocitos a su travs, a modo de ejemplo y no de limitacin, de aproximadamente 0,1 mm o ms, aproximadamente 0,25 mm o ms, aproximadamente 0,50 mm o ms, aproximadamente 1 mm o ms, o aproximadamente 2 mm, 3 mm, 4 mm o 5mm. Puede usarse una sucesin de filtros con tamaos de tamiz progresivamente menores para disociar gradualmente el tejido y liberar clulas. Las clulas disociadas se aclaran con un tampn que contiene inhibidor de proteasa, suero y/o plasma para inactivar la colagenasa y otras enzimas usadas en el proceso de perfusin, se separan mediante centrifugacin a baja velocidad, por ejemplo a entre 10 x g y 500 x g (ventajosamente, pueden sedimentarse sustancialmente todas las clulas vivas, mientras que las clulas muertas y desechos celulares se eliminan sustancialmente), y se lavan los sedimentos obtenidos con disolucin tampn enfriada con hielo para purificar la suspensin celular.</span>It contains divalent cations such as Ca2 + and Mg2 + and matrix degrading enzymes that act by digesting the tissue. Primary liver cells, especially hepatocytes, are usually released by mild mechanical destabilization, for example, scratching with a comb, shaking and compressing through filters, for example stainless steel filters, cheesecloth or nylon cloth, to mechanically complete the process of cell dissociation. Such filters may have sieve sizes that allow hepatocytes to pass through, by way of example and not limitation, of about 0.1 mm or more, about 0.25 mm or more, about 0.50 mm or more , about 1 mm or more, or about 2 mm, 3 mm, 4 mm or 5mm. A succession of filters with progressively smaller screen sizes can be used to gradually dissociate the tissue and release cells. The dissociated cells are rinsed with a buffer containing protease inhibitor, serum and / or plasma to inactivate collagenase and other enzymes used in the perfusion process, separated by centrifugation at low speed, for example between 10 xg and 500 xg ( advantageously, substantially all living cells can be sedimented, while dead cells and cellular debris are substantially removed), and the sediments obtained are washed with ice-cold buffer solution to purify the cell suspension.</span>
  </p>
  <p id="p00361" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El nmero y calidad de las clulas hepticas aisladas puede variar dependiendo, por ejemplo, de la calidad del tejido usado, las composiciones de las disoluciones tampn de perfusin y el tipo y la concentracin de enzima. Las enzimas usadas frecuentemente incluyen, pero sin limitacin, colagenasa, pronasa, tripsina, dispasa, hialuronidasa, termolisina y pancreatina, y combinaciones de las mismas. La colagenasa es la usada ms comnmente, preparada a menudo a partir de bacterias (por ejemplo, de Clostridium histolyticum), y puede consistir a menudo de una combinacin poco purificada de enzimas que puede tener una accin enzimtica inconsistente. Algunas de las enzimas exhiben actividad proteasa, que puede causar reacciones indeseadas que afecten a la calidad y cantidad de clulas viables/sanas. Se entiende por los expertos en la tcnica que hay que usar enzimas de suficiente pureza y calidad para obtener poblaciones de clulas hepticas viables.</span>The number and quality of the isolated liver cells may vary depending, for example, on the quality of the tissue used, the compositions of the perfusion buffer solutions and the type and concentration of enzyme. Frequently used enzymes include, but are not limited to, collagenase, pronase, trypsin, dispase, hyaluronidase, thermolysin and pancreatin, and combinations thereof. Collagenase is the most commonly used, often prepared from bacteria (for example, from Clostridium histolyticum), and can often consist of a poorly purified combination of enzymes that can have an inconsistent enzymatic action. Some of the enzymes exhibit protease activity, which can cause unwanted reactions that affect the quality and quantity of viable / healthy cells. It is understood by those skilled in the art that enzymes of sufficient purity and quality must be used to obtain viable liver cell populations.</span>
  </p>
  <p id="p00362" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Otros procedimientos de recogida de clulas hepticas primarias pueden excluir las tcnicas de digestin enzimtica. Se ha usado ampliamente la desestabilizacin mecnica, aunque los rendimientos de clulas hepticas producidas mediante este enfoque tienden a ser menores que mediante digestin con colagenasa, as como ser menos consistentes. Sin embargo, se han desarrollado con un xito razonable procedimientos recientes que implican la perfusin con sacarosa-EDTA en combinacin con una vibracin controlada en un entorno enfriado (Kravchenko y col. 2002. Cell. Biol. Int. 26: 1003-1006). La perfusin heptica se efecta in situ usando una disolucin de sacarosa que contiene EDTA (pH 7,4). Despus de la perfusin, se retira el hgado del cuerpo, se dispone en un disco y se divide finamente en un pequeo volumen de medio enfriado con hielo. Se liberan las clulas de los fragmentos hepticos mediante disgregacin vibracional mecnica controlada (MVD) usando un motor homogeneizador. La suspensin densa resultante producida mediante este procedimiento puede filtrarse entonces a travs de una malla gruesa dando una suspensin inicial de clulas hepticas. Las clulas pueden suspenderse en medio y recuperarse mediante centrifugacin. En consecuencia, en una realizacin, la disociacin del hgado o parte del mismo puede ser mediante desestabilizacin mecnica.</span>Other primary liver cell collection procedures may exclude enzymatic digestion techniques. Mechanical destabilization has been widely used, although the liver cell yields produced by this approach tend to be lower than by collagenase digestion, as well as being less consistent. However, recent procedures involving sucrose-EDTA infusion have been developed with reasonable success in combination with controlled vibration in a cooled environment (Kravchenko et al. 2002. Cell. Biol. Int. 26: 1003-1006). Hepatic perfusion is performed in situ using a sucrose solution containing EDTA (pH 7.4). After perfusion, the liver is removed from the body, placed on a disk and finely divided into a small volume of ice-cold medium. The cells of the liver fragments are released by controlled mechanical vibrational disintegration (MVD) using a homogenizing motor. The resulting dense suspension produced by this procedure can then be filtered through a coarse mesh giving an initial suspension of liver cells. Cells can be suspended in medium and recovered by centrifugation. Consequently, in one embodiment, the dissociation of the liver or part thereof can be by mechanical destabilization.</span>
  </p>
  <p id="p00363" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto ser consciente de que las tcnicas con colagenasa en dos etapas pueden ser particularmente adecuadas para liberar al menos hepatocitos a partir de tejido heptico. Las suspensiones celulares obtenidas usando dicha tcnica pueden comprender una proporcin considerable de hepatocitos, y pueden contener tambin otros tipos de clulas hepticas. Como se ha mencionado, los presentes inventores han advertido que dichas suspensiones celulares son un material de partida particularmente adecuado para la obtencin de la clula progenitora o clula madre de la invencin.</span>An expert will be aware that two-stage collagenase techniques may be particularly suitable for releasing at least hepatocytes from liver tissue. Cell suspensions obtained using said technique may comprise a considerable proportion of hepatocytes, and may also contain other types of liver cells. As mentioned, the present inventors have warned that said cell suspensions are a starting material particularly suitable for obtaining the progenitor cell or stem cell of the invention.</span>
  </p>
  <p id="p00364" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En una realizacin, el procedimiento de disociacin de hgado o parte del mismo puede formar una suspensin celular (como podra optimizarse fcilmente por un experto) que comprende al menos un 10%, por ejemplo al menos un 20%, al menos un 30%, por ejemplo al menos un 40%, al menos un 50%, por ejemplo al menos un 60%, al menos un 70%, por ejemplo al menos un 80% o al menos un 90% o hasta aproximadamente un 100% de clulas individuales, concretamente clulas nicas.</span>In one embodiment, the method of dissociating the liver or part thereof can form a cell suspension (as could easily be optimized by an expert) comprising at least 10%, for example at least 20%, at least 30%, for example at least 40%, at least 50%, for example at least 60%, at least 70%, for example at least 80% or at least 90% or up to about 100% of individual cells , specifically single cells.</span>
  </p>
  <p id="p00365" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se ha mencionado, disociar tejido heptico proporciona por tanto una poblacin de clulas primarias a partir de dicho hgado adulto o parte del mismo.</span>As mentioned, dissociating liver tissue thus provides a population of primary cells from said adult liver or part thereof.</span>
  </p>
  <p id="p00366" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se usa en la presente memoria, el trmino clula primaria incluye clulas presentes en una suspensin de clulas obtenida a partir de un tejido u rgano de un sujeto, por ejemplo, mediante disociacin del mismo (concretamente, una poblacin celular antes de ser sembrada), clulas presentes en un tejido extrado, ambas de las clases anteriores de clulas cuando se siembran por primera vez, y clulas de las suspensiones celulares derivadas de estas clulas sembradas por primera vez. El trmino clula secundaria designa clulas en todas las etapas posteriores de cultivo. Por tanto, cuando se someten a pases clulas primarias sembradas por primera vez, por ejemplo sacadas de la superficie de un sustrato y resembradas, se designan a menudo en la presente memoria como clulas secundarias, as como todas las clulas de pases posteriores.</span>As used herein, the term "primary cell" includes cells present in a suspension of cells obtained from a tissue or organ of a subject, for example, by dissociation thereof (specifically, a cell population before being seeded), cells present in a removed tissue, both of the previous classes of cells when first seeded, and cells of cell suspensions derived from these seeded cells for the first time. The term "secondary cell" designates cells in all subsequent stages of culture. Therefore, when primary cells seeded for the first time are subjected to passes, for example removed from the surface of a substrate and reseeded, they are often referred to herein as secondary cells, as well as all subsequent pass cells.</span>
  </p>
  <p id="p00367" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La poblacin de clulas primarias como se define y obtiene en la presente memoria disociando hgado o parte del mismo puede ser tpicamente heterognea, concretamente, puede comprender clulas que pertenecen a ms de un tipo celular que est comprendido en el hgado. Los tipos de clulas constituyentes del hgado ejemplares incluyen,</span>The population of primary cells as defined and obtained herein by dissociating liver or part thereof can be typically heterogeneous, namely, it can comprise cells belonging to more than one cell type that is comprised in the liver. Exemplary liver constituent cell types include,</span>
  </p>
  <p id="p00368" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00369" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00370" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00371" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00372" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00373" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00374" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00375" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00376" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00377" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00378" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00379" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00380" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">pero sin limitacin, hepatocitos, colangiocitos (clulas de conducto biliar), clulas de Kupffer, clulas estrelladas hepticas (clulas de Ito), clulas ovales y clulas endoteliales hepticas. Los trminos anteriores tienen significados establecidos en la tcnica y se interpreta ampliamente en la presente memoria que engloban cualquier tipo de clula clasificado como tal. Los tipos de clula constituyentes del hgado engloban adicionalmente tanto clulas hepticas parenquimticas como no parenquimticas.</span>but without limitation, hepatocytes, cholangiocytes (bile duct cells), Kupffer cells, liver starred cells (Ito cells), oval cells and liver endothelial cells. The foregoing terms have meanings established in the art and are widely interpreted herein that encompass any type of cell classified as such. The constituent cell types of the liver additionally encompass both parenchymal and non-parenchymal liver cells.</span>
  </p>
  <p id="p00381" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A modo de ilustracin adicional pero no de limitacin, hepatocito engloba clulas hepticas epiteliales parenquimticas incluyendo, pero sin limitacin, hepatocitos de diferentes tamaos (por ejemplo, hepatocitos pequeos, medianos y grandes), ploidas (por ejemplo, diploides, tetraploides u octaploides) u otras caractersticas. Por ejemplo, algunos autores proponen que los hepatocitos grandes, como definen los mismos, son las clulas parenquimticas responsables de las funciones fisiolgicas del hgado, mientras que los hepatocitos pequeos proporcionan una reserva de clulas progenitoras asignadas al desarrollo hasta hepatocitos (vase, por ejemplo, Mitaka y col. Biochem. Biophys. Res. Commun. 214: 310-7, 1995). Adicionalmente, a modo de ilustracin y no de limitacin, colangiocitos engloba las clulas epiteliales de los conductos biliares. Tambin a modo de ilustracin y no de limitacin, clula oval engloba clulas de morfologa (por ejemplo, la forma del ncleo) y expresin de marcadores celulares distintivas, como es conocido en la tcnica, que se propone que son clulas progenitoras capaces, en ciertas condiciones, de dar lugar a hepatocitos y clulas de conducto biliar (Lowes y col. KN. 2003. J. Gastroenterol. Hepatal. 18: 4-12; Yi y col. 1999. J. of Hepatology 31: 497-507).</span>By way of further illustration but not limitation, "hepatocyte" encompasses parenchymal epithelial liver cells including, but not limited to, hepatocytes of different sizes (eg, "small", "medium" and "large" hepatocytes), ploidies (for example , diploid, tetraploid or octaploid) or other characteristics. For example, some authors propose that "large" hepatocytes, as defined by them, are the parenchymal cells responsible for the physiological functions of the liver, while "small" hepatocytes provide a reserve of progenitor cells assigned to development to hepatocytes (see , for example, Mitaka et al. Biochem. Biophys. Res. Commun. 214: 310-7, 1995). Additionally, by way of illustration and not limitation, "cholangiocytes" encompasses bile duct epithelial cells. Also by way of illustration and not limitation, "oval cell" encompasses morphology cells (for example, the shape of the nucleus) and expression of distinctive cell markers, as is known in the art, which is proposed to be capable progenitor cells, under certain conditions, to give rise to hepatocytes and bile duct cells (Lowes et al. KN. 2003. J. Gastroenterol. Hepatal. 18: 4-12; Yi et al. 1999. J. of Hepatology 31: 497-507 ).</span>
  </p>
  <p id="p00382" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por tanto, la presente memoria descriptiva describe tambin una poblacin heterognea de clulas hepticas primarias que puede comprender clulas de al menos dos, por ejemplo al menos tres o al menos cuatro o ms, tipos de clula constituyentes del hgado, por ejemplo clulas que pertenecen a todos, o sustancialmente todos, los tipos de clula constituyentes del hgado incluyendo, pero sin limitacin, los tipos de clula heptica enumerados anteriormente. Un experto apreciar que la poblacin heterognea puede comprender tipos de clula heptica que se han descrito anteriormente como tales, tanto in vivo como in vitro, as como tipos de clula heptica que no se han descrito, clasificado, aislado y/o caracterizado anteriormente en la tcnica.</span>Therefore, the present specification also describes a heterogeneous population of primary liver cells that may comprise cells of at least two, for example at least three or at least four or more, constituent cell types of the liver, for example cells belonging to all, or substantially all, the constituent cell types of the liver including, but not limited to, the liver cell types listed above. An expert will appreciate that the heterogeneous population may comprise liver cell types that have been described above as such, both in vivo and in vitro, as well as liver cell types that have not been described, classified, isolated and / or characterized above in the technique.</span>
  </p>
  <p id="p00383" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto apreciar tambin que la poblacin celular heterognea puede comprender, pero no es necesario, diversos tipos de clula heptica en las mismas, o sustancialmente las mismas, proporciones relativas que estn presentes en el hgado o parte del mismo que se ha disociado. Por ejemplo, un experto sabe que las maneras particulares de disociar tejidos hepticos pueden conducir a un aislamiento ms eficaz de uno o ms tipos de clula en comparacin con uno o ms tipos de clula distintos, con lo que la suspensin celular obtenida puede estar enriquecida inadvertida o intencionalmente en el uno o ms tipos de clula anteriores. Adems, algunos procedimientos de disociacin pueden afectar de forma diferente a la supervivencia y/o viabilidad de los diferentes tipos de clula heptica. Tambin, un experto ser bien consciente de los procedimientos de la tcnica para enriquecer una poblacin celular obtenida disociando hgado o parte del mismo en uno o ms tipos de clula heptica deseada. Dichos procedimientos incluyen, pero sin limitacin, centrifugacin diferencial, centrifugacin por gradiente de densidad de flotacin, filtracin, elutriacin celular, purificacin por afinidad, digestin con proteasa o similares.</span>An expert will also appreciate that the heterogeneous cell population may comprise, but is not necessary, various types of liver cell therein, or substantially the same, relative proportions that are present in the liver or part thereof that has dissociated. For example, an expert knows that particular ways of dissociating liver tissues can lead to more efficient isolation of one or more cell types compared to one or more different cell types, whereby the cell suspension obtained may be inadvertently enriched. or intentionally in the one or more previous cell types. In addition, some dissociation procedures may affect differently the survival and / or viability of different types of liver cells. Also, an expert will be well aware of the procedures of the technique for enriching a cell population obtained by dissociating liver or part thereof into one or more desired liver cell types. Such procedures include, but are not limited to, differential centrifugation, flotation density gradient centrifugation, filtration, cell elutriation, affinity purification, protease digestion or the like.</span>
  </p>
  <p id="p00384" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tambin segn la presente memoria descriptiva, la poblacin heterognea de clulas hepticas primarias puede comprender clulas que pertenecen a todos o sustancialmente todos los tipos de clula constituyentes del hgado. Los presentes inventores desarrollaron un procedimiento para obtener un tipo anteriormente no dado a conocer de clula progenitora o clula madre a partir de hgado. No obstante, los inventores no desean ligarse a hiptesis alguna en cuanto al origen de dicha clula progenitora o clula madre novedosa.</span>Also according to the present specification, the heterogeneous population of primary liver cells may comprise cells that belong to all or substantially all of the constituent cell types of the liver. The present inventors developed a procedure to obtain a previously undisclosed type of progenitor cell or stem cell from liver. However, the inventors do not wish to link to any hypothesis as to the origin of said progenitor cell or novel stem cell.</span>
  </p>
  <p id="p00385" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A modo de ejemplo y no de limitacin, dicha clula progenitora o clula madre, o ancestro de la misma, puede haber estado presente en el hgado, por ejemplo en el parnquima o no en el parnquima del mismo. Por ejemplo, dicho ancestro puede haber tenido un fenotipo idntico, similar o diferente a la clula progenitora o clula madre aislada (por ejemplo, cultivar como se describe en la presente memoria puede haber alterado el fenotipo del ancestro). Como alternativa, o adems, la clula progenitora o clula madre aislada puede haber surgido debido a la alteracin, por ejemplo diferenciacin o desdiferenciacin, de uno o ms tipos de clula heptica, por ejemplo un tipo de clula heptica conocido anteriormente o no. A la vista de ello, el procedimiento tal como se describe en la presente memoria puede comenzar preferiblemente a partir de una poblacin celular representativa de todos o sustancialmente todos los tipos de clula heptica.</span>By way of example and not limitation, said progenitor cell or stem cell, or ancestor thereof, may have been present in the liver, for example in the parenchyma or not in the parenchyma thereof. For example, said ancestor may have had an identical phenotype, similar or different from the progenitor cell or isolated stem cell (for example, cultivating as described herein may have altered the ancestor phenotype). Alternatively, or in addition, the progenitor cell or isolated stem cell may have arisen due to the alteration, for example differentiation or dedifferentiation, of one or more types of liver cell, for example a type of liver cell known previously or not. In view of this, the process as described herein may preferably start from a representative cell population of all or substantially all types of liver cells.</span>
  </p>
  <p id="p00386" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los inventores han advertido que la clula progenitora o clula madre de la invencin puede obtenerse ventajosamente a partir de una poblacin celular formada disociando hgado o parte del mismo, en el que dicha poblacin celular comprende hepatocitos. Por tanto, un procedimiento adecuado para disociar hgado o parte del mismo tal como se describe en la presente memoria forma una poblacin celular que comprende hepatocitos. Sin ligarse a teora alguna, los inventores creen que la clula progenitora o clula madre de la invencin, o un ancestro de la misma, se libera conjuntamente a partir de tejido heptico disociando el hgado de manera que se liberen al menos hepatocitos a partir del hgado.</span>The inventors have warned that the progenitor cell or stem cell of the invention can be obtained advantageously from a cell population formed by dissociating liver or part thereof, in which said cell population comprises hepatocytes. Therefore, a suitable method for dissociating liver or part thereof as described herein forms a cell population comprising hepatocytes. Without being bound by theory, the inventors believe that the progenitor cell or stem cell of the invention, or an ancestor thereof, is released together from liver tissue by dissociating the liver so that at least hepatocytes are released from the liver. .</span>
  </p>
  <p id="p00387" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En una realizacin, el procedimiento de disociacin de hgado o parte del mismo puede formar una poblacin celular que comprende una proporcin de hepatocitos que es de al menos aproximadamente un 10%, al menos aproximadamente un 20%, al menos un 30%, al menos un 40%, preferiblemente al menos aproximadamente un</span>In one embodiment, the liver dissociation process or part thereof can form a cell population comprising a proportion of hepatocytes that is at least about 10%, at least about 20%, at least 30%, at least 40%, preferably at least about</span>
  </p>
  <p id="p00388" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00389" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00390" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00391" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00392" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00393" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00394" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00395" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00396" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00397" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00398" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00399" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50%, por ejemplo al menos un 60%, ms preferiblemente al menos aproximadamente un 70%, por ejemplo al menos aproximadamente un 80%, an ms preferiblemente al menos aproximadamente un 90% o ms, tal como al menos aproximadamente un 95%, al menos aproximadamente un 96%, al menos aproximadamente un 97%, al menos aproximadamente un 98% o al menos aproximadamente un 99%. Los inventores advirtieron que el procedimiento de disociacin de hgado o parte del mismo que forma una poblacin celular que comprende una proporcin sustancial de hepatocitos, por ejemplo al menos aproximadamente un 50% o ms como anteriormente, proporciona una poblacin celular de partida adecuada para obtener la clula progenitora o clula madre de la invencin.</span>50%, for example at least 60%, more preferably at least about 70%, for example at least about 80%, even more preferably at least about 90% or more, such as at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99%. The inventors warned that the method of dissociation of liver or part thereof that forms a cell population comprising a substantial proportion of hepatocytes, for example at least about 50% or more as above, provides a suitable starting cell population to obtain progenitor cell or stem cell of the invention.</span>
  </p>
  <p id="p00400" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin que puede obtenerse una poblacin celular que comprende las proporciones anteriores de hepatocitos disociando hgado o parte del mismo, sin incluir etapas de enriquecimiento adicional de la poblacin celular en hepatocitos y/u otros tipos de clula.</span>The present specification also describes that a cell population comprising the above proportions of hepatocytes can be obtained by dissociating liver or part thereof, not including additional enrichment stages of the cell population in hepatocytes and / or other cell types.</span>
  </p>
  <p id="p00401" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin que puede obtenerse una poblacin celular que comprende las proporciones anteriores de hepatocitos disociando hgado o parte del mismo y una o ms etapas adicionales para enriquecer la poblacin celular en hepatocitos y/u otros tipos de clula, especialmente hepatocitos. Sin embargo, un experto apreciar que, aunque la clula progenitora o clula madre de la invencin, o ancestro de la misma, puede liberarse a partir del hgado en condiciones de disociacin adecuadas para la liberacin de hepatocitos a partir del mismo, puede purificarse simultneamente, pero no necesariamente siempre, con hepatocitos o uno o ms subgrupos de hepatocitos (por ejemplo, hepatocitos grandes o pequeos) u otros tipos de clula, en procedimientos para enriquecer una poblacin celular en hepatocitos, subgrupos de los mismos u otros tipos de clula. Est dentro de la capacidad de un experto seleccionar los procedimientos para enriquecer hepatocitos u otros tipos de clula, especialmente hepatocitos, que retengan la clula progenitora o clula madre de la invencin, o ancestro de la misma, en la poblacin celular resultante.</span>The present specification also describes that a cell population comprising the above proportions of hepatocytes can be obtained by dissociating liver or part thereof and one or more additional steps to enrich the cell population in hepatocytes and / or other cell types, especially hepatocytes. However, an expert will appreciate that, although the progenitor cell or stem cell of the invention, or ancestor thereof, can be released from the liver under conditions of dissociation suitable for hepatocyte release therefrom, it can be purified simultaneously, but not necessarily always, with hepatocytes or one or more subgroups of hepatocytes (for example, "large" or "small" hepatocytes) or other cell types, in procedures to enrich a cell population in hepatocytes, subgroups thereof or other types of cell. It is within the ability of an expert to select the procedures for enriching hepatocytes or other cell types, especially hepatocytes, that retain the progenitor cell or stem cell of the invention, or ancestor thereof, in the resulting cell population.</span>
  </p>
  <p id="p00402" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adems, un experto entender que la clula progenitora o clula madre de la invencin, o un ancestro de la misma, puede tener ciertas propiedades (por ejemplo, propiedades fsicas o de expresin de marcador de superficie) que pueden permitir su enriquecimiento en la poblacin celular obtenida a partir de hgado, usando una tcnica de separacin adecuada. Puede estar dentro del alcance de un experto determinar qu fraccin de una poblacin celular separada basndose en uno o ms criterios comprende, o est enriquecida en, la clula progenitora o clula madre de la invencin, o un ancestro de la misma. Esto puede hacerse, por ejemplo, cultivando clulas de las diversas fracciones de ensayo segn el procedimiento tal como se describe en la presente memoria y determinando cules fracciones proporcionan la clula progenitora o clula madre de la invencin.</span>In addition, an expert will understand that the progenitor cell or stem cell of the invention, or an ancestor thereof, may have certain properties (for example, physical or surface marker expression properties) that may allow enrichment in the cell population obtained from liver, using a suitable separation technique. It may be within the scope of an expert to determine which fraction of a separate cell population based on one or more criteria comprises, or is enriched in, the progenitor cell or stem cell of the invention, or an ancestor thereof. This can be done, for example, by culturing cells of the various test fractions according to the procedure as described herein and determining which fractions provide the progenitor cell or stem cell of the invention.</span>
  </p>
  <p id="p00403" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Una poblacin enriquecida de clulas designa una poblacin de clulas en que estn presentes uno o ms tipos de clula en proporciones relativas mayores que lo que podra encontrarse in vivo o en la poblacin celular sometida a enriquecimiento.</span>An "enriched population" of cells designates a population of cells in which one or more cell types are present in relative proportions greater than what could be found in vivo or in the cell population undergoing enrichment.</span>
  </p>
  <p id="p00404" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Siembra de clulas primarias procedentes de tejido heptico</span>Seeding of primary cells from liver tissue</span>
  </p>
  <p id="p00405" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El procedimiento tal como se describe en la presente memoria comprende cultivar la poblacin de clulas primarias obtenida disociando tejido heptico como se explica. Con este objetivo, se siembra la poblacin primaria de clulas hepticas sobre un sustrato que permita la adherencia de las clulas al mismo.</span>The method as described herein comprises culturing the primary cell population obtained by dissociating liver tissue as explained. With this objective, the primary population of liver cells is sown on a substrate that allows the cells to adhere to it.</span>
  </p>
  <p id="p00406" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino siembra se usa en la presente memoria como sinnimo de diseminacin o inoculacin, y designa generalmente introducir una poblacin celular en un entorno in vitro capaz de promover la supervivencia y/o el crecimiento de las clulas introducidas. Tpicamente, dicho entorno puede proporcionarse en un sistema que est adecuadamente delimitado de los alrededores, de tal modo que pueda evitar un intercambio indeseado de material entre dicho entorno y los alrededores (evitando as, por ejemplo, la contaminacin del entorno o el escape de medio de cultivo o clulas del mismo), mientras que puede permitir un intercambio continuo o intermitente de otros componentes materiales tiles entre dicho entorno y los alrededores (por ejemplo, un intercambio ocasional de parte o todo el medio de cultivo, el intercambio continuo de gases o la recogida de clulas despus del cultivo, etc.). Habitualmente, pueden generarse entornos adecuados para el cultivo de clulas en recipientes de cultivo bien conocidos en la tcnica tales como, por ejemplo, matraces de cultivo celular, placas de pocillos y discos de diversos formatos.</span>The term "seeding" is used herein as a synonym for dissemination or inoculation, and generally designates introducing a cell population into an in vitro environment capable of promoting the survival and / or growth of introduced cells. Typically, said environment can be provided in a system that is adequately delimited from the surroundings, such that it can avoid an unwanted exchange of material between said environment and the surroundings (thus avoiding, for example, contamination of the environment or the escape of medium of culture or cells thereof), while it may allow a continuous or intermittent exchange of other useful material components between said environment and the surroundings (for example, an occasional exchange of part or all of the culture medium, the continuous exchange of gases or cell collection after culture, etc.). Typically, suitable environments for cell culture can be generated in culture vessels well known in the art such as, for example, cell culture flasks, well plates and discs of various formats.</span>
  </p>
  <p id="p00407" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe que se siembran clulas (por ejemplo, clulas hepticas primarias) sobre un sustrato que permita la adherencia de las clulas al mismo, concretamente, una superficie que no sea en general repulsora de la adhesin o unin celular. Esto puede llevarse a cabo, por ejemplo, sembrando las clulas en un sistema de cultivo (por ejemplo un recipiente de cultivo) que presente una o ms superficies de sustrato compatibles con la adhesin celular. Cuando dichas una o ms superficies de sustrato entran en contacto con la suspensin de clulas (por ejemplo, suspensin en un medio) introducida en el sistema de cultivo, puede seguir una adhesin celular entre las clulas y las superficies del sustrato. En consecuencia, el trmino sembrar sobre un sustrato que permita la adherencia de clulas sobre el mismo designa introducir clulas en un sistema de cultivo que ofrezca al menos una superficie de sustrato que sea en general compatible con la adherencia de las clulas al mismo, de tal modo que las clulas sembradas puedan entrar en contacto con dicha superficie de sustrato. Los principios generales de mantenimiento de cultivos de clulas adherentes son bien conocidos en la tcnica.</span>The present specification also describes that cells (for example, primary liver cells) are sown on a substrate that allows the adhesion of the cells thereto, namely, a surface that is not generally repulsive of adhesion or cell binding. This can be accomplished, for example, by sowing the cells in a culture system (for example a culture vessel) that has one or more substrate surfaces compatible with cell adhesion. When said one or more substrate surfaces come into contact with the cell suspension (eg, suspension in a medium) introduced into the culture system, cell adhesion can follow between the cells and the substrate surfaces. Consequently, the term "sowing on a substrate that allows the adhesion of cells on it" means introducing cells into a culture system that offers at least one substrate surface that is generally compatible with the adhesion of the cells thereto, such that seeded cells can come into contact with said substrate surface. The general principles of maintenance of adherent cell cultures are well known in the art.</span>
  </p>
  <p id="p00408" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00409" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00410" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00411" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00412" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00413" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00414" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00415" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00416" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00417" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00418" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00419" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00420" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Generalmente, un sustrato que permita la adherencia de clulas al mismo puede ser cualquier sustrato sustancialmente hidrfilo. Como es conocido en la tcnica, los recipientes de cultivo, por ejemplo matraces de cultivo, placas de pocillos, discos o similares, pueden estar hechos habitualmente de una gran variedad de materiales polimricos incluyendo, pero sin limitacin, poliacrilatos, polimetacrilatos, policarbonatos, poliestirenos, polisulfonas, polihidroxicidos, polianhdridos, poliortosteres, polifosfazenos, polifosfatos, polisteres, nailones o mezclas de los mismos, etc. En general, los recipientes de cultivo hechos de dichos materiales se tratan en superficie despus del moldeo para proporcionar superficies de sustrato hidrfilas y potenciar as la probabilidad de una unin celular eficaz. El tratamiento de superficie puede tomar la forma de un recubrimiento de superficie, o puede implicar el uso de energa dirigida a la superficie con la intencin de generar grupos qumicos sobre la superficie polimrica. Estos grupos qumicos tendrn una afinidad genrica por el agua o exhibirn de otro modo suficiente polaridad para permitir una adsorcin estable con otro grupo polar. Estos grupos funcionales conducen a hidrofilia y/o a un aumento del oxgeno de superficie, y son propiedades reconocidas por potenciar el crecimiento celular sobre las superficies de sustrato as modificadas. Dichos grupos qumicos pueden incluir grupos tales como aminas, amidas, carbonilos, carboxilatos, steres, hidroxilos, sulfhidrilos y similares. Los ejemplos de energa dirigida incluyen descarga en corona atmosfrica, tratamiento con plasma a vaco con radiofrecuencia (RF) y descarga luminiscente o tratamiento con plasma a CC (por ejemplo, documento US 6.617.152). Las prcticas estndares actuales para cultivar clulas adherentes pueden implicar el uso de medios qumicos definidos con adicin de suero bovino, humano o de otro animal. El suero aadido, adems de proporcionar nutrientes y/o promotores del crecimiento, puede promover tambin la adhesin celular al recubrir las superficies de plstico tratado con una capa de matriz a la que las clulas pueden adherirse mejor.</span>Generally, a substrate that allows cell adhesion thereto can be any substantially hydrophilic substrate. As is known in the art, culture vessels, for example culture flasks, well plates, discs or the like, can usually be made of a wide variety of polymeric materials including, but not limited to, polyacrylates, polymethacrylates, polycarbonates, polystyrenes. , polysulfones, polyhydroxy acids, polyanhydrides, polyorthoesters, polyphosphazes, polyphosphates, polyesters, nylon or mixtures thereof, etc. In general, culture vessels made of such materials are surface treated after molding to provide hydrophilic substrate surfaces and thereby enhance the likelihood of an effective cell binding. The surface treatment may take the form of a surface coating, or it may involve the use of energy directed to the surface with the intention of generating chemical groups on the polymeric surface. These chemical groups will have a generic affinity for water or otherwise exhibit sufficient polarity to allow stable adsorption with another polar group. These functional groups lead to hydrophilicity and / or an increase in surface oxygen, and are recognized properties for enhancing cell growth on substrate surfaces thus modified. Such chemical groups may include groups such as amines, amides, carbonyls, carboxylates, esters, hydroxyls, sulfhydryls and the like. Examples of directed energy include atmospheric corona discharge, radiofrequency (RF) vacuum plasma treatment and luminescent discharge or DC plasma treatment (eg, US 6,617,152). Current standard practices for culturing adherent cells may involve the use of defined chemical means with the addition of bovine, human or other animal serum. The added serum, in addition to providing nutrients and / or growth promoters, can also promote cell adhesion by coating the treated plastic surfaces with a matrix layer to which cells can adhere better.</span>
  </p>
  <p id="p00421" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Una superficie de sustrato alternativa compatible con la adhesin celular puede ser vidrio, opcionalmente tratado en superficie para introducir grupos funcionales, por ejemplo como se enumeran anteriormente, para aumentar la hidrofilia del mismo.</span>An alternative substrate surface compatible with cell adhesion can be glass, optionally surface treated to introduce functional groups, for example as listed above, to increase hydrophilicity thereof.</span>
  </p>
  <p id="p00422" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pueden generarse otras superficies de sustrato adherentes mediante recubrimiento de superficie, por ejemplo, recubrimiento de las superficies polimricas o polimricas tratadas como anteriormente. En un ejemplo no limitante, el recubrimiento puede implicar policationes adecuados tales como, por ejemplo, poliornitina o polilisina.</span>Other adherent substrate surfaces can be generated by surface coating, for example, coating of the polymeric or polymeric surfaces treated as above. In a non-limiting example, the coating may involve suitable polycations such as, for example, polyiorithin or polylysine.</span>
  </p>
  <p id="p00423" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En otro ejemplo, el recubrimiento preferido, y en consecuencia el sustrato, comprende uno o ms componentes de matriz extracelular, por ejemplo, las protenas de MEC fibrina, laminina, colgeno, preferiblemente colgeno de tipo 1, glucosaminoglucanos, por ejemplo heparina o sulfato de heparano, fibronectina, gelatina, vitronectina, elastina, tenascina, agrecano, agrina, sialoprotena sea, protena de matriz de cartlago, fibringeno, fibulina, mucinas, entactina, osteopontina, plasmingeno, restrictina, serglicina, SPARC/osteonectina, versicano, trombospondina 1 o molculas de adhesin celular incluyendo cadherinas, conexinas o selectinas, por s mismas o en diversas combinaciones.</span>In another example, the preferred coating, and consequently the substrate, comprises one or more extracellular matrix components, for example, MEC proteins fibrin, laminin, collagen, preferably type 1 collagen, glycosaminoglycans, for example heparin or sulfate. heparanus, fibronectin, gelatin, vitronectin, elastin, tenascin, aggrecan, agrin, bone sialoprotein, cartilage matrix protein, fibrinogen, fibulin, mucins, entactin, osteopontin, plasminogen, restrictin, serglycine, SPARC / osteonectin, versicine, thrombospondin 1 Cell adhesion molecules including cadherins, connexins or selectins, by themselves or in various combinations.</span>
  </p>
  <p id="p00424" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los ejemplos preferidos pueden incluir fibrina, laminina o colgeno. Los ejemplos preferidos adicionales pueden implicar composiciones que comprenden componentes de la MEC tales como, por ejemplo, Matrigel Basement Membrane Matrix (BD Biosciences), que es una preparacin de membrana basal solubilizada extrada de sarcoma de ratn EHS, un tumor rico en protenas de la mEc, con laminina como componente principal, seguido de colgeno de tipo 4, sulfato de heparano, proteoglucanos y entactina.</span>Preferred examples may include fibrin, laminin or collagen. Additional preferred examples may involve compositions comprising components of the MEC such as, for example, Matrigel Basement Membrane Matrix (BD Biosciences), which is a solubilized basement membrane preparation extracted from EHS mouse sarcoma, a protein-rich tumor of mEc, with laminin as the main component, followed by type 4 collagen, heparan sulfate, proteoglycans and entactin.</span>
  </p>
  <p id="p00425" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un ejemplo particularmente preferido incluye recubrimiento que consiste en o que comprende colgeno, esp. colgeno de tipo 1.</span>A particularly preferred example includes coating consisting of or comprising collagen, esp. type 1 collagen.</span>
  </p>
  <p id="p00426" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se aprecia por los expertos en la tcnica, las clulas pueden contarse para facilitar la siembra posterior de las clulas a una densidad deseada. Cuando, como en la presente memoria descriptiva, las clulas despus de la siembra pueden adherirse principalmente a una superficie de sustrato presente en el sistema de cultivo (por ejemplo, en un recipiente de cultivo), la densidad de siembra puede expresarse como el nmero de clulas sembradas por mm2 o cm2 de dicha superficie de sustrato. En la presente memoria descriptiva, la densidad de siembra de las clulas primarias obtenidas por disociar hgado o parte del mismo puede estar entre 1 clula/mm2 y 1x106 clulas/mm2, por ejemplo entre 1x101 y 1x105 clulas/mm2 o entre 1x102 y 1x105 clulas/mm2, por ejemplo entre 1x103 y 1x105 clulas/mm2, entre 5x103 y 5x104 clulas/mm2, entre 1x101 y 1x103 clulas/mm2, entre 1x102 y 1x104 clulas/mm2 por ejemplo aproximadamente 1x101, 5x101, 1x102, 5x102, 1x103, 5x103, 6x103, 7x103, 8x103, 9x103,</span>As seen by those skilled in the art, cells can be counted to facilitate subsequent planting of the cells at a desired density. When, as in the present specification, the cells after seeding can adhere mainly to a substrate surface present in the culture system (for example, in a culture vessel), the sowing density can be expressed as the number of cells seeded by mm2 or cm2 of said substrate surface. In the present specification, the seeding density of the primary cells obtained by dissociating liver or part thereof can be between 1 cell / mm2 and 1x106 cells / mm2, for example between 1x101 and 1x105 cells / mm2 or between 1x102 and 1x105 cells / mm2, for example between 1x103 and 1x105 cells / mm2, between 5x103 and 5x104 cells / mm2, between 1x101 and 1x103 cells / mm2, between 1x102 and 1x104 cells / mm2 for example approximately 1x101, 5x101, 1x102, 5x102, 1x103, 5x103 , 6x103, 7x103, 8x103, 9x103,</span>
  </p>
  <p id="p00427" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1x104, 2x104, 3x104, 4x104, 5x104 o 1x105 clulas/mm2.</span>1x104, 2x104, 3x104, 4x104, 5x104 or 1x105 cells / mm2.</span>
  </p>
  <p id="p00428" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tpicamente, despus de sembrar las clulas hepticas primarias, se deja la suspensin celular en contacto con la superficie adherente para permitir la adherencia de clulas de la poblacin celular a dicho sustrato. Al poner en contacto las clulas hepticas primarias con sustrato adherente, las clulas pueden suspenderse ventajosamente en un entorno que comprende al menos un medio, en los procedimientos tal como se describen en la presente memoria tpicamente un medio lquido, que apoya la supervivencia y/o crecimiento de las clulas. El medio puede aadirse al sistema antes, junto con o despus de la introduccin de las clulas al mismo. El medio puede ser reciente, concretamente no usado anteriormente para cultivar clulas, o puede comprender al menos una porcin que se ha acondicionado mediante cultivo previo de las clulas en el mismo, por ejemplo, cultivo de las clulas que se estn sembrando o ancestros de las mismas, o cultivo de clulas relacionadas ms lejanamente o no relacionadas con las clulas que se estn sembrando.</span>Typically, after seeding the primary liver cells, the cell suspension is left in contact with the adherent surface to allow adhesion of cells of the cell population to said substrate. By contacting the primary liver cells with adherent substrate, the cells can be advantageously suspended in an environment comprising at least one medium, in the procedures as described herein typically a liquid medium, which supports survival and / or cell growth The medium can be added to the system before, together with or after the introduction of the cells thereto. The medium may be recent, specifically not previously used for culturing cells, or it may comprise at least a portion that has been conditioned by prior culture of the cells therein, for example, culture of the cells being sown or ancestors of the cells. same, or culture of cells more closely related or unrelated to the cells being sown.</span>
  </p>
  <p id="p00429" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00430" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00431" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00432" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00433" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00434" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00435" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00436" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00437" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00438" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00439" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00440" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para facilitar dicha adherencia, la presente memoria descriptiva describe que la suspensin de clulas primarias puede ponerse en contacto con la superficie adherente durante al menos aproximadamente 0,5 h, por ejemplo durante al menos aproximadamente 1 h, preferiblemente durante al menos aproximadamente 2 h, por ejemplo durante al menos aproximadamente 4 h, ms preferiblemente durante al menos aproximadamente 8 h, durante al menos aproximadamente 12 h, an ms preferiblemente durante al menos aproximadamente 16 h, por ejemplo durante al menos aproximadamente 20 h y lo ms preferiblemente durante al menos aproximadamente 24 h o ms, por ejemplo durante al menos aproximadamente 28, 32, 36, 40, 44 o 48 h.</span>To facilitate such adhesion, the present specification describes that the suspension of primary cells can be in contact with the adherent surface for at least about 0.5 h, for example for at least about 1 h, preferably for at least about 2 h, for example for at least about 4 h, more preferably for at least about 8 h, for at least about 12 h, even more preferably for at least about 16 h, for example for at least about 20 h and most preferably for at least about 24 h or more, for example for at least about 28, 32, 36, 40, 44 or 48 h.</span>
  </p>
  <p id="p00441" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe adicionalmente que la suspensin de clulas primarias puede ponerse en contacto con la superficie adherente durante entre aproximadamente 2 h y aproximadamente 48 h, por ejemplo durante entre aproximadamente 12 h y aproximadamente 48 h, preferiblemente durante entre aproximadamente 12 h y aproximadamente 36 h, por ejemplo durante entre aproximadamente 16 h y aproximadamente 32 h, an ms preferiblemente durante entre aproximadamente 20 h y aproximadamente 28 h, y lo ms preferiblemente durante aproximadamente 24 h.</span>The present specification also further describes that the suspension of primary cells can be contacted with the adherent surface for between about 2 h and about 48 h, for example for between about 12 h and about 48 h, preferably for between about 12 h and about 36 h , for example for between about 16 h and about 32 h, even more preferably for between about 20 h and about 28 h, and most preferably for about 24 h.</span>
  </p>
  <p id="p00442" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Aunque se prefieren los tiempos anteriores, tambin pueden proporcionarse tiempos ms cortos o ms largos para la unin de clulas compatibles con la presente memoria descriptiva, y un experto puede optimizar tales tiempos.</span>Although the above times are preferred, shorter or longer times may also be provided for the binding of cells compatible with the present specification, and an expert can optimize such times.</span>
  </p>
  <p id="p00443" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Despus de permitir a las clulas de la poblacin de clulas hepticas primarias unirse al sustrato adherente como se describe anteriormente, se retira el material no adherente del sistema de cultivo. El material no adherente puede comprender, pero sin limitacin, clulas que no se han unido al sustrato adherente (tales como, por ejemplo, clulas que no tienden a la adherencia, o clulas que no se unieron al cabo del tiempo permitido para ello), clulas no viables o muertas, desechos celulares, etc. El material no adherente puede retirarse tpicamente desechando el medio del sistema de cultivo, con lo que las clulas adherentes permanecen unidas al sustrato, y opcionalmente lavando, una vez o repetidamente, las clulas adherentes y el sistema de cultivo con medio o tampn isotnico adecuado (por ejemplo, PBS). As, las clulas de la poblacin de clulas hepticas primarias que se han adherido a la superficie del sustrato se seleccionan para cultivo adicional.</span>After allowing the cells of the primary liver cell population to bind to the adherent substrate as described above, the non-adherent material is removed from the culture system. The non-adherent material may comprise, but is not limited to, cells that have not joined the adherent substrate (such as, for example, cells that do not tend to adhere, or cells that did not join after the time allowed for it), non-viable or dead cells, cell debris, etc. The non-adherent material can typically be removed by discarding the medium from the culture system, whereby the adherent cells remain attached to the substrate, and optionally washing, once or repeatedly, the adherent cells and the culture system with suitable isotonic medium or buffer ( for example, PBS). Thus, the cells of the primary liver cell population that have adhered to the substrate surface are selected for further culture.</span>
  </p>
  <p id="p00444" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El entorno en el que se siembran las clulas y se permiten unirse puede comprender al menos un medio, en los procedimientos tal como se describen en la presente memoria tpicamente un medio lquido, que apoya la supervivencia y/o crecimiento de las clulas. El medio puede aadirse al sistema antes, junto con o despus de la introduccin de las clulas al mismo. El medio puede ser reciente, concretamente no usado anteriormente para el cultivo de clulas, o puede comprender al menos una porcin que se ha acondicionado mediante cultivo anterior de clulas en el mismo, por ejemplo, cultivo de las clulas que se estn sembrando o ancestros de las mismas, o cultivo de clulas relacionadas ms lejanamente o no relacionadas con las clulas que se estn sembrando.</span>The environment in which cells are seeded and allowed to bind may comprise at least one medium, in the procedures as described herein typically a liquid medium, which supports the survival and / or growth of the cells. The medium can be added to the system before, together with or after the introduction of the cells thereto. The medium may be recent, specifically not previously used for cell culture, or it may comprise at least a portion that has been conditioned by prior culture of cells therein, for example, culture of the cells being sown or ancestors of the same, or culture of cells more closely related or unrelated to the cells being sown.</span>
  </p>
  <p id="p00445" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El medio puede ser un medio de cultivo adecuado como se describe en otro lugar de esta memoria descriptiva. Preferiblemente, la composicin del medio puede tener los siguientes rasgos, puede ser la misma o sustancialmente la misma que la composicin del medio usado en las etapas siguientes de cultivo de las clulas unidas. De otro modo, el medio puede ser diferente. Ventajosamente, el medio puede comprender suero o plasma, que pueden facilitar adicionalmente la adherencia celular.</span>The medium may be a suitable culture medium as described elsewhere in this specification. Preferably, the composition of the medium may have the following features, it may be the same or substantially the same as the composition of the medium used in the subsequent stages of culturing the bound cells. Otherwise, the medium may be different. Advantageously, the medium may comprise serum or plasma, which can further facilitate cell adhesion.</span>
  </p>
  <p id="p00446" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cultivo de clulas primarias a partir de tejido heptico</span>Primary cell culture from liver tissue</span>
  </p>
  <p id="p00447" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se cultivan posteriormente clulas de la poblacin de clulas primarias que se han adherido a dicho sustrato, preferiblemente en dicho entorno, durante al menos 7 das, por ejemplo durante al menos 8 das o durante al menos 9 das, preferiblemente durante al menos 10 das, por ejemplo al menos 11 o al menos 12 das, al menos 13 das o al menos 14 das, ms preferiblemente durante al menos 15 das, por ejemplo durante al menos 16 das o durante al menos 17 das o incluso durante al menos 18 das, por ejemplo durante al menos 19 das o al menos 20 das o ms. El trmino cultivar es comn en la tcnica y designa ampliamente el mantenimiento y/o crecimiento de clulas y/o la progenie de las mismas.</span>Cells from the population of primary cells that have adhered to said substrate are preferably cultured, preferably in said environment, for at least 7 days, for example for at least 8 days or for at least 9 days, preferably for at least 10 days, for example at least 11 or at least 12 days, at least 13 days or at least 14 days, more preferably for at least 15 days, for example for at least 16 days or for at least 17 days or even for at least 18 days, for example for at least 19 days or at least 20 days or more. The term "cultivate" is common in the art and broadly designates the maintenance and / or growth of cells and / or the progeny thereof.</span>
  </p>
  <p id="p00448" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones, las clulas primarias pueden cultivarse durante al menos entre aproximadamente 10 das y aproximadamente 40 das, preferiblemente durante al menos entre aproximadamente 15 das y aproximadamente 35 das, por ejemplo durante al menos aproximadamente 15 das y 20 das, tal como durante al menos aproximadamente 15, 16, 17, 18, 19 o 20 das. Preferiblemente, las clulas primarias pueden cultivarse as durante no ms de 60 das, o no ms de 50 das o no ms de 45 das.</span>In embodiments, the primary cells can be cultured for at least about 10 days to about 40 days, preferably for at least about 15 days to about 35 days, for example for at least about 15 days and 20 days, such as for at least approximately 15, 16, 17, 18, 19 or 20 days. Preferably, the primary cells can thus be cultured for no more than 60 days, or no more than 50 days or no more than 45 days.</span>
  </p>
  <p id="p00449" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como aprecian los expertos en la tcnica, el cultivo prolongado de clulas en un sistema de cultivo puede necesitar un cambio regular del medio de cultivo por un medio reciente. Un experto es capaz de valorar la necesidad de cambio de medio inspeccionando los parmetros de cultivo celular tales como, por ejemplo, el pH del mismo, la densidad celular o la apariencia celular. Tpicamente, el medio puede cambiarse a intervalos regulares, por ejemplo cada 1 a 10 das, preferiblemente entre 16 y 32 horas (por ejemplo, aproximadamente 24 horas) despus de sembrar y entonces preferiblemente cada 2 a 6 das, o ms preferiblemente cada 2 a 4 das, por ejemplo aproximadamente cada 2, 3 o 4 das. Puede cambiarse el volumen completo de medio o, como alternativa, puede cambiarse solo parte del medio, de tal modo que se retenga una porcin del medio acondicionado mediante el cultivo previo de las clulas. En una realizacin, se cambia sustancialmente todo el volumen de medio por medio</span>As those skilled in the art appreciate, prolonged cell culture in a culture system may require a regular change of the culture medium by a recent medium. An expert is able to assess the need for media change by inspecting cell culture parameters such as, for example, the pH thereof, cell density or cell appearance. Typically, the medium can be changed at regular intervals, for example every 1 to 10 days, preferably between 16 and 32 hours (for example, approximately 24 hours) after sowing and then preferably every 2 to 6 days, or more preferably every 2 to 4 days, for example approximately every 2, 3 or 4 days. The entire volume of the medium can be changed or, alternatively, only part of the medium can be changed, so that a portion of the conditioned medium is retained by pre-culturing the cells. In one embodiment, substantially the entire volume of medium is changed by means</span>
  </p>
  <p id="p00450" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00451" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00452" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00453" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00454" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00455" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00456" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00457" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00458" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00459" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00460" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00461" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">reciente. En otra realizacin preferida, el medio no se cambia durante un cultivo prolongado de las clulas.</span>recent. In another preferred embodiment, the medium is not changed during prolonged cell culture.</span>
  </p>
  <p id="p00462" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La suspensin de clulas primarias y las clulas adherentes posteriores se cultivan en presencia de un medio de cultivo lquido. Tpicamente, el medio comprender una formulacin de medio basal como es conocida en la tcnica. Pueden usarse muchas formulaciones de medio basal (disponibles, por ejemplo, en la American Type Culture Collection, ATCC; o en Invitrogen, Carlsbad, California) para cultivar las clulas primarias en el mismo incluyendo, pero sin limitacin, medio esencial mnimo de Eagle (MEM), medio de Eagle modificado por Dulbecco (DMEM), medio esencial mnimo modificado a (a-MEM), medio esencial basal (BME), medio de Dulbecco modificado por Iscove (IMDM), medio BGJb, medio nutriente F-12 (Ham), Liebovitz L-15, DmEM/F-12, medio de Eagle esencial modificado (eMeM), RPMI-1640, medio 199, MB 752/1 de Waymouth o medio E de Williams y modificaciones y/o combinaciones de los mismos. Las composiciones de los medios basales anteriores son conocidas en general en la tcnica y estn dentro de la experiencia de un experto en la tcnica modificar o modular las concentraciones de medios y/o medios complementados segn sea necesario para las clulas cultivadas. En un ejemplo, la formulacin de medio basal preferido puede ser medio E de Williams, que es una formulacin rica que se ha notificado que sustenta el cultivo in vitro de clulas hepticas adultas. Otros ejemplos pueden emplear formulaciones de medios basales adicionales tales como las elegidas de las anteriores.</span>The primary cell suspension and subsequent adherent cells are cultured in the presence of a liquid culture medium. Typically, the medium will comprise a basal medium formulation as is known in the art. Many basal medium formulations (available, for example, in the American Type Culture Collection, ATCC; or Invitrogen, Carlsbad, California) can be used to grow the primary cells therein including, but not limited to, Eagle's minimum essential medium ( MEM), Dulbecco-modified Eagle medium (DMEM), minimum essential medium modified to (a-MEM), basal essential medium (BME), Iscove-modified Dulbecco medium (IMDM), BGJb medium, F-12 nutrient medium ( Ham), Liebovitz L-15, DmEM / F-12, Modified Essential Eagle Medium (eMeM), RPMI-1640, Medium 199, Waymouth MB 752/1 or Williams Medium E and modifications and / or combinations thereof . The compositions of the above basal media are generally known in the art and it is within the skill of a person skilled in the art to modify or modulate the concentrations of media and / or supplemented media as necessary for cultured cells. In one example, the preferred basal medium formulation may be Williams' E medium, which is a rich formulation that has been reported to support the in vitro culture of adult liver cells. Other examples may employ additional baseline media formulations such as those chosen from the foregoing.</span>
  </p>
  <p id="p00463" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Dichas formulaciones de medios basales contienen los ingredientes necesarios para el desarrollo de clulas de mamfero que son conocidos per se. A modo de ilustracin y no de limitacin, estos ingredientes pueden incluir sales inorgnicas (en particular sales que contienen Na, K, Mg, Ca, Cl, P y posiblemente Cu, Fe, Se y Zn), tampones fisiolgicos (por ejemplo, HEPES, bicarbonato), nucletidos, nuclesidos y/o bases de cido nucleico, ribosa, desoxirribosa, aminocidos, vitaminas, antioxidantes (por ejemplo glutatin) y fuentes de carbono (por ejemplo, glucosa, piruvato, por ejemplo piruvato de sodio, acetato, por ejemplo acetato de sodio), etc. Resultar tambin evidente que muchos medios estn disponibles como formulaciones pobres en glucosa con o sin piruvato de sodio.</span>Said baseline media formulations contain the ingredients necessary for the development of mammalian cells that are known per se. By way of illustration and not limitation, these ingredients may include inorganic salts (in particular salts containing Na, K, Mg, Ca, Cl, P and possibly Cu, Fe, Se and Zn), physiological buffers (eg, HEPES , bicarbonate), nucleotides, nucleosides and / or bases of nucleic acid, ribose, deoxyribose, amino acids, vitamins, antioxidants (for example glutathione) and carbon sources (for example, glucose, pyruvate, for example sodium pyruvate, acetate, for example sodium acetate), etc. It will also be clear that many media are available as glucose-poor formulations with or without sodium pyruvate.</span>
  </p>
  <p id="p00464" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para uso en cultivo, pueden suministrarse a los medios basales uno o ms componentes adicionales. Por ejemplo, pueden usarse complementos adicionales para suministrar a las clulas los elementos traza necesarios y sustancias para un crecimiento y expansin ptimos. Dichos complementos incluyen insulina, transferrina, sales de selenio y combinaciones de los mismos. Estos componentes pueden incluirse en una disolucin salina tal como, pero sin limitacin, disolucin salina equilibrada de Hanks (HBSS) o disolucin salina de Earle. Pueden aadirse complementos antioxidantes adicionales, por ejemplo, p-mercaptoetanol. Aunque muchos medios basales contienen ya aminocidos, pueden complementarse con algunos aminocidos despus, por ejemplo L-glutamina, que es conocida por ser menos estable en disolucin. Pueden suministrarse adicionalmente a un medio compuestos antibiticos y/o antimicticos tales como, tpicamente, mezclas de penicilina y estreptomicina y/u otros compuestos ejemplificados, pero sin limitacin, por anfotericina, ampicilina, gentamicina, bleomicina, higromicina, kanamicina, mitomicina, cido micofenlico, cido nalidxico, neomicina, nistatina, paromomicina, polimixina, puromicina, rifampicina, espectinomicina, tetraciclina, tilosina y zeocina.</span>For use in culture, one or more additional components may be supplied to the basal media. For example, additional supplements can be used to supply the cells with the necessary trace elements and substances for optimal growth and expansion. Such supplements include insulin, transferrin, selenium salts and combinations thereof. These components may be included in a saline solution such as, but not limited to, Hanks balanced salt solution (HBSS) or Earle's saline solution. Additional antioxidant supplements may be added, for example, p-mercaptoethanol. Although many basal media already contain amino acids, they can be supplemented with some amino acids later, for example L-glutamine, which is known to be less stable in solution. Antibiotic and / or antifungal compounds such as, typically, mixtures of penicillin and streptomycin and / or other exemplified compounds may be additionally supplied to a medium, but without limitation, by amphotericin, ampicillin, gentamicin, bleomycin, hygromycin, kanamycin, mitomycin, mycophenolic acid , nalidixic acid, neomycin, nystatin, paromomycin, polymyxin, puromycin, rifampin, spectinomycin, tetracycline, tylosin and zeocin.</span>
  </p>
  <p id="p00465" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tambin pueden usarse ventajosamente hormonas en el cultivo celular e incluyen, pero sin limitacin, D- aldosterona, dietilestilbestrol (DES), dexametasona, estradiol, hidrocortisona, insulina, prolactina, progesterona, somatostatina/hormona de crecimiento humano (HGH), tirotropina, tiroxina, L-tironina, factor de crecimiento epitelial (EGF) y factor de crecimiento de hepatocito (HGF). Las clulas hepticas pueden beneficiarse tambin del cultivo con triyododitironina, acetato de a-tocoferol y glucagn.</span>Hormones can also be used advantageously in cell culture and include, but are not limited to, D-aldosterone, diethylstilbestrol (DES), dexamethasone, estradiol, hydrocortisone, insulin, prolactin, progesterone, somatostatin / human growth hormone (HGH), thyrotropin, thyroxine , L-thyronine, epithelial growth factor (EGF) and hepatocyte growth factor (HGF). Liver cells can also benefit from culture with triiododithyronine, a-tocopherol acetate and glucagon.</span>
  </p>
  <p id="p00466" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pueden usarse tambin lpidos y portadores lipdicos para complementar medios de cultivo celular. Dichos lpidos y portadores pueden incluir, pero sin limitacin, ciclodextrina, colesterol, cido linoleico conjugado con albmina, cido linoleico y cido oleico conjugados con albmina, cido linoleico no conjugado, cido linoleico-oleico-araquidnico conjugado con albmina, cido oleico no conjugado y conjugado con albmina, entre otros. La albmina puede usarse de forma similar en formulaciones exentas de cidos grasos.</span>Lipids and lipid carriers can also be used to complement cell culture media. Such lipids and carriers may include, but are not limited to, cyclodextrin, cholesterol, albumin-conjugated linoleic acid, albumin-conjugated linoleic acid and oleic acid, unconjugated linoleic acid, albumin-conjugated linoleic-oleic-arachidonic acid, and non-conjugated oleic acid and albumin conjugate, among others. Albumin can be used similarly in fatty acid-free formulations.</span>
  </p>
  <p id="p00467" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se contempla tambin la complementacin del medio de cultivo celular con plasma o suero de mamfero. El plasma o suero a menudo contienen factores y componentes celulares que son necesarios para la viabilidad y multiplicacin. El uso de reemplazos de suero adecuados est tambin contemplado.</span>The complementation of the cell culture medium with mammalian plasma or serum is also contemplated. Plasma or serum often contain cellular factors and components that are necessary for viability and multiplication. The use of suitable serum replacements is also contemplated.</span>
  </p>
  <p id="p00468" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino plasma es como se define convencionalmente. El plasma se obtiene habitualmente a partir de una muestra de sangre entera, a la que se proporciona o se pone en contacto con un anticoagulante tal como heparina, citrato (por ejemplo, citrato de sodio o citrato cido de dextrosa), oxalato o EDTA, al extraer la muestra de sangre o poco despus para evitar la coagulacin. Posteriormente, se separan los componentes celulares de la muestra de sangre del componente lquido (plasma) mediante una tcnica apropiada, tpicamente mediante centrifugacin. El trmino plasma designa por lo tanto una composicin que no forma parte de un cuerpo humano o animal.</span>The term "plasma" is as conventionally defined. Plasma is usually obtained from a whole blood sample, which is provided or contacted with an anticoagulant such as heparin, citrate (for example, sodium citrate or dextrose acid citrate), oxalate or EDTA, when drawing the blood sample or shortly thereafter to prevent clotting. Subsequently, the cellular components of the blood sample are separated from the liquid component (plasma) by an appropriate technique, typically by centrifugation. The term "plasma" therefore designates a composition that is not part of a human or animal body.</span>
  </p>
  <p id="p00469" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino suero es como se define convencionalmente. El suero puede obtenerse habitualmente a partir de una muestra de sangre completa dejando en primer lugar que tenga lugar la coagulacin en la muestra y separando posteriormente el cogulo as formado y los componentes celulares de la muestra de sangre del componente lquido (suero) mediante una tcnica apropiada, tpicamente mediante centrifugacin. Un catalizador inerte, por ejemplo perlas o polvo de vidrio, puede facilitar la coagulacin. Ventajosamente, el suero puede prepararse usando recipientes separadores de suero (SST) conocidos en la tcnica, que contienen el catalizador inerte para facilitar la</span>The term "serum" is as conventionally defined. The serum can usually be obtained from a whole blood sample, leaving coagulation in the sample first and then separating the clot thus formed and the cellular components of the blood sample from the liquid component (serum) by a technique. appropriate, typically by centrifugation. An inert catalyst, for example beads or glass powder, can facilitate coagulation. Advantageously, the serum can be prepared using serum separator vessels (SST) known in the art, which contain the inert catalyst to facilitate the</span>
  </p>
  <p id="p00470" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00471" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00472" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00473" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00474" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00475" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00476" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00477" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00478" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00479" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00480" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00481" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">coagulacin e incluyen adicionalmente un gel de densidad diseada para disponerse entre el componente lquido y el cogulo y los componentes celulares despus de la centrifugacin, simplificando por tanto la separacin. Como alternativa, el suero puede obtenerse a partir del plasma retirando anticoagulante y fibrina. El trmino suero designa por lo tanto una composicin que no forma parte de un cuerpo humano o animal.</span>coagulation and additionally include a density gel designed to be disposed between the liquid component and the clot and the cellular components after centrifugation, thereby simplifying separation. Alternatively, serum can be obtained from plasma by removing anticoagulant and fibrin. The term "serum" therefore designates a composition that is not part of a human or animal body.</span>
  </p>
  <p id="p00482" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El plasma o suero aislados pueden usarse directamente en los procedimientos tal como se describen en la presente memoria. Pueden almacenarse tambin apropiadamente para un uso posterior en el procedimiento tal como se describe en la presente memoria. Tpicamente, el plasma o suero puede almacenarse durante periodos cortos de tiempo, por ejemplo de hasta aproximadamente 1-2 semanas, a una temperatura por encima de los puntos de congelacin respectivos de plasma o suero, pero por debajo de la temperatura ambiente. Habitualmente, esta temperatura ser de aproximadamente 15C o menos, preferiblemente de aproximadamente 10C o menos, ms preferiblemente de aproximadamente 5C o menos, por ejemplo, de aproximadamente 5C, 4C, 3C, 2C o aproximadamente 1C, lo ms preferiblemente de aproximadamente 5C o aproximadamente 4C. Como alternativa, el plasma o suero pueden almacenarse a temperaturas por debajo de sus puntos de congelacin respectivos, concretamente mediante almacenamiento en congelador. Como es habitual en la tcnica, las temperaturas ventajosas para el almacenamiento en congelador de plasma o suero pueden ser de aproximadamente -70C o menos, por ejemplo de aproximadamente -75C o menos o de aproximadamente -80C o menos. Dichas temperaturas pueden evitar ventajosamente cualquier descongelacin del plasma o suero almacenado, conservando as la calidad del mismo. El almacenamiento en congelador puede usarse independientemente del periodo de tiempo durante el que sea necesario almacenar el plasma o suero, pero puede ser particularmente adecuado si se requiere un almacenamiento largo, por ejemplo durante ms de unos pocos das o durante ms de 1-2 semanas.</span>The isolated plasma or serum can be used directly in the procedures as described herein. They can also be properly stored for later use in the process as described herein. Typically, the plasma or serum may be stored for short periods of time, for example up to about 1-2 weeks, at a temperature above the respective freezing points of plasma or serum, but below room temperature. Typically, this temperature will be about 15  C or less, preferably about 10  C or less, more preferably about 5  C or less, for example, about 5  C, 4  C, 3  C, 2  C or about 1  C, most preferably about 5  C or about 4  C. Alternatively, the plasma or serum can be stored at temperatures below their respective freezing points, specifically by freezer storage. As is customary in the art, the advantageous temperatures for plasma or serum freezer storage may be about -70  C or less, for example about -75  C or less or about -80  C or less. Said temperatures can advantageously prevent any thawing of the stored plasma or serum, thus preserving its quality. Freezer storage can be used regardless of the period of time during which it is necessary to store the plasma or serum, but it may be particularly suitable if long storage is required, for example for more than a few days or for more than 1-2 weeks .</span>
  </p>
  <p id="p00483" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Antes del almacenamiento o uso, el plasma o suero aislado puede inactivarse trmicamente. La inactivacin trmica se usa en la tcnica principalmente para retirar el complemento. Por tanto la inactivacin trmica implica tpicamente incubar el plasma o suero a 56C durante 30 a 60 min, por ejemplo 30 min, con agitacin sostenida, despus de lo cual se permite enfriar gradualmente el plasma o suero hasta temperatura ambiente. Un experto ser consciente de cualquier modificacin y requisito comn del procedimiento anterior.</span>Before storage or use, the isolated plasma or serum can be thermally inactivated. Thermal inactivation is used in the art primarily to remove the complement. Thus thermal inactivation typically involves incubating the plasma or serum at 56  C for 30 to 60 min, for example 30 min, with sustained stirring, after which it is allowed to gradually cool the plasma or serum to room temperature. An expert will be aware of any modification and common requirement of the previous procedure.</span>
  </p>
  <p id="p00484" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Opcionalmente, el plasma o suero puede esterilizarse tambin antes del almacenamiento o uso. Los medios habituales de esterilizacin pueden implicar, por ejemplo, filtracin a travs de uno o ms filtros de tamao de poro menor de 1 |im, preferiblemente menor de 0,5 |im, por ejemplo menor de 0,45 |im, 0,40 |im, 0,35 |im, 0,30 |im o 0,25 |im, ms preferiblemente de 0,2 |im o menor, por ejemplo 0,15 |im o menor, 0,10 |im o menor.</span>Optionally, the plasma or serum can also be sterilized before storage or use. The usual means of sterilization may involve, for example, filtration through one or more filters of pore size less than 1 m, preferably less than 0.5 m, for example less than 0.45 m, 0, 40 | im, 0.35 | im, 0.30 | im or 0.25 | im, more preferably 0.2 | im or less, for example 0.15 | im or less, 0.10 | im or less .</span>
  </p>
  <p id="p00485" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los sueros o plasmas adecuados para uso en los medios como se describen en la presente memoria pueden incluir suero o plasma humano, o suero o plasma de animales no humanos, preferiblemente mamferos no humanos tales como, por ejemplo, primates no humanos (por ejemplo, lmures, monos, simios, etc.), suero o plasma fetal o adulto bovino, de caballo, porcino, de cordero, de cabra, de perro, de conejo, de ratn o rata, etc. En otra realizacin, la presente memoria descriptiva prev el uso de cualquiera combinacin de los plasmas y/o sueros anteriores.</span>Serums or plasmas suitable for use in the media as described herein may include serum or human plasma, or serum or plasma of non-human animals, preferably non-human mammals such as, for example, non-human primates (e.g., lemurs, monkeys, apes, etc.), fetal or adult serum or plasma, bovine, horse, pig, lamb, goat, dog, rabbit, mouse or rat, etc. In another embodiment, the present specification provides for the use of any combination of the plasmas and / or previous sera.</span>
  </p>
  <p id="p00486" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe que el suero o plasma pueden obtenerse a partir de un organismo de la misma especie que la especie de la que se obtienen las clulas hepticas primarias. En un ejemplo no limitante, puede usarse suero o plasma humano para cultivar clulas hepticas humanas primarias.</span>The present specification describes that serum or plasma can be obtained from an organism of the same species as the species from which the primary liver cells are obtained. In a non-limiting example, human serum or plasma can be used to grow primary human liver cells.</span>
  </p>
  <p id="p00487" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En otro ejemplo preferido, el medio comprende suero o plasma bovino, preferiblemente suero o plasma fetal bovino (de ternero), ms preferiblemente suero fetal bovino (de ternero) (FCS o FBS).</span>In another preferred example, the medium comprises bovine serum or plasma, preferably bovine (calf) fetal serum or plasma, more preferably bovine (calf) fetal serum (FCS or FBS).</span>
  </p>
  <p id="p00488" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En otro ejemplo, el medio usado para cultivar clulas hepticas primarias comprende suero o plasma bovino, preferiblemente suero o plasma fetal bovino (de ternero), ms preferiblemente suero fetal bovino (de ternero) (FCS o FBS).</span>In another example, the medium used to grow primary liver cells comprises bovine serum or plasma, preferably bovine (calf) fetal serum or plasma, more preferably bovine (calf) fetal serum (FCS or FBS).</span>
  </p>
  <p id="p00489" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En ejemplos, el medio comprende entre aproximadamente un 0,5% y aproximadamente un 40% (v/v) de suero o plasma o suero de reposicin, preferiblemente entre aproximadamente un 5% y un 20% (v/v), por ejemplo entre aproximadamente un 5% y un 15% (v/v), ms preferiblemente entre aproximadamente un 8% (v/v) y aproximadamente un 12% (v/v), por ejemplo aproximadamente un 10% (v/v) de suero o plasma o suero de reposicin, especialmente el suero o plasma preferido como se define anteriormente.</span>In examples, the medium comprises between about 0.5% and about 40% (v / v) serum or plasma or replacement serum, preferably between about 5% and 20% (v / v), for example between about 5% and 15% (v / v), more preferably between about 8% (v / v) and about 12% (v / v), for example about 10% (v / v) of serum or plasma or replacement serum, especially the preferred serum or plasma as defined above.</span>
  </p>
  <p id="p00490" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo preferido adicional, el medio usado para cultivar clulas hepticas humanas primarias comprende un suero o plasma bovino, preferiblemente suero o plasma fetal bovino (de ternero), ms preferiblemente suero fetal bovino (de ternero) (FCS o FBS), en una cantidad de entre aproximadamente un 0,5% y aproximadamente un 40% (v/v), preferiblemente entre aproximadamente un 5% y un 20% (v/v), por ejemplo entre aproximadamente un 5% y un 15% (v/v), ms preferiblemente entre aproximadamente un 8% (v/v) y aproximadamente un 12% (v/v), por ejemplo aproximadamente un 10%.</span>In a further preferred example, the medium used to grow primary human liver cells comprises a bovine serum or plasma, preferably bovine (calf) fetal serum or plasma, more preferably bovine (calf) fetal serum (FCS or FBS), in a amount of between about 0.5% and about 40% (v / v), preferably between about 5% and 20% (v / v), for example between about 5% and 15% (v / v), more preferably between about 8% (v / v) and about 12% (v / v), for example about 10%.</span>
  </p>
  <p id="p00491" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En an otros ejemplos, un medio puede comprender plasma o suero derivado de ms de una especie. Por ejemplo, el medio puede comprender una mezcla de suero o plasma derivado de una especie correspondiente a las clulas hepticas primarias cultivadas y de otra especie. Por ejemplo, un medio para cultivar clulas hepticas humanas puede comprender una mezcla de plasma o suero humano, preferiblemente suero humano, y plasma o suero bovino, preferiblemente suero bovino.</span>In still other examples, a medium may comprise plasma or serum derived from more than one species. For example, the medium may comprise a mixture of serum or plasma derived from a species corresponding to the cultured primary liver cells and from another species. For example, a means for culturing human liver cells may comprise a mixture of plasma or human serum, preferably human serum, and bovine plasma or serum, preferably bovine serum.</span>
  </p>
  <p id="p00492" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00493" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00494" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00495" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00496" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00497" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00498" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00499" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00500" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00501" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00502" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00503" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adicionalmente, el medio puede comprender adicionalmente un factor de crecimiento aadido exgenamente (concretamente, adems del plasma o suero). Un experto apreciara que los componentes ordinarios de los medios basales (antes de la adicin de suero o plasma), por ejemplo particularmente, disolucin salina isotnica, tampones, sales inorgnicas, aminocidos, fuentes de carbono, vitaminas, antioxidantes, indicadores del pH y antibiticos, no se consideran factores de crecimiento ni factores de diferenciacin en la tcnica. Por otro lado, el suero o plasma es una composicin compleja que comprende posiblemente uno o ms de dichos factores de crecimiento o factores de diferenciacin.</span>Additionally, the medium may additionally comprise an exogenously added growth factor (specifically, in addition to plasma or serum). An expert would appreciate that the ordinary components of the basal media (before the addition of serum or plasma), for example particularly, isotonic saline, buffers, inorganic salts, amino acids, carbon sources, vitamins, antioxidants, pH indicators and antibiotics , are not considered growth factors or differentiation factors in the technique. On the other hand, serum or plasma is a complex composition that possibly comprises one or more of said growth factors or differentiation factors.</span>
  </p>
  <p id="p00504" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El trmino factor de crecimiento como se usa en la presente memoria designa una sustancia biolgicamente activa que influye en la proliferacin, crecimiento, diferenciacin, supervivencia y/o migracin de diversos tipos de clulas, y puede efectuar cambios de desarrollo, morfolgicos y funcionales en un organismo solo o cuando se modula por otras sustancias. Un factor de crecimiento puede actuar tpicamente unindose, como ligando, a un receptor (por ejemplo, receptor de superficie o intracelular) presente en clulas sensibles al factor de crecimiento. Un factor de crecimiento de la presente memoria puede ser particularmente una entidad proteica que comprende una o ms cadenas polipeptdicas.</span>The term "growth factor" as used herein designates a biologically active substance that influences the proliferation, growth, differentiation, survival and / or migration of various cell types, and may effect developmental, morphological and functional changes. in an organism alone or when modulated by other substances. A growth factor can typically act by binding, as a ligand, to a receptor (eg, surface or intracellular receptor) present in cells sensitive to growth factor. A growth factor herein can be particularly a protein entity comprising one or more polypeptide chains.</span>
  </p>
  <p id="p00505" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A modo de ejemplo y no de limitacin, el trmino factor de crecimiento engloba los miembros de la familia del factor de crecimiento de fibroblastos (FGF), la familia de la protena morfogentica sea (BMP), la familia del factor de crecimiento derivado de plaquetas (PDGF), la familia del factor de crecimiento transformante beta (TGFp), la familia del factor de crecimiento nervioso (NGF), la familia del factor de crecimiento epidrmico (EGF), la familia del factor de crecimiento relacionado con insulina (IGF), la familia del factor de crecimiento de hepatocitos (HGF), los factores de crecimiento hematopoyticos (HeGFs), el factor de crecimiento de clulas endoteliales derivadas de plaquetas (PD-ECGF), angiopoyetina, la familia del factor de crecimiento endotelial vascular (VEGF), glucocorticoides y similares.</span>By way of example and not limitation, the term "growth factor" encompasses the members of the fibroblast growth factor (FGF) family, the bone morphogenetic protein (BMP) family, the derived growth factor family of platelets (PDGF), the family of transforming growth factor beta (TGFp), the family of nerve growth factor (NGF), the family of epidermal growth factor (EGF), the family of insulin-related growth factor ( IGF), the hepatocyte growth factor family (HGF), hematopoietic growth factors (HeGFs), platelet-derived endothelial cell growth factor (PD-ECGF), angiopoietin, the family of vascular endothelial growth factor (VEGF), glucocorticoids and the like.</span>
  </p>
  <p id="p00506" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo preferido, el medio comprende un factor de crecimiento que es un miembro de la familia de factor de crecimiento epidrmico (EGF). En una realizacin adicional, dicho miembro de la familia del EGF es cualquiera elegido del grupo que consiste en anfirregulina, betacelulina, EGF, epirregulina, HB-EGF (factor de crecimiento de tipo EGF de unin a heparina, NRG1 (neurregulina 1) isoforma GGF2, NRG1 isoforma SMDF, NRG1-a, NRG1-P, TGFa, tomorregulina 1 y TMEFF2. En una realizacin particularmente preferida, el medio comprende EGF.</span>In a preferred example, the medium comprises a growth factor that is a member of the epidermal growth factor (EGF) family. In a further embodiment, said member of the EGF family is any chosen from the group consisting of anfirregulin, betacellulin, EGF, epirregulin, HB-EGF (heparin-binding EGF type growth factor, NRG1 (neurregulin 1) isoform GGF2 , NRG1 isoform SMDF, NRG1-a, NRG1-P, TGFa, tomorregulin 1 and TMEFF2 In a particularly preferred embodiment, the medium comprises EGF.</span>
  </p>
  <p id="p00507" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo adicional, el medio comprende un factor de crecimiento que es un miembro de la familia del factor de crecimiento relacionado con insulina (IGF). En una realizacin adicional, dicho miembro de la familia del IGF es cualquiera elegido del grupo que consiste en insulina, IGF1A (factor de crecimiento de tipo insulina 1A), IGF1B, IGF2, INSL3 (de tipo insulina 3), INSL5, INSL6 y relaxina. En una realizacin particularmente preferida, el medio comprende insulina.</span>In a further example, the medium comprises a growth factor that is a member of the insulin related growth factor (IGF) family. In a further embodiment, said member of the IGF family is any chosen from the group consisting of insulin, IGF1A (insulin-like growth factor 1A), IGF1B, IGF2, INSL3 (insulin-type 3), INSL5, INSL6 and relaxin . In a particularly preferred embodiment, the medium comprises insulin.</span>
  </p>
  <p id="p00508" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo adicional, el medio comprende un factor de crecimiento que es un glucocorticoide. En una realizacin adicional, dicho glucocorticoide es cualquiera elegido del grupo que consiste en dexametasona, hidrocortisona, prednisolona, metilprednisolona, prednisona, triamcinolona, corticosterona, fluocinolona, cortisona, betametasona. En una realizacin particularmente preferida, el medio comprende dexamentasona.</span>In a further example, the medium comprises a growth factor that is a glucocorticoid. In a further embodiment, said glucocorticoid is any chosen from the group consisting of dexamethasone, hydrocortisone, prednisolone, methylprednisolone, prednisone, triamcinolone, corticosterone, fluocinolone, cortisone, betamethasone. In a particularly preferred embodiment, the medium comprises dexamentasona.</span>
  </p>
  <p id="p00509" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En ejemplos preferidos adicionales, el medio puede comprender una combinacin de dos cualquiera o ms factores de crecimiento aadidos exgenamente o factores de crecimiento preferidos como se definen anteriormente. A modo de ejemplo y no de limitacin, el medio puede comprender EGF e insulina, o EGF y dexametasona, o insulina y dexametasona o cada uno de EGF, insulina y dexametasona; un medio que comprende estos factores de crecimiento aadidos exgenamente puede comprender preferiblemente suero o plasma como se define en las realizaciones anteriores.</span>In additional preferred examples, the medium may comprise a combination of any two or more exogenously added growth factors or preferred growth factors as defined above. By way of example and not limitation, the medium may comprise EGF and insulin, or EGF and dexamethasone, or insulin and dexamethasone or each of EGF, insulin and dexamethasone; A medium comprising these exogenously added growth factors may preferably comprise serum or plasma as defined in the previous embodiments.</span>
  </p>
  <p id="p00510" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto es generalmente conocedor de las concentraciones en que los factores de crecimiento particulares pueden inducir un efecto, especialmente sobre clulas cultivadas in vitro, y puede usar dichas concentraciones para los factores de crecimiento anteriormente enumerados. A modo de ejemplo y no de limitacin, el EGF puede usarse tpicamente a concentraciones entre aproximadamente 0,1 ng/ml y 1 |ig/ml, y preferiblemente entre 1 ng/ml y 100 ng/ml, preferiblemente a aproximadamente 25 ng/ml; la insulina puede usarse tpicamente a concentraciones entre aproximadamente 0,1 |ig/ml y 1 mg/ml y preferiblemente entre aproximadamente 1 |ig/ml y 100 |ig/ml, preferiblemente aproximadamente a 10 |ig/ml; la dexametasona puede usarse tpicamente a concentraciones entre aproximadamente 0,1 nM y 1 |iM, preferiblemente entre aproximadamente 1 |iM y 100 nM, por ejemplo a aproximadamente 10 nM.</span>An expert is generally aware of the concentrations in which particular growth factors can induce an effect, especially on cells grown in vitro, and can use such concentrations for the growth factors listed above. By way of example and not limitation, EGF can typically be used at concentrations between about 0.1 ng / ml and 1 | ig / ml, and preferably between 1 ng / ml and 100 ng / ml, preferably at about 25 ng / ml; Insulin can typically be used at concentrations between about 0.1 g / ml and 1 mg / ml and preferably between about 1 g / ml and 100 g / ml, preferably at about 10 g / ml; Dexamethasone can typically be used at concentrations between about 0.1 nM and 1 M, preferably between about 1 M and 100 nM, for example at about 10 nM.</span>
  </p>
  <p id="p00511" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo preferido, esp. cuando el procedimiento se usa para clulas hepticas humanas, el factor de crecimiento usado en el presente procedimiento puede ser un factor de crecimiento humano. Como se usa en la presente memoria, el trmino factor de crecimiento humano designa un factor de crecimiento sustancialmente igual que un factor de crecimiento humano de origen natural. Por ejemplo, cuando el factor de crecimiento es una entidad proteica, el o los pptidos o polipptidos constituyentes del mismo pueden tener una secuencia aminoacdica primaria idntica a un factor de crecimiento humano de origen natural. Se prefiere el uso de factores de crecimiento humanos en el presente procedimiento, ya que se espera que dichos factores de crecimiento desencadenen un efecto deseable sobre la funcin celular.</span>In a preferred example, esp. When the procedure is used for human liver cells, the growth factor used in the present procedure can be a human growth factor. As used herein, the term "human growth factor" designates a growth factor substantially the same as a human growth factor of natural origin. For example, when the growth factor is a protein entity, the constituent peptide or polypeptides thereof may have a primary amino acid sequence identical to a naturally occurring human growth factor. The use of human growth factors in the present process is preferred, since such growth factors are expected to trigger a desirable effect on cell function.</span>
  </p>
  <p id="p00512" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00513" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00514" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00515" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00516" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00517" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00518" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00519" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00520" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00521" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00522" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00523" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00524" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se ha descrito, los presentes inventores han advertido que cultivando clulas hepticas primarias durante periodos de tiempo como se han definido anteriormente, y usando preferiblemente composiciones de medios como se han descrito anteriormente, emerge y prolifera una clula progenitora o clula madre de la invencin, mientras que los tipos de clula heptica diferenciados se vuelven menos prevalentes en el cultivo prolongado de las clulas hepticas primarias. Sin limitarse a hiptesis alguna, los tipos de clula heptica diferenciados pueden, por ejemplo, no conseguir proliferar, morir y/o retrodiferenciarse durante el cultivo prolongado. Como se detalla en la seccin experimental, la clula progenitora o clula madre puede distinguirse de los dems tipos de clula presentes en el cultivo de clulas primarias, entre otras cosas, por su morfologa, que, segn el conocimiento de los inventores, puede denotarse como morfologa mesenquimtica o de tipo mesenquimal y puede comprender tpicamente una forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos.</span>As described, the present inventors have warned that by culturing primary liver cells for periods of time as defined above, and preferably using media compositions as described above, a progenitor cell or stem cell of the invention emerges and proliferates, while differentiated liver cell types become less prevalent in prolonged culture of primary liver cells. Without being limited to any hypothesis, differentiated liver cell types may, for example, fail to proliferate, die and / or re-differentiate during prolonged culture. As detailed in the experimental section, the progenitor cell or stem cell can be distinguished from the other cell types present in the culture of primary cells, among other things, by their morphology, which, according to the inventors' knowledge, can be denoted as mesenchymal or mesenchymal type morphology and can typically comprise a flattened shape, broad cytoplasm and ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00525" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los inventores han advertido tambin que la emergencia, proliferacin y enriquecimiento del cultivo primario con dicha clula progenitora o clula madre puede promoverse adicionalmente alterando el medio de cultivo de modo que ste favorezca la eliminacin adicional de uno o ms tipos de clula heptica diferenciada, especialmente de hepatocitos que pueden prevalecer en un cultivo de clulas hepticas primarias aisladas. En dichas condiciones, la clula progenitora o clula madre de la invencin puede proliferar ventajosamente y volverse el tipo de clula prevalente en el cultivo de clulas hepticas primarias. Los tipos de clula heptica diferenciados pueden perderse, por ejemplo, debido a que uno o ms tipos celulares diferenciados se reducen o eliminan fsicamente durante el cultivo; como alternativa, los fenotipos diferenciados pueden reducirse debido a uno o ms tipos celulares se retrodiferencian durante el cultivo.</span>The inventors have also warned that the emergence, proliferation and enrichment of the primary culture with said progenitor cell or stem cell can be further promoted by altering the culture medium so that it favors the further elimination of one or more differentiated liver cell types, especially hepatocytes that may prevail in a culture of isolated primary liver cells. Under such conditions, the progenitor cell or stem cell of the invention can advantageously proliferate and become the type of cell prevalent in the cultivation of primary liver cells. Differentiated liver cell types may be lost, for example, because one or more differentiated cell types are physically reduced or eliminated during culture; alternatively, differentiated phenotypes can be reduced because one or more cell types are re-differentiated during culture.</span>
  </p>
  <p id="p00526" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Puede usarse cualquier medio que favorezca la eliminacin de uno o ms tipos de clula heptica diferenciada, especialmente hepatocitos, sustentando la proliferacin de la clula progenitora o clula madre de la invencin (como puede juzgarse fcilmente, por ejemplo, mediante inspeccin visual en el cultivo celular de la prevalencia de los diferentes tipos de clula). A modo de ilustracin, como se ejemplifica por los inventores, una alteracin puede ser el uso de un medio basal que comprende una alta concentracin de glucosa, por ejemplo, una concentracin entre 3000 mg/l y 6000 mg/l, preferiblemente entre 4000 mg/l y 5000 mg/l, y tpicamente de aproximadamente 4500 mg/l. Una alteracin adicional puede ser la ausencia de factores de crecimiento aadidos exgenamente (concretamente, adems de aquellos presentes en el suero o plasma). A modo de ejemplo, al menos insulina, dexametasona y/o EGF aadidos exgenamente pueden estar ausentes del medio. Una alteracin adicional ms puede ser el uso de un medio basal distinto de medio E de Williams (que puede ser particularmente adecuado para el cultivo a largo plazo de tipos celulares hepticos primarios, especialmente hepatocitos). A modo de ejemplo y no de limitacin, pueden usarse ventajosamente medios basales tales como MEM, DMEM, a-MEM o EMEM. Ha de entenderse que el medio puede alterarse en uno, ms de uno o todos los modos anteriores. Ha de entenderse adicionalmente que el medio comprende suero o plasma o suero de reposicin como se describe anteriormente, incluyendo los ejemplos preferidos detallados anteriormente de los mismos.</span>Any medium that favors the elimination of one or more differentiated liver cell types, especially hepatocytes, can be used to support the proliferation of the progenitor cell or stem cell of the invention (as can be easily judged, for example, by visual inspection in the cell culture of the prevalence of different cell types). By way of illustration, as exemplified by the inventors, an alteration may be the use of a basal medium comprising a high concentration of glucose, for example, a concentration between 3000 mg / l and 6000 mg / l, preferably between 4000 mg / ly 5000 mg / l, and typically about 4500 mg / l. A further alteration may be the absence of exogenously added growth factors (specifically, in addition to those present in the serum or plasma). By way of example, at least insulin, dexamethasone and / or EGF added exogenously may be absent from the medium. A further alteration may be the use of a basal medium other than Williams E (which may be particularly suitable for long-term culture of primary hepatic cell types, especially hepatocytes). By way of example and not limitation, basal means such as MEM, DMEM, a-MEM or EMEM can be advantageously used. It is to be understood that the medium can be altered in one, more than one or all of the above modes. It should be further understood that the medium comprises serum or plasma or replacement serum as described above, including the preferred examples detailed above thereof.</span>
  </p>
  <p id="p00527" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo, puede aadirse un medio que favorezca la eliminacin de uno o ms tipos de clula heptica diferenciada, y que promueva la clula progenitora o clula madre de la invencin como se describe anteriormente, al comienzo del cultivo de las clulas hepticas primarias. En otra realizacin, el medio puede alterarse as durante el cultivo prolongado de las clulas hepticas primarias. A modo de ejemplo, el medio puede alterarse as empezando aproximadamente 1 da, aproximadamente 2 das, 3 das, por ejemplo aproximadamente 4 o 5 das, o empezando aproximadamente 6 das tal como, por ejemplo, aproximadamente 7 u 8 das, o empezando aproximadamente 9 das tal como, por ejemplo, aproximadamente, 10 u 11 das, empezando aproximadamente 12 das, por ejemplo, aproximadamente 13 o 14 das, ms preferiblemente empezando aproximadamente 15 das, por ejemplo, aproximadamente 16, 17, 18, 19 o 20 das despus de la siembra de las clulas hepticas primarias. En una realizacin ejemplar, el medio puede alterarse as entre 16 y 32 horas despus de la siembra, por ejemplo, aproximadamente 24 horas. En realizaciones, despus de alterar as el medio, puede cambiarse/renovarse, por ejemplo, cada 2 a 6 das, preferiblemente cada 4 das, por ejemplo, cada 3 o 4 das.</span>In one example, a medium can be added that favors the elimination of one or more differentiated liver cell types, and that promotes the progenitor cell or stem cell of the invention as described above, at the beginning of the primary liver cell culture. In another embodiment, the medium can thus be altered during prolonged culture of the primary liver cells. By way of example, the medium can thus be altered starting about 1 day, about 2 days, 3 days, for example about 4 or 5 days, or starting about 6 days such as, for example, about 7 or 8 days, or starting about 9 days such as, for example, about 10 or 11 days, starting about 12 days, for example, about 13 or 14 days, more preferably starting about 15 days, for example, about 16, 17, 18, 19 or 20 days after seeding of primary liver cells. In an exemplary embodiment, the medium can thus be altered between 16 and 32 hours after sowing, for example, approximately 24 hours. In embodiments, after thus altering the medium, it can be changed / renewed, for example, every 2 to 6 days, preferably every 4 days, for example, every 3 or 4 days.</span>
  </p>
  <p id="p00528" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por tanto, en un ejemplo preferido a modo de ejemplo, las clulas hepticas primarias pueden cultivarse despus de la siembra en un medio que favorezca la supervivencia de los tipos de clula heptica primaria, incluyendo los tipos de clula heptica diferenciados tales como hepatocitos, y al tiempo anterior, el medio puede alterarse a un medio que favorezca la eliminacin de uno o ms tipos de clula heptica diferenciada, incluyendo hepatocitos, y que promueva la clula progenitora o clula madre de la invencin. Por ejemplo, las clulas hepticas primarias pueden cultivarse en primer lugar en un medio que tenga uno, ms de uno o todos los siguientes rasgos: que comprenda un medio basal rico tal como, por ejemplo, medio E de Williams, que comprenda poca glucosa, por ejemplo, entre 500 mg/l y 2999 mg/l, y preferiblemente entre 1000 mg/l y 2000 mg/l, que comprenda al menos un factor de crecimiento aadido exgenamente y preferiblemente uno, ms de uno o todos de insulina, dexametasona y EGF. Despus de ello, a los tiempos anteriores, el medio puede alterarse para incluir uno, ms de uno o todos los siguientes rasgos: que comprenda un medio basal distinto de medio E de Williams, por ejemplo medios basales tales como MEM, DMEM, a-MEM o EMEM, que comprenda mucha glucosa, que no comprenda factores de crecimiento aadidos exgenamente o que no comprenda al menos dexametasona, insulina y/o EGF. Ha de entenderse que los medios anteriores comprenderan suero o plasma o suero de reposicin como se describe anteriormente, incluyendo los ejemplos preferidos detallados anteriores de los mismos.</span>Thus, in an exemplary preferred example, primary liver cells can be cultured after planting in a medium that favors the survival of primary liver cell types, including differentiated liver cell types such as hepatocytes, and at Previously, the medium can be altered to a medium that favors the elimination of one or more differentiated liver cell types, including hepatocytes, and that promotes the progenitor cell or stem cell of the invention. For example, primary liver cells can be cultured first in a medium that has one, more than one or all of the following traits: that comprises a rich basal medium such as, for example, Williams' E medium, which comprises low glucose, for example, between 500 mg / l and 2999 mg / l, and preferably between 1000 mg / l and 2000 mg / l, comprising at least one exogenously added growth factor and preferably one, more than one or all of insulin, dexamethasone and EGF . After that, at the previous times, the medium can be altered to include one, more than one or all of the following features: comprising a basal medium other than Williams E, for example basal media such as MEM, DMEM, a- MEM or EMEM, which comprises a lot of glucose, that does not include exogenously added growth factors or that does not comprise at least dexamethasone, insulin and / or EGF. It is to be understood that the above means would comprise serum or plasma or replacement serum as described above, including the above detailed preferred examples thereof.</span>
  </p>
  <p id="p00529" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se ha descrito, el cultivo anterior de clulas hepticas primarias conduce a la emergencia y proliferacin de</span>As described, the previous culture of primary liver cells leads to the emergence and proliferation of</span>
  </p>
  <p id="p00530" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00531" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00532" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00533" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00534" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00535" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00536" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00537" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00538" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00539" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00540" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00541" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">una clula progenitora o clula madre de la invencin en el cultivo. Dicho cultivo puede continuarse ventajosamente hasta que la clula progenitora o clula madre de la invencin haya proliferado suficientemente. Por ejemplo, dicho cultivo puede continuarse hasta que la poblacin celular alcanza un cierto grado de confluencia, por ejemplo, al menos un 40%, preferiblemente al menos un 50%, ms preferiblemente al menos un 60% y an ms preferiblemente al menos un 70%, por ejemplo, al menos un 80% o al menos un 90% o ms confluencia. El trmino confluencia, como se usa en la presente memoria, designa la densidad de clulas cultivadas a que las clulas entran en contacto entre s cubriendo sustancialmente todas las superficies disponibles para crecimiento (concretamente, confluencia total).</span>a progenitor cell or stem cell of the invention in the culture. Said culture can be advantageously continued until the progenitor cell or stem cell of the invention has proliferated sufficiently. For example, said culture can be continued until the cell population reaches a certain degree of confluence, for example, at least 40%, preferably at least 50%, more preferably at least 60% and even more preferably at least 70 %, for example, at least 80% or at least 90% or more confluence. The term "confluence," as used herein, designates the density of cultured cells that the cells come into contact with each other substantially covering all available surfaces for growth (namely, total confluence).</span>
  </p>
  <p id="p00542" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pase de clulas</span>Cell pass</span>
  </p>
  <p id="p00543" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Despus del cultivo anterior de las clulas hepticas primarias y la emergencia y proliferacin de las clulas progenitoras o clulas madre de la invencin, puede someterse a un pase la poblacin celular as obtenida al menos una vez, y preferiblemente al menos dos veces.</span>After the previous culture of the primary liver cells and the emergence and proliferation of the progenitor cells or stem cells of the invention, the cell population thus obtained can be subjected to a pass at least once, and preferably at least twice.</span>
  </p>
  <p id="p00544" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores advirtieron sorprendentemente de que las clulas progenitoras o clulas madre de la invencin que emergan en el cultivo de clulas primarias retenan sustancialmente su capacidad de proliferacin despus de someter a pase, lo que permite por tanto ventajosamente enriquecer adicionalmente la poblacin celular en estas clulas. Por razones de simplicidad, el pase efectuado en esta etapa del procedimiento se designa en la presente memoria como primer pase (o pase 1) en el procedimiento tal como se describe en la presente memoria. Las clulas pueden someterse a pases al menos una vez y preferiblemente dos o ms veces. Cada pase posterior al pase 1 se designa en la presente memoria con un nmero que va aumentando en 1, por ejemplo, pase 2, 3, 4, 5, etc.</span>The present inventors surprisingly warned that the progenitor cells or stem cells of the invention that emerged in the culture of primary cells substantially retained their ability to proliferate after passing through, which thus advantageously allows additionally enriching the cell population in these cells. . For reasons of simplicity, the pass made at this stage of the procedure is referred to herein as "first pass" (or pass 1) in the procedure as described herein. The cells may undergo passes at least once and preferably two or more times. Each pass after pass 1 is designated herein with a number that increases by 1, for example, pass 2, 3, 4, 5, etc.</span>
  </p>
  <p id="p00545" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cuando se someten a pase, las clulas cultivadas se separan y se disocian del sustrato de cultivo y entre s. La separacin y disociacin de las clulas pueden llevarse a cabo como es conocido en general en la tcnica, por ejemplo, mediante tratamiento enzimtico con enzimas proteolticas (por ejemplo, elegidas de tripsina, colagenasa, por ejemplo de tipo I, II, III o IV, dispasa, pronasa, papana, etc.), tratamiento con quelantes de iones divalentes (por ejemplo, EDTA o EGTA) o tratamiento mecnico (por ejemplo, pipeteado repetido a travs de una pipeta de orificio pequeo o punta de pipeta) o cualquier combinacin de estos tratamientos. Preferiblemente, la separacin y disociacin de las clulas cultivadas proporcionara una proporcin sustancial de clulas como clulas nicas. Por ejemplo, pueden recuperarse como clulas nicas un 40% o ms de las clulas, por ejemplo al menos un 50%, preferiblemente al menos un 60%, por ejemplo al menos un 70%, ms preferiblemente al menos un 80%, por ejemplo al menos un 90% o al menos un 95% de las clulas pueden recuperarse como clulas nicas. Adems, las clulas restantes pueden estar presentes en grupos o conglomerados de clulas la mayora de los cuales puede contener un nmero relativamente pequeo de clulas, por ejemplo, de media entre ms de 1 y 10 clulas, por ejemplo menos de 8 clulas, preferiblemente menos de 6 clulas, ms preferiblemente menos de 4 clulas, por ejemplo menos de 3 o menos de 2 clulas.</span>When passed, the cultured cells separate and dissociate from the culture substrate and each other. The separation and dissociation of the cells can be carried out as is generally known in the art, for example, by enzymatic treatment with proteolytic enzymes (for example, chosen from trypsin, collagenase, for example of type I, II, III or IV , dispasa, pronase, papain, etc.), treatment with chelating agents of divalent ions (for example, EDTA or EGTA) or mechanical treatment (for example, repeated pipetting through a small orifice pipette or pipette tip) or any combination of these treatments. Preferably, separation and dissociation of cultured cells would provide a substantial proportion of cells as single cells. For example, 40% or more of the cells can be recovered as single cells, for example at least 50%, preferably at least 60%, for example at least 70%, more preferably at least 80%, for example At least 90% or at least 95% of the cells can be recovered as single cells. In addition, the remaining cells may be present in groups or conglomerates of cells, most of which may contain a relatively small number of cells, for example, on average between more than 1 and 10 cells, for example less than 8 cells, preferably less of 6 cells, more preferably less than 4 cells, for example less than 3 or less than 2 cells.</span>
  </p>
  <p id="p00546" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tpicamente, un procedimiento adecuado de separacin y dispersin celular debera mantener la viabilidad de las clulas. Preferiblemente, una suspensin celular obtenida despus de la separacin y dispersin puede comprender al menos un 60% de clulas viables, por ejemplo al menos un 70%, ms preferiblemente al menos un 80% y lo ms preferiblemente al menos un 90% y hasta un 100% de clulas viables. Un experto sabr generalmente elegir las condiciones que aseguren el grado deseado de separacin y dispersin celulares, manteniendo la viabilidad celular.</span>Typically, a suitable cell separation and dispersion procedure should maintain the viability of the cells. Preferably, a cell suspension obtained after separation and dispersion can comprise at least 60% of viable cells, for example at least 70%, more preferably at least 80% and most preferably at least 90% and up to 100% viable cells. An expert will generally know how to choose the conditions that ensure the desired degree of cell separation and dispersion, while maintaining cell viability.</span>
  </p>
  <p id="p00547" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A continuacin, las clulas as separadas y disociadas (tpicamente en forma de una suspensin celular en un tampn isotnico o un medio) se resiembran en un sustrato que permita la adherencia de clulas al mismo, y se cultivan posteriormente en un medio como se describe anteriormente que sustente la proliferacin adicional de las clulas progenitoras o clulas madre de la invencin. Tpicamente, las clulas pueden resembrarse a una densidad de siembra de entre 1x101 y 1x106 clulas/cm2, por ejemplo, entre 1x102 y 1x106 clulas/cm2, y preferiblemente entre 1x103 y 1x105 clulas/cm2, por ejemplo aproximadamente a 1x103 clulas/cm2, aproximadamente a 5x103 clulas/cm2, aproximadamente a 1x104 clulas/cm2, aproximadamente a 5x104 clulas/cm2 o aproximadamente a 1 x105 clulas/cm2, y preferiblemente a entre aproximadamente 1x103 y 1x104 clulas/mm2.</span>Next, the cells thus separated and dissociated (typically in the form of a cell suspension in an isotonic buffer or medium) are seeded into a substrate that allows the adhesion of cells thereto, and subsequently cultured in a medium as described above. that supports the additional proliferation of the progenitor cells or stem cells of the invention. Typically, the cells can be reseeded at a seeding density of between 1x101 and 1x106 cells / cm2, for example, between 1x102 and 1x106 cells / cm2, and preferably between 1x103 and 1x105 cells / cm2, for example about 1x103 cells / cm2, about 5x103 cells / cm2, about 1x104 cells / cm2, about 5x104 cells / cm2 or about 1x105 cells / cm2, and preferably at about 1x103 and 1x104 cells / mm2.</span>
  </p>
  <p id="p00548" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como alternativa, las clulas pueden resembrarse a una relacin de divisin de, por ejemplo, entre aproximadamente 1/8 y 1/2, preferiblemente entre aproximadamente 1/4 y 1/2, y ms preferiblemente a aproximadamente 1/2 o aproximadamente 1/3. La relacin de divisin denota la fraccin de clulas sometidas a pase que se siembra en un recipiente de cultivo vaco (tpicamente nuevo) de la misma rea superficial que el recipiente del que se obtuvieron las clulas.</span>Alternatively, the cells can be reseeded at a division ratio of, for example, between about 1/8 and 1/2, preferably between about 1/4 and 1/2, and more preferably at about 1/2 or about 1 / 3. The division ratio denotes the fraction of cells subjected to pass that is sown in an empty (typically new) culture vessel of the same surface area as the container from which the cells were obtained.</span>
  </p>
  <p id="p00549" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El sustrato adherente sobre el que se resiembran las clulas es como se describe con detalle en otro lugar de esta memoria descriptiva. El sustrato puede ser preferiblemente de la misma clase que el sustrato sobre el que se sembraron las clulas hepticas primarias, incluyendo las realizaciones preferidas de dicho sustrato descritas anteriormente, o puede ser diferente. Preferiblemente, este sustrato es tambin colgeno, esp. colgeno de tipo I como se describe anteriormente.</span>The adherent substrate on which the cells are seeded is as described in detail elsewhere in this specification. The substrate may preferably be of the same class as the substrate on which the primary liver cells were seeded, including the preferred embodiments of said substrate described above, or it may be different. Preferably, this substrate is also collagen, esp. Type I collagen as described above.</span>
  </p>
  <p id="p00550" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las clulas as sometidas a pase se cultivan adicionalmente, ventajosamente hasta que las clulas se han</span>The cells thus subjected to pass are further cultured, advantageously until the cells have</span>
  </p>
  <p id="p00551" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00552" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00553" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00554" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00555" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00556" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00557" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00558" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00559" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00560" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00561" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00562" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">convertido al menos un 50% en confluentes, por ejemplo al menos un 60%, preferiblemente al menos un 70%, por ejemplo al menos un 80%, ms preferiblemente al menos un 90%, por ejemplo al menos un 95% o incluso completamente confluentes.</span>converted at least 50% into confluents, for example at least 60%, preferably at least 70%, for example at least 80%, more preferably at least 90%, for example at least 95% or even completely confluent</span>
  </p>
  <p id="p00563" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores han advertido que aunque la poblacin celular obtenida en esta etapa del procedimiento comprende una fraccin sustancial de clulas progenitoras o clulas madre de la invencin, puede someterse a pase ventajosamente al menos una vez ms (concretamente, al menos un segundo pase), esencialmente como se describe anteriormente para el primer pase. Esto aumenta adicionalmente la proporcin de clulas progenitoras o clulas madre de la invencin en la poblacin celular, a juzgar por el anlisis de morfologa y/o marcadores, e incluso puede obtenerse una poblacin sustancialmente homognea de clulas progenitoras o clulas madre de la invencin.</span>The present inventors have warned that although the cell population obtained at this stage of the process comprises a substantial fraction of progenitor cells or stem cells of the invention, it can be advantageously passed at least once more (specifically, at least a second pass), essentially as described above for the first pass. This further increases the proportion of progenitor cells or stem cells of the invention in the cell population, judging by the analysis of morphology and / or markers, and a substantially homogeneous population of progenitor cells or stem cells of the invention can even be obtained.</span>
  </p>
  <p id="p00564" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por tanto, la presente memoria descriptiva tambin describe que despus de la siembra y cultivo de clulas hepticas primarias que conducen a la emergencia y proliferacin de las clulas progenitoras o clulas madre en dicho cultivo, se someten a pases las clulas cultivadas al menos una vez (concretamente, primer pase) y preferiblemente al menos dos veces (concretamente, primer y segundo pases), y opcionalmente ms veces (concretamente, primer, segundo y cada pase posterior). Por ejemplo, las clulas pueden someterse a pases al menos una vez, al menos 2 veces, al menos 3 veces, al menos 4 veces o al menos 5 veces despus de la siembra de clulas hepticas primarias. En otra realizacin, las clulas pueden someterse a pases entre 2 y 10 veces, por ejemplo entre 2 y 8 veces o entre 2 y 5 veces, despus de la siembra de clulas hepticas primarias. Los pases adicionales (por ejemplo, separacin y dispersin celular, resiembra, sustrato, etc.) y el cultivo (por ejemplo, medio, cambios de medio, confluencia resultante, etc.) pueden efectuarse en condiciones sustancialmente idnticas o anlogas a las del primer pase, como se describe anteriormente, incluyendo las realizaciones preferidas del mismo, y pueden incluir modificaciones que sern obvias para el experto.</span>Therefore, the present specification also describes that after the sowing and cultivation of primary liver cells that lead to the emergence and proliferation of the progenitor cells or stem cells in said culture, the cultured cells are subjected to passes at least once ( specifically, first pass) and preferably at least twice (specifically, first and second passes), and optionally more times (specifically, first, second and each subsequent pass). For example, cells can undergo passes at least once, at least 2 times, at least 3 times, at least 4 times or at least 5 times after seeding of primary liver cells. In another embodiment, the cells may undergo passes 2 to 10 times, for example 2 to 8 times or 2 to 5 times, after seeding of primary liver cells. Additional passes (for example, separation and cell dispersion, reseeding, substrate, etc.) and culture (for example, medium, media changes, resulting confluence, etc.) can be carried out under substantially identical or analogous conditions to those of the first pass, as described above, including preferred embodiments thereof, and may include modifications that will be obvious to the expert.</span>
  </p>
  <p id="p00565" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El procedimiento tal como se describe en la presente memoria puede proporcionar por tanto una poblacin celular que comprende una fraccin considerable de clulas progenitoras o clulas madre como se definen en esta divulgacin, y la fraccin de dichas clulas progenitoras o clulas madre puede aumentarse mediante uno o ms pases del cultivo prolongado de clulas hepticas primarias. Tpicamente, la poblacin comprender al menos aproximadamente un 10%, por ejemplo al menos aproximadamente un 20% de dichas clulas progenitoras o clulas madre, pero los inventores encontraron que se obtendrn proporciones tpicamente mayores de dichas clulas progenitoras o clulas madre, por ejemplo de al menos un 30%, al menos un 40%, al menos un 50%, al menos un 60%, al menos un 70%, al menos un 80% o al menos un 90% o ms. Adems, el procedimiento puede incluso proporcionar una poblacin sustancialmente homognea u homognea de dichas clulas progenitoras o clulas madre. La fraccin de las clulas progenitoras o clulas madre puede evaluarse mediante cualquier procedimiento estndar apropiado, por ejemplo mediante citometra de flujo.</span>The method as described herein can therefore provide a cell population comprising a considerable fraction of progenitor cells or stem cells as defined in this disclosure, and the fraction of said progenitor cells or stem cells can be increased by one or more passes of the prolonged culture of primary liver cells. Typically, the population will comprise at least about 10%, for example at least about 20% of said progenitor cells or stem cells, but the inventors found that typically greater proportions of said progenitor cells or stem cells will be obtained, for example from at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80% or at least 90% or more. In addition, the method may even provide a substantially homogeneous or homogeneous population of said progenitor cells or stem cells. The fraction of the progenitor cells or stem cells can be evaluated by any appropriate standard procedure, for example by flow cytometry.</span>
  </p>
  <p id="p00566" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Mantenimiento de las clulas obtenidas</span>Maintenance of the cells obtained</span>
  </p>
  <p id="p00567" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cuando se consigue una poblacin que comprende las clulas progenitoras o clulas madre derivadas de hgado de la invencin mediante los procedimientos tal como se describen en la presente memoria, y posiblemente enriquecida adicionalmente en dichas clulas progenitoras o clulas madre, la poblacin celular puede mantenerse y/o propagarse a continuacin en condiciones que permitan el crecimiento y duplicacin de dichas clulas progenitoras o clulas madre sin diferenciacin. Dichas condiciones pueden ser, por ejemplo, aquellas usadas para obtener las clulas progenitoras o clulas madre. Un experto que sea capaz de valorar la presencia o ausencia de diferenciacin celular puede establecer fcilmente condiciones adicionales. Esto puede aumentar ventajosamente el nmero de clulas progenitoras o clulas madre disponibles para uso adicional de las mismas.</span>When a population comprising the progenitor cells or liver-derived stem cells of the invention is achieved by the methods as described herein, and possibly further enriched in said progenitor cells or stem cells, the cell population can be maintained and / or then propagate under conditions that allow the growth and duplication of said progenitor cells or stem cells without differentiation. Such conditions may be, for example, those used to obtain the progenitor cells or stem cells. An expert who is able to assess the presence or absence of cell differentiation can easily establish additional conditions. This can advantageously increase the number of progenitor cells or stem cells available for further use thereof.</span>
  </p>
  <p id="p00568" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores han advertido que el pase primario o cualquier otro posterior podra crioconservarse para uso posterior, como es conocido en general en la tcnica para clulas de mamfero.</span>The present inventors have warned that the primary or any subsequent pass could be cryopreserved for later use, as is generally known in the art for mammalian cells.</span>
  </p>
  <p id="p00569" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores han advertido que las clulas progenitoras o clulas madre de la invencin que emergieron en el cultivo de clulas primarias retienen sustancialmente su capacidad de proliferacin despus de congelar y descongelar. Dichas clulas pueden almacenarse en forma de suspensin celular concentrada congelada, descongelarse como se hace en general en la tcnica, y resembrarse en las mismas condiciones que se describen en otro lugar de esta memoria descriptiva.</span>The present inventors have warned that the progenitor cells or stem cells of the invention that emerged in the culture of primary cells substantially retain their proliferation capacity after freezing and thawing. Said cells may be stored in the form of a frozen concentrated cell suspension, thawed as is generally done in the art, and reseeded under the same conditions as described elsewhere in this specification.</span>
  </p>
  <p id="p00570" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clulas progenitoras o clulas madre de la invencin</span>Progenitor cells or stem cells of the invention</span>
  </p>
  <p id="p00571" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores han advertido que la poblacin celular obtenida tras el cultivo, y preferiblemente tambin el pase de clulas hepticas primarias como se describe anteriormente, comprende clulas progenitoras o clulas madre derivadas de hgado tal como se describen en la presente memoria que expresan simultneamente (concretamente son positivos de) al menos un marcador mesenquimal, especialmente uno, ms de uno, por ejemplo 2, 3 o 4, o todos los marcadores CD90, CD73, CD44, vimentina y a-actina de msculo liso (ASMA), con el marcador de hepatocito albmina (ALB) y posiblemente con uno o ms marcadores hepticos o de hepatocitos distintos, preferiblemente uno, ms de uno o todos de CD29, a-fetoproteina (AFP), a-1-antitripsina y/o transportador MRP2.</span>The present inventors have warned that the cell population obtained after culture, and preferably also the passage of primary liver cells as described above, comprises progenitor cells or liver-derived stem cells as described herein that express simultaneously (specifically they are positive for) at least one mesenchymal marker, especially one, more than one, for example 2, 3 or 4, or all CD90, CD73, CD44, vimentin and smooth muscle a-actin (ASMA) markers, with the marker of hepatocyte albumin (ALB) and possibly with one or more other hepatic or hepatocyte markers, preferably one, more than one or all of CD29, a-fetoprotein (AFP), a-1-antitrypsin and / or MRP2 transporter.</span>
  </p>
  <p id="p00572" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo ms particular, las clulas progenitoras o clulas madre derivadas de hgado tal como se describen</span>In a more particular example, progenitor cells or liver-derived stem cells as described</span>
  </p>
  <p id="p00573" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00574" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00575" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00576" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00577" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00578" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00579" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00580" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00581" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00582" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00583" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00584" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00585" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">en la presente memoria pueden expresar simultneamente (concretamente son positivos de) al menos un marcador mesenquimal, especialmente uno, ms de uno, por ejemplo 2, 3 o 4 o todos los marcadores CD90, CD73, CD44, vimentina y a-actina de msculo liso (ASMA), con el marcador de hepatocito albmina (ALB) y posiblemente con uno o ms marcadores de hepatocitos distintos, preferiblemente uno o ambos de a-1-antitripsina y transportador MRP2, y con al menos un marcador heptico CD29 o a-fetoprotena (AFP).</span>herein they can simultaneously express (specifically they are positive of) at least one mesenchymal marker, especially one, more than one, for example 2, 3 or 4 or all CD90, CD73, CD44, vimentin and a-actin muscle markers smooth (ASMA), with the albumin hepatocyte marker (ALB) and possibly with one or more different hepatocyte markers, preferably one or both of a-1-antitrypsin and MRP2 transporter, and with at least one liver marker CD29 or a- fetoprotein (AFP).</span>
  </p>
  <p id="p00586" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cualquiera de dichas clulas progenitoras o clulas madre hepticas adultas puede expresar adicionalmente una, ms de una o todas las siguientes molculas, indicativas de propiedades o funciones de tipo hepatocito: G6P, CYP1B1, CYP3A4, HNF-4, TDO, TAT, GS, GGT, CK8, EAAT2. Dicha clula progenitora o clula madre heptica adulta puede caracterizarse adicionalmente por uno, ms de uno o todos los siguientes: negativo para al menos los marcadores hematopoyticos CD45 y CD34 y posiblemente tambin de uno o ms de otros marcadores hematopoyticos tales como, por ejemplo, CD105 y HLA-DR; negativo para el marcador epitelial de colancioticos citoqueratina-19 (CK-19) y posiblemente para ms marcadores epiteliales; negativo para al menos los marcadores de clulas madre indiferenciadas CD117 y Oct-4 y posiblemente tambin de uno o ms de un marcador de clula madre embrinica y bajo nivel de expresin de a-fetoprotena (AFP). Preferiblemente, dicha clula progenitora o clula madre heptica adulta puede tener una morfologa similar a la mesenquimtica, en particular implicando uno, ms de uno o todos de crecimiento en monocapas, forma aplanada, citoplasma amplio y/o ncleos ovoides con uno o dos nucleolos.</span>Any of said progenitor cells or adult liver stem cells may additionally express one, more than one or all of the following molecules, indicative of hepatocyte-like properties or functions: G6P, CYP1B1, CYP3A4, HNF-4, TDO, TAT, GS, GGT , CK8, EAAT2. Said progenitor cell or adult liver stem cell can be further characterized by one, more than one or all of the following: negative for at least the hematopoietic markers CD45 and CD34 and possibly also one or more other hematopoietic markers such as, for example, CD105 and HLA-DR; negative for the epithelial marker of cholanciotic cytokeratin-19 (CK-19) and possibly for more epithelial markers; negative for at least the undifferentiated CD117 and Oct-4 stem cell markers and possibly also of one or more of an embryonic stem cell marker and low level of a-fetoprotein (AFP) expression. Preferably, said progenitor cell or adult liver stem cell can have a morphology similar to mesenchymal, in particular involving one, more than one or all of growth in monolayers, flattened form, wide cytoplasm and / or ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00587" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La identificacin de molculas de superficie celular particulares por sus denominaciones DC (determinante comn) es un lugar comn en la tcnica. Se usan tambin otros nombres o denominaciones de molculas en la presente solicitud como bien establecidos en la tcnica. Puede encontrarse tambin en los ejemplos una especificacin adicional de molculas particulares.</span>The identification of particular cell surface molecules by their DC denominations ("common determinant") is a common place in the art. Other names or denominations of molecules are also used in the present application as well established in the art. An additional specification of particular molecules can also be found in the examples.</span>
  </p>
  <p id="p00588" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Si una clula se dice que es positiva de un marcador particular, esto significa que un experto concluir la presencia o evidencia de una seal distintiva de ese marcador, por ejemplo, detectable por anticuerpo o de deteccin posible mediante reaccin en cadena de la polimerasa de transcripcin inversa, al llevar a cabo la medida apropiada, en comparacin con controles adecuados. Cuando el procedimiento permite la valoracin cuantitativa del marcador, las clulas positivas pueden generar de media una seal que es significativamente diferente del control, por ejemplo pero sin limitacin, al menos 1,5 veces mayor que dicha seal generada por clulas de control, por ejemplo, al menos 2 veces, al menos 4 veces, al menos 10 veces, al menos 20 veces, al menos 30 veces, al menos 40 veces, al menos 50 veces mayor o incluso mayor.</span>If a cell is said to be positive for a particular marker, this means that an expert will conclude the presence or evidence of a distinctive signal from that marker, for example, detectable by antibody or possible detection by transcription polymerase chain reaction. conversely, when carrying out the appropriate measure, in comparison with appropriate controls. When the procedure allows quantitative assessment of the marker, positive cells can generate on average a signal that is significantly different from the control, for example but without limitation, at least 1.5 times greater than said signal generated by control cells, for example , at least 2 times, at least 4 times, at least 10 times, at least 20 times, at least 30 times, at least 40 times, at least 50 times greater or even greater.</span>
  </p>
  <p id="p00589" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La expresin de marcadores especficos de clula puede detectarse usando cualquier tcnica inmunolgica adecuada conocida en la tcnica, tal como citometra de flujo, inmunocitoqumica o adsorcin por afinidad, anlisis de transferencia Western, ELISA, etc., o mediante cualquier tcnica adecuada de medida de la cantidad de ARNm de marcador, por ejemplo, transferencia Northern, PCR-Ti semicuantitativa o cuantitativa, etc.</span>The expression of cell-specific markers can be detected using any suitable immunological technique known in the art, such as flow cytometry, immunocytochemistry or affinity adsorption, Western blot analysis, ELISA, etc., or by any suitable technique for measuring the amount of marker mRNA, for example, Northern blot, semi-quantitative or quantitative PCR-Ti, etc.</span>
  </p>
  <p id="p00590" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto apreciar que la poblacin celular obtenida mediante el presente procedimiento, que comprende las clulas progenitoras o clulas madre anteriores, puede recogerse (por ejemplo mediante cualquier tcnica de separacin adecuada) y opcionalmente enriquecerse adicionalmente en clulas que presenten caractersticas especficas mediante procedimientos conocidos en general en la tcnica (por tanto, dichas clulas pueden aislarse a partir de dicha poblacin). A modo de ilustracin y no de limitacin, las clulas que presentan una o ms molculas de superficie caractersticas de las clulas progenitoras o clulas madre de la invencin, por ejemplo, uno o ms de los marcadores enumerados anteriormente, pueden reconocerse por anticuerpos especficos (marcados) u otros agentes de reconocimiento ante dichos marcadores y clasificarse separadamente de clulas que no presentan dichas molculas de superficie, por ejemplo, usando clasificacin celular activada por fluorescencia o usando unin por afinidad, por ejemplo, a columnas, perlas o superficies (adsorcin). Est tambin incluido en la memoria descriptiva cualquier otro modo de enriquecimiento de las clulas.</span>An expert will appreciate that the cell population obtained by the present process, which comprises the progenitor cells or previous stem cells, can be collected (for example by any suitable separation technique) and optionally further enriched in cells having specific characteristics by known procedures in general in the art (therefore, said cells can be isolated from said population). By way of illustration and not limitation, cells that have one or more surface molecules characteristic of the progenitor cells or stem cells of the invention, for example, one or more of the markers listed above, can be recognized by specific antibodies (labeled ) or other recognition agents before said markers and be classified separately from cells that do not have said surface molecules, for example, using fluorescence activated cell sorting or using affinity binding, for example, to columns, beads or surfaces (adsorption). Any other form of cell enrichment is also included in the specification.</span>
  </p>
  <p id="p00591" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La memoria descriptiva tambin describe una clula progenitora o clula madre aislada novedosa (una clula de vertebrado, preferiblemente de mamfero, an ms preferiblemente humana) originada a partir de hgado adulto, caracterizada porque expresa simultneamente (es decir, es positivo para) al menos un marcador mesenquimal, esp. uno, ms de uno, por ejemplo, 2, 3 o 4, todos de los marcadores CD90, CD29, CD44, vimentina y a-actina de msculo liso (ASMA) con el marcador de hepatocito albmina (ALB) y posiblemente con uno o ms marcadores de hepatocitos distintos. Dicha clula progenitora o clula madre heptica adulta puede caracterizarse adicionalmente por uno, ms de uno o todos los siguientes: negativo para al menos los marcadores hematopoyticos CD45, CD34 y CD117 y posiblemente tambin de uno o ms de otros marcadores hematopoyticos; negativo para citoqueratina-19 (CK-19); morfologa similar a la mesenquimtica, en particular que implica cualquiera o todos de crecimiento en monocapas, forma aplanada, citoplasma amplio y/o ncleos ovoides con uno o dos nucleolos.</span>The specification also describes a novel progenitor cell or isolated stem cell (a vertebrate, preferably mammalian, even more preferably human) cell originating from an adult liver, characterized in that it simultaneously expresses (i.e., is positive for) at least one mesenchymal marker, esp. one, more than one, for example, 2, 3 or 4, all of the markers CD90, CD29, CD44, vimentin and smooth muscle a-actin (ASMA) with the albumin hepatocyte marker (ALB) and possibly with one or more markers of different hepatocytes. Said progenitor cell or adult liver stem cell can be further characterized by one, more than one or all of the following: negative for at least the hematopoietic markers CD45, CD34 and CD117 and possibly also one or more other hematopoietic markers; negative for cytokeratin-19 (CK-19); Similar to mesenchymal morphology, in particular that involves any or all growth in monolayers, flattened form, wide cytoplasm and / or ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00592" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por tanto, en una realizacin particular (1), la clula progenitora o clula madre derivada de hgado aislada expresa simultneamente CD90, CD73, CD44, vimentina y a-actina de msculo liso (ASMA) con ALB. En una realizacin adicional (2), la clula progenitora o clula madre derivada de hgado expresa simultneamente CD90, CD44, vimentina y a-actina de msculo liso (ASMA) con ALB y a-1-antitripsina. En una realizacin adicional (3), la clula progenitora o clula madre derivada de hgado expresa simultneamente CD90, CD73, CD44, vimentina y a-actina de msculo liso (ASMA) con ALB y MRP2. En otra realizacin (4), la clula progenitora o clula madre derivada de</span>Therefore, in a particular embodiment (1), the progenitor cell or stem cell derived from isolated liver simultaneously expresses CD90, CD73, CD44, vimentin and smooth muscle a-actin (ASMA) with ALB. In a further embodiment (2), the liver-derived progenitor cell or stem cell simultaneously expresses CD90, CD44, vimentin and smooth muscle a-actin (ASMA) with ALB and a-1-antitrypsin. In a further embodiment (3), the liver-derived progenitor cell or stem cell simultaneously expresses CD90, CD73, CD44, vimentin and smooth muscle a-actin (ASMA) with ALB and MRP2. In another embodiment (4), the progenitor cell or stem cell derived from</span>
  </p>
  <p id="p00593" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00594" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00595" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00596" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00597" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00598" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00599" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00600" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00601" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00602" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00603" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00604" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">hgado expresa simultneamente CD90, CD44, vimentina y a-actina de msculo liso (ASMA) con ALB, a-1- antitripsina y MRP2. En realizaciones adicionales (5), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (4) expresa adicionalmente CD29. En realizaciones adicionales (6), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (4) expresa adicionalmente a-fetoprotena. En realizaciones adicionales (7), la clula progenitora o clula madre derivada de hgado de cualquiera de la realizaciones adicionales (1) a (4) expresa adicionalmente CD29 y a-fetoprotena.</span>liver simultaneously expresses CD90, CD44, vimentin and smooth muscle a-actin (ASMA) with ALB, a-1- antitrypsin and MRP2. In further embodiments (5), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (4) further expresses CD29. In further embodiments (6), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (4) further expresses a-fetoprotein. In further embodiments (7), the progenitor cell or liver-derived stem cell of any of the additional embodiments (1) to (4) further expresses CD29 and a-fetoprotein.</span>
  </p>
  <p id="p00605" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (8), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (7) es negativa para CD45 y CD34. En realizaciones adicionales (9), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (7) es negativa para CD117 y Oct-4. En realizaciones adicionales (10), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (7) es negativa para CD45, CD34, CD117 y Oct-4.</span>In further embodiments (8), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (7) is negative for CD45 and CD34. In further embodiments (9), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (7) is negative for CD117 and Oct-4. In further embodiments (10), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (7) is negative for CD45, CD34, CD117 and Oct-4.</span>
  </p>
  <p id="p00606" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (11), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (10) es negativa para CK19. En realizaciones adicionales (12), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (10) es negativa para CK19 y CK7. En realizaciones adicionales (13), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (10) son negativas para CK19 y CK7.</span>In further embodiments (11), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) through (10) is negative for CK19. In further embodiments (12), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (10) is negative for CK19 and CK7. In further embodiments (13), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (10) are negative for CK19 and CK7.</span>
  </p>
  <p id="p00607" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (14), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (13) muestran morfologa de tipo mesenquimal, que implica preferiblemente cualquiera o todos de crecimiento en monocapas, forma aplanada, citoplasma amplio y/o ncleos ovoides con uno o dos nucleolos.</span>In further embodiments (14), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (13) show mesenchymal type morphology, which preferably involves any or all of growth in monolayers, flattened form, cytoplasm broad and / or ovoid nuclei with one or two nucleoli.</span>
  </p>
  <p id="p00608" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (15), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (14) expresa adicionalmente una, ms de una o todas las siguientes molculas indicativas de propiedades o funcin de tipo hepatocito: G6P, CYP1B1, CYP3A4, HNF-4, TDO, TAT, GS, GGT, CK8 y EAAT2.</span>In further embodiments (15), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (14) additionally expresses one, more than one or all of the following molecules indicative of hepatocyte-like properties or function: G6P, CYP1B1, CYP3A4, HNF-4, TDO, TAT, GS, GGT, CK8 and EAAT2.</span>
  </p>
  <p id="p00609" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (16), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (15) expresa adicionalmente una, ms de una o todas las siguientes molculas: CD49e, CD13, CD54, complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>In further embodiments (16), the liver-derived progenitor cell or stem cell of any of the above embodiments (1) to (15) additionally expresses one, more than one or all of the following molecules: CD49e, CD13, CD54, major complex of histocompatibility (MHC) class I (HLA-ABC).</span>
  </p>
  <p id="p00610" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (17), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (1) a (16) son negativas para una, ms de una o todas las siguientes molculas: CD105, HLA-DR, CD133, CD49b, CD49f y CD140</span>In further embodiments (17), the progenitor cell or liver-derived stem cell of any of the above embodiments (1) to (16) are negative for one, more than one or all of the following molecules: CD105, HLA-DR, CD133 , CD49b, CD49f and CD140</span>
  </p>
  <p id="p00611" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En realizaciones adicionales (18), la clula progenitora o clula madre derivada de hgado de cualquiera de las realizaciones anteriores (6) a (17) expresan un bajo nivel de expresin de a-fetoprotena (AFP). Preferiblemente, dicho bajo nivel corresponde esencialmente con el nivel de expresin medido en hepatocitos normales. Preferiblemente, es menor que el nivel de expresin medido en la lnea de clulas hepticas humanas modificadas tumorignica, por ejemplo HepG2.</span>In further embodiments (18), the progenitor cell or liver-derived stem cell of any of the above embodiments (6) to (17) express a low level of a-fetoprotein (AFP) expression. Preferably, said low level essentially corresponds to the level of expression measured in normal hepatocytes. Preferably, it is less than the level of expression measured in the tumorigenic modified human liver cell line, for example HepG2.</span>
  </p>
  <p id="p00612" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La clula progenitora o clula madre derivada de hgado aislada de la invencin puede presentar preferiblemente caractersticas de clula madre, especialmente, puede presentar tpicamente al menos una autorrenovacin limitada (y posiblemente sustancialmente ilimitada), concretamente, la capacidad de propagarse sin diferenciacin. A modo de ejemplo y no de limitacin, las clulas progenitoras o clulas madre de la invencin pueden propagarse as durante al menos 4 pases, por ejemplo al menos 6 pases, al menos 10 pases o al menos 20 pases, al menos 50 pases o ms.</span>The progenitor cell or liver-derived stem cell isolated from the invention may preferably have stem cell characteristics, especially, it may typically have at least a limited (and possibly substantially unlimited) self-renewal, namely, the ability to propagate without differentiation. By way of example and not limitation, the progenitor cells or stem cells of the invention can thus propagate for at least 4 passes, for example at least 6 passes, at least 10 passes or at least 20 passes, at least 50 passes or more .</span>
  </p>
  <p id="p00613" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe una clula progenitora o clula madre heptica adulta aislada, una lnea celular de la misma y/o una poblacin celular que comprende la misma, obtenible u obtenida directamente usando un procedimiento que comprende: (a) disociar, preferiblemente mediante un procedimiento con colagenasa de dos etapas, hgado humano o una parte del mismo a partir de un sujeto, preferiblemente un sujeto vertebrado, mamfero y preferiblemente humano, formando una poblacin de clulas primarias a partir de dicho hgado adulto o parte de mismo; (b) sembrar la poblacin de clulas primarias sobre sustrato recubierto con colgeno de tipo I en medio E de Williams que comprende preferiblemente 10% (v/v) de suero de ternera fetal, EGF preferiblemente 25 ng/ml, insulina preferiblemente 10 |ig/ml y dexametasona preferiblemente 1 |iM; (c) permitir la adherencia de las clulas de la poblacin de clulas primarias a dicho sustrato durante 24 horas e cambiar despus de ello el medio por medio reciente que tiene la composicin de (b); (d) cultivar las clulas en dicho medio de (c) durante dos semanas (preferiblemente 15 das); (e) cambiar el medio por DMEM rico en glucosa y que comprende preferiblemente 10% de FCS, y cultivar adicionalmente las clulas, con lo que las clulas progenitoras o clulas madre de la invencin emergen y proliferan; (f) opcional y preferiblemente, permitir a las clulas volverse aproximadamente un 70% confluentes y someter a pase las clulas al menos una vez y preferiblemente al menos dos veces, en el que las clulas se siembran sobre el sustrato como en (b) y se cultivan en un medio como en (e).</span>The present specification also describes a progenitor cell or isolated adult liver stem cell, a cell line thereof and / or a cell population comprising the same, obtainable or obtained directly using a method comprising: (a) dissociating, preferably by a process with two-stage collagenase, human liver or a part thereof from a subject, preferably a vertebrate, mammalian and preferably human subject, forming a population of primary cells from said adult liver or part thereof; (b) sow the population of primary cells on a substrate coated with type I collagen in Williams medium E preferably comprising 10% (v / v) fetal calf serum, EGF preferably 25 ng / ml, insulin preferably 10 | ig / ml and dexamethasone preferably 1 | iM; (c) allow the adhesion of the cells of the primary cell population to said substrate for 24 hours and then change the medium by recent means having the composition of (b); (d) culturing the cells in said medium of (c) for two weeks (preferably 15 days); (e) changing the medium to DMEM rich in glucose and preferably comprising 10% FCS, and further culturing the cells, whereby the progenitor cells or stem cells of the invention emerge and proliferate; (f) optionally and preferably, allow the cells to become approximately 70% confluent and pass the cells at least once and preferably at least twice, in which the cells are seeded on the substrate as in (b) and they are grown in a medium as in (e).</span>
  </p>
  <p id="p00614" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La etapa (a) puede incluir preferiblemente la disociacin de las clulas primarias mediante pase de las clulas a</span>Step (a) may preferably include the dissociation of the primary cells by passing the cells to</span>
  </p>
  <p id="p00615" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00616" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00617" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00618" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00619" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00620" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00621" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00622" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00623" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00624" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00625" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00626" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">travs de al menos un tamiz que tiene un tamao de poro de 0,25 mm, y preferiblemente a travs de una sucesin de tamices que tienen tamaos de poro gradualmente menores hasta 0,25 mm, como en el ejemplo 1.</span>through at least one sieve having a pore size of 0.25 mm, and preferably through a succession of sieves having gradually smaller pore sizes up to 0.25 mm, as in example 1.</span>
  </p>
  <p id="p00627" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El medio de la etapa (e) puede no comprender preferiblemente dexametasona, insulina y EGF y en una realizacin. El medio puede en una realizacin adicional no comprender ningn factor de crecimiento aadido exgenamente.</span>The medium of step (e) may not preferably comprise dexamethasone, insulin and EGF and in one embodiment. The medium may in a further embodiment not comprise any exogenously added growth factor.</span>
  </p>
  <p id="p00628" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe una clula progenitora o clula madre heptica aislada, una lnea celular de la misma y/o una poblacin celular que comprende la misma, obtenible u obtenida directamente siguiendo el protocolo indicado en el ejemplo 1.</span>The present specification also describes an isolated progenitor cell or liver stem cell, a cell line thereof and / or a cell population comprising the same, obtainable or obtained directly following the protocol indicated in example 1.</span>
  </p>
  <p id="p00629" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe que los presentes inventores han establecido una poblacin celular (lnea celular) de clulas progenitoras o clulas madre hepticas humanas adultas usando los procedimientos tal como se describen en la presente memoria, en particular como se documenta en el ejemplo 1, y han depositado dicha lnea celular aislada el 20 de febrero de 2006 segn el Tratado de Budapest en la Coleccin Coordinada de Microorganismos Belga (BCCM) con el nmero de registro LMBP 6452CB (dado por la autoridad depositaria internacional; referencia de identificacin dada por el depositante: ADHLSC). En consecuencia, la presente memoria descriptiva tambin describe una clula aislada, lnea celular y poblacin celular depositada en las BCCM con el nmero de registro LMBP 6452CB (en la presente memoria, la lnea celular LMBP 6452CB), a sublneas de la misma incluyendo sublneas clonales y a progenie de la misma, incluyendo progenie diferenciada de la misma, especialmente hepatocitos o clulas de tipo hepatocito preparadas a partir de la misma, y a derivados modificados genticamente o de otro modo de la misma.</span>The present specification also describes that the present inventors have established a cell population (cell line) of adult human liver progenitor cells or stem cells using the procedures as described herein, in particular as documented in Example 1, and have deposited said isolated cell line on February 20, 2006 under the Budapest Treaty in the Belgian Coordinated Collection of Microorganisms (BCCM) with the registration number LMBP 6452CB (given by the international depository authority; identification reference given by the depositor : ADHLSC). Accordingly, the present specification also describes an isolated cell, cell line and cell population deposited in the BCCM with the registration number LMBP 6452CB (herein, the cell line "LMBP 6452CB"), to sublines thereof including Clonal sublines already progeny thereof, including differentiated progeny thereof, especially hepatocytes or hepatocyte-type cells prepared therefrom, already genetically modified derivatives or otherwise thereof.</span>
  </p>
  <p id="p00630" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto apreciar que las clulas progenitoras o clulas madre, lneas celulares de las mismas y poblaciones celulares que comprenden las mismas, obtenibles segn los procedimientos tal como se describen en la presente memoria a partir de hgado humano adulto, pueden tener propiedades biolgicas, especialmente capacidad de proliferacin y diferenciacin, morfologa celular y/o expresin de marcadores, idnticas o anlogas a la lnea celular depositada anteriormente, aunque pueden ser genticamente diferentes (debido a la variacin gentica normal entre seres humanos). En consecuencia, se describe tambin en la presente memoria descriptiva una clula progenitora o clula madre humana o poblacin celular, especialmente derivada de hgado, que tiene propiedades biolgicas idnticas o similares a la poblacin celular depositada.</span>An expert will appreciate that the progenitor cells or stem cells, cell lines thereof and cell populations comprising the same, obtainable according to the procedures as described herein from adult human liver, may have biological properties, especially ability proliferation and differentiation, cell morphology and / or expression of markers, identical or analogous to the previously deposited cell line, although they may be genetically different (due to normal genetic variation between humans). Accordingly, a progenitor cell or human stem cell or cell population, especially liver-derived, having biological properties identical or similar to the deposited cell population is also described herein.</span>
  </p>
  <p id="p00631" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe una poblacin celular que comprende las clulas progenitoras o clulas madre hepticas humanas aisladas de las caractersticas anteriores, y opcionalmente modificados adicionalmente, por ejemplo modificados genticamente. En una realizacin, dicha poblacin celular puede comprender aproximadamente un 5% o ms, por ejemplo aproximadamente un 10% o ms de dichas clulas progenitoras o clulas madre, aproximadamente un 20% o ms, aproximadamente un 30% o ms, aproximadamente un 40% o ms, aproximadamente un 50% o ms, aproximadamente un 60% o ms, aproximadamente un 70% o ms, aproximadamente un 80% o ms o aproximadamente un 90% o ms de las clulas progenitoras o clulas madre, o es una poblacin sustancialmente homognea u homognea de dichas clulas progenitoras o clulas madre.</span>The present specification also describes a cell population comprising the progenitor cells or human liver stem cells isolated from the above characteristics, and optionally further modified, for example genetically modified. In one embodiment, said cell population may comprise about 5% or more, for example about 10% or more of said progenitor cells or stem cells, about 20% or more, about 30% or more, about 40% or more, about 50% or more, about 60% or more, about 70% or more, about 80% or more or about 90% or more of the progenitor cells or stem cells, or is a population substantially homogeneous or homogeneous of said progenitor cells or stem cells.</span>
  </p>
  <p id="p00632" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe una lnea celular establecida mediante propagacin de las clulas progenitoras o clulas madre derivadas de hgado de la invencin, opcionalmente modificados adicionalmente, por ejemplo modificados genticamente. Dicha propagacin puede partir de una clula progenitora o clula madre (una lnea celular clonal) o de ms de una clula.</span>The present specification also describes a cell line established by propagation of the progenitor cells or liver-derived stem cells of the invention, optionally further modified, for example genetically modified. Such propagation can be from a progenitor cell or stem cell (a clonal cell line) or from more than one cell.</span>
  </p>
  <p id="p00633" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe una clula progenitora o clula madre heptica adulta aislada, una lnea celular de la misma y/o una poblacin celular que comprende la misma, obtenible o directamente obtenida usando los procedimientos anteriormente descritos tal como se describen en la presente memoria, incluyendo realizaciones preferidas de los mismos.</span>The present specification also describes an isolated adult progenitor cell or liver stem cell, a cell line thereof and / or a cell population comprising the same, obtainable or directly obtained using the procedures described above as described herein. , including preferred embodiments thereof.</span>
  </p>
  <p id="p00634" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe un procedimiento para aislar una poblacin de clulas madre de tipo mesenquimal progenitores viables a partir de hgado adulto normal (humano) (figura 1). Las clulas madre eran capaces de proliferar en un medio de cultivo, y expresaban marcadores de varios tipos de clula heptica tales como, por ejemplo, albmina (hepatocitos), vimentina (clulas estrelladas), a-actina de msculo liso (ASMA) (figura 2A). No tienen fenotipo biliar, como se muestra por la inmunotincin negativa y los ensayos de PCR-TI de citoqueratina 19 (figura 2B). Cuando se ensayaron usando citometra de flujo, las ADHLSC eran negativas de CD45, CD34 y CD117, indicando su no contaminacin por linaje linfohematopoytico. En contraposicin, las ADHLSC eran positivas de CD90, CD29 y CD44, marcadores de linaje mesenquimal.</span>The present specification also describes a procedure for isolating a population of viable mesenchymal stem cells from normal adult (human) liver (Figure 1). Stem cells were able to proliferate in a culture medium, and expressed markers of various types of liver cells such as, for example, albumin (hepatocytes), vimentin (starred cells), smooth muscle a-actin (ASMA) (Figure 2A). They have no biliary phenotype, as shown by negative immunostaining and the cytokeratin-19 PCR-IT assays (Figure 2B). When tested using flow cytometry, ADHLSCs were negative for CD45, CD34 and CD117, indicating their non-contamination by lymphohematopoietic lineage. In contrast, ADHLSC were positive for CD90, CD29 and CD44, markers of mesenchymal lineage.</span>
  </p>
  <p id="p00635" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En una realizacin, las clulas son capaces de retener su capacidad de proliferacin despus del tratamiento con tripsina/EDTA. La incubacin en un medio definido permita a estas clulas diferenciarse especficamente en hepatocitos (figura 3). Como criterios de especificidad adicionales, no eran capaces de transdiferenciarse en osteocitos o adipocitos, como se habra observado usando clulas de mdula sea mesenquimales humanas multipotentes. Su capacidad de proliferacin y su especificidad heptica conducen a una eficacia y seguridad aumentadas para el trasplante de clulas hepticas. Adems, debido a su origen adulto, estas clulas madre obvian los problemas inmunitarios, ticos y carcinognicos asociados a las clulas embrionarias.</span>In one embodiment, the cells are able to retain their proliferation capacity after trypsin / EDTA treatment. Incubation in a defined medium allowed these cells to differentiate specifically into hepatocytes (Figure 3). As additional specificity criteria, they were not able to transdifferentiate into osteocytes or adipocytes, as would have been observed using multipotent human mesenchymal bone marrow cells. Its proliferation capacity and liver specificity lead to increased efficacy and safety for liver cell transplantation. In addition, due to their adult origin, these stem cells obviate the immune, ethical and carcinogenic problems associated with embryonic cells.</span>
  </p>
  <p id="p00636" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00637" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00638" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00639" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00640" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00641" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00642" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00643" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00644" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00645" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00646" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00647" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Diferenciacin de las clulas progenitoras o clulas madre de la invencin</span>Differentiation of the progenitor cells or stem cells of the invention</span>
  </p>
  <p id="p00648" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adems de detectar los marcadores celulares, el estudio de la diferenciacin celular in vitro y/o in vivo puede ser informativo.</span>In addition to detecting cell markers, the study of cell differentiation in vitro and / or in vivo can be informative.</span>
  </p>
  <p id="p00649" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los presentes inventores advirtieron adicionalmente de que las clulas progenitoras o clulas madre derivadas de hgado obtenidos usando los procedimientos anteriores pueden poseer una capacidad de diferenciacin especfica. En particular, las clulas pueden diferenciarse en hepatocitos o clulas de tipo hepatocito. En una realizacin adicional ms, las clulas no se diferencian en tipos de clula mesodrmicos (mesenquimales) tales como, por ejemplo, osteocitos, condrocitos, miocitos, clulas de tejido conectivo, tendinocitos, adipocitos o clulas estromales.</span>The present inventors further warned that progenitor cells or liver-derived stem cells obtained using the above procedures may possess a specific differentiation capacity. In particular, the cells can be differentiated into hepatocytes or hepatocyte-like cells. In a further embodiment, the cells are not differentiated into mesodermal (mesenchymal) cell types such as, for example, osteocytes, chondrocytes, myocytes, connective tissue cells, tendinocytes, adipocytes or stromal cells.</span>
  </p>
  <p id="p00650" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La clula progenitora o clula madre heptica aislada de la invencin, lneas celulares de la misma o poblaciones celulares que comprenden la misma (mencionando especficamente, pero por supuesto sin limitacin, la lnea LMBP 6452CB), o progenie de la misma, puede inducirse ventajosamente a diferenciarse en clulas de linaje de hepatocito, en particular hepatocitos o clulas de tipo hepatocito. Dicha diferenciacin puede ocurrir in vivo, in vitro o ex vivo. En consecuencia, la presente memoria descriptiva describe adicionalmente un procedimiento para la generacin de hepatocitos o clulas de tipo hepatocito a partir de la clula progenitora o clula madre aislada de la invencin, y los hepatocitos o clulas de tipo hepatocito resultantes.</span>The progenitor cell or liver stem cell isolated from the invention, cell lines thereof or cell populations comprising the same (specifically mentioning, but of course without limitation, the LMBP 6452CB line), or progeny thereof, can be advantageously induced to differentiate into hepatocyte lineage cells, in particular hepatocytes or hepatocyte type cells. Such differentiation can occur in vivo, in vitro or ex vivo. Accordingly, the present specification further describes a process for the generation of hepatocytes or hepatocyte-like cells from the progenitor cell or isolated stem cell of the invention, and the resulting hepatocytes or hepatocyte-like cells.</span>
  </p>
  <p id="p00651" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe que la clula progenitora o clula madre derivada de hgado de la invencin se caracteriza por tanto por su capacidad de diferenciarse en hepatocitos o clulas de tipo hepatocito y por la falta de diferenciacin hacia tipos de clula mesodrmicos tales como, por ejemplo, osteocitos y adipocitos.</span>The present specification also describes that the progenitor cell or liver-derived stem cell of the invention is therefore characterized by its ability to differentiate into hepatocytes or hepatocyte-like cells and by the lack of differentiation towards mesodermal cell types such as, by example, osteocytes and adipocytes.</span>
  </p>
  <p id="p00652" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se entender por los expertos en la tcnica, la capacidad de diferenciarse en un tipo de clula especfico o la falta de dicha capacidad puede observarse in vitro, ex vivo o in vivo. A modo de ejemplo, la diferenciacin in vitro o ex vivo puede valorarse exponiendo la clula a medios inductores de la diferenciacin especficos como es conocido en general en la tcnica. De otro modo, la diferenciacin puede valorarse in vivo siguiendo el destino de una clula introducida (por ejemplo, trasplantada, inyectada o administrada de otro modo). Un experto es capaz de reconocer la diferenciacin en tipos de clula particulares valorando criterios fenotpicos que incluyen, pero sin limitacin, morfologa celular, expresin de protena marcadora y/o actividad de rutas metablicas u otras fisiolgicas especficas.</span>As will be understood by those skilled in the art, the ability to differentiate into a specific cell type or the lack of such capacity can be observed in vitro, ex vivo or in vivo. By way of example, in vitro or ex vivo differentiation can be assessed by exposing the cell to specific differentiation inducing media as is generally known in the art. Otherwise, differentiation can be assessed in vivo following the fate of an introduced cell (for example, transplanted, injected or otherwise administered). An expert is able to recognize differentiation in particular cell types by assessing phenotypic criteria that include, but are not limited to, cell morphology, marker protein expression and / or activity of metabolic or other specific physiological pathways.</span>
  </p>
  <p id="p00653" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La diferenciacin en clulas de linaje de hepatocito puede efectuarse ventajosamente en presencia de citocinas y factores de crecimiento, que pueden ser especficos de hgado. A modo de ilustracin, el factor de crecimiento de hepatocitos (HGF), o factor de difusin, es una citocina bien conocida que promueve la diferenciacin en un fenotipo de hepatocito. De forma similar, una lista no limitante de citocinas adicionales incluye factor de crecimiento epidrmico (EGF), FGF bsico, insulina, nicotinamida, oncostatina M, dexametasona, inhibidores de HDAC (por ejemplo, butirato de sodio), DMSO, vitamina A o componentes de matriz tales como sulfato de heparano, que se han implicado tambin en la diferenciacin en hepatocitos. Los protocolos para inducir la diferenciacin en hepatocitos son conocidos en general en la tcnica y pueden optimizarse adicionalmente por un experto.</span>Differentiation in hepatocyte lineage cells can be advantageously carried out in the presence of cytokines and growth factors, which may be liver specific. By way of illustration, hepatocyte growth factor (HGF), or diffusion factor, is a well-known cytokine that promotes differentiation in a hepatocyte phenotype. Similarly, a non-limiting list of additional cytokines includes epidermal growth factor (EGF), basic FGF, insulin, nicotinamide, oncostatin M, dexamethasone, HDAC inhibitors (eg, sodium butyrate), DMSO, vitamin A or components of matrix such as heparan sulfate, which have also been implicated in hepatocyte differentiation. Protocols for inducing hepatocyte differentiation are generally known in the art and can be further optimized by an expert.</span>
  </p>
  <p id="p00654" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La identificacin y posterior aislamiento de clulas diferenciadas a partir de sus contrapartidas indiferenciadas pueden llevarse a cabo mediante procedimientos bien conocidos en la tcnica. Por ejemplo, las clulas que se han inducido a diferenciarse pueden identificarse cultivando selectivamente las clulas en condiciones en que las clulas diferenciadas superen a las clulas indiferenciadas. De forma similar, las clulas diferenciadas pueden identificarse por cambios morfolgicos y caractersticas que no estn presentes en sus contrapartidas indiferenciadas, tales como el tamao celular, forma o complejidad de la distribucin de orgnulos intracelulares. Se contemplan tambin procedimientos de identificacin de clulas por su expresin de protenas marcadoras especficas, tales como marcadores de superficie celular. La deteccin y aislamiento de estas clulas puede conseguirse, por ejemplo, mediante citometra de flujo, ELISA y/o perlas magnticas. La reaccin en cadena de la polimerasa con transcripcin inversa (PCR-TI) puede usarse tambin para controlar los cambios en la expresin gnica en respuesta a la diferenciacin. Adems, puede usarse el anlisis de genoma completo usando tecnologa de micromatrices para identificar las clulas diferenciadas.</span>The identification and subsequent isolation of differentiated cells from their undifferentiated counterparts can be carried out by procedures well known in the art. For example, cells that have been induced to differentiate can be identified by selectively culturing the cells under conditions where differentiated cells outperform undifferentiated cells. Similarly, differentiated cells can be identified by morphological changes and characteristics that are not present in their undifferentiated counterparts, such as cell size, shape or complexity of the distribution of intracellular organelles. Cell identification procedures are also contemplated for their expression of specific marker proteins, such as cell surface markers. The detection and isolation of these cells can be achieved, for example, by flow cytometry, ELISA and / or magnetic beads. The polymerase chain reaction with reverse transcription (PCR-TI) can also be used to control changes in gene expression in response to differentiation. In addition, complete genome analysis can be used using microarray technology to identify differentiated cells.</span>
  </p>
  <p id="p00655" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Modificacin gentica de las clulas progenitoras o clulas madre de la invencin</span>Genetic modification of the progenitor cells or stem cells of the invention</span>
  </p>
  <p id="p00656" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Dicha clula progenitora o clula madre heptica adulta puede modificarse adicionalmente, por ejemplo modificarse genticamente como se describe anteriormente. La memoria descriptiva describe adicionalmente la progenie, incluyendo la progenie diferenciada, de la clula progenitora o clula madre heptica adulta.</span>Said progenitor cell or adult liver stem cell can be further modified, for example genetically modified as described above. The specification further describes the progeny, including the differentiated progeny, of the progenitor cell or adult liver stem cell.</span>
  </p>
  <p id="p00657" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva tambin describe que para aumentar la capacidad replicativa de las clulas progenitoras o clulas madre obtenidas de la invencin, las clulas pueden telomerizarse como es conocido en general en la tcnica. Una clula se describe como telomerizada si se ha alterado genticamente con un cido nucleico que codifica una telomerasa transcriptasa inversa (TERT) de cualquier especie de tal manera que la TERT se transcriba y traduzca en la clula. El trmino se aplica tambin a la progenie de la clula originalmente alterada que ha heredado la capacidad de expresar la regin de codificacin de TERT a un nivel elevado. La secuencia de codificacin de TERT se toma o adapta tpicamente a partir de un gen de TERT de mamfero, ejemplificado por TERT humano y de ratn, como se indica a continuacin. Las clulas pueden telomerizarse alterndolas</span>The present specification also describes that to increase the replicative capacity of the progenitor cells or stem cells obtained from the invention, the cells can be telomerized as is generally known in the art. A cell is described as "telomerized" if it has been genetically altered with a nucleic acid encoding a telomerase reverse transcriptase (TERT) of any species such that TERT is transcribed and translated into the cell. The term also applies to the progeny of the originally altered cell that has inherited the ability to express the TERT coding region at a high level. The TERT coding sequence is typically taken or adapted from a mammalian TERT gene, exemplified by human and mouse TERT, as indicated below. Cells can be telomerized by altering them</span>
  </p>
  <p id="p00658" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00659" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00660" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00661" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00662" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00663" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00664" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00665" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00666" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00667" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00668" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00669" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00670" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">genticamente con un vector adecuado, de modo que expresen el componente cataltico de telomerasa (TERT) a un nivel elevado. Es particularmente adecuado el componente cataltico de la telomerasa humana (hTERT), proporcionado en el documento WO 1998/14592. Para algunas aplicaciones, pueden usarse otras secuencias de TERt. Se contemplan tambin otros procedimientos de inmortalizacin de clulas, tales como alterar genticamente las clulas con ADN que codifica el antgeno T grande de SV40 (documentos US 5.869.243, WO 1997/32972), infectar con virus de Epstein Barr, introducir oncogenes tales como myc y/o ras, introducir genes de replicacin vrica tales como E1a adenovrico y fusionar clulas que tengan el fenotipo deseado con una lnea celular inmortalizada. La transfeccin con oncogenes u productos oncovricos es habitualmente menos adecuada cuando las clulas se van a usar con fines teraputicos.</span>genetically with a suitable vector, so that they express the catalytic component of telomerase (TERT) at a high level. The catalytic component of human telomerase (hTERT), provided in WO 1998/14592, is particularly suitable. For some applications, other TERt sequences may be used. Other cell immortalization procedures are also contemplated, such as genetically altering the cells with DNA encoding the SV40 large T antigen (US 5,869,243, WO 1997/32972), infecting with Epstein Barr virus, introducing oncogenes such as myc and / or ras, introduce viral replication genes such as adenoviral E1a and fuse cells that have the desired phenotype with an immortalized cell line. Transfection with oncogenes or oncoviral products is usually less suitable when cells are to be used for therapeutic purposes.</span>
  </p>
  <p id="p00671" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Generalmente, podra preferirse que las presentes clulas progenitoras o clulas madre no estn modificados por telomerizacin u otros modos de inmortalizacin cuando se contemple el uso en terapia de dichas clulas o la progenie de las mismas, incluyendo la progenie diferenciada de las mismas, por ejemplo, cuando dichas clulas se van a introducir en un cuerpo humano o animal, especialmente humano.</span>Generally, it may be preferred that the present progenitor cells or stem cells are not modified by telomerization or other immortalization methods when the use in therapy of said cells or the progeny thereof, including the differentiated progeny thereof, for example, is contemplated. when these cells are going to be introduced into a human or animal body, especially human.</span>
  </p>
  <p id="p00672" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se describe anteriormente, las clulas progenitoras o clulas madre derivadas de hgado obtenidos o la progenie de los mismos puede transfectarse o transformarse estable o transitoriamente con un cido nucleico de inters antes del uso adicional, por ejemplo, en terapia o investigacin, esencialmente como es conocido en la tcnica. Las secuencias de cido nucleico de inters pueden incluir, pero sin limitacin, aquellas que codifican productos gnicos que potencian el crecimiento, diferenciacin y/o funcionamiento de tipos de clula tiles en terapia, por ejemplo, tipos de clula derivables de las clulas progenitoras o clulas madre de la invencin, y particularmente de hepatocitos o clulas de tipo hepatocito, o que suministran un gen teraputico a un sitio de administracin o implante de dichas clulas.</span>As described above, the progenitor cells or stem cells derived from liver or the progeny thereof can be transfected or stably or transiently transformed with a nucleic acid of interest before further use, for example, in therapy or research, essentially as is known in the art. Nucleic acid sequences of interest may include, but are not limited to, those encoding gene products that enhance the growth, differentiation and / or functioning of cell types useful in therapy, for example, cell types derivable from progenitor cells or cells. mother of the invention, and particularly of hepatocytes or hepatocyte-like cells, or that deliver a therapeutic gene to a site of administration or implantation of said cells.</span>
  </p>
  <p id="p00673" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A modo de ejemplo y no de limitacin, las clulas progenitoras o clulas madre obtenidas la progenie de los mismos puede modificarse para sobreexpresar constitutiva o induciblemente un polipptido expresado normalmente por clulas hepticas, especialmente hepatocitos, pero que es defectivo o est ausente en un paciente, siendo este defecto la causa subyacente de un estado patolgico del paciente. La administracin de las clulas as modificadas puede restaurar la produccin de la protena y ayudar as a tratar el paciente. Por ejemplo, las clulas progenitoras o clulas madre o la progenie de las mismas puede contener ADN heterlogo que codifica una protena metablica tal como ornitina transcarbamilasa, argininosuccinato sintetasa, argininosuccinato liasa, arginasa, fosfato de carbamilo sintasa, glutamato de N-acetilo sintasa, glutamina sintetasa, glucgeno sintetasa, glucosa-6-fosfatasa, succinato deshidrogenasa, glucocinasa, piruvato cinasa, acetil CoA carboxilasa, cido graso sintetasa, alanina aminotransferasa, glutamato deshidrogenasa, ferritina, receptor de lipoprotena de baja densidad (LDL), enzimas P450 y/o alcohol deshidrogenasa. Como alternativa, las clulas pueden contener ADN que codifica una protena plasmtica secretada tal como albmina, transferrina, componente C3 del complemento, a2-macroglobulina, fibringeno, factor XIII, factor IX, a1-antitripsina o similares.</span>By way of example and not limitation, the progenitor cells or stem cells obtained the progeny thereof can be modified to constitutively or inducibly overexpress a polypeptide normally expressed by liver cells, especially hepatocytes, but which is defective or absent in a patient, this defect being the underlying cause of a pathological state of the patient. The administration of the cells thus modified can restore the production of the protein and thus help to treat the patient. For example, the progenitor cells or stem cells or the progeny thereof may contain heterologous DNA encoding a metabolic protein such as ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, arginase, carbamyl synthase phosphate, N-acetyl synthase glutamate, glutamine synthetase, glycogen synthetase, glucose-6-phosphatase, succinate dehydrogenase, glucokinase, pyruvate kinase, acetyl CoA carboxylase, fatty acid synthetase, alanine aminotransferase, glutamate dehydrogenase, ferritin, low density lipoprotein receptor (LDL) and enzymes (LD4 and 50), enzy alcohol dehydrogenase Alternatively, the cells may contain DNA encoding a secreted plasma protein such as albumin, transferrin, complement component C3, a2-macroglobulin, fibrinogen, factor XIII, factor IX, a1-antitrypsin or the like.</span>
  </p>
  <p id="p00674" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El hgado es el centro de produccin de muchas protenas secretoras. Est conectado anatmicamente con el sistema circulatorio de tal modo que permite una liberacin eficaz de diversas protenas a la corriente sangunea. Por lo tanto, pueden insertarse genes que codifican protenas que tienen efectos sistmicos en clulas hepticas de la presente invencin, en contraposicin a los tipos de clula especficos que las producen normalmente, especialmente si es difcil integrar genes en estas clulas. Por ejemplo, puede insertarse una variedad de genes de hormonas o genes de anticuerpos especficos en clulas hepticas de la presente invencin para la secrecin de sus productos gnicos en la circulacin.</span>The liver is the center of production of many secretory proteins. It is anatomically connected to the circulatory system in such a way that it allows an effective release of various proteins to the bloodstream. Therefore, genes encoding proteins that have systemic effects can be inserted into liver cells of the present invention, as opposed to the specific cell types that normally produce them, especially if it is difficult to integrate genes into these cells. For example, a variety of hormone genes or specific antibody genes can be inserted into liver cells of the present invention for the secretion of their gene products into the circulation.</span>
  </p>
  <p id="p00675" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se usan procedimientos de transferencia gnica convencionales para introducir cidos nucleicos en clulas. El procedimiento preciso usado para introducir un gen no es crtico. Por ejemplo, los procedimientos fsicos para la introduccin de ADN en clulas incluyen microinyeccin y electroporacin. Los procedimientos qumicos tales como precipitacin simultnea con fosfato de calcio e incorporacin de ADN a liposomas son tambin procedimientos estndares de introduccin de ADN en clulas de mamfero. Tambin se contempla la transfeccin vrica. El ADN se introduce usando vectores estndares tales como los derivados de retrovirus de murino y aviar (vase, por ejemplo, Gluzman y col., Viral Vectors, Cold Spring Harbour Laboratory, Cold Spring Harbour, N.Y., 1988). Los procedimientos de ADN recombinante estndares son bien conocidos en la tcnica (vase, por ejemplo, Ausubel y col., Current Protocols in Molecular Biology, John Wiley &amp; Sons, Nueva York, 1989), y se han desarrollado y usado clnicamente con xito vectores vricos para terapia gnica (vase, por ejemplo, Rosenberg, y col., N. Engl. J. Med., 323: 370, 1990).</span>Conventional gene transfer procedures are used to introduce nucleic acids into cells. The precise procedure used to introduce a gene is not critical. For example, physical procedures for the introduction of DNA into cells include microinjection and electroporation. Chemical procedures such as simultaneous precipitation with calcium phosphate and incorporation of DNA into liposomes are also standard procedures for introducing DNA into mammalian cells. Viral transfection is also contemplated. DNA is introduced using standard vectors such as murine and avian retrovirus derivatives (see, for example, Gluzman et al., "Viral Vectors", Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1988). Standard recombinant DNA procedures are well known in the art (see, for example, Ausubel et al., "Current Protocols in Molecular Biology", John Wiley &amp; Sons, New York, 1989), and have been developed and used clinically with Successful viral vectors for gene therapy (see, for example, Rosenberg, et al., N. Engl. J. Med., 323: 370, 1990).</span>
  </p>
  <p id="p00676" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Usos de las clulas progenitoras o clulas madre de la invencin</span>Uses of the progenitor cells or stem cells of the invention</span>
  </p>
  <p id="p00677" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las clulas progenitoras o clulas madre originadas en hgado aisladas de la invencin, las lneas celulares de las mismas o las poblaciones que comprenden las mismas pueden usarse con diferentes fines (ha de entenderse que los usos y aplicaciones a continuacin se contemplan ampliamente para cualquier clula progenitora o clula madre heptica adulta como se define anteriormente, en particular para clulas obtenibles u obtenidas directamente usando los procedimientos anteriormente definidos, clulas que presentan las caractersticas anteriormente definidas, as como para la lnea celular LMBP 6452CB, en una realizacin particular, una lnea de clulas madre derivadas de hgado adulto, preferiblemente una lnea de clulas madre derivadas de hgado humano adulto (ADHLSC); la</span>The progenitor cells or liver-originated stem cells isolated from the invention, the cell lines thereof or the populations comprising them can be used for different purposes (it is understood that the uses and applications below are widely contemplated for any progenitor cell or adult liver stem cell as defined above, in particular for cells obtainable or obtained directly using the procedures defined above, cells having the characteristics defined above, as well as for the LMBP 6452CB cell line, in a particular embodiment, a cell line stem cells derived from adult liver, preferably a stem cell line derived from adult human liver (ADHLSC);</span>
  </p>
  <p id="p00678" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00679" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00680" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00681" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00682" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00683" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00684" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00685" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00686" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00687" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00688" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">progenie de las mismos o derivados modificados genticamente de las mismas) incluyendo, pero sin limitacin:</span>progeny thereof or genetically modified derivatives thereof) including, but not limited to:</span>
  </p>
  <p id="p00689" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el trasplante de clulas hepticas para tratar deficiencias metablicas hepticas, enfermedades degenerativas hepticas o insuficiencia heptica fulminante, usando las clulas progenitoras o clulas madre o una poblacin de las mismas tal como se describe en la presente memoria,</span>- liver cell transplantation to treat hepatic metabolic deficiencies, degenerative liver diseases or fulminant liver failure, using progenitor cells or stem cells or a population thereof as described herein,</span>
  </p>
  <p id="p00690" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la preparacin de dispositivos hepticos bioartificiales usando las clulas progenitoras o clulas madre aisladas o una poblacin de los mismos tal como se describe en la presente memoria,</span>- the preparation of bioartificial liver devices using the progenitor cells or isolated stem cells or a population thereof as described herein,</span>
  </p>
  <p id="p00691" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la preparacin de modelos animales de enfermedades hepticas humanas gracias al trasplante de clulas progenitoras o clulas madre aisladas o una poblacin de los mismos tal como se describe en la presente memoria en animales,</span>- the preparation of animal models of human liver diseases thanks to the transplantation of progenitor cells or isolated stem cells or a population thereof as described herein in animals,</span>
  </p>
  <p id="p00692" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la preparacin de modelos in vitro y animales de toxicologa y farmacologa usando las clulas progenitoras o clulas madre aisladas o una poblacin de los mismos tal como se describe en la presente memoria,</span>- the preparation of in vitro and animal models of toxicology and pharmacology using the progenitor cells or isolated stem cells or a population thereof as described herein,</span>
  </p>
  <p id="p00693" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el ensayo de nuevos frmacos sobre las clulas progenitoras o clulas madre aisladas o una poblacin de los mismos tal como se describe en la presente memoria, incluyendo frmacos antivricos para virus de hepatitis humanos.</span>- the testing of new drugs on progenitor cells or isolated stem cells or a population thereof as described herein, including antiviral drugs for human hepatitis viruses.</span>
  </p>
  <p id="p00694" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por ejemplo, el anlisis de los hgados de ratones uPA+/+-SCID y SCID trasplantados intraesplnicamente con ADHLSC (lnea LMBP 6452CB) demostr que estas clulas eran capaces de injertarse y diferenciarse en hepatocitos maduros (figuras 4 y 5). Adems, se detect albmina humana en el suero de estos ratones trasplantados 10 semanas despus del trasplante, mientras que no se detectaron niveles de a-fetoprotena.</span>For example, analysis of the livers of uPA + / + - SCID and SCID mice transplanted intrasplenically with ADHLSC (LMBP line 6452CB) showed that these cells were able to graft and differentiate into mature hepatocytes (Figures 4 and 5). In addition, human albumin was detected in the serum of these transplanted mice 10 weeks after transplantation, while no levels of a-fetoprotein were detected.</span>
  </p>
  <p id="p00695" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria tambin describe que las clulas progenitoras o clulas madre hepticas (mencionado especficamente, aunque por supuesto sin limitacin, la lnea LMBP 6452CB) pueden usarse para trasplante en errores congnitos del metabolismo, para trasplante en modelos animales de insuficiencia heptica o para trasplante en modelos animales de hepatitis vrica humana. Las presentes clulas pueden usarse por lo tanto en el tratamiento de enfermedades asociadas al hgado incluyendo, pero sin limitacin, insuficiencia heptica, hepatitis y errores congnitos del metabolismo.</span>The present specification also describes that progenitor cells or liver stem cells (specifically mentioned, although of course without limitation, the LMBP 6452CB line) can be used for transplantation in congenital metabolism errors, for transplantation in animal models of liver failure or for transplantation in Animal models of human viral hepatitis. The present cells can therefore be used in the treatment of diseases associated with the liver including, but not limited to, liver failure, hepatitis and congenital metabolism errors.</span>
  </p>
  <p id="p00696" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En el ejemplo 1, los inventores demuestran que las clulas progenitoras o clulas madre hepticas humanas de la invencin, cuando se administran mediante inyeccin intraesplnica a un mamfero inmunodeficiente, ms preferiblemente un roedor, especialmente un ratn o rata, retienen su capacidad de proliferacin e injerto en el hgado hospedador. En consecuencia, la presente memoria descriptiva describe que una poblacin celular que comprende clulas progenitoras o clulas madre hepticas de la invencin, preferiblemente de origen humano (mencionando especficamente, aunque por supuesto sin limitacin, la lnea LMBP6452CB) se introduce, por ejemplo se inyecta, y se permite injertar en un mamfero vuelto inmunodeficiente gentica o qumicamente, obtenindose un modelo animal. Preferiblemente, dicha poblacin puede comprender al menos 2 x 106 clulas de la invencin. Un experto apreciar otros modos de administracin de la poblacin celular de la invencin para inducir el injerto heptico de dichas clulas progenitoras o clulas madre derivadas de hgado adulto.</span>In Example 1, the inventors demonstrate that the progenitor cells or human liver stem cells of the invention, when administered by intrasplenic injection to an immunodeficient mammal, more preferably a rodent, especially a mouse or rat, retain their proliferation and grafting ability in the host liver. Accordingly, the present specification describes that a cell population comprising progenitor cells or liver stem cells of the invention, preferably of human origin (specifically mentioning, although of course without limitation, the LMBP6452CB line) is introduced, for example, injected, and it is allowed to graft in a mammal made genetically or chemically immunodeficient, obtaining an animal model. Preferably, said population may comprise at least 2 x 10 6 cells of the invention. An expert will appreciate other modes of administration of the cell population of the invention to induce hepatic grafting of said progenitor cells or stem cells derived from adult liver.</span>
  </p>
  <p id="p00697" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se detalla en el ejemplo 1, las clulas injertadas no sobreproliferaban, recalcando as sus ventajas en el trasplante de clulas en seres humanos u otros animales, preferiblemente mamferos.</span>As detailed in example 1, the grafted cells did not overproliferate, thus emphasizing their advantages in the transplantation of cells in humans or other animals, preferably mammals.</span>
  </p>
  <p id="p00698" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin el uso de las clulas progenitoras o clulas madre aisladas o una poblacin de los mismos tal como se describe en la presente memoria (mencionando especficamente, aunque por supuesto sin limitacin, la lnea LMBP 6452CB), con los siguientes fines:</span>The present specification also describes the use of progenitor cells or isolated stem cells or a population thereof as described herein (specifically mentioning, although of course without limitation, the LMBP 6452CB line), for the following purposes :</span>
  </p>
  <p id="p00699" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el trasplante de clulas progenitoras o clulas madre hepticas para tratar deficiencias metablicas congnitas basadas en el hgado: los ejemplos no exhaustivos de dichas enfermedades incluyen fenilcetonuria y otras aminoacidopatas, hemofilia y otras deficiencias de factor de coagulacin, hipercolesterolemia familiar y otros trastornos del metabolismo lipdico, trastornos del ciclo de la urea, glucogenosis, galactosemia, fructosemia, tirosinemia, deficiencias del metabolismo de protenas e hidratos de carbono, aciduria orgnica, enfermedades mitocondriales, trastornos peroxismicos y lisosmicos, anomalas de la sntesis de protenas, defectos de transportadores de clulas hepticas, defecto de glucosilacin y similares,</span>- Transplantation of progenitor cells or liver stem cells to treat congenital metabolic deficiencies based on the liver: non-exhaustive examples of such diseases include phenylketonuria and other aminoacidopathies, hemophilia and other coagulation factor deficiencies, familial hypercholesterolemia and other disorders of lipid metabolism , urea cycle disorders, glycogenosis, galactosemia, fructosemia, tyrosinemia, deficiencies of protein and carbohydrate metabolism, organic aciduria, mitochondrial diseases, peroxisomal and lysosomal disorders, abnormalities of protein synthesis, liver cell transporter defects , glycosylation defect and the like,</span>
  </p>
  <p id="p00700" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el trasplante de clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria para tratar enfermedades degenerativas hepticas progresivas adquiridas,</span>- transplantation of progenitor cells or liver stem cells as described herein to treat acquired progressive degenerative liver diseases,</span>
  </p>
  <p id="p00701" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el uso de clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria para tratar insuficiencia heptica fulminante e insuficiencia heptica aguda o crnica,</span>- the use of progenitor cells or liver stem cells as described herein to treat fulminant liver failure and acute or chronic liver failure,</span>
  </p>
  <p id="p00702" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el uso de clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria en dispositivos hepticos bioartificiales y dispositivos auxiliares hepticos,</span>- the use of progenitor cells or liver stem cells as described herein in bioartificial liver devices and liver aids,</span>
  </p>
  <p id="p00703" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- modelos animales de enfermedades hepticas humanas gracias al trasplante de clulas progenitoras o clulas</span>- animal models of human liver diseases thanks to the transplantation of progenitor cells or cells</span>
  </p>
  <p id="p00704" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00705" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00706" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00707" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00708" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00709" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00710" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00711" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00712" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00713" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00714" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00715" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">madre hepticas tal como se describe en la presente memoria en animales pequeos y grandes,</span>hepatic mothers as described herein in small and large animals,</span>
  </p>
  <p id="p00716" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la preparacin de modelos animales de infecciones vricas hepatotrpicas (HBV, HAV, HCV, HEV, HDV,...) para estudiar el historial natural, transmisin, resistencia, efectos del tratamiento, uso de frmacos antivricos o cualquier investigacin que use clulas progenitoras o clulas madre hepticas trasplantadas tal como se describe en la presente memoria,</span>- the preparation of animal models of hepatotropic viral infections (HBV, HAV, HCV, HEV, HDV, ...) to study the natural history, transmission, resistance, effects of treatment, use of antiviral drugs or any research using progenitor cells or transplanted liver stem cells as described herein,</span>
  </p>
  <p id="p00717" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la preparacin de modelos animales in vitro de toxicologa, farmacologa y farmacogentica usando las clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria,</span>- the preparation of in vitro animal models of toxicology, pharmacology and pharmacogenetics using progenitor cells or liver stem cells as described herein,</span>
  </p>
  <p id="p00718" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el ensayo de nuevos frmacos en las clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria,</span>- testing of new drugs in progenitor cells or liver stem cells as described herein,</span>
  </p>
  <p id="p00719" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la terapia gnica, mediante la insercin de secuencias vricas en las clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria, que pueden multiplicarse entonces in vitro,</span>- gene therapy, by inserting viral sequences into the progenitor cells or liver stem cells as described herein, which can then be multiplied in vitro,</span>
  </p>
  <p id="p00720" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- modelos animales para estudiar el metabolismo de clulas hepticas humanas,</span>- animal models to study the metabolism of human liver cells,</span>
  </p>
  <p id="p00721" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- la tolerancia de clulas alognicas gracias al uso de clulas progenitoras o clulas madre hepticas tal como se describe en la presente memoria, y/o</span>- the tolerance of allogeneic cells thanks to the use of progenitor cells or liver stem cells as described herein, and / or</span>
  </p>
  <p id="p00722" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- el uso de clulas progenitoras o clulas madre tal como se describe en la presente memoria para evitar, prevenir o tratar el rechazo de aloinjerto de hgado o clulas hepticas.</span>- the use of progenitor cells or stem cells as described herein to prevent, prevent or treat rejection of liver allograft or liver cells.</span>
  </p>
  <p id="p00723" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las presentes clulas progenitoras o clulas madre o la progenie de los mismos, incluyendo la progenie diferenciada, puede pretenderse en un ejemplo de la invencin para aplicaciones teraputicas, por ejemplo, para ingeniera de tejidos y terapia celular.</span>The present progenitor cells or stem cells or the progeny thereof, including the differentiated progeny, can be intended in an example of the invention for therapeutic applications, for example, for tissue engineering and cell therapy.</span>
  </p>
  <p id="p00724" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un experto apreciar que los usos detallados en la presente memoria pueden implicar el uso de las clulas progenitoras o clulas madre, lneas celulares de las mismas, poblaciones celulares que comprenden las mismas, as como el uso de la progenie de las mismas, incluyendo la progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, o derivados modificados genticamente de las mismas.</span>An expert will appreciate that the uses detailed herein may involve the use of progenitor cells or stem cells, cell lines thereof, cell populations comprising the same, as well as the use of the progeny thereof, including the progeny differentiated, especially hepatocytes or hepatocyte-like cells, or genetically modified derivatives thereof.</span>
  </p>
  <p id="p00725" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como se observa anteriormente, las clulas progenitoras o clulas madre originadas en hgado de la invencin, las lneas celulares de los mismos o las poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque por supuesto sin limitacin, la lnea LMBP 6452CB), o la progenie de los mismos, opcionalmente modificada genticamente, pueden usarse en terapias de sustitucin celular. Las clulas pueden administrarse a un tejido de inters en un sujeto para complementar clulas en funcionamiento o reemplazar clulas que han perdido la funcin. Como alternativa, se contemplan tambin procedimientos para proporcionar clulas diferenciadas, particularmente hepatocitos o clulas de tipo hepatocito, en las que las clulas progenitoras o clulas madre se diferencian en presencia de factores de diferenciacin, se aslan y se administran a un sujeto.</span>As noted above, the progenitor cells or liver-originated stem cells of the invention, the cell lines thereof or the cell populations comprising the same (specifically mentioning, but of course without limitation, the LMBP 6452CB line), or the progeny thereof, optionally genetically modified, can be used in cell replacement therapies. Cells can be administered to a tissue of interest in a subject to complement functioning cells or replace cells that have lost function. Alternatively, methods are also contemplated to provide differentiated cells, particularly hepatocytes or hepatocyte-like cells, in which the progenitor cells or stem cells differentiate in the presence of differentiation factors, are isolated and administered to a subject.</span>
  </p>
  <p id="p00726" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los estados patolgicos o deficiencias tipificados por la prdida de masa y/o funcin heptica, y que podran beneficiarse de las clulas progenitoras o clulas madre de la invencin, incluyen aquellos enumerados anteriormente, e incluyen adicionalmente, pero sin limitacin, sndrome de Alagille, enfermedad heptica alcohlica (cirrosis inducida por alcohol), deficiencia de a-1-antitripsina (todos los fenotipos), hiperlipidemias y otros trastornos del metabolismo lipdico, hepatitis autoinmune sndrome de Budd-Chiari, atresia biliar, colestasis familiar progresiva de tipos I, II y III, cncer de hgado, enfermedad de Caroli, sndrome de Crigler-Najjar, fructosemia, galactosemia, defectos de glucosilacin deficiente de hidratos de carbono, otros trastornos del metabolismo de hidratos de carbono, enfermedad de Refsum y otras enfermedades peroxismicas, enfermedad de Niemann Pick, enfermedad de Wolman y otros trastornos lisosmicos, tirosinemia, triple H, y otros trastornos metablicos aminoacdicos, sndrome de Dubin-Johnson, esteatosis heptica (esteatohepatitis no alcohlica), sndrome de Gilbert, enfermedad de almacenamiento de glucgeno I y III, hemocromatosis, hepatitis A-G, porfiria, cirrosis biliar primaria, colangitis esclerosante, tirosinemia, deficiencias de factor de coagulacin, hemofilia B, fenilcetonuria, enfermedad de Wilson, insuficiencia heptica fulminante, insuficiencia heptica posthepatectoma y enfermedades de la cadena respiratoria mitocondrial. Adems, las clulas pueden usarse tambin para tratar trastornos hepticos adquiridos debido a infecciones vricas.</span>The pathological conditions or deficiencies typified by the loss of liver mass and / or function, and which could benefit from the progenitor cells or stem cells of the invention, include those listed above, and additionally include, but are not limited to, Alagille syndrome, disease alcoholic liver (alcohol-induced cirrhosis), a-1-antitrypsin deficiency (all phenotypes), hyperlipidemias and other disorders of lipid metabolism, autoimmune hepatitis Budd-Chiari syndrome, biliary atresia, progressive familial cholestasis types I, II and III, liver cancer, Caroli disease, Crigler-Najjar syndrome, fructosemia, galactosemia, carbohydrate deficient glycosylation defects, other carbohydrate metabolism disorders, Refsum disease and other peroxisomal diseases, Niemann Pick disease , Wolman disease and other lysosomal disorders, tyrosinemia, triple H, and other trast aminoacidic metabolic orns, Dubin-Johnson syndrome, hepatic steatosis (non-alcoholic steatohepatitis), Gilbert's syndrome, glycogen storage disease I and III, hemochromatosis, hepatitis AG, porphyria, primary biliary cirrhosis, sclerosing cholangitis, tyrosinemia, factor deficiencies of coagulation, hemophilia B, phenylketonuria, Wilson's disease, fulminant liver failure, posthepatectomy liver failure and mitochondrial respiratory chain diseases. In addition, cells can also be used to treat acquired liver disorders due to viral infections.</span>
  </p>
  <p id="p00727" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En consecuencia, en un aspecto se proporcionan clulas progenitoras o clulas madre hepticas adultas de la invencin, lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, pero sin limitacin, la lnea LMBP 6452CB) o progenie de la misma incluyendo progenie diferenciada, esp. hepatocitos o clulas de tipo hepatocito, opcionalmente modificados genticamente como se detalla anteriormente, para uso en terapia y/o el uso de los mismos para la fabricacin de un medicamento para el tratamiento de enfermedades hepticas. Dichas enfermedades pueden incluir trastornos que afectan al tejido heptico; las enfermedades que afectan a la viabilidad y/o funcin de hepatocitos estn contempladas especficamente y pueden representar, por ejemplo, errores congnitos, el efecto de una afeccin patolgica, el efecto de un traumatismo, efectos txicos, infecciones vricas, etc. Las enfermedades hepticas enumeradas en la presente memoria descriptiva se contemplan especficamente. La administracin de clulas segn la invencin</span>Accordingly, in one aspect adult progenitor cells or liver stem cells of the invention, cell lines thereof or cell populations comprising the same are provided (specifically mentioning, but not limited to, the LMBP 6452CB line) or progeny thereof including differentiated progeny, esp. hepatocytes or hepatocyte-type cells, optionally genetically modified as detailed above, for use in therapy and / or the use thereof for the manufacture of a medicament for the treatment of liver diseases. Such diseases may include disorders that affect liver tissue; diseases that affect the viability and / or function of hepatocytes are specifically contemplated and may represent, for example, congenital errors, the effect of a pathological condition, the effect of trauma, toxic effects, viral infections, etc. The liver diseases listed herein are specifically contemplated. The administration of cells according to the invention</span>
  </p>
  <p id="p00728" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00729" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00730" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00731" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00732" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00733" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00734" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00735" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00736" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00737" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00738" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00739" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">puede conducir a la reconstitucin o regeneracin de tejido en el sujeto. Las clulas se administran de manera que las permita injertarse en o migrar al sitio de tejido pretendido y reconstituir o regenerar el rea deficiente funcionalmente.</span>It can lead to reconstitution or regeneration of tissue in the subject. The cells are administered in a manner that allows them to graft into or migrate to the intended tissue site and reconstitute or regenerate the functionally deficient area.</span>
  </p>
  <p id="p00740" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Otro aspecto de la invencin es un procedimiento para prevenir y/o tratar una enfermedad heptica, que comprende la administracin de clulas progenitoras o clulas madre hepticas adultas de la invencin, lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque sin limitacin, la lnea LMBP 6452CB), o la progenie de los mismos, incluyendo la progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificados genticamente, a un sujeto, especialmente un ser humano, necesitado de dicho tratamiento. Dicha administracin es tpicamente en una cantidad teraputicamente eficaz, concretamente, en general una cantidad que proporcione un efecto y rendimiento local o sistmico deseado.</span>Another aspect of the invention is a method for preventing and / or treating a liver disease, which comprises the administration of progenitor cells or adult liver stem cells of the invention, cell lines thereof or cell populations comprising the same (specifically mentioning, although without limitation, the line LMBP 6452CB), or the progeny thereof, including the differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified, to a subject, especially a human being, in need of such treatment. Such administration is typically in a therapeutically effective amount, namely, in general an amount that provides a desired local or systemic effect and performance.</span>
  </p>
  <p id="p00741" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un aspecto adicional, la invencin se refiere a una composicin farmacutica que comprende las clulas progenitoras o clulas madre hepticas adultas de la invencin, lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque sin limitacin, la lnea LMBP 6452CB) o progenie de la misma incluyendo progenie diferenciada, esp. hepatocitos o clulas de tipo hepatocito, opcionalmente modificados como anteriormente.</span>In a further aspect, the invention relates to a pharmaceutical composition comprising the progenitor cells or adult liver stem cells of the invention, cell lines thereof or cell populations comprising the same (specifically mentioning, but not limited to, the LMBP line 6452CB) or progeny thereof including differentiated progeny, esp. hepatocytes or hepatocyte type cells, optionally modified as above.</span>
  </p>
  <p id="p00742" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A modo de ejemplo y no de limitacin, las clulas progenitoras o clulas madre hepticas adultas aisladas de la invencin, lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque sin limitacin, la lnea LMBP 6452CB), o la progenie de los mismos, puede administrarse ventajosamente mediante inyeccin (englobando tambin la administracin en catter) o implante, por ejemplo inyeccin localizada, inyeccin sistmica, inyeccin intraesplnica (vase tambin Gupta y col., Seminars in Liver Disease 12: 321, 1992), inyeccin en una vena porta, inyeccin en pulpa heptica, por ejemplo, detrs de la cpsula heptica, administracin parenteral o inyeccin intrauterina en un embrin o feto.</span>By way of example and not limitation, the progenitor cells or adult liver stem cells isolated from the invention, cell lines thereof or cell populations comprising the same (specifically mentioning, but not limited to, the LMBP 6452CB line), or progeny thereof, it can be advantageously administered by injection (also including catheter administration) or implant, for example localized injection, systemic injection, intrasplenic injection (see also Gupta et al., Seminars in Liver Disease 12: 321, 1992), portal vein injection, liver pulp injection, for example, behind the liver capsule, parenteral administration or intrauterine injection into an embryo or fetus.</span>
  </p>
  <p id="p00743" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin que las clulas progenitoras o clulas madre originadas en hgado de la invencin, las lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque por supuesto sin limitacin, la lnea LMBP 6452CB), la progenie de los mismos, opcionalmente modificados genticamente, pueden usarse para ingeniera de tejido y terapia celular mediante trasplante de clulas hepticas (TCH). El trasplante de clulas hepticas y el trasplante de clulas madre hepticas (TCBH) designan la tcnica de infusin de hepatocitos maduros o clulas progenitoras hepticas, incluyendo las clulas de la invencin, de cualquiera modo que conduzca al acceso e injerto heptico de las clulas, preferiblemente por la vena porta, pero tambin mediante inyeccin heptica directa, o mediante inyeccin intraesplnica.</span>The present specification also describes that the progenitor cells or liver-originated stem cells of the invention, the cell lines thereof or cell populations comprising the same (specifically mentioning, but of course without limitation, the LMBP 6452CB line), the progeny thereof, optionally genetically modified, can be used for tissue engineering and cell therapy by liver cell transplantation (TCH). Liver cell transplantation and liver stem cell transplantation (TCBH) designate the technique of infusion of mature hepatocytes or liver progenitor cells, including the cells of the invention, in any way that leads to access and liver grafting of the cells, preferably through the portal vein, but also by direct liver injection, or by intrasplenic injection.</span>
  </p>
  <p id="p00744" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por ejemplo, las clulas pueden proporcionarse en forma de suspensin celular en cualquier medio de conservacin, preferiblemente que contiene albmina humana, despus del procedimiento de aislamiento o despus de descongelar tras la crioconservacin.</span>For example, the cells can be provided in the form of a cell suspension in any preservation medium, preferably containing human albumin, after the isolation procedure or after thawing after cryopreservation.</span>
  </p>
  <p id="p00745" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En una realizacin, la presente invencin contempla usar el propio tejido heptico de un paciente para aislar las clulas progenitoras o clulas madre de la invencin. Dichas clulas seran autlogas del paciente y podran administrarse fcilmente al paciente. Adems, si el paciente contuviera un defecto gentico subyacente de una afeccin patolgica particular, dicho defecto podra evitarse mediante la manipulacin gentica de las clulas obtenidas.</span>In one embodiment, the present invention contemplates using a patient's own liver tissue to isolate the progenitor cells or stem cells of the invention. Such cells would be autologous to the patient and could easily be administered to the patient. In addition, if the patient contained an underlying genetic defect of a particular pathological condition, that defect could be avoided by genetic manipulation of the cells obtained.</span>
  </p>
  <p id="p00746" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En otra realizacin, las clulas progenitoras o clulas madre de la invencin pueden aislarse a partir de tejido que no es propio del paciente. Cuando se contempla la administracin de dichas clulas a un paciente, puede ser preferible que el tejido heptico sometido al procedimiento de la presente invencin para obtener las clulas progenitoras o clulas madres se seleccione de tal modo que se maximice, al menos dentro de los lmites conseguibles, la compatibilidad de tejido entre el paciente y las clulas administradas, reduciendo as la probabilidad de rechazo de las clulas administradas por el sistema inmunitario del paciente (por ejemplo, rechazo de injerto frente al hospedador).</span>In another embodiment, the progenitor cells or stem cells of the invention can be isolated from tissue that is not the patient's own. When the administration of said cells to a patient is contemplated, it may be preferable that the liver tissue subjected to the method of the present invention to obtain the progenitor cells or stem cells is selected so that it is maximized, at least within the achievable limits , tissue compatibility between the patient and the administered cells, thus reducing the likelihood of rejection of the cells administered by the patient's immune system (eg graft rejection against the host).</span>
  </p>
  <p id="p00747" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La capacidad del sistema inmunitario de diferenciar lo propio de lo ajeno est determinada en gran medida por los productos del complejo principal de histocompatibilidad (MHC), cuyos genes estn en el cromosoma 6 y pertenecen a la superfamilia gnica de las inmunoglobulinas. Los productos de MHC de clase I consisten en HLA-A, HLA-B y HLA-C; estos tienen una amplia distribucin y estn presentes en la superficie de esencialmente todas las clulas nucleadas y en plaquetas. Los productos de MHC de clase II consisten en HLA-D, HLA-DR, HLA-DP y HLA-DQ; tienen una distribucin ms limitada, incluyendo linfocitos B, macrfagos, clulas dendrticas, clulas de Langerhans y linfocitos T activados (pero no en reposo).</span>The ability of the immune system to differentiate itself from that of others is largely determined by the products of the main histocompatibility complex (MHC), whose genes are on chromosome 6 and belong to the gene superfamily of immunoglobulins. MHC class I products consist of HLA-A, HLA-B and HLA-C; these have a wide distribution and are present on the surface of essentially all nucleated cells and in platelets. MHC class II products consist of HLA-D, HLA-DR, HLA-DP and HLA-DQ; they have a more limited distribution, including B lymphocytes, macrophages, dendritic cells, Langerhans cells and activated T lymphocytes (but not at rest).</span>
  </p>
  <p id="p00748" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los loci de HLA son en general multiallicos, por ejemplo, usando anticuerpos especficos pueden reconocerse al menos 26 alelos HLA-A, 59 alelos HLA-B, 10 alelos HLA-C, 26 alelos HLA-D, 22 alelos HLA-DR, 9 alelos HLA-DQ y 6 alelos HLA-DP. Debido a que los loci de HLA estn estrechamente ligados, los antgenos de HLA pueden estar presentes tambin como haplotipos conservados.</span>HLA loci are generally multiallelic, for example, using specific antibodies, at least 26 HLA-A alleles, 59 HLA-B alleles, 10 HLA-C alleles, 26 HLA-D alleles, 22 HLA-DR alleles, 9 can be recognized HLA-DQ alleles and 6 HLA-DP alleles. Because HLA loci are closely linked, HLA antigens may also be present as conserved haplotypes.</span>
  </p>
  <p id="p00749" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00750" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00751" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00752" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00753" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00754" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00755" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00756" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00757" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00758" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00759" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00760" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">60</span>60</span>
  </p>
  <p id="p00761" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un sujeto necesitado de terapia con clulas de la presente invencin, puede cribarse la presencia de anticuerpos anti-HLA y de su genotipo y/o fenotipo de HLA (por ejemplo, en linfocitos, por ejemplo usando procedimientos serolgicos o anlisis de ADN gentico). En las clulas progenitoras o clulas madre obtenibles tal como se describen en la presente memoria, o el tejido heptico fuente o el donante del mismo, puede ensayarse tpicamente su fenotipo y/o genotipo de HLA y seleccionarse los tejidos o clulas adecuados para la administracin, que tienen haplotipos de HLA idnticos al paciente o que tienen la mayora de alelos antignicos de HLA comunes con el paciente y ninguno o una minora de los antgenos de HLA del paciente contienen anticuerpos anti-HLA preexistentes. La probabilidad de que las clulas trasplantadas se acepten exitosamente aumenta con el nmero de antgenos de HLA idnticos. Un experto entender las variaciones adicionales de estas consideraciones.</span>In a subject in need of cell therapy of the present invention, the presence of anti-HLA antibodies and their genotype and / or HLA phenotype can be screened (for example, in lymphocytes, for example using serological procedures or genetic DNA analysis) . In progenitor cells or stem cells obtainable as described herein, or the source liver tissue or donor thereof, their HLA phenotype and / or genotype can typically be tested and tissues or cells suitable for administration can be selected, who have HLA haplotypes identical to the patient or who have the majority of HLA antigen alleles common with the patient and none or a minority of the patient's HLA antigens contain pre-existing anti-HLA antibodies. The probability that the transplanted cells will be accepted successfully increases with the number of identical HLA antigens. An expert will understand the additional variations of these considerations.</span>
  </p>
  <p id="p00762" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se contemplan tambin otros modos de obtener un perfil de MHC parecido al del paciente, por ejemplo, la manipulacin gentica de las clulas progenitoras o clulas madre obtenidas de la invencin o la progenie de los mismos.</span>Other ways of obtaining an MHC profile similar to that of the patient are also contemplated, for example, the genetic manipulation of the progenitor cells or stem cells obtained from the invention or the progeny thereof.</span>
  </p>
  <p id="p00763" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Si las clulas derivan de una fuente heterloga (concretamente no autloga), puede administrarse tpicamente una terapia de inmunosupresin concomitante, por ejemplo, usando agentes inmunosupresores tales como ciclosporina o tacrolims (FK506). Como alternativa, las clulas pueden encapsularse en una membrana que permite el intercambio de fluidos pero previene el contacto clula/clula. Es conocido en la tcnica el trasplante de clulas microencapsuladas, por ejemplo, Balladur y col., 1995, Surgery 117: 189-194; y Dixit y col., 1992, Cell Transplantation 1: 275-279. Preferiblemente, las clulas pueden ser autlogas o exhibir una coincidencia estrecha de HLA como se explica.</span>If the cells are derived from a heterologous (specifically non-autologous) source, concomitant immunosuppression therapy can typically be administered, for example, using immunosuppressive agents such as cyclosporine or tacrolimus (FK506). Alternatively, cells can be encapsulated in a membrane that allows fluid exchange but prevents cell / cell contact. Transplantation of microencapsulated cells is known in the art, for example, Balladur et al., 1995, Surgery 117: 189-194; and Dixit et al., 1992, Cell Transplantation 1: 275-279. Preferably, the cells can be autologous or exhibit a close coincidence of HLA as explained.</span>
  </p>
  <p id="p00764" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En un ejemplo, el hgado adulto o parte del mismo es de un sujeto animal no humano, preferiblemente un sujeto mamfero no humano. Las clulas progenitoras o clulas madre, o lneas celulares o progenie de las mismas, derivados tal como se describe en la presente memoria de hgados de sujetos animales no humanos o mamferos no humanos, pueden usarse ventajosamente, por ejemplo, en investigacin y en la terapia de enfermedades hepticas en miembros de la misma especie, relacionada u otra animal no humana o de mamfero no humano, o incluso en la terapia de pacientes humanos que padecen enfermedades hepticas (por ejemplo, xenotrasplante, dispositivos hepticos bioartificiales que comprenden clulas animales no humanas o de mamferos no humanos). A modo de ejemplo y no de limitacin, las clulas de mamfero no humano particularmente adecuadas para uso en terapia humana pueden originarse en cerdos.</span>In one example, the adult liver or part thereof is of a non-human animal subject, preferably a non-human mammalian subject. Progenitor cells or stem cells, or cell lines or progeny thereof, derivatives as described herein of livers of non-human animal or non-human mammalian subjects, can be advantageously used, for example, in research and therapy. of liver diseases in members of the same species, related or other non-human or non-human mammalian animal, or even in the therapy of human patients suffering from liver diseases (e.g., xenotransplantation, bioartificial liver devices comprising non-human animal cells or of non-human mammals). By way of example and not limitation, non-human mammalian cells particularly suitable for use in human therapy can originate in pigs.</span>
  </p>
  <p id="p00765" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Es un problema referente al uso teraputico de las clulas progenitoras o clulas madre de la invencin la cantidad de clulas necesarias para conseguir un efecto ptimo. Las dosis para administracin pueden ser variables, y pueden incluir una administracin inicial seguida de administraciones posteriores; y pueden determinarse por el experto dotado de la presente divulgacin. Tpicamente, la o las dosis administradas proporcionarn una cantidad teraputicamente eficaz de clulas, concretamente, una que consiga el efecto y rendimiento local o sistmico deseado.</span>It is a problem concerning the therapeutic use of the progenitor cells or stem cells of the invention the amount of cells necessary to achieve an optimal effect. Doses for administration may be variable, and may include an initial administration followed by subsequent administrations; and can be determined by the expert endowed with the present disclosure. Typically, the dose (s) administered will provide a therapeutically effective amount of cells, namely, one that achieves the desired local or systemic effect and performance.</span>
  </p>
  <p id="p00766" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En estudios humanos actuales de clulas de mdula sea mononucleares autlogas, se han usado dosis empricas en el intervalo de 1 a 4 x 107 clulas con resultados alentadores. Sin embargo, diferentes situaciones pueden requerir la optimizacin de la cantidad de clulas administradas. Por tanto, la cantidad de clulas que se van a administrar variar con el sujeto que se est tratando. En una realizacin preferida, pueden administrarse a un sujeto humano entre 102 y 109, o entre 103 y 109, o entre 104 y 109, tal como entre 104 y 108, o entre 105 y 107, por ejemplo,</span>In current human studies of autologous mononuclear bone marrow cells, empirical doses in the range of 1 to 4 x 10 7 cells have been used with encouraging results. However, different situations may require optimization of the amount of cells administered. Therefore, the amount of cells to be administered will vary with the subject being treated. In a preferred embodiment, they can be administered to a human subject between 102 and 109, or between 103 and 109, or between 104 and 109, such as between 104 and 108, or between 105 and 107, for example,</span>
  </p>
  <p id="p00767" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aproximadamente 1x105, aproximadamente 5x105, aproximadamente 1x106 aproximadamente 5x106,</span>about 1x105, about 5x105, about 1x106 about 5x106,</span>
  </p>
  <p id="p00768" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aproximadamente 1x107, o aproximadamente 2x107, aproximadamente 3x107, aproximadamente 4x107, aproximadamente 5x107, aproximadamente 6x107, aproximadamente 7x107, aproximadamente 8x107,</span>about 1x107, or about 2x107, about 3x107, about 4x107, about 5x107, about 6x107, about 7x107, about 8x107,</span>
  </p>
  <p id="p00769" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aproximadamente 9x107, o aproximadamente 1x108 clulas. Sin embargo, la determinacin precisa de una dosis teraputicamente eficaz puede estar basada en factores individuales de cada paciente, incluyendo su tamao, edad, tamao de la lesin de tejido y periodo de tiempo desde que ocurri la lesin, y puede determinarse fcilmente por los expertos en la tcnica a partir de esta divulgacin y el conocimiento de la tcnica.</span>about 9x107, or about 1x108 cells. However, the precise determination of a therapeutically effective dose may be based on individual factors of each patient, including their size, age, tissue lesion size and period of time since the injury occurred, and can easily be determined by experts. in the technique from this disclosure and knowledge of the technique.</span>
  </p>
  <p id="p00770" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Preferiblemente, la pureza de una poblacin celular que comprende las clulas progenitoras o clulas madre de la invencin para administracin puede ser de aproximadamente 50 a aproximadamente 55%, de aproximadamente 55 a aproximadamente 60%, y de aproximadamente 65 a aproximadamente 70%. Ms preferiblemente, la pureza puede ser de aproximadamente 70 a aproximadamente 75%, de aproximadamente 75 a aproximadamente 80%, de aproximadamente 80 a aproximadamente 85%; y lo ms preferiblemente la pureza puede ser de aproximadamente 85 a aproximadamente 90%, de aproximadamente 90 a aproximadamente 95% y de aproximadamente 95 a aproximadamente 100%. La pureza de las clulas madre puede determinarse, por ejemplo, segn el perfil de marcadores de superficie celular en una poblacin celular. Las dosificaciones pueden ajustarse fcilmente por los expertos en la tcnica (por ejemplo, una menor pureza puede requerir un aumento de la dosificacin).</span>Preferably, the purity of a cell population comprising the progenitor cells or stem cells of the invention for administration may be from about 50 to about 55%, from about 55 to about 60%, and from about 65 to about 70%. More preferably, the purity may be from about 70 to about 75%, from about 75 to about 80%, from about 80 to about 85%; and most preferably the purity can be from about 85 to about 90%, from about 90 to about 95% and from about 95 to about 100%. The purity of the stem cells can be determined, for example, according to the profile of cell surface markers in a cell population. Dosages can be easily adjusted by those skilled in the art (for example, lower purity may require an increase in dosage).</span>
  </p>
  <p id="p00771" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El experto puede determinar fcilmente la cantidad de clulas y aditivos, vehculos y/o portadores opcionales en las composiciones que se van a administrar en los procedimientos tal como se describen en la presente memoria. Tpicamente, puede estar presente cualquier aditivo (adems de las clulas progenitoras o clulas madre y/o citocinas) en una cantidad de disolucin de 0,001 a 50% (p/p o p/v) en disolucin salina tamponada con fosfato, y el ingrediente activo puede estar tpicamente presente del orden de microgramos a miligramos, tal como de</span>The expert can easily determine the amount of cells and optional additives, vehicles and / or carriers in the compositions to be administered in the procedures as described herein. Typically, any additive (in addition to the progenitor cells or stem cells and / or cytokines) may be present in a solution amount of 0.001 to 50% (w / pop / v) in phosphate buffered saline, and the active ingredient may be typically present on the order of micrograms to milligrams, such as from</span>
  </p>
  <p id="p00772" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00773" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00774" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00775" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00776" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00777" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00778" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00779" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00780" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00781" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00782" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00783" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aproximadamente 0,0001 a aproximadamente 5% (p/p o p/v), preferiblemente de aproximadamente 0,0001 a aproximadamente 1%, lo ms preferiblemente de aproximadamente 0,0001 a aproximadamente 0,05%, o de aproximadamente 0,001 a aproximadamente 20%, preferiblemente de aproximadamente 0,01 a aproximadamente 10%, y lo ms preferiblemente de aproximadamente 0,05 a aproximadamente 5%.</span>about 0.0001 to about 5% (w / pop / v), preferably from about 0.0001 to about 1%, most preferably from about 0.0001 to about 0.05%, or from about 0.001 to about 20% , preferably from about 0.01 to about 10%, and most preferably from about 0.05 to about 5%.</span>
  </p>
  <p id="p00784" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cuando se administra una composicin teraputica tal como se describe en la presente memoria, puede formularse en general en una forma de dosificacin unitaria inyectable (por ejemplo, disolucin, suspensin, dispersin o emulsin). Las formulaciones farmacuticas adecuadas para inyeccin incluyen disoluciones y dispersiones acuosas estriles. Como se usan en la presente memoria, las disoluciones o dispersiones incluyen un portador o diluyente farmacuticamente aceptable en que las clulas de la invencin permanecen viables. El portador puede ser un disolvente o medio de dispersin farmacuticamente aceptable que contiene, por ejemplo, agua, disolucin salina, disolucin salina tamponada con fosfato, poliol (por ejemplo, glicerol, propilenglicol, polietilenglicol lquido y similares) y mezclas adecuadas de los mismos.</span>When a therapeutic composition is administered as described herein, it can be formulated in general in an injectable unit dosage form (eg, solution, suspension, dispersion or emulsion). Pharmaceutical formulations suitable for injection include sterile aqueous solutions and dispersions. As used herein, the solutions or dispersions include a pharmaceutically acceptable carrier or diluent in which the cells of the invention remain viable. The carrier can be a pharmaceutically acceptable solvent or dispersion medium containing, for example, water, saline, phosphate buffered saline, polyol (eg, glycerol, propylene glycol, liquid polyethylene glycol and the like) and suitable mixtures thereof.</span>
  </p>
  <p id="p00785" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adicionalmente, pueden aadirse diversos aditivos que potencian la estabilidad, esterilidad e isotonicidad de las composiciones, incluyendo conservantes antimicrobianos, antioxidantes, agentes quelantes y tampones. Puede asegurase la prevencin de la accin de microorganismos mediante diversos agentes antibacterianos y antifngicos, por ejemplo, parabenos, clorobutanol, fenol, cido srbico y similares.</span>Additionally, various additives that enhance the stability, sterility and isotonicity of the compositions, including antimicrobial preservatives, antioxidants, chelating agents and buffers, can be added. The prevention of the action of microorganisms can be ensured by various antibacterial and antifungal agents, for example, parabens, chlorobutanol, phenol, sorbic acid and the like.</span>
  </p>
  <p id="p00786" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">En muchos casos, ser deseable incluir agentes isotnicos para asegurar la viabilidad de las clulas, por ejemplo, azcares, cloruro de sodio y similares. La isotonicidad deseada de las composiciones tal como se describen en la presente memoria puede lograrse usando cloruro de sodio u otros agentes farmacuticamente aceptables tales como dextrosa, cido brico, tartrato de sodio, propilenglicol u otros solutos inorgnicos u orgnicos. El cloruro de sodio se prefiere particularmente para tampones que contienen iones de sodio.</span>In many cases, it will be desirable to include isotonic agents to ensure the viability of the cells, for example, sugars, sodium chloride and the like. The desired isotonicity of the compositions as described herein can be achieved using sodium chloride or other pharmaceutically acceptable agents such as dextrose, boric acid, sodium tartrate, propylene glycol or other inorganic or organic solutes. Sodium chloride is particularly preferred for buffers containing sodium ions.</span>
  </p>
  <p id="p00787" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para aumentar potencialmente la supervivencia celular cuando se introducen las clulas progenitoras o clulas madre o la progenie diferenciada de inters de los mismos en un sujeto necesitado de ello, pueden incorporarse dichas clulas en un biopolmero o polmero sinttico. Los ejemplos de biopolmeros adecuados incluyen, pero sin limitacin, fibronectina, fibrina, fibringeno, trombina, colgeno y proteoglicanos. Esto podra realizarse con o sin citocinas, factores de crecimiento, factores de diferenciacin o construcciones de expresin de cido nucleico, etc., incluidos. Dichos biopolmeros podran estar, por ejemplo, en suspensin o podran formar un gel tridimensional con las clulas embebidas en el mismo. Dichos polmeros pueden ser preferiblemente biodegradables.</span>To potentially increase cell survival when the progenitor cells or stem cells or the differentiated progeny of interest are introduced into a subject in need thereof, said cells can be incorporated into a synthetic biopolymer or polymer. Examples of suitable biopolymers include, but are not limited to, fibronectin, fibrin, fibrinogen, thrombin, collagen and proteoglycans. This could be done with or without cytokines, growth factors, differentiation factors or nucleic acid expression constructs, etc., included. Such biopolymers could be, for example, in suspension or they could form a three-dimensional gel with the cells embedded therein. Said polymers may preferably be biodegradable.</span>
  </p>
  <p id="p00788" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Puede causarse una absorcin prolongada de la forma farmacutica inyectable mediante el uso de agentes que retarden la absorcin, por ejemplo, monoestearato de aluminio y gelatina. Sin embargo, segn la presente memoria descriptiva, cualquier vehculo, diluyente o aditivo usado tendra que ser compatible con las clulas progenitoras o clulas madre.</span>Prolonged absorption of the injectable pharmaceutical form can be caused by the use of agents that delay absorption, for example, aluminum monostearate and gelatin. However, according to the present specification, any vehicle, diluent or additive used would have to be compatible with the progenitor cells or stem cells.</span>
  </p>
  <p id="p00789" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pueden prepararse disoluciones inyectables estriles incorporando las clulas utilizadas en la prctica de la presente invencin en la cantidad necesaria de disolvente apropiado con diversas cantidades de los dems ingredientes, segn se desee.</span>Sterile injectable solutions can be prepared by incorporating the cells used in the practice of the present invention in the necessary amount of appropriate solvent with various amounts of the other ingredients, as desired.</span>
  </p>
  <p id="p00790" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Dichas composiciones pueden estar adicionalmente mezclados con un portador, diluyente o excipiente adecuado tal como agua estril, disolucin salina fisiolgica, glucosa, dextrosa o similares. Las composiciones pueden contener sustancias auxiliares tales como agentes de humectacin o emulsionantes, agentes tamponadores del pH, aditivos potenciadores de la gelificacin o viscosidad, conservante, agentes aromatizantes, colorantes y similares, dependiendo de la va de administracin y de la preparacin deseadas.</span>Said compositions may be further mixed with a suitable carrier, diluent or excipient such as sterile water, physiological saline, glucose, dextrose or the like. The compositions may contain auxiliary substances such as wetting agents or emulsifiers, pH buffering agents, gelling or viscosity enhancing additives, preservative, flavoring agents, colorants and the like, depending on the desired route of administration and preparation.</span>
  </p>
  <p id="p00791" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pueden consultarse textos estndares tales como Remington's Pharmaceutical Science, 17a edicin, 1985, incorporado a la presente memoria como referencia, para preparar preparaciones adecuadas sin experimentacin indebida.</span>Standard texts such as "Remington's Pharmaceutical Science", 17th edition, 1985, incorporated herein by reference, may be consulted to prepare suitable preparations without undue experimentation.</span>
  </p>
  <p id="p00792" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Puede mantenerse la viscosidad de las composiciones al nivel seleccionado, si se desea, usando un agente espesante farmacuticamente aceptable. Se prefiere metilcelulosa porque est disponible fcil y econmicamente y es fcil de trabajar. Otros agentes espesantes adecuados incluyen, por ejemplo, goma xantana, carboximetilcelulosa, hidroxipropilcelulosa, carbmero y similares. La concentracin preferida de espesante depender del agente seleccionado. La cuestin es usar una cantidad que consiga la viscosidad seleccionada. Las composiciones viscosas se preparan normalmente a partir de disoluciones mediante la adicin de dichos agentes espesantes.</span>The viscosity of the compositions can be maintained at the selected level, if desired, using a pharmaceutically acceptable thickening agent. Methyl cellulose is preferred because it is available easily and economically and is easy to work. Other suitable thickening agents include, for example, xanthan gum, carboxymethyl cellulose, hydroxypropyl cellulose, carbomer and the like. The preferred concentration of thickener will depend on the agent selected. The question is to use an amount that achieves the selected viscosity. The viscous compositions are usually prepared from solutions by the addition of said thickening agents.</span>
  </p>
  <p id="p00793" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Usos adicionales de las clulas progenitoras o clulas madre de la invencin</span>Additional uses of the progenitor cells or stem cells of the invention</span>
  </p>
  <p id="p00794" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se contemplan a continuacin los usos adicionales de las clulas progenitoras o clulas madre de la invencin, de las lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque sin limitacin la lnea LMBP 6452CB), o la progenie de los mismos incluyendo la progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, opcionalmente modificados genticamente.</span>The additional uses of the progenitor cells or stem cells of the invention, of the cell lines thereof or cell populations comprising them (specifically mentioning, but not limited to the LMBP 6452CB line), or the progeny of themselves including the differentiated progeny, especially hepatocytes or hepatocyte-type cells, optionally genetically modified.</span>
  </p>
  <p id="p00795" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por tanto, las clulas progenitoras o clulas madre o derivadas diferenciadas de las mismas, especialmente</span>Therefore, the progenitor cells or stem cells or differentiated derivatives thereof, especially</span>
  </p>
  <p id="p00796" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00797" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00798" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00799" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00800" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00801" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00802" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00803" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00804" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00805" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00806" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00807" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">hepatocitos o clulas de tipo hepatocito, pueden usarse para detectar respuestas celulares (por ejemplo toxicidad) ante agentes bioactivos (biolgicos o farmacolgicos), lo que comprende poner en contacto un cultivo de clulas, o de los derivados diferenciados de las mismas, con uno o ms agentes biolgicos o farmacolgicos, identificar una o ms respuestas celulares ante el uno o ms agentes biolgicos o farmacolgicos y comparar las respuestas celulares de los cultivos celulares con las respuestas celulares de los cultivos de control. Dichas respuestas pueden determinarse controlando las actividades de molculas tales como, pero sin limitacin, fosfatasa alcalina, citocromo P450 y enzimas de la ruta de la urea, entre otras.</span>hepatocytes or hepatocyte-like cells, can be used to detect cellular responses (eg toxicity) to bioactive agents (biological or pharmacological), which comprises contacting a culture of cells, or of the differentiated derivatives thereof, with one or more biological or pharmacological agents, identify one or more cellular responses to the one or more biological or pharmacological agents and compare the cellular responses of the cell cultures with the cellular responses of the control cultures. Such responses can be determined by controlling the activities of molecules such as, but not limited to, alkaline phosphatase, cytochrome P450 and urea pathway enzymes, among others.</span>
  </p>
  <p id="p00808" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adems, pueden cribarse citocinas, quimiocinas, composiciones farmacuticas y factores de crecimiento, por ejemplo, usando las clulas progenitoras o clulas madre de la invencin o derivados diferenciados de los mismos, especialmente hepatocitos o clulas de tipo hepatocito, para elucidar ms claramente sus efectos sobre la diferenciacin y funcin de dichas clulas.</span>In addition, cytokines, chemokines, pharmaceutical compositions and growth factors can be screened, for example, using the progenitor cells or stem cells of the invention or differentiated derivatives thereof, especially hepatocytes or hepatocyte-like cells, to elucidate more clearly their effects on the differentiation and function of said cells.</span>
  </p>
  <p id="p00809" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La presente memoria descriptiva describe tambin un rgano modificado por ingeniera de tejido, o porcin o seccin especfica del mismo, un dispositivo modificado por ingeniera de tejido que comprende un tejido de inters y, opcionalmente, citocinas, factores de crecimiento o factores de diferenciacin, en el que las clulas de la invencin se usan para generar tejidos, especialmente tejido heptico, especialmente tejidos que comprenden hepatocitos. Los rganos modificados por ingeniera de tejido pueden usarse con un armazn biocompatible para apoyar el crecimiento celular en una configuracin tridimensional, que puede ser biodegradable. Los rganos modificados por ingeniera de tejido generados a partir de los clulas madre de la presente invencin pueden implantarse en un sujeto necesitado de un rgano de reemplazo, una porcin o seccin especfica del mismo. La presente memoria descriptiva describe tambin el uso de los clulas madre o clulas diferenciadas a partir de los mismos como parte de un biorreactor, por ejemplo, un dispositivo auxiliar heptico.</span>The present specification also describes an organ modified by tissue engineering, or specific portion or section thereof, a device modified by tissue engineering comprising a tissue of interest and, optionally, cytokines, growth factors or differentiation factors, in which cells of the invention are used to generate tissues, especially liver tissue, especially tissues comprising hepatocytes. Tissue-engineered organs can be used with a biocompatible framework to support cell growth in a three-dimensional configuration, which can be biodegradable. Tissue-engineered organs generated from the stem cells of the present invention can be implanted in a subject in need of a replacement organ, a specific portion or section thereof. The present specification also describes the use of stem cells or differentiated cells therefrom as part of a bioreactor, for example, a hepatic auxiliary device.</span>
  </p>
  <p id="p00810" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los rganos, porciones o secciones derivadas de los clulas madre de la invencin pueden implantarse en un hospedador. El trasplante puede ser autlogo, de tal modo que el donante de los clulas madre de los que deriva el rgano o unidades de rgano es el receptor del tejido modificado por ingeniera. El trasplante puede ser heterlogo, de tal modo que el donante de las clulas madre de los que deriva el rgano o unidades de rgano no es el receptor del tejido modificado por ingeniera. Una vez transferidos al hospedador, los rganos modificados por ingeniera de tejido pueden reasumir la arquitectura y funcin del tejido hospedador nativo. Los rganos modificados por ingeniera de tejido beneficiarn a sujetos en una amplia variedad de aplicaciones, incluyendo el tratamiento de cncer y otras enfermedades dadas a conocer en la presente memoria, defectos congnitos o lesin debida a extirpacin quirrgica.</span>The organs, portions or sections derived from the stem cells of the invention can be implanted in a host. The transplant can be autologous, such that the donor of the stem cells from which the organ or organ units is derived is the recipient of the engine-modified tissue. The transplant can be heterologous, such that the donor of the stem cells from which the organ or organ units are derived is not the engineered tissue receptor. Once transferred to the host, tissue-engineered organs can resume the architecture and function of the native host tissue. Tissue-modified organs will benefit subjects in a wide variety of applications, including the treatment of cancer and other diseases disclosed herein, congenital defects or injury due to surgical excision.</span>
  </p>
  <p id="p00811" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como herramienta para el ensayo y desarrollo de frmacos, las clulas hepticas y su progenie podran usarse para valorar cambios en los patrones de expresin gnica causados por frmacos en consideracin para desarrollo. Los cambios en el patrn de expresin gnica de frmacos potenciales podran compararse con los causados por frmacos conocidos por afectar al hgado. Esto permitira a una compaa farmacutica cribar en compuestos su efecto sobre el hgado ms temprano en el proceso de desarrollo, ahorrando tiempo y dinero. Tambin podra usarse el linaje completo de las clulas hepticas, desde progenitoras a clulas maduras, para ensayar la toxicidad heptica de frmacos y para estudiar cmo se metaboliza el frmaco. Actualmente, las compaas farmacuticas tienen dificultades para obtener un suministro consistente de clulas hepticas para ensayos de toxicidad. Los procedimientos y clulas de la presente invencin responden a esta necesidad.</span>As a tool for drug testing and development, liver cells and their progeny could be used to assess changes in gene expression patterns caused by drugs under consideration for development. Changes in the gene expression pattern of potential drugs could be compared with those caused by drugs known to affect the liver. This would allow a pharmaceutical company to screen in compounds its effect on the liver earlier in the development process, saving time and money. The complete lineage of liver cells, from progenitors to mature cells, could also be used to test the liver toxicity of drugs and to study how the drug is metabolized. Currently, pharmaceutical companies have difficulty obtaining a consistent supply of liver cells for toxicity tests. The methods and cells of the present invention respond to this need.</span>
  </p>
  <p id="p00812" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Adicionalmente, las clulas progenitoras o clulas madre de hgado adulto de la invencin, o la progenie de los mismos incluyendo progenie diferenciada, especialmente hepatocitos o clulas de tipo hepatocito, son tiles como componentes biolgicos de dispositivos de detoxificacin tales como dispositivos de perfusin heptica o auxiliares hepticos.</span>Additionally, the progenitor cells or adult liver stem cells of the invention, or the progeny thereof including differentiated progeny, especially hepatocytes or hepatocyte-like cells, are useful as biological components of detoxification devices such as hepatic or auxiliary perfusion devices. Hepatic</span>
  </p>
  <p id="p00813" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un dispositivo auxiliar heptico convencional incluye una cubierta externa de plstico rgido y fibras huecas de membrana semipermeable en que se siembran clulas madre o hepatocitos diferenciados o derivados de los clulas madre. Las fibras pueden tratarse con colgeno, lecitina, laminina o fibronectina para la unin de clulas o dejarse sin tratar. Se perfunde fluido corporal a travs del dispositivo para detoxificacin segn procedimientos bien conocidos y se devuelve entonces al paciente. Se describe un ejemplo de un DAH adecuado para las clulas de la presente invencin en la publicacin de patente internacional n de serie PCT US00/15524.</span>A conventional hepatic auxiliary device includes an outer shell of rigid plastic and hollow semipermeable membrane fibers in which stem cells or differentiated hepatocytes or stem cell derivatives are sown. The fibers can be treated with collagen, lecithin, laminin or fibronectin for cell binding or left untreated. Body fluid is perfused through the detoxification device according to well known procedures and then returned to the patient. An example of a DAH suitable for the cells of the present invention is described in International Patent Publication Serial No. PCT US00 / 15524.</span>
  </p>
  <p id="p00814" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las clulas progenitoras o clulas madre hepticas adultas de la invencin o la progenie de los mismos pueden diferenciarse in vitro y usarse adicionalmente en lugar de hepatocitos maduros en ADMET (administracin, distribucin, metabolismo, eliminacin y toxicologa) o ensayos de citotoxicidad.</span>The adult liver progenitor cells or stem cells of the invention or the progeny thereof can be differentiated in vitro and additionally used instead of mature hepatocytes in "ADMET" (administration, distribution, metabolism, elimination and toxicology) or cytotoxicity assays.</span>
  </p>
  <p id="p00815" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Los hepatocitos o clulas de tipo hepatocito obtenidas mediante diferenciacin de las clulas progenitoras o clulas madre hepticas adultas de la invencin, o la progenie de los mismos, pueden proporcionar un modelo in vitro para el estudio del desarrollo heptico, el metabolismo de clulas hepticas o la biologa de clulas hepticas; y para cribar molculas en diferenciacin, proliferativas o txicas. Contemplada adicionalmente la manipulacin gentica de dichas clulas, pueden usarse para estudiar genes implicados en el desarrollo heptico, el metabolismo o la biologa de clulas hepticas.</span>The hepatocytes or hepatocyte-like cells obtained by differentiation of the progenitor cells or adult liver stem cells of the invention, or the progeny thereof, can provide an in vitro model for the study of liver development, liver cell metabolism or liver cell biology; and to screen differentiated, proliferative or toxic molecules. Further contemplated the genetic manipulation of said cells, they can be used to study genes involved in liver development, metabolism or liver cell biology.</span>
  </p>
  <p id="p00816" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00817" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00818" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00819" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00820" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00821" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00822" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00823" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00824" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00825" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00826" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">55</span>55</span>
  </p>
  <p id="p00827" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ejemplo 1</span>Example 1</span>
  </p>
  <p id="p00828" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento de aislamiento de clulas hepticas</span>Liver cell isolation procedure</span>
  </p>
  <p id="p00829" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se obtuvieron clulas hepticas humanas a partir de hgado completo o segmentos de hgado originarios de donantes sanos fallecidos o sin latido cardiaco. Se aislaron las clulas despus de un tiempo de pinzamiento (por ejemplo, despus de entre 6 y 12 horas de tiempo de pinzamiento) mientras los hgados se mantenan en hielo en medio de la Universidad de Wisconsin hasta la perfusin. Se aislaron los hepatocitos usando una tcnica de perfusin en dos etapas clsica {Seglen, 1976}, {Stephenne, 2005}. Se perfundi secuencialmente tejido heptico por los vasos sanguneos aparentes con una disolucin de EGTA (disolucin salina equilibrada de Earl sin Ca++ y Mg++, EGTA 0,5 mM, Hepes 5 mM, gentamicina 2 mg/l y 100.000 UI/l de penicilina G) y una disolucin de enzima de digestin durante 9 a 12 horas, cada una a 37C. La disolucin de digestin (EBSS con Ca++ y Mg++, Hepes 5 mM, gentamicina 2 mg/l y 100.000 UI/l de penicilina G) inclua colagenasa P 0,9 mg/ml e inhibidor de tripsina de soja 0,03 mg/ml. Se realiz una incisin de la cpsula heptica y se liberaron los hepatocitos mediante agitacin suave. Se detuvo la digestin con medio de lavado enfriado con hielo (medio M199, Hepes 5 mM, gentamicina 2 mg/l y 100.000 UI/l de penicilina G) que contena inhibidor de tripsina de soja 0,03 mg/ml y plasma humano 100 ml/l. Se filtraron las clulas y se aclararon a travs de 4 tamices metlicos de respectivamente 4,5 mm, 1 mm, 0,5 mm y 0,25 mm de tamao de poro. Se lavaron las clulas 3 veces mediante centrifugacin a 1200 rpm durante 3 minutos en un medio de lavado M199 fro.</span>Human liver cells were obtained from whole liver or liver segments originating from deceased healthy donors or without heartbeat. The cells were isolated after a clamping time (for example, after 6 to 12 hours of clamping time) while the livers were kept on ice in the middle of the University of Wisconsin until perfusion. Hepatocytes were isolated using a classical two-stage perfusion technique {Seglen, 1976}, {Stephenne, 2005}. Hepatic tissue was sequentially perfused by the apparent blood vessels with a solution of EGTA (Earl balanced saline solution without Ca ++ and Mg ++, 0.5 mM EGTA, 5 mM Hepes, 2 mg / L gentamicin and 100,000 IU / L of penicillin G) and a digestion enzyme solution for 9 to 12 hours, each at 37  C. The digestion solution (EBSS with Ca ++ and Mg ++, 5 mM Hepes, 2 mg / l gentamicin and 100,000 IU / l penicillin G) included collagenase P 0.9 mg / ml and soy trypsin inhibitor 0.03 mg / ml. An incision of the hepatic capsule was made and hepatocytes were released by gentle agitation. Digestion was stopped with ice-cold washing medium (M199 medium, 5 mM Hepes, 2 mg / l gentamicin and 100,000 IU / l penicillin G) containing 0.03 mg / ml soy trypsin inhibitor and 100 ml human plasma / l. The cells were filtered and rinsed through 4 metal sieves respectively 4.5 mm, 1 mm, 0.5 mm and 0.25 mm pore size. The cells were washed 3 times by centrifugation at 1200 rpm for 3 minutes in a cold M199 wash medium.</span>
  </p>
  <p id="p00830" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cultivo de clulas primarias</span>Primary cell culture</span>
  </p>
  <p id="p00831" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se resuspendieron suspensiones de clulas nicas en medio E de Williams (Invitrogen) complementado con suero de ternera fetal (FCS) al 10% (Perbio, Hyclone), EGF 25 ng/ml (Peprotech), insulina 10 |ig/ml, dexametasona 1 |iM y 1% de penicilina/estreptomicina (P/S) (Invitrogen). Se sembraron las clulas en matraces o placas recubiertos con colgeno I de cola de rata (BD Biosciences) (por ejemplo placas de 6 pocillos) (Greiner Bio-one) y se cultivaron a 37C en una atmsfera totalmente humidificada que contena 5% de CO2. Despus de 24 horas, se cambi el medio para eliminar las clulas no adherentes y despus de ello se renov cada tres das. Durante dos semanas, se sigui el cultivo microscpicamente cada da y se analiz el medio de cultivo cada tres das. Se cambi entonces el medio de cultivo a DMEM con concentraciones altas de glucosa (Invitrogen) complementado con 10% de FCS (Perbio, Hyclone) y 1% de P/S (Invitrogen) para acelerar la eliminacin de hepatocitos adultos. Emergi entonces espontneamente un tipo de clula con morfologa de tipo mesenquimtica, prolifer y rellen el espacio vaco en la placa de pocillos, como se confirma mediante microscopa de contraste de fases. Estas clulas aparecieron entre el da 15 y 20 del cultivo y presentaban una forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos (figura 1). Al alcanzar un 70% de confluencia, se sacaron las clulas con 0,25% de tripsina y EDTA 1 mM y se resembraron a la concentracin deseada. El anlisis de la suspensin celular usando citometra de flujo mostr que la poblacin se volva homognea despus del pase 2. Para cada pase, se analiz la suspensin celular tambin usando PCT-TI e inmunofluorescencia.</span>Single cell suspensions were resuspended in Williams E medium (Invitrogen) supplemented with 10% fetal calf serum (FCS) (Perbio, Hyclone), 25 ng / ml EGF (Peprotech), 10 | ig / ml insulin, dexamethasone 1 | iM and 1% penicillin / streptomycin (P / S) (Invitrogen). The cells were seeded in flasks or plates coated with rat tail collagen I (BD Biosciences) (eg 6-well plates) (Greiner Bio-one) and grown at 37  C in a fully humidified atmosphere containing 5% of CO2. After 24 hours, the medium was changed to remove non-adherent cells and after that it was renewed every three days. For two weeks, the culture was followed microscopically every day and the culture medium was analyzed every three days. The culture medium was then changed to DMEM with high glucose concentrations (Invitrogen) supplemented with 10% FCS (Perbio, Hyclone) and 1% P / S (Invitrogen) to accelerate the elimination of adult hepatocytes. A type of cell with mesenchymal type morphology then spontaneously emerged, proliferating and filling the empty space in the well plate, as confirmed by phase contrast microscopy. These cells appeared between day 15 and 20 of the culture and presented a flattened shape, wide cytoplasm and ovoid nuclei with one or two nucleoli (Figure 1). Upon reaching 70% confluence, the cells were removed with 0.25% trypsin and 1 mM EDTA and reseeded at the desired concentration. Analysis of the cell suspension using flow cytometry showed that the population became homogeneous after pass 2. For each pass, the cell suspension was also analyzed using PCT-TI and immunofluorescence.</span>
  </p>
  <p id="p00832" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Caracterizacin de las clulas</span>Characterization of the cells</span>
  </p>
  <p id="p00833" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para evitar la posible contaminacin por otros tipos de clula, se efectu la inmunohistoqumica para estudiar el fenotipo de estas clulas. Debido a su origen heptico, se ha analizado la expresin de marcadores especficos tales como albmina en clulas fijadas con paraformaldehdo. Como se muestra en la figura 2, se detect albmina, que se expresa exclusivamente en hepatocitos, usando tanto anticuerpos monoclonales (clon HAS-111 de Sigma) como policlonales (Chemicon). En paralelo, se ha evaluado tambin la expresin de marcadores de clulas mesenquimales, demostrando que estas clulas son inmunopositivas de vimentina y a-actina de msculo liso (figura 2). Hasta ahora, las caractersticas fenotpicas se han estudiado durante 7 pases con gran estabilidad.</span>To avoid possible contamination by other cell types, immunohistochemistry was performed to study the phenotype of these cells. Due to its hepatic origin, the expression of specific markers such as albumin in cells fixed with paraformaldehyde has been analyzed. As shown in Figure 2, albumin was detected, which is expressed exclusively in hepatocytes, using both monoclonal antibodies (Sigma HAS-111 clone) and polyclonal (Chemicon). In parallel, the expression of mesenchymal cell markers has also been evaluated, demonstrating that these cells are immunopositive of vimentin and smooth muscle a-actin (Figure 2). So far, phenotypic characteristics have been studied for 7 passes with great stability.</span>
  </p>
  <p id="p00834" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Diferenciacin celular</span>Cell differentiation</span>
  </p>
  <p id="p00835" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se sembraron clulas a una densidad de 0,5 - 1x104/cm2 en placas de 6 pocillos recubiertas con colgeno de tipo I de cola de rata en DMEM complementado con FCS y P/S. Se cambi el medio de cultivo 24 horas despus por medio Dulbecco modificado por Iscove (IMDM) (Invitrogen). Para la induccin, se incubaron las clulas durante 2 semanas con medio de induccin que contena IMDM complementado con HGF 20 ng/ml (Biosource), bFGF 10 ng/ml (Peprotech) y nicotinamida 0,61 g/l (Sigma). Despus de ello, se incubaron las clulas con medio de maduracin que contena IMDM complementado con oncostatina M 20 ng/ml M (Sigma), dexametasona 1 |iM (Sigma) e ITS (insulina, transferrina, selenio) 50 mg/ml (Invitrogen). Para las etapas de induccin y maduracin, se cambi el medio y se analiz cada 3 das. Despus de la exposicin a estos ccteles, las clulas empezaron a perder sus bordes marcados, se encogieron progresivamente y perdieron su morfologa inicial adoptando una forma poligonal (figura 3).</span>Cells were seeded at a density of 0.5-1x104 / cm 2 in 6-well plates coated with rat tail type I collagen in DMEM supplemented with FCS and P / S. The culture medium was changed 24 hours later by Dulbecco medium modified by Iscove (IMDM) (Invitrogen). For induction, the cells were incubated for 2 weeks with induction medium containing IMDM supplemented with 20 ng / ml HGF (Biosource), 10 ng / ml bFGF (Peprotech) and 0.61 g / l nicotinamide (Sigma). After that, the cells were incubated with maturation medium containing IMDM supplemented with oncostatin M 20 ng / ml M (Sigma), 1 | iM dexamethasone (Sigma) and STI (insulin, transferrin, selenium) 50 mg / ml (Invitrogen ). For the induction and maturation stages, the medium was changed and analyzed every 3 days. After exposure to these cocktails, the cells began to lose their marked edges, progressively shrunk and lost their initial morphology by adopting a polygonal shape (Figure 3).</span>
  </p>
  <p id="p00836" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Citometra de flujo</span>Flow cytometry</span>
  </p>
  <p id="p00837" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se recogieron clulas despus de centrifugacin a 1200 rpm durante 5 min y se resuspendieron a una concentracin de 500 a 1000/|il en PBS. Se incubaron entonces las clulas durante 30 minutos a 4C con anticuerpos. Se usaron los isotipos de control correspondientes para la evaluacin de la unin no especfica de anticuerpos monoclonales.</span>Cells were collected after centrifugation at 1200 rpm for 5 min and resuspended at a concentration of 500 to 1000 l in PBS. The cells were then incubated for 30 minutes at 4  C with antibodies. The corresponding control isotypes were used for the evaluation of non-specific binding of monoclonal antibodies.</span>
  </p>
  <p id="p00838" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00839" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00840" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00841" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00842" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00843" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00844" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00845" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00846" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00847" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50</span>fifty</span>
  </p>
  <p id="p00848" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se lavaron entonces las clulas y se resuspendieron en Isoton (Beckham Coulter) para lectura con un citmetro de flujo Beckham Coulter.</span>The cells were then washed and resuspended in Isoton (Beckham Coulter) for reading with a Beckham Coulter flow cytometer.</span>
  </p>
  <p id="p00849" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">RT-PCR</span>RT-PCR</span>
  </p>
  <p id="p00850" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se extrajo el ARN total de clulas cultivadas en placas de 6 pocillos usando el reactivo de aislamiento TriPure (Roche) y se gener ADNc usando el kit de transcripcin inversa segn las instrucciones del fabricante. Se efectuaron las amplificaciones por PCR usando polimerasa elongasa en un volumen final de 25 |il y cebadores apropiados. Se sometieron despus de ello las muestras a electroforesis en gel de agarosa al 1% y se visualizaron los cidos nucleicos mediante tincin con bromuro de etidio.</span>Total RNA was extracted from cells cultured in 6-well plates using TriPure isolation reagent (Roche) and cDNA was generated using the reverse transcription kit according to the manufacturer's instructions. PCR amplifications were performed using polymerase elongase in a final volume of 25 l and appropriate primers. The samples were then subjected to 1% agarose gel electrophoresis and nucleic acids were visualized by ethidium bromide staining.</span>
  </p>
  <p id="p00851" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Inmunofluorescencia</span>Immunofluorescence</span>
  </p>
  <p id="p00852" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para inmunotincin, se fijaron con paraformaldehdo al 4% (v/v) durante 15 min a temperatura ambiente las clulas cultivadas sobre cubreobjetos de vidrio redondos de 12 mm recubiertos con colgeno I de cola de rata, y despus de ello se permeabilizaron con Triton X100 al 1% (v/v) en TBS (Tris-HCl 50 mM, NaCl 150 mM, pH 7,4) durante 15 min Se evit la inmunotincin no especfica mediante una incubacin de 1 h en una disolucin de TBS que contena leche desecada desnatada al 3% a 37C. Se incubaron entonces sucesivamente las clulas en la misma disolucin durante 1 h a temperatura ambiente con anticuerpos primarios, se aclararon 5 veces con TBS, y durante 1 hora con anticuerpos secundarios (1/500). Se tieron los ncleos durante 30 min con el tinte nuclear DAPI (1/5.000). Despus de 3 aclarados, se montaron las preparaciones en medio Fluoprep (BioMerieux, Bruselas, Blgica) y se examinaron usando un microscopio invertido Olympus IX70 acoplado con una cmara CCD (T.I.L.L. Photonics, Martinsried, Alemania). Se obtuvo la luz de excitacin (552, 488 y 372 nm para Cy-3, FITC y DAPI, respectivamente) con una lmpara de xenn acoplada con un monocromador (T.I.L.L. Photonics, Martinsried, Alemania). Se adquirieron imgenes digitales usando filtros apropiados y se combinaron usando el software TILLvision.</span>For immunostaining, cells cultured on round 12mm glass coverslips coated with rat tail collagen I were fixed with 4% paraformaldehyde for 15 min at room temperature, and then permeabilized with Triton X100 1% (v / v) in TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) for 15 min Nonspecific immunostaining was avoided by incubation for 1 h in a TBS solution containing dried milk 3% skim at 37  C. The cells were then successively incubated in the same solution for 1 h at room temperature with primary antibodies, rinsed 5 times with TBS, and for 1 hour with secondary antibodies (1/500). The nuclei were stained for 30 min with the DAPI nuclear dye (1 / 5,000). After 3 rinses, the preparations were mounted in Fluoprep medium (BioMerieux, Brussels, Belgium) and examined using an Olympus IX70 inverted microscope coupled with a CCD camera (T.I.L.L. Photonics, Martinsried, Germany). The excitation light (552, 488 and 372 nm for Cy-3, FITC and DAPI, respectively) was obtained with a xenon lamp coupled with a monochromator (T.I.L.L. Photonics, Martinsried, Germany). Digital images were acquired using appropriate filters and combined using the TILLvision software.</span>
  </p>
  <p id="p00853" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Molculas detectadas en las clulas progenitoras o clulas madre de la invencin</span>Molecules detected in the progenitor cells or stem cells of the invention</span>
  </p>
  <p id="p00854" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Usando los enfoques anteriores, se ha establecido el siguiente perfil de expresin de una serie de marcadores celulares en un experimento para las clulas establecidas en este ejemplo (ADHLSC):</span>Using the above approaches, the following expression profile of a series of cell markers has been established in an experiment for the cells established in this example (ADHLSC):</span>
  </p>
  <p id="p00855" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para CD90. La CD90, o Thy-1, es una protena de superficie celular que se considera que es indicativa del linaje mesenquimal.</span>Positive for CD90. CD90, or Thy-1, is a cell surface protein that is considered to be indicative of the mesenchymal lineage.</span>
  </p>
  <p id="p00856" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para CD44. La CD44 es una molcula de adhesin celular y se usa para identificar al menos algunos tipos de clulas madre mesenquimales (CBM).</span>Positive for CD44. CD44 is a cell adhesion molecule and is used to identify at least some types of mesenchymal stem cells (CBM).</span>
  </p>
  <p id="p00857" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para vimentina. La vimentina es un filamento intermedio de tipo III detectado comnmente en clulas mesenquimales y fibroblastos.</span>Positive for vimentin. Vimentin is an intermediate type III filament commonly detected in mesenchymal cells and fibroblasts.</span>
  </p>
  <p id="p00858" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para albmina. La albmina es una protena plasmtica producida y secretada por el hgado. En los hepatocitos, la albmina se encuentra habitualmente como protena citoplasmtica.</span>Positive for albumin. Albumin is a plasma protein produced and secreted by the liver. In hepatocytes, albumin is usually found as a cytoplasmic protein.</span>
  </p>
  <p id="p00859" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para CD29. La CD29, tambin conocida como integrina p-1, es una glucoprotena transmembrana, tambin presente en tejido heptico, que se cree que forma con la integrina a un complejo receptor funcional implicado en la interaccin con la matriz extracelular.</span>Positive for CD29. CD29, also known as p-1 integrin, is a transmembrane glycoprotein, also present in liver tissue, which is believed to form a functional receptor complex with integrin involved in interaction with the extracellular matrix.</span>
  </p>
  <p id="p00860" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para CD73. La CD73 es una ecto-5'-nucleotidasa que se considera que es un marcador mesenquimal.</span>Positive for CD73. CD73 is an ecto-5'-nucleotidase that is considered to be a mesenchymal marker.</span>
  </p>
  <p id="p00861" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para CD49b. La CD49b se denomina tambin integrina a-2 o receptor de colgeno y est implicada en la interaccin celular con la matriz extracelular.</span>Positive for CD49b. CD49b is also called a-2 integrin or collagen receptor and is involved in cellular interaction with the extracellular matrix.</span>
  </p>
  <p id="p00862" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para HLA-ABC. Los HLA-ABC (antgenos de leucocitos humanos A, B y C) son antgenos de clase I de complejo principal de histocompatibilidad que forman heterodmeros de membrana.</span>Positive for HLA-ABC. HLA-ABC (human leukocyte antigens A, B and C) are class I major histocompatibility complex antigens that form membrane heterodimers.</span>
  </p>
  <p id="p00863" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Alfa-fetoprotena: bajos niveles de expresin. La a-fetoprotena es una protena expresada durante el desarrollo del endodermo primitivo, y a lo largo de la maduracin refleja el linaje endodrmico. Altos niveles de expresin de a- fetoprotena revelan habitualmente una desviacin tumorignica.</span>Alpha-fetoprotein: low levels of expression. A-fetoprotein is a protein expressed during the development of the primitive endoderm, and throughout maturation it reflects the endodermal lineage. High levels of expression of afetoprotein usually reveal a tumorigenic deviation.</span>
  </p>
  <p id="p00864" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para a-1-antitripsina. La a-1-antitripsina es una protena plasmtica sintetizada por el hgado.</span>Positive for a-1-antitrypsin. A-1-antitrypsin is a plasma protein synthesized by the liver.</span>
  </p>
  <p id="p00865" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para glucosa 6-fosfatasa (G6P). La G6P es una enzima heptica que hidroliza glucosa 6-fosfato a glucosa y fosfato inorgnico, permitiendo a la glucosa del hgado entrar en la sangre.</span>Positive for glucose 6-phosphatase (G6P). G6P is a liver enzyme that hydrolyzes glucose 6-phosphate to glucose and inorganic phosphate, allowing liver glucose to enter the blood.</span>
  </p>
  <p id="p00866" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para citocromo P450 1B1 (CYP1B1). El CYP1B1 es un citocromo inducible por dioxina responsable del metabolismo de fase I de un amplio intervalo de sustratos estructuralmente distintos.</span>Positive for cytochrome P450 1B1 (CYP1B1). CYP1B1 is a dioxin-inducible cytochrome responsible for phase I metabolism of a wide range of structurally distinct substrates.</span>
  </p>
  <p id="p00867" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para citocromo P450 3A4 (CYP3A4). La CYP3A4 es una enzima crucial implicada en el metabolismo de xenobiticos.</span>Positive for cytochrome P450 3A4 (CYP3A4). CYP3A4 is a crucial enzyme involved in xenobiotic metabolism.</span>
  </p>
  <p id="p00868" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00869" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00870" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00871" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00872" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00873" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00874" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00875" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00876" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45</span>Four. Five</span>
  </p>
  <p id="p00877" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para factor nuclear de hepatocitos 4 (HNF-4). El HNF4, un receptor nuclear, es un factor de transcripcin implicado en la regulacin del metabolismo de la energa.</span>Positive for nuclear hepatocyte factor 4 (HNF-4). HNF4, a nuclear receptor, is a transcription factor involved in the regulation of energy metabolism.</span>
  </p>
  <p id="p00878" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivas de triptfano 2,3-dioxigenasa (TDO). La TDO es la primera enzima implicada en la oxidacin de triptfano en el hgado.</span>Positive tryptophan 2,3-dioxygenase (TDO). TDO is the first enzyme involved in the oxidation of tryptophan in the liver.</span>
  </p>
  <p id="p00879" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para tirosina aminotransferasa (TAT). La TAT es una enzima especfica de hgado mitocondrial implicada en el metabolismo de aminocidos y la gluconeognesis.</span>Positive for tyrosine aminotransferase (TAT). TAT is a specific mitochondrial liver enzyme involved in amino acid metabolism and gluconeogenesis.</span>
  </p>
  <p id="p00880" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para glutamina sintasa (GS). La GS es una enzima clave para la asimilacin de amonio.</span>Positive for glutamine synthase (GS). GS is a key enzyme for the assimilation of ammonium.</span>
  </p>
  <p id="p00881" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para gamma-glutamil transpeptidasa (GGT). La GGT es una enzima implicada en el metabolismo del glutatin.</span>Positive for gamma-glutamyl transpeptidase (GGT). GGT is an enzyme involved in glutathione metabolism.</span>
  </p>
  <p id="p00882" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para citoqueratina 8 (CK8). La CK8 es un filamento intermedio especfico de clulas epiteliales.</span>Positive for cytokeratin 8 (CK8). CK8 is a specific intermediate filament of epithelial cells.</span>
  </p>
  <p id="p00883" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para protena multirresistente a frmacos 2 (MRP2). La MRP2 es un transportador de aniones orgnicos responsable de la exportacin de aniones orgnicos intracelulares desde los hepatocitos al rbol biliar.</span>Positive for multi-drug resistant protein 2 (MRP2). MRP2 is an organic anion transporter responsible for the export of intracellular organic anions from hepatocytes to the biliary tree.</span>
  </p>
  <p id="p00884" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Positivos para transportador de glutamato 2 (EAAT2). La presencia de muchas de las molculas anteriores que pueden particular en la funcin y el metabolismo heptico es indicativa del estrecho ligamiento de la lnea celular ADHLSC con fenotipos hepticos.</span>Positive for glutamate transporter 2 (EAAT2). The presence of many of the above molecules that may be particular in liver function and metabolism is indicative of the close linkage of the ADHLSC cell line with liver phenotypes.</span>
  </p>
  <p id="p00885" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para CD117. La CD117, tambin denominada c-kit, es un receptor de superficie celular en tipos de clula de mdula sea que identifica HSC y MSC y por lo tanto caracteriza clulas madre bastante indiferenciados.</span>Negative for CD117. CD117, also called c-kit, is a cell surface receptor in bone marrow cell types that identifies HSC and MSC and therefore characterizes fairly undifferentiated stem cells.</span>
  </p>
  <p id="p00886" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para CD34. La CD34 es una protena de superficie celular en clulas de mdula sea, indicativa de HSC y progenitor endotelial.</span>Negative for CD34. CD34 is a cell surface protein in bone marrow cells, indicative of HSC and endothelial progenitor.</span>
  </p>
  <p id="p00887" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para CD45. La CD45, tambin denominada antgeno de leucocitos, es una tirosina fosfatasa expresada en clulas de linaje hematopoytico, incluyendo clulas madre hematopoyticas.</span>Negative for CD45. CD45, also called leukocyte antigen, is a tyrosine phosphatase expressed in hematopoietic lineage cells, including hematopoietic stem cells.</span>
  </p>
  <p id="p00888" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para CD105. La CD105, tambin denominada SH2 o endoglina, es una molcula de adhesin. Se considera tambin que es un marcador de clulas madre mesenquimales.</span>Negative for CD105. CD105, also called SH2 or endoglin, is an adhesion molecule. It is also considered to be a marker of mesenchymal stem cells.</span>
  </p>
  <p id="p00889" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para CD133. La CD133 es un marcador de clulas madre hematopoyticas.</span>Negative for CD133. CD133 is a marker of hematopoietic stem cells.</span>
  </p>
  <p id="p00890" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para HLA-DR. Estos antgenos de clase II de complejo principal de histocompatibilidad son heterodmeros de membrana expresados restrictivamente en clulas presentadoras de antgeno.</span>Negative for HLA-DR. These class II major histocompatibility complex antigens are membrane heterodimers expressed restrictively in antigen presenting cells.</span>
  </p>
  <p id="p00891" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para Oct-4. El Oct-4 es un factor de transcripcin expresado solo por clulas madre pluripotentes y esencial para el mantenimiento del estado indiferenciado.</span>Negative for Oct-4. Oct-4 is a transcription factor expressed only by pluripotent stem cells and essential for the maintenance of the undifferentiated state.</span>
  </p>
  <p id="p00892" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para citoqueratina 19 (CK19). La CK19 se usa ampliamente como marcador de clulas biliares, concretamente colangiocitos.</span>Negative for cytokeratin 19 (CK19). CK19 is widely used as a marker for bile cells, specifically cholangiocytes.</span>
  </p>
  <p id="p00893" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Negativos para citocromo P 2B6 (CYP2B6). El CYP2B6 est implicado en el metabolismo de endo- y xenobiticos. CD54: Molcula de adhesin intercelular 1 (ICAM-1), una glucoprotena de membrana.</span>Negative for cytochrome P 2B6 (CYP2B6). CYP2B6 is involved in the metabolism of endo- and xenobiotics. CD54: Intercellular adhesion molecule 1 (ICAM-1), a membrane glycoprotein.</span>
  </p>
  <p id="p00894" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sin pretender limitar en modo alguno, los presentes inventores, basndose en su conocimiento de los marcadores celulares, plantearon una posible interpretacin de los datos anteriores: Esta combinacin de marcadores define una lnea celular original que expresa marcadores del linaje mesenquimal (CD90, CD73, vimentina, CD44) as como marcadores caractersticos de la ruta de diferenciacin heptica (CD29 y albmina, a-1-antitripsina, HNF4, transportador MRP2). La presencia de albmina detectada tanto por inmunofluorescencia como por PCR-TI aboga fuertemente en contra de una posible contaminacin con clulas estrelladas. La ADHLSC no parece ser clulas madre mesenquimales indiferenciados pluripotentes (negativa de CD45, negativa de CD34, negativa de CD117, negativa de Oct-4), ni clulas estrelladas hepticas (positiva para albmina). La lnea ADHLSC parece asignada al linaje heptico (positiva para CD29, que expresa albmina y a-1-antitripsina), pero no expresa el marcador biliar tpico (negativa para CK19 y 7). Por tanto, las clulas y lneas celulares de la invencin pueden denotarse, en un modo no limitante, como una lnea de clulas madre mesenquimales con caractersticas de progenitor de hepatocito.</span>Without intending to limit in any way, the present inventors, based on their knowledge of cell markers, raised a possible interpretation of the above data: This combination of markers defines an original cell line that expresses markers of the mesenchymal lineage (CD90, CD73, vimentin , CD44) as well as characteristic markers of the hepatic differentiation pathway (CD29 and albumin, a-1-antitrypsin, HNF4, MRP2 transporter). The presence of albumin detected both by immunofluorescence and by PCR-TI strongly advocates possible contamination with star cells. ADHLSC does not appear to be pluripotent undifferentiated mesenchymal stem cells (CD45 negative, CD34 negative, CD117 negative, Oct-4 negative), or hepatic starred cells (positive for albumin). The ADHLSC line appears to be assigned to the liver lineage (positive for CD29, which expresses albumin and a-1-antitrypsin), but does not express the typical biliary marker (negative for CK19 and 7). Therefore, the cells and cell lines of the invention can be denoted, in a non-limiting way, as a mesenchymal stem cell line with hepatocyte progenitor characteristics.</span>
  </p>
  <p id="p00895" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Trasplante, histologa e inmunohistoqumica de ratones uPA-SCID</span>Transplantation, histology and immunohistochemistry of uPA-SCID mice</span>
  </p>
  <p id="p00896" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se inyectaron un milln de ADHLSC (&gt;90% de viabilidad) en el bazo de ratones uPA+/+-SCID de 6-14 das de edad. Antes del trasplante, los ratones mostraron una albmina srica indetectable. La inmunohistoqumica en muestras de hgado de ratn se efectu en secciones de hgado de 4 |im de grosor que se tieron con hematoxilina y eosina (HE) para evaluacin histopatolgica global. Para la inmunotincin, se incubaron cortes de hgado durante una noche con anticuerpos primarios a temperatura ambiente. Se efectu la deteccin despus de incubar los cortes con</span>One million ADHLSC (&gt; 90% viability) was injected into the spleen of uPA + / + - SCID mice aged 6-14 days. Before transplantation, the mice showed an undetectable serum albumin. Immunohistochemistry in mouse liver samples was performed in 4 | im thick liver sections that were stained with hematoxylin and eosin (HE) for global histopathological evaluation. For immunostaining, liver cuts were incubated overnight with primary antibodies at room temperature. Detection was performed after incubating the cuts with</span>
  </p>
  <p id="p00897" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5</span>5</span>
  </p>
  <p id="p00898" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
  </p>
  <p id="p00899" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
  </p>
  <p id="p00900" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
  </p>
  <p id="p00901" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
  </p>
  <p id="p00902" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
  </p>
  <p id="p00903" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
  </p>
  <p id="p00904" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
  </p>
  <p id="p00905" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">polmero marcado con peroxidasa y sustrato cromognico (Envision-DAB System, Dako, Carpintera, CA). Se efectu la contratincin usando hematoxilina.</span>polymer labeled with peroxidase and chromogenic substrate (Envision-DAB System, Dako, Carpintera, CA). Contratinction was performed using hematoxylin.</span>
  </p>
  <p id="p00906" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El modelo de ratn transgnico utilizado con este fin combina una patologa heptica (uPA) con inmunodeficiencia (SCID). Despus del trasplante intraesplnico de la suspensin de ADHLSC, se dejaron recuperaron los ratones uPA+/+-SCID durante 10 semanas. El anlisis de los hgados de los ratones uPA/SCID trasplantados con ADHLSC demostr que estas clulas eran capaces de injertarse (figura 4) y de diferenciarse en hepatocitos maduros (figura 5). Adems, se detect albmina humana en el suero de estos ratones trasplantados 10 semanas despus del trasplante, mientras que el nivel de a-fetoprotena expresada, un marcador del desarrollo tumoral, permaneca indetectable.</span>The transgenic mouse model used for this purpose combines a liver pathology (uPA) with immunodeficiency (SCID). After intrasplenic transplantation of the ADHLSC suspension, the uPA + / + - SCID mice were allowed to recover for 10 weeks. Analysis of the livers of uPA / SCID mice transplanted with ADHLSC showed that these cells were able to graft (figure 4) and differentiate into mature hepatocytes (figure 5). In addition, human albumin was detected in the serum of these transplanted mice 10 weeks after transplantation, while the level of expressed a-fetoprotein, a marker of tumor development, remained undetectable.</span>
  </p>
  <p id="p00907" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Las clulas trasplantadas no sobreproliferaron como se muestra por observacin microscpica, indicando la ausencia de colonias tumorignicas y un nivel normal de expresin de los marcadores tumorignicos a-fetoprotena y Ki67. El nivel normal de expresin corresponde esencialmente con el nivel de expresin medido en hepatocitos normales, y es menor que el nivel de expresin medido en una lnea celular de hgado humano modificada tumorignica, por ejemplo, HepG2.</span>The transplanted cells did not overproliferate as shown by microscopic observation, indicating the absence of tumorigenic colonies and a normal level of expression of the tumorigenic markers a-fetoprotein and Ki67. The normal level of expression corresponds essentially to the level of expression measured in normal hepatocytes, and is lower than the level of expression measured in a tumorigenic modified human liver cell line, for example, HepG2.</span>
  </p>
  <p id="p00908" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ejemplo 2</span>Example 2</span>
  </p>
  <p id="p00909" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Un tratamiento ejemplar con las clulas progenitoras o clulas madre originadas en hgado de la invencin, las lneas celulares de los mismos o poblaciones celulares que comprenden los mismos (mencionando especficamente, aunque por supuesto sin limitacin, la lnea LMBP 6452C), o la progenie de los mismos, opcionalmente modificados genticamente, puede ser el siguiente.</span>An exemplary treatment with the progenitor cells or stem cells originating in liver of the invention, the cell lines thereof or cell populations comprising the same (specifically mentioning, but of course without limitation, the LMBP 6452C line), or the progeny of they, optionally genetically modified, can be the following.</span>
  </p>
  <p id="p00910" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Se infunden clulas en inyecciones en serie, preferiblemente no superando las 25 a 50 x 106 clulas/kg, preferiblemente separadas 4 horas, o separadas 8 horas, o ms de 8 horas hasta una semana, o ms de una semana. Se infunden una cantidad total de clulas de 250 x 108 clulas/kg, o 500 x 106 clulas/kg durante unos das, preferiblemente una o preferiblemente dos semanas. Las infusiones en serie pueden repetirse segn sea necesario, cada mes o cada seis meses o cada ao o ms.</span>Cells are infused into serial injections, preferably not exceeding 25 to 50 x 106 cells / kg, preferably 4 hours apart, or 8 hours apart, or more than 8 hours to a week, or more than a week. A total amount of cells of 250 x 108 cells / kg, or 500 x 106 cells / kg are infused for a few days, preferably one or preferably two weeks. Serial infusions can be repeated as necessary, every month or every six months or every year or more.</span>
  </p>
  <p id="p00911" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">El acceso a la vena porta es mediante puncin directa con gua radiolgica o ultrasnica, mediante una aguja de puncin o mediante un catter percutneo, o mediante un dispositivo Port-a-cath, o mediante un dispositivo Broviac insertado quirrgicamente en cualquier vaso que drene la vena porta, preferiblemente la vena mesentrica inferior o una vena colnica. El catter puede dejarse durante varias horas, preferiblemente varios das, preferiblemente varias semanas o preferiblemente varios meses hasta dos aos, o preferiblemente ms, para infusiones repetidas siempre que sea necesario.</span>Access to the portal vein is by direct puncture with radiological or ultrasonic guidance, by means of a puncture needle or by a percutaneous catheter, or by a Port-a-cath device, or by a Broviac device surgically inserted into any vessel that drain the portal vein, preferably the inferior mesenteric vein or a colonic vein. The catheter may be left for several hours, preferably several days, preferably several weeks or preferably several months up to two years, or preferably more, for repeated infusions whenever necessary.</span>
  </p>
  <p id="p00912" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">La inmunosupresin se inicia el da de infusin, preferiblemente el da antes, preferiblemente con tacrolims (FK506) y esteroides. El nivel sanguneo continuo de tacrolims es preferiblemente de 8 ng/ml inicialmente, de 6 ng/ml despus de tres meses, de 4 ng/ml despus de 6 meses y se mantiene entonces aproximadamente a 4 ng/ml. Los esteroides se administran preferiblemente en forma de prednisona o prednisolona, inicialmente a 5 mg/kg el da 1, 4 mg/kg el da 2, 3 mg/kg el da 3, 2 mg/kg el da 4, 1 mg/kg el da 5, y entonces se reducen progresivamente para alcanzar 0,25 mg/kg a los 3 meses, y se termina a los 6 meses. La inmunosupresin alternativa puede incluir, solos o en combinacin, ciclosporina A, anticuerpos anti-receptor de IL-2, globulinas anti-timocito o cualquier anticuerpo monoclonal o policlonal anti-linfocito humano, micofenolato de mofetilo o azatioprina o cualquier agente antimetablico, ciclosporina, rapamune o cualquier otro inhibidor de calcineurina.</span>Immunosuppression begins on the day of infusion, preferably the day before, preferably with tacrolimus (FK506) and steroids. The continuous blood level of tacrolimus is preferably 8 ng / ml initially, 6 ng / ml after three months, 4 ng / ml after 6 months and is then maintained at approximately 4 ng / ml. Steroids are preferably administered in the form of prednisone or prednisolone, initially at 5 mg / kg on day 1, 4 mg / kg on day 2, 3 mg / kg on day 3, 2 mg / kg on day 4, 1 mg / kg on day 5, and then gradually reduce to reach 0.25 mg / kg at 3 months, and end at 6 months. Alternative immunosuppression may include, alone or in combination, cyclosporin A, anti-IL-2 receptor antibodies, anti-thymocyte globulins or any human anti-lymphocyte monoclonal or polyclonal antibody, mycophenolate mofetil or azathioprine or any antimetabolic agent, cyclosporine, rapamune or any other calcineurin inhibitor.</span>
  </p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(17)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Spanish</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM131817186" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">2.</span>2.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15 3.</span>15 3.</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">4.</span>Four.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5. 35</span>5. 35</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">6. 45</span>6. 45</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">REIVINDICACIONES
    </span></span></claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso en el tratamiento de una enfermedad heptica, en la que dicha clula progenitora o clula madre heptica humana es:</span>Progenitor cell or human liver stem cell for use in the treatment of a liver disease, wherein said progenitor cell or human liver stem cell is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one marker of lymphohematopoietic lineage selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) tal como se define en (i), y es una lnea celular, o</span>(ii) as defined in (i), and is a cell line, or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) tal como se define en (i), y est comprendida en una poblacin celular.</span>(iii) as defined in (i), and is comprised in a cellular population.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn la reivindicacin 1, en la que dicha clula progenitora o clula madre humana aislada es tambin negativa para citoqueratina-19 (CK-19) y CD133.</span>Progenitor cell or human liver stem cell for use according to claim 1, wherein said isolated progenitor cell or human stem cell is also negative for cytokeratin-19 (CK-19) and CD133.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn la reivindicacin 1 o 2, en la que dicha clula progenitora o clula madre humana aislada expresa adems una, ms de una o todas de las siguientes molculas: CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>Progenitor cell or human liver stem cell for use according to claim 1 or 2, wherein said isolated progenitor cell or human stem cell further expresses one, more than one or all of the following molecules: CD49e, CD13, CD54 and major complex of histocompatibility (MHC) class I (HLA-ABC).</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn cualquiera de las reivindicaciones 1 a 3, en la que la enfermedad heptica es fenilcetonuria y otras aminoacidopatas, hemofilia y otras deficiencias de factor de coagulacin, hipercolesterolemia familiar y otros trastornos del metabolismo lipdico, trastornos del ciclo de la urea, glucogenosis, galactosemia, fructosemia, tirosinemia, deficiencias del metabolismo de protenas e hidratos de carbono, aciduria orgnica, enfermedades mitocondriales, trastornos peroxismicos y lisosmicos, anomalas de la sntesis de protenas, defectos de transportadores de clulas hepticas, defecto de glucosilacin, hepatitis, cirrosis, errores congnitos del metabolismo, insuficiencia heptica aguda, infecciones hepticas agudas, toxicidad qumica aguda, insuficiencia heptica crnica, colangitis, cirrosis biliar, sndrome de Alagille, deficiencia de a-1-antitripsina, hepatitis autoinmune, atresia biliar, cncer de hgado, enfermedad qustica del hgado, esteatosis heptica, galactosemia, clculos biliares, sndrome de Gilbert, hemocromatosis, hepatitis A, hepatitis B, hepatitis C y otras infecciones vricas de hepatitis, porfiria, colangitis esclerosante primaria, sndrome de Reye, sarcoidosis, tirosinemia, enfermedad de almacenamiento de glucgeno de tipo 1 o enfermedad de Wilson.</span>Progenitor cell or human liver stem cell for use according to any of claims 1 to 3, wherein the liver disease is phenylketonuria and other aminoacidopathies, hemophilia and other coagulation factor deficiencies, familial hypercholesterolemia and other disorders of lipid metabolism, disorders of the urea cycle, glycogenosis, galactosemia, fructosemia, tyrosinemia, deficiencies of carbohydrate and protein metabolism, organic aciduria, mitochondrial diseases, peroxisomal and lysosomal disorders, protein synthesis abnormalities, liver cell transporter defects, defect of glycosylation, hepatitis, cirrhosis, congenital metabolism errors, acute liver failure, acute liver infections, acute chemical toxicity, chronic liver failure, cholangitis, biliary cirrhosis, Alagille syndrome, a-1-antitrypsin deficiency, autoimmune hepatitis, biliary atresia cancer r liver, cystic liver disease, hepatic steatosis, galactosemia, gallstones, Gilbert's syndrome, hemochromatosis, hepatitis A, hepatitis B, hepatitis C and other viral infections of hepatitis, porphyria, primary sclerosing cholangitis, Reye's syndrome, sarcoidosis, tyrosinemia, type 1 glycogen storage disease or Wilson disease.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento de realizacin de pruebas de toxicidad in vitro que comprende exponer a un agente de prueba una clula progenitora o clula madre heptica humana y observar al menos un efecto sobre la viabilidad celular, funcin celular o ambas, en el que dicha clula progenitora o clula madre heptica humana es:</span>Procedure for conducting in vitro toxicity tests comprising exposing a progenitor cell or human liver stem cell to a test agent and observing at least one effect on cell viability, cell function or both, in which said progenitor cell or stem cell Human liver is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one marker of lymphohematopoietic lineage selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) tal como se define en (i), y es una lnea celular, o</span>(ii) as defined in (i), and is a cell line, or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) tal como se define en (i), y est comprendida en una poblacin celular.</span>(iii) as defined in (i), and is comprised in a cellular population.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento de realizacin de estudios de metabolismo de frmacos in vitro, que comprende exponer a un agente de prueba una clula progenitora o clula madre heptica humana y observar un cambio en la estructura, concentracin o ambos del agente de prueba, en el que dicha clula progenitora o clula madre heptica humana es:</span>Procedure for conducting in vitro drug metabolism studies, which comprises exposing a progenitor cell or human liver stem cell to a test agent and observing a change in the structure, concentration or both of the test agent, in which said progenitor cell or human liver stem cell is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one marker of lymphohematopoietic lineage selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) tal como se define en (i), y es una lnea celular, o</span>(ii) as defined in (i), and is a cell line, or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">8.</span>8.</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">9.</span>9.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25</span>25</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30 10.</span>30 10.</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">11.</span>eleven.</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12.</span>12.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">13.</span>13.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40</span>40</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">14.</span>14.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) tal como se define en (i), y est comprendida en una poblacin celular.</span>(iii) as defined in (i), and is comprised in a cellular population.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento de realizacin de pruebas para detectar agentes para tratar infecciones hepticas, que comprende infectar con un agente infeccioso vrico de inters una clula progenitora o clula madre heptica humana y proporcionar una poblacin infectada, exponer la poblacin infectada a una cantidad predeterminada de agente de prueba, y observar los efectos, si hay alguno, de la exposicin de dicha cantidad predeterminada de agente de prueba sobre la replicacin vrica del agente infeccioso vrico en la poblacin infectada, y en el que dicha clula progenitora o clula madre heptica humana es:</span>Procedure for conducting tests to detect agents for treating liver infections, which comprises infecting with a viral infectious agent of interest a progenitor cell or human liver stem cell and providing an infected population, exposing the infected population to a predetermined amount of test agent, and observing the effects, if any, of the exposure of said predetermined amount of test agent on viral replication of the viral infectious agent in the infected population, and in which said progenitor cell or human liver stem cell is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one marker of lymphohematopoietic lineage selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) tal como se define en (i), y es una lnea celular, o</span>(ii) as defined in (i), and is a cell line, or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) tal como se define en (i), y est comprendida en una poblacin celular.</span>(iii) as defined in (i), and is comprised in a cellular population.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento segn la reivindicacin 7, en el que el agente infeccioso incluye un virus de la hepatitis.</span>Method according to claim 7, wherein the infectious agent includes a hepatitis virus.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento de produccin de una protena de inters que comprende introducir en una clula progenitora o clula madre heptica humana un gen funcional que codifica una protena de inters, incubar la poblacin de las clulas progenitoras o clulas madre hepticas en condiciones eficaces para la transcripcin y traduccin, y recoger la protena de inters, y en el que dicha clula progenitora o clula madre heptica humana es</span>Method of producing a protein of interest comprising introducing into a progenitor cell or human liver stem cell a functional gene that encodes a protein of interest, incubating the population of the progenitor cells or liver stem cells under effective conditions for transcription and translation, and collecting the protein of interest, and wherein said progenitor cell or human liver stem cell is</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one marker of lymphohematopoietic lineage selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) tal como se define en (i), y es una lnea celular, o</span>(ii) as defined in (i), and is a cell line, or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) tal como se define en (i), y est comprendida en una poblacin celular.</span>(iii) as defined in (i), and is comprised in a cellular population.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento segn la reivindicacin 9, en el que la protena de inters comprende un antgeno de vacuna.</span>Method according to claim 9, wherein the protein of interest comprises a vaccine antigen.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento segn cualquiera de las reivindicaciones 5 a 10, en el que dicha clula progenitora o clula madre humana aislada es tambin negativa para citoqueratina-19 (CK-19) y CD133.</span>Method according to any one of claims 5 to 10, wherein said isolated progenitor cell or human stem cell is also negative for cytokeratin-19 (CK-19) and CD133.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procedimiento segn cualquiera de las reivindicaciones 5 a 11, en el que dicha clula progenitora o clula madre humana aislada expresa adems una, ms de una o todas de las siguientes molculas: CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>A method according to any of claims 5 to 11, wherein said isolated progenitor cell or human stem cell further expresses one, more than one or all of the following molecules: CD49e, CD13, CD54 and major histocompatibility complex (MHC) class I (HLA-ABC).</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn cualquiera de las reivindicaciones 1 a 4, o procedimiento segn cualquiera de las reivindicaciones 5 a 12, en el que dicha clula progenitora o clula madre heptica humana aislada es:</span>Progenitor cell or human liver stem cell for use according to any one of claims 1 to 4, or method according to any of claims 5 to 12, wherein said progenitor cell or isolated human liver stem cell is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) negativa para CD45, CD34, CD117, CD133 y CK-19; y</span>(i) negative for CD45, CD34, CD117, CD133 and CK-19; Y</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) positiva para CD90, CD29 CD44, vimentina, ASMA y ALB.</span>(ii) positive for CD90, CD29 CD44, vimentin, ASMA and ALB.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn cualquiera de las reivindicaciones 1 a 4, o procedimiento segn cualquiera de las reivindicaciones 5 a 12, en el que dicha clula progenitora o clula madre heptica humana aislada es:</span>Progenitor cell or human liver stem cell for use according to any one of claims 1 to 4, or method according to any of claims 5 to 12, wherein said progenitor cell or isolated human liver stem cell is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) negativa para CD45, CD34, CD117, CD133 y CK-19;</span>(i) negative for CD45, CD34, CD117, CD133 and CK-19;</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) positiva para CD90, CD29 CD44, vimentina, ASMA y ALB; y</span>(ii) positive for CD90, CD29 CD44, vimentin, ASMA and ALB; Y</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) expresa adems CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>(iii) also expresses CD49e, CD13, CD54 and major histocompatibility complex (MHC) of class I (HLA-ABC).</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn cualquiera de las reivindicaciones 1 a 4, o procedimiento segn cualquiera de las reivindicaciones 5 a 12, en el que la clula progenitora o</span>Progenitor cell or human liver stem cell for use according to any of claims 1 to 4, or method according to any of claims 5 to 12, wherein the progenitor cell or</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">17.</span>17.</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">18.</span>18.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10</span>10</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">19.</span>19.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15</span>fifteen</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20.</span>twenty.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20</span>twenty</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">25 21.</span>25 21.</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">22.</span>22</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30</span>30</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35</span>35</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">40 23.</span>40 23.</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">24.</span>24.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">45 25.</span>45 25.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">clula madre heptica humana puede diferenciarse en hepatocitos y no se diferencia en osteocitos o adipocitos.</span>Human liver stem cell can differentiate into hepatocytes and does not differ into osteocytes or adipocytes.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn cualquiera de las reivindicaciones 1 a 4, o procedimiento segn cualquiera de las reivindicaciones 5 a 12, en el que la clula progenitora o clula madre heptica humana se modifica adems genticamente.</span>Progenitor cell or human liver stem cell for use according to any one of claims 1 to 4, or method according to any of claims 5 to 12, wherein the progenitor cell or human liver stem cell is further genetically modified.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn la reivindicacin 16 o procedimiento segn la reivindicacin 16, en el que dicha clula se modifica genticamente para aumentar su capacidad replicativa.</span>Progenitor cell or human liver stem cell for use according to claim 16 or method according to claim 16, wherein said cell is genetically modified to increase its replicative capacity.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn la reivindicacin 16 o procedimiento segn la reivindicacin 16, en el que dicha clula se transfecta o se transforma de manera estable o transitoria con un cido nucleico que codifica un producto gnico que potencia el crecimiento, la diferenciacin y/o el funcionamiento de dicha clula.</span>Progenitor cell or human liver stem cell for use according to claim 16 or method according to claim 16, wherein said cell is transfected or stably or transiently transformed with a nucleic acid encoding a gene product that enhances growth, the differentiation and / or operation of said cell.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana para su uso segn la reivindicacin 16 o procedimiento segn la reivindicacin 16, en el que dicha clula se modifica genticamente para sobreexpresar de manera constitutiva o inducible un polipptido normalmente expresado por hepatocitos.</span>Progenitor cell or human liver stem cell for use according to claim 16 or method according to claim 16, wherein said cell is genetically modified to constitutively or inducibly overexpress a polypeptide normally expressed by hepatocytes.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana modificada genticamente para su uso segn la reivindicacin 19 o procedimiento segn la reivindicacin 19, en el que dicha clula se modifica genticamente para sobreexpresar de manera constitutiva o inducible un polipptido seleccionado del grupo que consiste en ornitina transcarbamilasa, arginosuccinato sintetasa, argininosuccinato liasa, arginasa, fosfato de carbamilo sintasa, glutamato de N-acetilo sintasa, glutamina sintetasa, glucgeno sintetasa, glucosa-6-fosfatasa, succinato deshidrogenasa, glucocinasa, piruvato cinasa, acetil CoA carboxilasa, cido graso sintetasa, alanina aminotransferasa, glutamato deshidrogenasa, ferritina, receptor de lipoprotena de baja densidad (LDL), enzimas P450, alcohol deshidrogenasa, albmina, transferrina, componente C3 del complemento, a2-macroglobulina, fibringeno, factor XIII, factor IX y a1-antitripsina.</span>Genetically modified human liver stem cell or progenitor cell for use according to claim 19 or method according to claim 19, wherein said cell is genetically modified to constitutively or inducibly overexpress a polypeptide selected from the group consisting of ornithine transcarbamylase, arginosuccinate synthetase, argininosuccinate lyase, arginase, carbamyl synthase phosphate, N-acetyl synthase glutamate, glutamine synthetase, glycogen synthetase, glucose-6-phosphatase, succinate dehydrogenase, glucokinase, pyruvate kinase, acetyl CoA carboxylase, acid fatty acid, transferase, acid glutamate dehydrogenase, ferritin, low density lipoprotein (LDL) receptor, P450 enzymes, alcohol dehydrogenase, albumin, transferrin, complement component C3, a2-macroglobulin, fibrinogen, factor XIII, factor IX and a1-antitrypsin.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clula progenitora o clula madre heptica humana modificada genticamente para su uso segn la reivindicacin 16, en la que dicha clula se modifica genticamente para expresar una hormona o un anticuerpo, y en la que dicha hormona o anticuerpo se secreta en la circulacin.</span>Genetically modified human liver stem cell or progenitor cell for use according to claim 16, wherein said cell is genetically modified to express a hormone or an antibody, and wherein said hormone or antibody is secreted into the circulation.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Composicin farmacutica para su uso en el tratamiento de una enfermedad heptica que comprende:</span>Pharmaceutical composition for use in the treatment of a liver disease comprising:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- una clula progenitora o clula madre heptica humana, en la que dicha clula progenitora o clula madre heptica humana es:</span>- a progenitor cell or human liver stem cell, wherein said progenitor cell or human liver stem cell is:</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(i) una clula progenitora o clula madre humana aislada originada a partir de hgado adulto humano que tiene crecimiento en monocapas, forma aplanada, citoplasma amplio y ncleos ovoides con uno o dos nucleolos y que tiene las siguientes caractersticas: negativa para al menos un marcador de linaje linfohematopoytico seleccionado de CD45, CD34 y CD117; positiva para al menos un marcador mesenquimal seleccionado de CD90, CD29 y CD44; positiva para el marcador de hepatocito albmina (ALB); positiva para vimentina y a-actina de msculo liso (ASMA), o</span>(i) an isolated human progenitor cell or stem cell originating from human adult liver that has growth in monolayers, flattened form, broad cytoplasm and ovoid nuclei with one or two nucleoli and that has the following characteristics: negative for at least one marker of lymphohematopoietic lineage selected from CD45, CD34 and CD117; positive for at least one selected mesenchymal marker of CD90, CD29 and CD44; positive for the albumin hepatocyte marker (ALB); positive for vimentin and smooth muscle a-actin (ASMA), or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(ii) tal como se define en (i), y es una lnea celular, o</span>(ii) as defined in (i), and is a cell line, or</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(iii) tal como se define en (i), y est comprendida en una poblacin celular; y</span>(iii) as defined in (i), and is comprised in a cell population; Y</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- un portador farmacuticamente aceptable.</span>- a pharmaceutically acceptable carrier.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Composicin farmacutica para su uso segn la reivindicacin 22, en la que dicha clula progenitora o clula madre humana aislada es tambin negativa para citoqueratina-19 (CK-19) y CD133.</span>Pharmaceutical composition for use according to claim 22, wherein said isolated progenitor cell or human stem cell is also negative for cytokeratin-19 (CK-19) and CD133.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Composicin farmacutica para su uso segn la reivindicacin 22 o 23, en la que dicha clula progenitora o clula madre humana aislada expresa adems una, ms de una o todas de las siguientes molculas: CD49e, CD13, CD54 y complejo principal de histocompatibilidad (MHC) de clase I (HLA-ABC).</span>Pharmaceutical composition for use according to claim 22 or 23, wherein said progenitor cell or isolated human stem cell further expresses one, more than one or all of the following molecules: CD49e, CD13, CD54 and major histocompatibility complex (MHC) Class I (HLA-ABC).</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Composicin farmacutica para su uso segn cualquiera de las reivindicaciones 22 a 24, en la que dicha clula progenitora o clula madre heptica humana se modifica adems genticamente.</span>Pharmaceutical composition for use according to any one of claims 22 to 24, wherein said progenitor cell or human liver stem cell is further genetically modified.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Composicin farmacutica para su uso segn cualquiera de las reivindicaciones 22 a 24, en la que dicha composicin farmacutica se formula en una forma de dosificacin unitaria inyectable.</span>Pharmaceutical composition for use according to any of claims 22 to 24, wherein said pharmaceutical composition is formulated in an injectable unit dosage form.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (16)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2917998B2/en"><a id="link" href="#" class="style-scope state-modifier">JP2917998B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-02-05</span>
                    <span class="td style-scope patent-result">1999-07-12</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Modified hepatocytes and their uses
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6069005A/en"><a id="link" href="#" class="style-scope state-modifier">US6069005A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-08-07</span>
                    <span class="td style-scope patent-result">2000-05-30</span>
                    <span class="td style-scope patent-result">Albert Einstein College Of Medicine Of Yeshwa University</span>
                    <span class="td style-scope patent-result">Hapatoblasts and method of isolating same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR950703640A/en"><a id="link" href="#" class="style-scope state-modifier">KR950703640A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-09</span>
                    <span class="td style-scope patent-result">1995-09-20</span>
                    <span class="td style-scope patent-result"> ,.</span>
                    <span class="td style-scope patent-result">
  LIVER RESERVE CELLS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5869243A/en"><a id="link" href="#" class="style-scope state-modifier">US5869243A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-05</span>
                    <span class="td style-scope patent-result">1999-02-09</span>
                    <span class="td style-scope patent-result">Rhode Island Hospital</span>
                    <span class="td style-scope patent-result">Immortalized hepatocytes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20000048820A/en"><a id="link" href="#" class="style-scope state-modifier">KR20000048820A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-10-01</span>
                    <span class="td style-scope patent-result">2000-07-25</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">Telomerase reverse transcriptase 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6774120B1/en"><a id="link" href="#" class="style-scope state-modifier">US6774120B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-01</span>
                    <span class="td style-scope patent-result">2004-08-10</span>
                    <span class="td style-scope patent-result">Sarah Ferber</span>
                    <span class="td style-scope patent-result">Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8778899B2/en"><a id="link" href="#" class="style-scope state-modifier">US8778899B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-01</span>
                    <span class="td style-scope patent-result">2014-07-15</span>
                    <span class="td style-scope patent-result">Sarah Ferber</span>
                    <span class="td style-scope patent-result">Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU782683B2/en"><a id="link" href="#" class="style-scope state-modifier">AU782683B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-19</span>
                    <span class="td style-scope patent-result">2005-08-18</span>
                    <span class="td style-scope patent-result">University Of North Carolina At Chapel Hill, The</span>
                    <span class="td style-scope patent-result">Liver tissue source 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2388330B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2388330B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-22</span>
                    <span class="td style-scope patent-result">2015-05-20</span>
                    <span class="td style-scope patent-result">StemCells, Inc.</span>
                    <span class="td style-scope patent-result">Liver engrafting cells, assays, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6617152B2/en"><a id="link" href="#" class="style-scope state-modifier">US6617152B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-04</span>
                    <span class="td style-scope patent-result">2003-09-09</span>
                    <span class="td style-scope patent-result">Corning Inc</span>
                    <span class="td style-scope patent-result">Method for creating a cell growth surface on a polymeric substrate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005506074A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005506074A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-18</span>
                    <span class="td style-scope patent-result">2005-03-03</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Conversion of hepatic stem and progenitor cells into functional pancreatic cells
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2004236573B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2004236573B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-12</span>
                    <span class="td style-scope patent-result">2009-10-22</span>
                    <span class="td style-scope patent-result">Sarah Ferber</span>
                    <span class="td style-scope patent-result">Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050074876A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050074876A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-10-03</span>
                    <span class="td style-scope patent-result">2005-04-07</span>
                    <span class="td style-scope patent-result">Inserm</span>
                    <span class="td style-scope patent-result">Bipotential liver cell lines from wild-type mammalian liver tissue 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20060036933A/en"><a id="link" href="#" class="style-scope state-modifier">KR20060036933A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-10-07</span>
                    <span class="td style-scope patent-result">2006-05-02</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">Cell differentiation of adipose-derived precursor cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2006126219A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2006126219A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-05-26</span>
                    <span class="td style-scope patent-result">2006-11-30</span>
                    <span class="td style-scope patent-result">Fresenius Medical Care Deutschland G.M.B.H.</span>
                    <span class="td style-scope patent-result">Liver progenitor cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2672205T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2672205T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-12-21</span>
                    <span class="td style-scope patent-result">2018-06-13</span>
                    <span class="td style-scope patent-result">Universit Catholique de Louvain</span>
                    <span class="td style-scope patent-result">
  Liver Stem Cells Isolated
 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (49)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2672205T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2672205T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-12-21</span>
                    <span class="td style-scope patent-result">2018-06-13</span>
                    <span class="td style-scope patent-result">Universit Catholique de Louvain</span>
                    <span class="td style-scope patent-result">
  Liver Stem Cells Isolated
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2008280143B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2008280143B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-07-20</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Cellartis Ab</span>
                    <span class="td style-scope patent-result">A novel population of hepatocytes derived via definitive endoderm (DE-hep) from human blastocysts stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3441458B9/en"><a id="link" href="#" class="style-scope state-modifier">EP3441458B9</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-03</span>
                    <span class="td style-scope patent-result">2023-08-23</span>
                    <span class="td style-scope patent-result">Koninklijke Nederlandse Akademie van Wetenschappen</span>
                    <span class="td style-scope patent-result">Culture medium for epithelial stem cells and organoids comprising said stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9752124B2/en"><a id="link" href="#" class="style-scope state-modifier">US9752124B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-03</span>
                    <span class="td style-scope patent-result">2017-09-05</span>
                    <span class="td style-scope patent-result">Koninklijke Nederlandse Akademie Van Wetenschappen</span>
                    <span class="td style-scope patent-result">Culture medium for epithelial stem cells and organoids comprising the stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2412800A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2412800A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-07-29</span>
                    <span class="td style-scope patent-result">2012-02-01</span>
                    <span class="td style-scope patent-result">Koninklijke Nederlandse Akademie van Wetenschappen</span>
                    <span class="td style-scope patent-result">Liver organoid, uses thereof and culture method for obtaining them 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011102532A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011102532A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-02-16</span>
                    <span class="td style-scope patent-result">2011-08-25</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Induced hepatocytes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012005690A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012005690A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-07-07</span>
                    <span class="td style-scope patent-result">2012-01-12</span>
                    <span class="td style-scope patent-result">Massachusetts Institute Of Technology</span>
                    <span class="td style-scope patent-result">Methods of reconstituting human hepatocytes and human hematopoietic cells in non-human mammals 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6000950B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6000950B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-08-12</span>
                    <span class="td style-scope patent-result">2016-10-05</span>
                    <span class="td style-scope patent-result">    </span>
                    <span class="td style-scope patent-result">
  Method for producing cells having characteristics of hepatocytes, cells produced by the method and use thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2825252C/en"><a id="link" href="#" class="style-scope state-modifier">CA2825252C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-01-25</span>
                    <span class="td style-scope patent-result">2018-10-16</span>
                    <span class="td style-scope patent-result">Universite Catholique De Louvain</span>
                    <span class="td style-scope patent-result">Compositions of an antithrombin activator and a thrombin inhibitor for use in cell transplantation 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9249394B2/en"><a id="link" href="#" class="style-scope state-modifier">US9249394B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-03-25</span>
                    <span class="td style-scope patent-result">2016-02-02</span>
                    <span class="td style-scope patent-result">Kyoto University</span>
                    <span class="td style-scope patent-result">Method for producing epithelial stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2600321T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2600321T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-08-04</span>
                    <span class="td style-scope patent-result">2017-02-08</span>
                    <span class="td style-scope patent-result">Ethianum Betriebsgesellschaft Mbh &amp; Co. Kg</span>
                    <span class="td style-scope patent-result">
  Means for liver regeneration
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5950235B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5950235B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-30</span>
                    <span class="td style-scope patent-result">2016-07-13</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Hepatocyte differentiation induction method, humanized liver chimeric non-human animal production method
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9775890B2/en"><a id="link" href="#" class="style-scope state-modifier">US9775890B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-01-25</span>
                    <span class="td style-scope patent-result">2017-10-03</span>
                    <span class="td style-scope patent-result">Universit Catholique de Louvain</span>
                    <span class="td style-scope patent-result">Factor Xa inhibitor used with liver-derived progenitor cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014089554A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014089554A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-07</span>
                    <span class="td style-scope patent-result">2014-06-12</span>
                    <span class="td style-scope patent-result">Antria, Inc.</span>
                    <span class="td style-scope patent-result">Formulations containing and kit for using adipose-derived stem cells and use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015001124A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015001124A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-07-05</span>
                    <span class="td style-scope patent-result">2015-01-08</span>
                    <span class="td style-scope patent-result">Universit Catholique de Louvain</span>
                    <span class="td style-scope patent-result">Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2922247C/en"><a id="link" href="#" class="style-scope state-modifier">CA2922247C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-28</span>
                    <span class="td style-scope patent-result">2023-03-07</span>
                    <span class="td style-scope patent-result">Promethera Biosciences S.A./N.V.</span>
                    <span class="td style-scope patent-result">Method for producing adult liver progenitor cells 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2016001839A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2016001839A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-06-30</span>
                    <span class="td style-scope patent-result">2016-01-07</span>
                    <span class="td style-scope patent-result">Stempeutics Research Pvt. Ltd.</span>
                    <span class="td style-scope patent-result">Management of liver disease using pooled mesenchymal stromal cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN106795489B/en"><a id="link" href="#" class="style-scope state-modifier">CN106795489B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-08-28</span>
                    <span class="td style-scope patent-result">2021-07-06</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Method for producing adult liver progenitor cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3148687A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3148687A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-11-26</span>
                    <span class="td style-scope patent-result">2016-06-02</span>
                    <span class="td style-scope patent-result">Accelerated Biosciences Corp.</span>
                    <span class="td style-scope patent-result">Induced hepatocytes and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR3035407B1/en"><a id="link" href="#" class="style-scope state-modifier">FR3035407B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-04-23</span>
                    <span class="td style-scope patent-result">2022-06-17</span>
                    <span class="td style-scope patent-result">Francais Du Sang Ets</span>
                    <span class="td style-scope patent-result">
  METHOD FOR PRESERVING CELLS, TISSUES OR ORGANS IN HYPOTHERMIA
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2016183231A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2016183231A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-05-12</span>
                    <span class="td style-scope patent-result">2016-11-17</span>
                    <span class="td style-scope patent-result">Baker Group, LLP</span>
                    <span class="td style-scope patent-result">Method and system for a bioartificial organ 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6582044B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6582044B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-05-14</span>
                    <span class="td style-scope patent-result">2019-09-25</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Method for producing frozen mesenchymal cells and method for producing therapeutic material for transplantation
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3307874A4/en"><a id="link" href="#" class="style-scope state-modifier">EP3307874A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-12</span>
                    <span class="td style-scope patent-result">2019-04-24</span>
                    <span class="td style-scope patent-result">Agency For Science, Technology And Research</span>
                    <span class="td style-scope patent-result">Derivation of hepatic stem cells and mature liver cell types and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10287543B2/en"><a id="link" href="#" class="style-scope state-modifier">US10287543B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-19</span>
                    <span class="td style-scope patent-result">2019-05-14</span>
                    <span class="td style-scope patent-result">Miltenyi Biotec, Gmbh</span>
                    <span class="td style-scope patent-result">Process and device for isolating cells from biological tissue 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10961507B2/en"><a id="link" href="#" class="style-scope state-modifier">US10961507B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-01-08</span>
                    <span class="td style-scope patent-result">2021-03-30</span>
                    <span class="td style-scope patent-result">Cynity Co., Ltd.</span>
                    <span class="td style-scope patent-result">Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6704617B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6704617B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-01-29</span>
                    <span class="td style-scope patent-result">2020-06-03</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">
  Subculture method for small hepatocytes
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3013630A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3013630A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-10</span>
                    <span class="td style-scope patent-result">2017-08-17</span>
                    <span class="td style-scope patent-result">Wake Forest University Health Sciences</span>
                    <span class="td style-scope patent-result">Model system of liver fibrosis and method of making and using the same 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MA45274A/en"><a id="link" href="#" class="style-scope state-modifier">MA45274A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-03-02</span>
                    <span class="td style-scope patent-result">2019-01-09</span>
                    <span class="td style-scope patent-result">Univ Catholique Louvain</span>
                    <span class="td style-scope patent-result">
  IMPROVED ADULT HEPATIC PROGENITOR CELL PREPARATIONS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3463394A4/en"><a id="link" href="#" class="style-scope state-modifier">EP3463394A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-05-24</span>
                    <span class="td style-scope patent-result">2020-01-22</span>
                    <span class="td style-scope patent-result">Albert P. Li</span>
                    <span class="td style-scope patent-result">Novel cell culture method, cell culture system and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2018208628A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2018208628A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-05-06</span>
                    <span class="td style-scope patent-result">2018-11-15</span>
                    <span class="td style-scope patent-result">Memphis Meats, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3064352A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3064352A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-05-24</span>
                    <span class="td style-scope patent-result">2018-11-29</span>
                    <span class="td style-scope patent-result">Thoeris Gmbh</span>
                    <span class="td style-scope patent-result">Use of glutamine synthetase for treating hyperammonemia 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3638777A4/en"><a id="link" href="#" class="style-scope state-modifier">EP3638777A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-07-13</span>
                    <span class="td style-scope patent-result">2021-05-12</span>
                    <span class="td style-scope patent-result">Memphis Meats, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for increasing the efficiency of cell cultures used for food production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11407979B2/en"><a id="link" href="#" class="style-scope state-modifier">US11407979B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-09-01</span>
                    <span class="td style-scope patent-result">2022-08-09</span>
                    <span class="td style-scope patent-result">Colorado State University Research Foundation</span>
                    <span class="td style-scope patent-result">Intermittent starvation techniques to prolong functional lifetime of liver cells in culture 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20210015844A1/en"><a id="link" href="#" class="style-scope state-modifier">US20210015844A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-03-14</span>
                    <span class="td style-scope patent-result">2021-01-21</span>
                    <span class="td style-scope patent-result">Beacon Medcare (Hk) Limited</span>
                    <span class="td style-scope patent-result">Composition for purification of biofluids 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN108823146A/en"><a id="link" href="#" class="style-scope state-modifier">CN108823146A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-06-22</span>
                    <span class="td style-scope patent-result">2018-11-16</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">A kind of preparation of liver stem cells and extracting method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020120666A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020120666A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-12-14</span>
                    <span class="td style-scope patent-result">2020-06-18</span>
                    <span class="td style-scope patent-result">Promethera Biosciences S.A./N.V.</span>
                    <span class="td style-scope patent-result">Liver progenitor cells expressing hla-g, and method for obtaining these cells compositions comprising said cells and their use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW202043463A/en"><a id="link" href="#" class="style-scope state-modifier">TW202043463A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-12-14</span>
                    <span class="td style-scope patent-result">2020-12-01</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Cell composition comprising liver progenitor cells expressing hla-e 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109735485B/en"><a id="link" href="#" class="style-scope state-modifier">CN109735485B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-29</span>
                    <span class="td style-scope patent-result">2021-04-16</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Humanized liver animal model and construction method and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW202100171A/en"><a id="link" href="#" class="style-scope state-modifier">TW202100171A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-03-26</span>
                    <span class="td style-scope patent-result">2021-01-01</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Adult liver progenitor cells for treating non-alcoholic fatty liver disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113677790B/en"><a id="link" href="#" class="style-scope state-modifier">CN113677790B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-03-26</span>
                    <span class="td style-scope patent-result">2024-05-24</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Adult hepatic progenitors for the treatment of chronic acute liver failure 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP7284985B2/en"><a id="link" href="#" class="style-scope state-modifier">JP7284985B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-03-29</span>
                    <span class="td style-scope patent-result">2023-06-01</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">
  Method for producing cell population containing hepatic progenitor cells
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW202106875A/en"><a id="link" href="#" class="style-scope state-modifier">TW202106875A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-04-30</span>
                    <span class="td style-scope patent-result">2021-02-16</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Preparation of human allogeneic liver-derived progenitor cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3963049A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3963049A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-04-30</span>
                    <span class="td style-scope patent-result">2022-03-09</span>
                    <span class="td style-scope patent-result">Promethera Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Preparation of human allogeneic liver-derived progenitor cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3143640A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3143640A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-07-26</span>
                    <span class="td style-scope patent-result">2021-02-04</span>
                    <span class="td style-scope patent-result">Fei Yi</span>
                    <span class="td style-scope patent-result">Methods and compositions for producing hepatocytes 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP4041261A1/en"><a id="link" href="#" class="style-scope state-modifier">EP4041261A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-09</span>
                    <span class="td style-scope patent-result">2022-08-17</span>
                    <span class="td style-scope patent-result">Cellaion SA</span>
                    <span class="td style-scope patent-result">Use of liver progenitor or stem cells, lysates thereof, and/or conditioned medium in disorders characterized by vascular hyperpermeability 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2022011245A/en"><a id="link" href="#" class="style-scope state-modifier">MX2022011245A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-03-11</span>
                    <span class="td style-scope patent-result">2023-01-11</span>
                    <span class="td style-scope patent-result">Bit Bio Ltd</span>
                    <span class="td style-scope patent-result">Method of generating hepatic cells. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3881853A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3881853A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-03-20</span>
                    <span class="td style-scope patent-result">2021-09-22</span>
                    <span class="td style-scope patent-result">Promethera Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Human allogeneic liver-derived progenitor cells for use in the treatment of inflammatory and infectious lung diseases and systemic inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3929280A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3929280A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-06-26</span>
                    <span class="td style-scope patent-result">2021-12-29</span>
                    <span class="td style-scope patent-result">Medizinische Hochschule Hannover</span>
                    <span class="td style-scope patent-result">Process for producing liver cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2023180122A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2023180122A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-03-24</span>
                    <span class="td style-scope patent-result">2023-09-28</span>
                    <span class="td style-scope patent-result">Universit Catholique de Louvain</span>
                    <span class="td style-scope patent-result">Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2672205T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2672205T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-06-13</span>
                    <span class="td style-scope patent-result">
  Liver Stem Cells Isolated
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2359874T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2359874T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-05-27</span>
                    <span class="td style-scope patent-result">
  ISOLATED HEPATIC MOTHER CELLS.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2954834T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2954834T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-11-27</span>
                    <span class="td style-scope patent-result">
  Method to produce adult liver progenitor cells
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/12352541487150619115"><a id="link" href="#" class="style-scope state-modifier">Avital et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001</span>
                    <span class="td style-scope patent-result">Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2316353T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2316353T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-04-16</span>
                    <span class="td style-scope patent-result">
  HUMAN LIVER PROGENITATING CELLS.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20190046584A1/en"><a id="link" href="#" class="style-scope state-modifier">US20190046584A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-02-14</span>
                    <span class="td style-scope patent-result">Improved preparations of adult liver progenitor cells 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2385248T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2385248T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-20</span>
                    <span class="td style-scope patent-result">
  Human liver progenitor cells and methods of use thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU782683B2/en"><a id="link" href="#" class="style-scope state-modifier">AU782683B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-08-18</span>
                    <span class="td style-scope patent-result">Liver tissue source 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5263756B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5263756B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-14</span>
                    <span class="td style-scope patent-result">
  Cell culture method and cell culture
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2764850T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2764850T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-06-04</span>
                    <span class="td style-scope patent-result">
  Bioartificial proximal tubule systems and methods of use
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0620049A2/en"><a id="link" href="#" class="style-scope state-modifier">BRPI0620049A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-01</span>
                    <span class="td style-scope patent-result">
  isolated liver stem cells
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20210116469A/en"><a id="link" href="#" class="style-scope state-modifier">KR20210116469A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-09-27</span>
                    <span class="td style-scope patent-result">
  Cell composition comprising hepatic progenitor cells expressing HLA-E
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/2017965404938687367"><a id="link" href="#" class="style-scope state-modifier">Lombard et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021</span>
                    <span class="td style-scope patent-result">Cell transplantation</span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP05447286<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2005-12-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP05447286<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2005-12-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP2006010014<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2006-10-17</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        WOPCT/EP2006/010014<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2006-10-17</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu"></span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Anatomy</div>
          
            <div class="item style-scope dropdown-menu">Chemical class</div>
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          
            <div class="item style-scope dropdown-menu">Chemical group</div>
          
            <div class="item style-scope dropdown-menu">Diseases</div>
          
            <div class="item style-scope dropdown-menu">Drugs</div>
          
            <div class="item style-scope dropdown-menu">Effects</div>
          
            <div class="item style-scope dropdown-menu">Human genes</div>
          
            <div class="item style-scope dropdown-menu">Inorganic materials</div>
          
            <div class="item style-scope dropdown-menu">Methods</div>
          
            <div class="item style-scope dropdown-menu">Natural products</div>
          
            <div class="item style-scope dropdown-menu">Nutrition</div>
          
            <div class="item style-scope dropdown-menu">Polymers</div>
          
            <div class="item style-scope dropdown-menu">Proteins</div>
          
            <div class="item style-scope dropdown-menu">Species</div>
          
            <div class="item style-scope dropdown-menu">Substances</div>
          
            <div class="item style-scope dropdown-menu">Toxicity</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">stem cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">703</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">liver</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">365</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">742</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hepatocyte</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">150</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">marker</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">73</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Albumins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">64</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Vimentin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">37</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">vimentin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">37</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">CD44 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">35</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens CD44 antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">35</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Thy-1 membrane glycoprotein</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">35</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Thy-1 membrane glycoprotein</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">35</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Integrin beta-1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Integrin beta-1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">liver disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Receptor-type tyrosine-protein phosphatase C</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">31</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Receptor-type tyrosine-protein phosphatase C</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">31</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">31</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hematopoietic progenitor cell antigen CD34</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Hematopoietic progenitor cell antigen CD34</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Mast/stem cell growth factor receptor Kit</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Mast/stem cell growth factor receptor Kit</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">smooth muscle</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">27</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">treatment</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">24</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cytoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lymphohematopoietic effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Albumin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Vimentin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">155</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">liver cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">112</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Albumins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">63</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">differentiation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">58</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">proteins and genes</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">57</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Keratin, type I cytoskeletal 19</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">37</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Keratin-19</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">37</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">in vitro</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">proteins and genes</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">33</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chemical substances by application</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">25</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">testing method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">24</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Major Histocompatibility Complex</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">diseases, disorders, signs and symptoms</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">effects</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cellular effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pharmaceutical composition</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">defect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">15</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hepatitis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">15</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Toxicity style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hepatitis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">15</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">trypsin inhibitor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">15</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Prominin-1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Prominin-1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Intercellular adhesion molecule 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">infectious agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">change</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">deficiency</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">metabolic process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tyrosinemia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Aminopeptidase N</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Carrier Proteins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Congenital anomaly</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Galactosemias</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Aminopeptidase N</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Intercellular adhesion molecule 1</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">acute effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Acute Liver Failure</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Integrin alpha-5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Integrin alpha-5</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Low-density lipoprotein receptor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">disorder</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nucleic acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">viability</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glucose-6-Phosphatase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glucose-6-Phosphatase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Viral infection</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glycogen storage disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nucleic acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nucleic acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">processed proteins &amp; peptides</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">viral infection</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">virological effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Viruses</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">infectious disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polypeptide</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">processed proteins &amp; peptides</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">translation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Acute hepatic failure</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fibrinogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fibrinogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fructose intolerance</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hereditary fructose intolerance</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Peroxisomal disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Phenylketonuria</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug carrier</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fibrinogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glycosylation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glycosylation reaction</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hereditary fructose intolerance syndrome</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hormone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hormone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lipid metabolism</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">osteocyte</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Alagille syndrome</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Autoimmune hepatitis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Biliary Liver Cirrhosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cholangitis sclerosing</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Congenital absence of bile ducts</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">End Stage Liver Disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Fibrosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Gilbert Disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Gilbert syndrome</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hemochromatosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hemophilia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hemophilia A</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hepatolenticular Degeneration</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hyperlipoproteinemia Type II</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Lysosomal storage disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Organic aciduria</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Porphyria</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Porphyrias</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Transferrin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Transferrin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Type IIa hyperlipidaemia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Wilson disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">abnormality</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Toxicity style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">acute liver failure</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">adipocyte</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">biliary atresia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbohydrate metabolic process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chronic liver failure</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cirrhosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cirrhosis of liver</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">complement effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">familial hypercholesterolemia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">mitochondrial disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">organic acidemia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">protein metabolic process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">receptors</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">receptors</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sclerosing cholangitis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Toxicity style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">toxicity test</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">transferrin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Biliary cirrhosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Coagulation factor IX</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Coagulation factor deficiency</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hepatitis C</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Reye syndrome</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alpha 1-Antitrypsin Deficiency</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aminoacidopathy</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Toxicity style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chemical toxicity</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cholangitis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug metabolism</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">effect on cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gallstones</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hepatitis A</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hepatitis B</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">peroxisomal effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">primary sclerosing cholangitis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">protein synthesis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sarcoidosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">transcription</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">transcription</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">vaccine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">viral genome replication</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Acetyl-CoA carboxylase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Acetyl-CoA carboxylase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Alcohol dehydrogenase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Alcohol dehydrogenase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Arginase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Arginases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Argininosuccinate synthases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Argininosuccinate synthases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Biotin carboxylase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cytochrome P-450 Enzyme System</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cytochrome P-450 Enzyme System</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Factor IX</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Factor XIII</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ferritin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ferritin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ferritin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glutamate dehydrogenase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hepatic steatosis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">N-acetyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ornithine carbamoyltransferase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ornithine carbamoyltransferase, mitochondrial</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">PO4</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Pyruvate Kinase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Pyruvate Kinase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbamoyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbohydrates</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell function</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dietary fatty acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dosage form</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">factor ix</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">factor xiii</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fatty acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fatty acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glutamine synthetase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">replicative effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">translation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glucokinase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glucokinase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glycogen Synthase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-glutamic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Succinate Dehydrogenase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Succinate Dehydrogenase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cholelithiasis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glutamate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glutamine synthetase</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">LDL Lipoproteins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">LDL Lipoproteins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Argininosuccinic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Copper-Transporting ATPases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Lyases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Lyases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Transferases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Transferases</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fatty acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">urea cycle</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Actins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">abstract</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Actins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">abstract</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.13053756" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.13053756" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=288594518" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>